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The reproductive endocrinology of the cow during the oestrous cycle and 
early pregnancy has been reviewed, with emphasis on progesterone and how its 
measurement in milk may be used to improve reproductive performance.
Competitive colorimetric enzyme immunoassays (EIAs) performed in microtitre 
plate wells were developed, enabling progesterone concentrations in 
unextracted milk samples to be determined.
Dicyclohexylcarbodiimide/N-hydroxysuccinimide or disuccinimidyl carbonate 
was used to synthesize N-hydroxysuccinimide esters of progesterone deriv­
atives: these enabled formation of enzyme-labelled steroids in a more 
efficient manner than conventional procedures.
Poor sensitivity was observed with seven anti-progesterone lla-hemisuccinate 
antisera when lla-hemisuccinate, lla-hemimaleate or 3-carboxymethyloxime bridges 
were used to link progesterone with the enzyme label: this problem of bridge 
recognition was greatly reduced when the lla-glucuronide bridge was employed. 
Penicillinase as label provided more sensitive EIAs than alkaline phosphatase, 
peroxidase or 8-galactosidase but alkaline phosphatase offered practical advantages.
The heterologous EIA finally adopted employed progesterone lla-glucuronide- 
alkaline phosphatase as label, with progesterone lla-hemisuccinate antibody.
Assay sensitivity was similar to RIA, with a limit of detection of 5pg and 
50% label displacement with 24pg progesterone. Analytical recovery,linearity 
of response and precision of the assay also compared favourably with RIA.
Results of EIA of milk samples showed good correlation with determinations 
made after isolation of progesterone by HPLC (r = 0.910) and with deter­
minations by RIA (r = 0.933 ).
The assay enabled accurate monitoring of corpus luteum function in 
dairy cattle. This allowed insemination to be performed without the need 
for observation of behavioural oestrus or reduction of the pregnancy rate. 
When used for pregnancy testing, good correspondence was found with results 
derived from RIA performed in a commercial laboratory. Positive pregnancy 
tests by EIA proved 94% accurate when compared with diagnosis by palpation 
per rectum and in a separate study 93.5% were confirmed as correct according 
to calving dates.
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GLOSSARY
AI Artificial insemination
BSA Bovine serum albumin
Bg The quantity of labelled analyte bound to antibody in the absence
of competing analyte.
B5 0/B0 The quantity of labelled analyte bound to antibody in the presence
of 50pg of competing analyte relative to B^.
CV Coefficient of variation
ED__ The dose of analyte effective in reducing B by 50%
50 U
HPLC High pressure liquid chromatography
OD Optical density
ODS Octadecyl silica
ovX milk Milk taken from an ovariectomized cow
s.d. Standard deviation
uv Ultraviolet
CBC Ministry of Agriculture Fisheries and Food, Cattle Breeding Centre,
Shinfield, Reading
IRAD Institute for Research on Animal Diseases, Compton
NIRD National Institute for Research in Dairying, Shinfield, Reading
GUILDHAY Guildhay Antisera, University of Surrey, Guildford
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CHAPTER 1: 
GENERAL INTRODUCTION
1.1. THE IMPORTANCE OF MILK PROGESTERONE ASSAY IN THE MANAGEMENT OF 
REPRODUCTION IN DAIRY CATTLE.
The development of radioimmunoassay (RIA, Berson & Yalow, 1959; Ekins 
1960) heralded a revolution in the field of endocrinology by 
introducing a simple and accurate technique for determination of protein 
and polypeptide hormone concentrations in large numbers of blood samples.
This in turn enabled detailed studies of hormone secretion patterns to 
be made.
Although the potential of RIA in the steroid hormone field was not 
realised until several years later (Murphy, 1967; Abraham, 1969) it 
became and is still the most widely used technique for their detection 
(van der Molen, 1979) and has proved invaluable in elucidating the 
mechanisms involved in regulating the reproductive process of many species.
It has thus become possible to place our basic understanding of the 
secretion patterns and concentrations of the ovarian steroid hormones in 
blood in the context of ovarian status and the control of the oviducal 
and uterine environment. This has allowed various aspects of reproduc­
tive performance of individual animals to be assessed, provided 
a basis for the identification of major causes of sub-fertility and enabled 
the diagnosis and assignment of treatment for specific reproductive problems.
The cyclic rise and fall of progesterone in the blood of cows over the 21 
day period of the oestrous cycle directly relates to the functional status 
of the corpus luteum, the cycle ceasing and levels remaining high in the 
event of pregnancy. The quantitation of progesterone in the milk of dairy 
cows(Laing& Heap, 1971) by RIA has enabled a particularly valuable extension 
of such observation to be made (see Pope & Swinburne, 1980) since its 
concentration closely reflects that in plasma (Heap, Gwyn, Laing & Walters, 
1973; Hoffman & Hamburger, 1973) and samples may be simply and routinely 
taken by stockmen during milking.
In practice, however, there are severe limitations on the use of RIA
procedures for the rapid and routine monitoring of ovarian function in 
cattle and other domestic species in order to improve the management of 
reproduction. The performance of RIA requires technical expertise and the 
use of expensive equipment and reagents and radioisotopic health hazards 
restrict its use to licensed specialised laboratories. Thus although 
determination of progesterone concentrations in milk by RIA has provided 
a practical research tool in the investigation of ovarian function in 
herds and in individual cows (Hoffmann, Gunzler, Hamburger & Schmidt, 1976 
Lamming & Bulman, 1976; Foote, Oltenacu, Kummerfeld, Smith, Riek & Braun, 
1979; Ball & Jackson, 1979) its full potential remains untapped. The 
potential for management of reproduction can only be realised through a 
test capable of being performed locally, either in a veterinary laboratory 
or on-farm. Such a test must be safe, simple and rapid, with results 
available within a few hours as well as being cheap, since the resulting 
economic benefit, though considerable, is finite.
RIA by its very nature cannot fulfill these criteria and as a result 
commercial application of progesterone determination in milk has remained 
restricted to the provision of a postal pregnancy testing service. This 
application is of limited value since it does not enable animals which 
have not conceived to artificial insemination to be identified before the 
next oestrus and thereby precludes repeat insemination at that oestrus.
The economic value to the dairy farmer of a test fulfilling the above 
criteria may be summarised by its potential to reduce the calving index 
(the mean period between calvings of all the cows in a herd) and tighten 
calving patterns (defining and shortening to a few months the period over 
which all cows in a herd calve). It is well established (Esslemont, 1982) 
in the UK that effecting a calving index of 365 days enables substantial 
economic benefit to be achieved from increased milk and calf production: 
tight control of the calving period further ensures that maximum milk 
production coincides with the highest price for that commodity. The value 
of shortening the calving index is clear given that the mean calving index
in the UK is between 381-385 days (Warren, 1984): the financial consequences 
of failure to achieve the optimum index have recently been described by 
Baillie (1982).
The optimum index may be attained by reducing the number of unobserved 
and incorrectly identified oestrus events, by early identification of 
inseminated but non-pregnant cows and identification and treatment of 
subfertile individuals. Although all these measures are possible through 
the use of a programme of progesterone determinations in milk such 
applications have not hitherto been widely practised.
Additional applications of a suitably simple progesterone assay exist 
in research projects where large numbers of samples are required to be 
assayed. These may include investigation of the occurrence of early embryo 
death and the efficacy of hormone treatment in improving fertility and 
oestrous synchronisation regimes. Embryo transfer programmes would benefit 
since it is important to establish the stage of the oestrous cycle of both 
the donor and the recipient.
The elements of a cheap and easily performed test exist in enzymeimmuno­
assay (EIA). Published EIA techniques are, however, far from ideal since 
they offer no particular advantages of speed or convenience over RIA and 
have only been applied to the assay of extracted serum samples. In its 
potential, EIA possesses all the advantages of RIA in terms of sensitivity 
and specificity without the hazards of radioactive isotopes and the 
necessity for expensive counting equipment. The possibility of achieving 
a colorimetric end-point sets EIA aside in its advantage over many other 
immunoassay procedures since this could enable the visual assessment of 
analyte concentrations, an ideal for a simple on-farm test.
1.2. THE DETECTION OR SYNCHRONISATION OF OESTRUS AND THEIR IMPORTANCE IN
THE EFFICIENT MANAGEMENT OF HERDS USING ARTIFICIAL INSEMINATION (AI).
In the United Kingdom 78% of cows are bred by artificial insemination 
(Anon, 1982) and since pregnancy rates (calving rates) are generally in
the range 50-60% (Laing, 1970; Anon 1977) many cows have to be inseminated 
a second time at an interval of 21 days (the length of the 
oestrous cycle). Since AI eliminates nature’s means of ensuring that 
the timing of introduction of spermatozoon to ovum is optimum for 
fertilization, its successful use is almost totally dependent upon 
good oestrus detection by the stockman. The economic importance of 
this in seasonally calving dairy herds in particular is considerable 
(Esslemont, 1982): when oestrous detection is poor calving to conception 
intervals are extended, conception rates lowered, calving patterns scattered 
and a high culling rate for infertility often results. The mean duration of 
pregnancy in cows is 282 days (Hansel & McEntee, 1977) and if a calving 
interval of around 365 days is not maintained (i.e. conception not achieved 
within 85 days postpartum) losses may be made by the farmer in terms of 
decreased milk production: in the UK for 1982 this was estimated to be of 
the order of £2 .0 0  per cow for each day the cow is not pregnant beyond this 
target (Baillie, 1982).
1.2.1. The Timing of Insemination
In the cow and heifer, there is considerable variation in the timing and 
duration of oestrus and of the intensity of oestrous behaviour (Asdell, 
1964). In heifers, 85% of cycles are between 18 and 22 days in length (mean 20 
days) , while in cows, 84% fall between 18 and 24 days (mean 21 days) . The mean 
duration of overt oestrus as reported by several authors varies between 9.3 ± 2.3 
and 19. 3 ± 2. 3 hours (see Esslemont & Bryant, 1974), the variation reported 
probably reflecting the relative frequency (1 2) or infrequency (2 ) of 
observations made per day and which signs were considered as indicative of 
heat (0’Farrel, 1982). The study of Esslemont, Glencross, Bryant & Pope, 
(1980) involving 24 heifers in which observations were made day and night 
for 24 days indicated a duration of 10 hours. 0 ’Farrel (1984) subsequently 
reported that duration was not affected by herd size (range 46 - 120 cows) 
and that 23.3% of oestrous periods were of four hours duration or less.
Ovulation occurs about 14 hours after the end of the oestrus period and 
again there is much individual variation: in relation to the LH peak, 
however, its timing is not so variable and occurs about 25 hours after 
peak concentrations have been attained (mean ± sd = 25.7 ± 6.9hrs;
Scharas et at, 1977). Maximum fertility is achieved when AI is performed 
between the middle and the end of the oestrous period (Trimberger, 1948; 
Roberts, 1971). Based on the findings of Trimberger (1948) the recommended 
practice for AI in Britain is for insemination on the same day if oestrus 
is observed during the morning or early the following morning if observed 
during the afternoon. Although precise data regarding the viability
in vivo of spermatozoa and ova are difficult to obtain, it has become
axiomatic that both are incapable of retaining full viability and fertility 
in the female tract for much longer than 24 hours (Austin, 1969).
Inaccurate diagnosis of oestrus can lead to AI at a time too early for 
survival until ovulation occurs and conversely, if too late, at a time 
when the ovum is no longer viable.
1.2.2. Oestrous Behaviour and the Detection of Oestrus
Oestrus is in theory well defined and characterized in terms of 
intensified behavioural traits occuring over a short period before 
ovulation, the components of which include aggression (butting), investi­
gation (sniffing, rubbing, licking, chin-resting and orientation), 
disordered mounting (mounting without standing and disorientated mounting) 
and mounting with standing (Esslemont, Glencross, Bryant & Pope, 1980).
In practice, however, it is hindered by a number of factors. From the 
herdsmans point of view, the best single criterion for oestrus is to see 
a cow stand and allow mounting by other animals (Esslemont, 1974a; Foote, 
1975; Kiddy, 1979). Since not all animals show this clear cut "behavioural 
oestrus" and a proportion may not be observed (for instance at night) 
clearly its detection does not enable all cows to be artificially 
inseminated at the earliest appropriate time.
Williamson, Morris, Blood, Cannon & Wright (1972a) using continuous 
observation found that this "standing" behaviour was only 79% accurate 
when compared with palpation of follicles per rectum: other outward signs 
of oestrus such as mounting of other cows, ruffling of rump hair and 
abrasion of rump skin, vulval relaxation, moistness and erythema, oestrual 
mucus from the vulva and sensitivity to palpation of the rump were much 
less reliable as sole indicators of oestrus.
In temperate regions there is a tendency for oestrus to occur during 
the evenings and at night rather than in the day (Esslemont & Bryant,
1976; O'Farrel, 1982) making oestrous observation during normal working 
hours difficult. Observations may be further hampered in autumn calving 
herds because the conception period should by definition be during the 
autumn and winter months when the influence of colder weather, shorter 
days and a fall in nutritional status result in attenuated oestrous 
behaviour which is of shorter duration (see De Kruif, 1978).
The oestrus detection rate may be particularly low during the early 
postpartum period since there is an associated high incidence of "silent 
oestrus" related particularly to the first postpartum ovulation (Morrow, 
Roberts & McEntee, 1969a; King, Hurnik & Robertson, 1976; Lamming & Bullman, 
1976; Greve & Lehn-Jensen, 1980; Karg, Claus, Giinzler, Rattenberger 8s 
Pirchner, 1980; Ball 8s Lamming, 1983) and as a result there is considerable 
variation in the interval between calving and the first observed oestrous 
period (Morrow, Roberts 8s McEntee, 1969b). Hartigan, Langley, Nunn &
Griffin (1974) found a mean interval of 48 ± 22 (mean ± sd) days and 
observed that ovulation (deduced following palpation per rectum of a 
corpus luteum) occured in 58% of animals prior to the first oestrus.
Although there is little doubt that silent oestrus occurs,in general 
terms its incidence is considered by many to be over-estimated and to be 
more a reflection of the accuracy of heat detection and the infrequency 
of observations (Zemjanis, Fahning 8s Shultz, 1969; Williamson, Morris, 
Blood, Cannon 8s Wright, 1972b; Esslemont, 1973; McCaughey 8s Cooper, 1980;
Oltner & Edqvist, 1981; Henriksen, Andersen, Nielsen, Pedersen & Koefoed- 
Johnsen, 1982).
It has now been indicated that a substantial proportion of animals which 
fail to conciedye to AI may do so through incorrect diagnosis of oestrus 
(Williamson et at, 1972b): estimates were between 12 to 36% as determined 
by independent observation and 17% as indicated by determination of 
progesterone concentrations in milk (section 1.2.3., p 1.11) at AI 
(Appleyard §z Cook, 1976; McCaughey & Cooper, 1980).
In 1981/82, 78.2% of UK dairy cattle were artificially inseminated 
(Anon, 1982) for which accurate detection is necessary if conception is 
to result. It has been demonstrated by numerous authors, however, that on 
many dairy farms about 50% of oestrous periods are not detected (Bozworth, 
Ward, Call & Bonewitz, 1972; Esslemont, 1974a; Barr, 1975; King, Hurnik & 
Robertson, 1976).
Taken together, these findings indicate that even under ideal conditions 
behavioural signs alone are inadequate for the detection of all oestrous 
periods. In order to maintain a tight calving pattern and a mean calving 
interval within 365 days it is most important to serve a high proportion 
of cows from the earliest possible date postpartum (MacMillan & Watson, 
1973; O'Farrell, 1975; Esslemont, 1982): given the elapse of 35-40 day 
period to achieve uterine involution and resumption of normal fertility 
(Lamming & Bulman, 1976) this allows for three inseminations to be performed, 
if necessary, within the 85 day period. In order to take maximum advantage 
of these opportunities it is apparent that means of oestrus detection other 
than or additional to behavioural observations are required.
1.2.3. Oestrus Detection Aids
Numerous aids to oestrus detection have been devised, used and assessed 
in field trials although the majority have proved of equivocal value in 
practice. They appear to offer, at most, equal detection rates to 
behavioural observations: their failings appear to be due either to
technical problems or variability or insensitivity of response. Such methods 
include the use of chalk or crayon marks, tail paint or pressure sensitive 
devices to determine whether the cow has been mounted (Foote, 1975; Kiddy, 
1979; Ducker, Haggett, Fisher, Bloomfield 8s Morant, 1983; Kerr 8s McCaughey, 
1984). The fitting of chin devices to hormonally treated cows or steers or 
bulls with surgically diverted penises has provided a means of marking the 
oestrus cow when mounted by the treated animal (Hurnik, King 8s Robertson, 
1975; McDonald, Foote, Drost, Lu, Potrascu 8s Hall, 1976; Britt, 1980). 
Videotapes and pedometers have been used to show the increase in physical 
activity (Kiddy, 1977; Holdsworth 8s Markillie, 1982; Lewis 8s Newman, 1984) 
and probes and transducers to indicate changes in electrical resistance 
associated with the changing biochemical composition of vaginal mucus 
(Leidl 8s Stolla, 1976; Foote, Oltenacu, Mellinger, Bean, Scott 8s Marshall, 
1979; Foulkes, Hartley 8s Stewart, 1981) or changes in body or milk 
temperature (Ball, Morant 8s Cant, 1978; Kiddy, 1979; Schlunsen, Schon, 
Artman, Paul & Speckman, 1981; Lewis 8s Newman, 1984) around oestrus. Dogs 
trained to respond to specific odours of cows or their milk indicative of 
the oestrous period have also been used as a means of oestrus detection 
(Kiddy, Mitchell, Bolt 8s Hawk, 1978; Hawk, Conley 8s Kiddy, 1984) .Demise of 
the corpus luteum at the end of the oestrous cycle results in a dramatic fall 
in progesterone concentration in blood and milk over a short period approxi­
mately 3 days before ovulation and is a pre-requisite for oestrus to occur. 
Its measurement thus provides a near ideal method of predicting oestrus 
and the optimum time for AI and additionally it provides an aid for the 
diagnosis of ovarian dysfunction. Although progesterone determination by 
RIA has been used in a number of studies as a definitive and objective 
means of retrospectively assessing the accuracy of oestrus detection 
(Bulman 8s Lamming, 1978; Appleyard 8s Cook, 1976; Hoffmann, Giinzler,
Hamberger & Schmidt, 1976; McCaughey 8s Cooper, 1980) only in one study 
(Ball 8s Jackson, 1979) was it used in this predictive sense. The latter 
study indicated that although a highly effective means of determining the
timing of AI without recourse to behavioural observations a more rapid and 
simple procedure would be required for it to be of value in farm practice.
The value and potential of this approach will be discussed and illustrated 
further in section 1 .6 .
1.2.4. Oestrus Synchronisation
Alternatives to the determination of the oestrous period or the prediction 
of its occurrence to enable AI to be correctly timed have been developed. 
These involve hormonal treatments aimed at regulating the timing of 
oestrous cycle events in such a way that ovulation will occur at a 
predictable time following treatment or withdrawal of treatment: large 
numbers of animals can thus be synchronised and AI performed at a 
predetermined time without the necessity for oestrus observation.
Two methods (of which there are numerous variants) have been developed 
enabling cycle synchronisation and fixed time AI. The first is to treat 
all cattle with a progestational compound to inhibit oestrus and ovulation 
for sufficient time to allow regression of the corpora lutea of all animals 
(Hansel & Malven, 1960; Hansel & Beal, 1979). In theory, following with­
drawal of the compound all animals will come into oestrus and ovulate 
at a similar time. The second method involves induction of luteolysis 
in cows in the luteal phase by injection of prostaglandin F2U (or an 
analogue) followed by insemination at oestrus or 3 and 4 days later 
(see Roche, 1979).
Although promising for simplifying dairy herd breeding management and 
circumventing the need for oestrous detection both treatments have given 
rise to problems in practice.
In earlier studies, progesterone or synthetic prostagen were 
administered by a variety of methods including orally in water or food, 
silastic implant or vaginal pessaries. Treatments were for periods of ‘ 
18-20 days and although providing a good degree of oestrus synchronisation 
resulted in lower conception rates than untreated controls (Hansel, 1965;
Roche, 1974a). This may be due to formation of abnormal ova (van Niekerk 
& Belonje, 1970) or interference with the early cleavage stages of 
embryonic development and may also be associated with asynchrony between 
the conceptus and the uterine and oviductal environment (Wishart & Young, 
1974; Hansel & Beal, 1979). Both proestrous plasma progesterone and 
oestrogen concentrations are altered from the normal by the treatments 
(Britt& Ulberg, 1972; Henricks, Hill&Dickey, 1973). Reduction of the period 
of treatment to 9 or 12 days improved conception rates to a level 
comparable with the controls but gave rise to less effective synchroni­
zation and a poor oestrus response (Roche, 1974b). Combination of the 
short treatment with the use of a luteolytic agent such as oestradiol 
valerate (Wiltbank, Sturges, Wideman, Le Fever & Faulkner, 1971) or 
prostaglandin F2d (Thimonier, Chupin & Pelot, 1975; Chupin, Pelot & Mauleon, 
1977) appeared to resolve this problem since it gave rise to a high 
incidence of observed oestrus and conception rates comparable with 
untreated controls. The degree of synchronization achieved by the latter 
protocol shows promise for effective fixed time AI since pregnancy rates 
(by rectal palpation) at 45-60 days were higher (6 6%) than 
following two prostaglandin injections (52%) and compared with a pregnancy 
rate of 73% for control animals (Smith, Pomerantz, Beal, McCann, Pilbeam 
& Hansel, 1984).
Synchronization methods using prostaglandin treatment alone need to 
take account of the inability of this treatment to cause luteolysis while 
the corpus luteum is developing, i.e. during the first five days of the 
oestrous cycle (Rowson, Tervit & Brand, 1972). To ensure that all animals 
are synchronized by this treatment numerous treatment protocols have been 
devised (see Roche, 1979).
The most common protocols involve single or double prostaglandin 
treatments. Two prostaglandin F2CI (or analogue) injections at 11 or 12 
day intervals may be used followed by insemination at ensuing oestrus 
or 72 and 96 h after the second injection. Alternatively, close
observation for oestrus and insemination over a five day period enables 
treatment of all remaining animals with a single injection of prosta­
glandin F201 on day 5: insemination may then be performed following 
observation of ensuing oestrus or 72 and 96 h after treatment (Hansel & 
Beal, 1979). Although in particular circumstances good synchronization 
may be achieved and normal fertility rates obtained using a single 
insemination 72 h after treatment (Lamming, Hafs & Manns, 1975) a reduced 
fertility rate has been noted by others (Cooper, Hammond, Harker & Jackson, 
1976; Roche, 1979). In maiden heifers it appears that an insemination at 
72 and 96 h gives normal fertility rates in most cases (see Roche, 1979).
In dairy cows, however, synchronization using prostaglandin treatment 
has proven far more problematic and the efficacy of the 11 day double 
injection regime has been held in question (deKruif, Zikken, Kommerij & 
de Bois, 1976; Macmillan, Curnow & Morris, 1977) since lower conception 
rates result. This may possibly be due to greater variation in the timing 
of onset of oestrus and ovulation due to incomplete luteolysis or, once 
luteolysis has occurred,to prolongation of the follicular phase (Roche, 
1979; Baishya, Ball, Leaver & Pope, 1980). This indicates that a longer 
interval between injections (13 days) may be beneficial (Chupin, Pelot & 
Mauleon, 1978). Certainly a critical factor is ensuring that only cyclic 
animals are treated: this applies particularly to cows since this can not 
be ensured for a period of at least 42 days post-partum (Macmillan et al, 
1977; Roche & Prendiville, 1979; Ball & Lamming, 1983).
As with oestrous cycle control methods using progesterone treatment, 
highest pregnancy rates are achieved with dairy cows when insemination 
is performed at observed oestrus rather than at a fixed time (Schultz,
1978; Hyttel & Greve, 1983; Ball & Jackson, 1984) and thus these 
procedures have not yet obviated the necessity for oestrus observation.
1.3. HORMONAL EVENTS ASSOCIATED WITH THE BOVINE OESTROUS CYCLE AND
EARLY PREGNANCY.
1.3.1. The Bovine Oestrous Cycle
Events associated with the onset of breeding activity and the oestrous 
cycle in cows have been the subject of numerous reviews (Cupps, Anderson.
& Cole, 1969; Robinson, 1977; Hansel & Convey, 1983).
The onset of puberty in heifers occurs between five months and two 
years after birth (Hammond, 1927; Asdell, 1964). Its timing appears to be 
more closely related to achievement of a particular body size than to the 
absolute age of the animal: under good nutritional conditions a heifer 
will attain puberty at approximately two-thirds adult size (Robinson,1977).
With the onset of puberty, heifers exhibit oestrous behaviour (heat) 
for the first time (i.e. standing to be mounted or mounting other cattle) 
the behaviour being of variable duration. The subsequent recurrence of 
oestrus at mean intervals of 2 0 days (2 1 days in cows) is called the 
oestrous cycle: in temperate climates cycles occur continuously (poly­
oestrus) independent of season and normally cease only in the event of 
pregnancy (Asdell, 1964). The period of oestrous behaviour (day 0 of the 
oestrous cycle) corresponds with peak secretion of oestradiol-173 by the 
developing follicle prior to ovulation (Glencross et at, 1973). The 
release of LH by the pituitary results in ovulation, typically 12-14 h 
after the onset of oestrus. Since the release of LH occurs in the absence 
of external stimuli, ovulation is referred to as spontaneous. Only one 
follicle normally develops to the stage of ovulation (mono-ovulatory) and 
following ovulation luteinization and proliferation of the granulosa and 
thecal cells of the ruptured follicle give rise to the corpus luteum and 
thus to the secretion of progesterone: in the event of pregnancy the 
corpus luteum and associated progesterone secretion are maintained to 
term. If the animal does not become pregnant regression of the corpus 
luteum (luteolysis) occurs between days 17-19 of the cycle, a new follicle
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Fig. 1.1. Schematic representation of concentrations of a) progesterone, 
oestradiol-173 and LH in plasma during the oestrous cycle and b) progesterone 
in whole milk after parturition and during the early stages of pregnancy of 
the cow.
develops to ovuiation ana tne cycle continues (Fig. 1). The measurement 
of progesterone concentrations in plasma (Robertson & Sarda, 1971) or 
milk (Laing & Heap, 1971) at a fixed time following insemination has 
thus provided a means of testing for pregnancy in cattle.
1.3.2. Hormonal Control of the Oestrous Cycle
Ovarian events during the oestrous cycle may be conveniently divided 
into three periods in relation to the nature of hormonal control, folli­
cular development and ovulation, corpus luteum formation and luteolysis.
a) Follicular development and ovulation
During the period of follicular development, ovarian oestradiol-173 
secretion increases (Glencross, Munro, Senior & Pope, 1973; Hansel, 
Concannon & Lucaszewska, 1973), reaching a peak at oestrus: the rising 
levels of oestradiol-173 are thought to provide the stimulus which 
triggers the ensuing surge in concentrations of the gonadotrophins, 
luteinizing hormone (LH; Beck & Convey, 1977) and follicle stimu­
lating hormone (FSH; Martin, Henricks, Hill & Rawlings, 1978) 
which have been shown to occur around the onset of oestrus (Akbar, 
Reichert, Dunn, Kaltenback & Niswender, 1974). Progesterone would appear 
to have a negative feedback effect on gonadotrophin release, however, and 
thus surges of FSH and LH can only occur following a substantial reduction 
of circulating progesterone concentration such as normally occurs with 
luteolysis (Chenault, Thatcher, Kalra, Abrams & Wilcox, 1975; Kesner,
Convey & Anderson, 1981). During this period, LH, characterized by the 
pulsatile nature of its release, is secreted with increased frequency 
resulting in overall increased circulating concentrations (Rahe, Owens 
Fleeger, Newton & Harms, 1980) and may be responsible for 
stimulation of oestradiol-173 secretion from the pre-ovulatory follicle 
(Hansel & Convey, 1983). A mechanism whereby LH and FSH may work in concert 
to induce oestrogen synthesis in these follicles has been proposed in 
which LH stimulation of androgen synthesis by the theca interna occurs: 
the thecal cells are incapable of androgen aromatization and transference
of androgen to the granulosa cells occurs where oestrogen is synthesized 
under stimulation from FSH (Hansel & Fortune, 1978; Hansel & Convey, 1983).
As the follicle grows into a vesicular pre-ovulatory follicle the 
increasing LH influence may result in stimulation and luteinization of 
the follicle. This may be inhibited by the presence, within the follicle, 
of a"luteinization inhibitor" (Bernard, 1975). The LH surge is probably 
responsible for the removal of this inhibitory effect and results in 
oocyte maturation, ovulation following about 24 h after the LH peak 
(Thibier, 1976; Schams, Schallenburger, Hoffman & Karg, 1977).
The release of LH from the anterior pituitary is induced by the 
pulsatile release of the decapeptide gonadotrophin releasing hormone 
(GnRH) from the hypothalamus. In vitro the pituitary shows a marked 
increase in sensitivity to GnRH during the pre-ovulatory period due to 
high oestradiol-178 levels (Padmanabhan, Leung & Convey, 1982). It has 
been shown that both an increase in GnRH secretion and in pituitary 
responsiveness to it are necessary for the pre-ovulatory LH and FSH 
surges (Kesner & Convey, 1982). The termination of the surges appears to 
result from the refractoriness of the pituitary to GnRH (Kesner8s Convey, 
1982) rather than the depletion of gonadotrophin content (Convey, Kesner, 
Padmanabhan, Caruthers & Beck, 1981). Following the LH surge, LH, FSH 
oestradiol-178 and progesterone concentrations in blood are basal (see 
Hansel & Convey, 1983). Approximately 24h following the pre-ovulatory 
gonadotrophin surge a significant rise in FSH concentration occurs 
(Dobson, 1978; Ireland & Roche, 1983) which may play a role in recruit­
ment of pre-antral follicles for the next cycle.
b) Corpus luteum formation
The luteinization and growth of granulosa and thecal cells following 
ovulation results in formation of the corpus luteum (Hansel, Concannon 
& Lukaszawska, 1973) which reaches its mature size by day 7 of the cycle 
(Hammond, 1927). A large follicle develops concurrently and with this 
(Matton, Adelakoun, Coutre & Dufour, 1981; Ireland & Roche, 1983) the
oestrogen concentration in blood rises to a peak at day 6 (Glencross et at, 
1973; Glencross 85 Pope, 1981). The post-ovulatory increase in FSH may play 
a role in this development along with a secondary but slightly later rise 
in LH concentrations (Dobson, 1978). Neither FSH, LH or oestradiol rise 
to concentrations associated with the pre-ovulatory period and the 
follicle, failing to develop to ovulation, becomes atretic. It is thought 
that further increases in gonadotrophin secretion and follicular develop­
ment are inhibited by negative feedback of progesterone produced by the 
developing corpus luteum (Glencross, 1982).
LH is believed to be the main luteotrophic hormone in the cow, prolactin 
having no direct luteotrophic effect (Hansel, 1967; Hansel et at, 1973; 
Hoffman, Schams, Bopp, Ender, Giminez & Karg, 1974). It acts after binding 
to receptors in the corpus luteum cell membrane through intra-cellular 
stimulation of the "second messenger", cyclic AMP (Sutherland, Butcher, 
Robinson & Hardman, 1967). The latter activates intra-cellular protein 
kinase which in turn stimulates the steroidogenic enzymes (Marsh, 1976;
Ling & Marsh, 1977).
The progesterone and 208-dihydroprogesterone content of the corpus 
luteum (Hafs & Armstrong, 1968) and progesterone concentrations in 
peripheral blood (Glencross et at, 1973; Hansel et al, 1973) continue to 
rise during the luteal phase, reaching a maximum 1 0 -1 1  days after oestrus. 
Degenerative changes become apparent by day 17-19 (Mares et al, 1962) if 
the cow is not pregnant, the subsequent drop in peripheral progesterone 
concentrations permitting the development of a new follicle to ovulation. 
The source and nature of the signal initiating the onset of luteolysis 
is yet to be fully established. 
e) Luteolysis
It has been demonstrated that the uterus controls the lifespan of the 
bovine corpus luteum and is responsible for the induction of luteal 
regression during the cycle since hysterectomy leads to prolongation of 
the luteal phase (Wiltbank & Cassida, 1956; Malven & Hansel, 1964).
Indeed the induction of luteolysis is specifically related to the uterine
horn ipsilataral to the corpus luteum since unilateral hysterectomy 
results in maintenance of a corpus luteum of an ipsilateral but not a 
contralateral ovary (Mapletoft, Del Campo & Ginther, 1976).
One view of the physiological mechanism of luteolysis revolves around 
the possibility of transfer of a luteolysin via the uterine vein to the 
ovarian artery by a counter-current transfer process as originally 
demonstrated for sheep (McCracken, Carlson, Glew, Goding, Baird, Green 
& Samuelsson, 1972). Such a mechanism is made possible because the ovarian 
artery convolutes around and closely adheres to the walls of the utero- 
ovarian vein and at the area of contact the walls of the vein and the 
artery are very thin: various surgical re-arrangements of the vein and 
artery have provided evidence for such a mechanism (Ginther, 1974, 1981; 
Hixon 8s Hansel, 1974; Mapletoft et al, 1976). More recent evidence, again 
obtained from sheep, suggests that counter-current transfer is not the 
only mechanism involved and that the lymphatic drainage system may 
play a role in transport of luteolysin to the ovary (Abdel Rahim, Bland 8s 
Poyser, 1984; Heap, Fleet 8s Hamon, 1985).
A substantial body of information suggests that the luteolysin produced 
by and transferred from the uterus is prostaglandin F201 (PGF£a, Hansel 
et al, 1973; Thibier, 1976; Thatcher Ss Chenault, 1976) or its precursor, 
arachidonic acid (Hansel, 1975). Certainly, administration of PGF201 or 
its synthetic analogues mimics normal functional and morphological luteolysis 
in hysterectomized cows (La Voie, Poncelet, Han, Soliday, Lambert 8s Moody,
1975) and causes premature luteolysis followed by resumption of normal 
cyclicity in intact cows (Hansel et al, 1973). It has further been 
demonstrated that passive immunization against PGF201 can halt luteolysis 
and thus prolong the oestrous cycle (Fairclough, Smith 8s McGowan, 1981).
It has not, however, been adequately demonstrated that simultaneous or 
sequential changes in PGF201 concentrations occur in both uterine venous 
and ovarian arterial blood prior to a decline in ovarian progesterone 
output during the oestrous cycle of normal animals.
The luteolytic effect of PGF201 is thought to be achieved through 
antagonism of the luteotrophic action of LH, possible at the receptor 
level, through inhibition of the adenylate cyclase-cyclic AMP system 
(Henderson 8s McNatty, 1975).
It has been suggested (Thatcher, Wolfsen, Curl, Rice, Knickerbocker, 
Bazer 8s Drost, 1984) that oestrogens may regulate the onset of luteolysis 
through stimulation of uterine PGF201 release since administration of 
free or conjugated oestrogens during the luteal phase shortens the lifespan 
of the corpus luteum but is not effective in hysterectomized heifers 
and elevated levels of uterine PGF2a coincide with the start of the 
pre-ovulatory rise in follicular oestradiol.
With the recent finding that oxytocin may be synthesized in the bovine 
corpus luteum (Wathes & Swann, 1982) renewed attention has been paid to 
its possible role in regulating corpus luteum function. Measurements of 
arterial venous differences in oxytocin concentration across the ovine 
ovary have shown that the corpus luteum can secrete oxytocin (Flint & 
Sheldrick, 1983) and immunizing against oxytocin caused prolong­
ation of the oestrous cycle of sheep (Sheldrick, Mitchell 8s Flint, 1980; 
Scharas, Prokopp 8s Barth, 1983). Experiments, also in sheep, have 
indicated that uterine arterial administration of oxytocin gives rise to 
increased concentrations of PGF20C in uterine venous blood (Roberts 8s 
McCracken, 1976) and that this arises from endometrial tissues (Roberts, 
McCracken, Gavagen 8c Soloff, 1976). Current evidence thus suggests that 
in sheep and possibly in cattle, oxytocin may work through positive 
feedback on PGF201 release from the endometrium to induce a more rapid 
completion of luteolysis (Flint 8s Sheldrick, 1983; Wathes, 1984; Wathes, 
Swann 8s Pickering, 1984).
It has recently been proposed (McCracken, Schramm SsOkulicz, 1984.) that
the timing of this process is strictly regulated by the presence of 
oxytocin receptors in the endometrium, the synthesis of which is 
stimulated by oestradiol-178 and blocked by progesterone during the 
luteal phase. The block ceases after a physiologically defined period 
(for reasons not established) enabling the low levels of oestradiol-178 
present in plasma during the luteal phase to exert their stimulatory 
effect on oxytocin receptor synthesis.
1.3.3. The Maternal Recognition of Pregnancy
Progesterone is essential for the maintenance of all stages of preg­
nancy in the bovine and is provided by the corpus luteum through at 
least the first half of pregnancy.The continued presence of circulat­
ing progesterone is achieved by prolongation of the lifespan of the 
corpus luteum formed in the cycle of conception.The means by which 
the conceptus prevents luteolysis has yet to be fully established and 
is considered in detail in Appendix 1.Evidence that the conceptus may 
exert a direct luteotrophic effect on the corpus luteum is equivocal 
and it may additionally or alternatively exert its influence indirectly 
by reducing uterine prostaglandin F secretion or inducing release 
of an antagonist to its action.It is clear, however,that the mechanism 
must be operative prior to day 17 or the pregnancy will fail.
1.4. THE SECRETION, TRANSPORT AND TISSUE DISTRIBUTION OF PROGESTERONE
1.4.1. The Discovery of Characterization of Progesterone
It became apparent from the beginning of the century that corpora 
lutea of the ovaries of several mammals produced a substance which was 
responsible for the secretory activity of the endometrium and necessary 
for the implantation of the conceptus (Fieser 8s Fieser, 1959). Indeed, 
extracts of sow corpora lutea had been shown to maintain pregnancy in 
ovariectomized rabbits (Allen 8s Corner, 1929; 1930). By 1957 the substance 
involved had also been identified in adrenal (Beall, 1938) and placental 
(Salhanik, Neall, Zarrow 8s Samuels, 1952) tissue and in blood (Short, 1957).
The active principle of the corpus luteum was initially termed 
’'progestin” (Allen, 1930) because of its action but subsequent to the 
isolation and structural determination of the biologically active pure 
crystalline compound (see Allen, 1974; Butenand 8s Westphal, 1974) the
name ’’progesterone” was adopted (League of Nations, 1935) and still is 
the accepted trivial name. 4-Pregnene-3, 20-dione is the currently 
accepted systematic name (IUPAC-IUB, 1967) and its structural formula 
is shown in Fig. 1:2.
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Fig. 1.2. The structural formula of progesterone.
1.4.2. Hormone Function and Control
Hormones provide a biochemical means by which a variety of physiolo­
gical functions are regulated. By definition, they are secreted directly 
into the blood and transported to specific target organs where they 
exert their specific influence remote from their site of production. Thej^  
may, for instance, induce tissue growth, differentiation of cells or 
alterations in their metabolic activity. The target organ itself may be 
an endocrine gland which may in turn release hormones acting on other 
target organs or exert a feedback effect on the gland which stimulated 
its activity: this feedback interaction provides the means by which the 
endocrine system is regulated.
Ovarian steroid hormone production is controlled by a system which in 
its simplest form involves the hypothalmic-pituitary-ovarian axis. Ovarian 
steroid synthesis is stimulated by FSH and LH which originate in the 
anterior pituitary. Their release is in turn stimulated by the release of 
GnRH and may be modulated by feedback from the ovarian steroids. GnRH is 
produced in the hypothalamus and secreted directly into the anterior 
pituitary via the pituitary portal vessel. The control mechanisms involved 
have been reviewed by Hansel and Convey (1983) and are considered further 
in section 1.3.2.
1.4.3. Secretion of Steroid Hormones by the Bovine Ovary
Although a multiplicity of steroids are synthesized by the ovary, some 
only appear to serve as intermediaries in oestrogen biosynthesis. The 
presence of steroids in ovarian vein blood at concentrations higher than 
those in ovarian arterial blood or the systemic circulation has been taken 
to be indicative of ovarian origin. Such steroids include progesterone (Gomes 
& Erb, 1965; Dobrowolski, Stupnicki & Domanski, 1968) and oestradiol-173 
(Nancarrow et al, 1973). Changes in concentrations of plasma progesterone 
and oestradiol-173 during the bovine oestrous cycle are shown in Fig. 1.1.
The main source of oestrogen during the oestrous cycle is the ovarian follicle 
(Saumande & Testart, 1974; Saumande 8s Pelletier, 1975) while progesterone 
produced during the oestrous cycle and pregnancy derives largely from the 
corpus luteum (Pope, Gupta & Munro, 1969; Henricks, Dickey 8s Niswender,
1970). The levels of these hormones in peripheral plasma closely reflects 
the stages of development and regression of these structures (Pope et al,
1969; Henricks et al, 1970; Saumande 8s Testart, 1974; Saumande 8s Pelletier,
1975).
The bovine adrenal is capable of synthesizing and secreting progesterone 
into the peripheral circulation but its contribution is small compared with 
that of the corpus luteum (Wagner, Strohbehn 8s Harris, 1972; Dorfman, 1973; 
Watson 8s Munro, 1984). Although the foeto-placental unit is capable of 
synthesizing progesterone (Dorfman, 1973) the corpus luteum is considered to 
be the main source of progesterone throughout pregnancy (Edqvist, Ekman, 
Gustafsson 8s Lindell, 1973) and removal of the latter prior to day 200-230 of 
pregnancy may result in abortion (McDonald, McNutt 8s Nichols, 1953; Estergreen, 
Frost, Gomes, Erb 8s Bullard, 1967; Wendorf 8s First, 1972).
1.4.4. Transport of Ovarian Steroids
During transport to their respective target organs, only a small proportion 
of the steroid hormones are in free solution. As much as 98% may be bound to 
serum proteins, the most significant of which are albumin (Ka - 1 x 105 M”1) 
and in primates, the steroid binding globulins (Ka - 1 x 1 0 8M~1). The high
binding affinities of the latter ensure preferential binding and are thought 
to prevent indiscriminate exposure of body tissue to high concentrations of 
sex steroids: only cells with high affinity receptors would therefore be 
capable of effective retention (King & Mainwaring, 1974; Westphal, Stroupe & 
Cheng, 1977). The free and bound hormones exist in equilibrium and only the 
free steroid in blood is thought to exert biological activity or to be 
metabolized by the liver. A likely function of the binding proteins, there­
fore, would be to provide an efficient transport mechanism which effectively 
buffers circulating concentrations by reducing metabolic clearance (Clark & 
Peck, 1979).
1.4.5. Tissue distribution of Progesterone and its Mode of Action in the 
Uterus.
Early attempts to demonstrate preferential retention of steroids by target 
organ tissues using radiolabelled tracers were confounded because their 
relatively low specific activity necessitated the use of pharmacological 
rather than physiological doses of hormone. Following the synthesis of 
(3H)hexoestrol, (3H)oestradiol-173 and later (3H)progesterone of high 
specific activity, however, it was shown that the uterus, vagina and pituitary 
retained significant quantities of oestradiol-173 and progesterone against 
a marked concentration gradient (Glascock & Hoekstra, 1959; Jenson & Jacobson, 
1962; Laumas & Farooq, 1966). This finding provided an illustration that 
the proposals of Langley (1905) and Ehrlich (1913) that ’’drugs do not act 
unless they bind” also applied to hormones. Although much of the evidence 
is indirect or circumstantial it is now widely accepted that binding of 
steroid to specific cytoplasmic receptors followed by translocation of the 
steroid-receptor complex to the cell nucleus is a pre-requisite for the 
biological response (see Jensen, Mohla, Gorella, Tanaka & DeSombre, 1972; 
O'Malley & Means, 1974). The role of receptors in steroid hormone action 
has been reviewed recently by Clark 8s Peck (1979), Stormshak (1979) and 
Catelli 8c Mester (1983).
Current descriptions of the action of both progesterone and oestradiol-173 
involve a mechanism in which steroid enters the target cell and is specifically 
bound to a high affinity (Ka lx 109-101°M_1) cytosol receptor. Translocation 
to the cell nucleus is preceded by a change in size of the complex ( 11 transfor­
mation”) : once inside the nucleus binding of the steroid-receptor complex to 
’’acceptor sites” in the chromatin initiates genome transcription allowing 
expression of the particular characteristics of the target cell. This may 
result, for instance, in cell division, the synthesis of specific proteins 
and the secretion of specific products in particular circumstances (King & 
Mainwaring, 1974; Baulieu, Atger, Best-Belpomme et al, 1975).
The process by which the steroid enters the cell may simplistically be 
described by diffusion down a concentration gradient (maintained by removal 
of the free steroid on binding to the receptor). Other processes by which 
this might be more efficiently achieved remain a matter of speculation but 
include (i) the concept of specific accumulation and retention of albumin 
bound steroid by target tissues such as the uterus (Peterson & Spatziani,
1971), (ii) initial binding within the target cell to a receptor of lower 
affinity but higher capacity than the classical cytosol receptor (Clark &
Peck, 1979) or (iii) a mechanism analogous with the low density lipoprotein 
system effective in cholesterol uptake, storage and metabolism, involving 
endocytosis after binding to cell surface receptors (Goldstein 8s Brown, 1977; 
Clark 8s Peck, 1979) .
During the oestrous cycle of mammals, progesterone secretion occurs after 
a period of oestrogen dominance so that it normally acts on an oestrogen-primed 
uterus. Thus the actions of progesterone on the reproductive tract in animals 
during the oestrous cycle cannot be considered in isolation from those of 
oestradiol-173. Morphologically, during the follicular phase when the uterus 
is oestrogen dominated, growth and proliferation of the cells of the endometrium 
are evident (endometrial proliferative phase). Without this phase the endometrium 
is unable to respond to the progesterone secretion which follows ovulation and 
corpus luteum formation. Classically, the oestrogen-primed glandular
epithelium responds to the influence of progesterone by way of secretion 
of histotrophe (endometrial secretive phase) in preparation for the 
arrival of the conceptus. The control over the reproductive tract exerted 
by oestradiol-173 and progesterone has been observed through all stages of 
the reproductive process. This includes the control of transport of the 
fertilized egg to and the timing of its arrival in the uterus (control of 
contractility and |cajlary activity of the oviduct; see Anderson, 1977), 
the production of the oviductal and uterine histotrophe (provision of 
nutrients for the developing conceptus: Finn & Porter, 1975), the development 
of a uterine environment receptive to attachment or implantation of the 
conceptus (Cook & Hunter, 1978; Sauer, 1979) and the maintenance of myometrial 
quiescence until parturition (Catchpole, 1977).
1.5. BIOSYNTHESIS AND METABOLISM OF PROGESTERONE
1.5.1. Ovarian Synthesis and Metabolism of Progesterone
Pathways leading to the production of progesterone from cholesterol in 
the ovary have been established from in vitro studies in which sliced or 
minced ovarian tissue or isolated ovarian compartments have been incubated 
with radiolabelled precursors and the labelled products identified. Four 
types of enzyme are responsible for the synthesis and catabolism of 
progesterone: the dehydrogenases add or remove hydrogen from carbon atoms 
of the steroid nucleus, the hydroxylases add hydroxyl groups to the steroid 
nucleus, the isomerases transfer a double bond between carbon atoms after a 
dehydrogenase has acted and the lyases cause splitting of a side chain or 
loss of methyl groups (Feder, 1981).
The similarity of the enzyme systems involved, their sub-cellular sites 
and their control by the trophic hormones (see section 1,. 3 .2) 
indicate that the same synthetic pathways are operable in the majority of 
steroid producing tissues (Henricks 8s Mayer, 1977) and are outlined in Fig. 1.3 
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(Solod et al, 1966) even though the corpus luteum possesses all the enzymes 
required for de novo synthesis from acetate (Hellig & Savard, 1965) and does 
produce some cholesterol. Its conversion to pregnenolone is brought about in 
the mitochondria by a multicomponent enzyme system which hydroxylates and 
cleaves the side chain between C20 and C22 (Fig* 1.3). The side chain 
cleavage system is membrane bound and thus pregnenolone, when formed, is 
free to traverse the mitochondrial membrane to be utilized for the 
synthesis of hormones by the microsomal enzyme systems.
Pregnenolone is the main precursor for the steroid hormones produced by 
the ovary, adrenal gland and placenta (Henricks 8s Mayer, 1977). The involvement 
of progesterone as an intermediary in the synthesis of the androgens and 
oestrogens, however, will depend on whether the A1* 3-keto (4-en-3 one) 
configuration of progesterone or the A5 33-hydroxy (33-hydroxy-5-en) 
configuration of pregnenolone is maintained (Fig. 1.4) in the so-called A4 
and A 5 pathways-respectively (van der Molen, 1979). In both^cases the enzymes 
associated with transformations to the androgens and oestrogens are found 
in the endoplasmic reticulum. It has been speculated that the enzymes are 
associated in an organized group such that the substrate is exposed to each 
enzyme within the complex in turn and "released" only when the end of the 
pathway is reached (Savard, 1973; Tamaoki, 1973).
1.5.2 .^ li^abolism of Progesterone in the Bovine Ovary
The A5 pathway would appear to provide the predominant anabolic route in 
bovine follicular tissue (Short, 1962; Lacroix, Eechaute & Leusen, 1974;
Mori, 1975). The formation of oestrogens is thought to result from the action 
of the synthetic enzymes of the granulosa or thecal follicular tissue.
The likelihood is that both cell types work in concert (Short, 1964; Lacroix 
et al, 1974) since the thecal cells possess the capability of androgen 
synthesis but not aromatization and the granulosa cells are capable of 
oestrogen synthesis only when provided with aromatizable substrate or 
co-cultured with thecal tissue (Hansel & Fortune, 1978). The corpus luteum,
however, is incapable of production of oestrogens, either from acetate or from 
testosterone since it lacks the 19-hydroxylase-aromatase enzyme complex for 
the conversion of androgens to oestrogens (Savard & Telegdy, 1965). The bovine 
corpus luteum thus produces a more limited range of metabolites than any other 
species studied (Savard, 1973), consisting of progesterone (as the main 
product) 203-hydroxy-4-pregnen-3-one, pregnenolone (Hayano, Lindberg, Wiener, 
Rosencrontz & Dorfman, 1954; Mason, Marsh & Savard, 1962; Axelson, Schumacher, 
Sjovall, Gustafsson & Lindell, 1975) and 17-hydroxyprogesterone (Gomes & Erb, 
1965; Thibier, Castanier, Tea & Scholler, 1973). jpregpenolone and allopregnano- 
lone (33-hydroxy-5a-pregnan-20-one) (Axelson et al, 1975) and their fatty acid 
esters (Albert, Porticovo & Lieberman, 1980) have also been reported to be 
present in bovine corpora lutea, although the significance of the latter 
remains a matter of speculation.
1.5.3. Catabolism of Progesterone in the Bovine
The levels of progesterone in blood are determined by its rate of synthesis 
and entry into the circulation compared with its rate of excretion and metabo­
lism. Production rates can be calculated by determination of the metabolic 
clearance rate (MCR) since the MCR may remain relatively constant regardless 
of physiological state and hormone concentration (Heap et al, 1975). Changes 
of hormone levels in blood accurately reflect production rates and secretory 
activity of the organ and the availability of the steroid to the target organ.
Since the hormones constitute a control mechanism and the intensity of 
hormone activity is proportional to the hormone concentration in blood it is 
important that blood hormone levels reflect secretion rate. The circulating 
steroid hormones have relatively short half lives, typified by that of 
progesterone in the bovine peripheral circulation (36.3 mins; Miller, Williams, 
Pipes & Turner, 1963). This enables a rapid response to pituitary control to 
be made (Samuels & Eik-Nes, 1968). Target-cell intracellular half lives are 
longer however since the avidity of binding to receptors is several orders 
of magnitude higher than to plasma proteins and they remain bound to the
receptor during receptor transformation and translocation (King & Mainwaring, 
1974).
Physiologically potent steroids are largely deactivated in the liver. 
Circulating steroids are, for the most, bound to plasma proteins and the liver 
can only act on that proportion of steroid which is free.
In the case of progesterone, metabolism occurs by reduction 
at C-3, C-20 and at the C-4, C-5 double bond in ring A (Fig. 1.5) 
and the configuration of the metabolites formed is very much tissue- 
dependent. In the bovine liver, 'in vivo and in vitvo studies have indicated 
essentially complete reduction of progesterone. Products of reduction at the 
C-4, C-5 double bond are of 53 configuration and hydroxylation at C-3 
results in products of a-configuration (Purdy, Durocher, Moore & Rao, 1980; 
Clemens & Estergreen, 1982). Hydroxylation at C-20 gave rise to 203-hydroxy 
metabolites in vivo (Purdy et at, 1980) whereas in vitvo both 20a-hydroxy (the 
majority) and 203-hydroxy metabolites were found (Clemens & Estergreen, 1982). 
In both studies, greater than 40% of hydroxylated products were found to be
in the form of glucuronides, and that these were of the 3a type (Purdy et at ,
1980).
The pattern of in vivo metabolism by kidney indicated that two thirds of 
the progesterone content is in a reduced form. In contrast with liver reduction
at C-4, *C-5 gave rise to 5a products. The main metabolites were 203-hydroxy-4-
pregnen-3-one and the 3a-hydroxy and 33-hydroxy-5a-pregnan-20-one and the 
5a-pregnane-33, 203-diol (Purdy et 'at, 1980).
Adipose tissue is known to provide a reservoir for endogenous progesterone 
in dairy cows (McCracken, 1964) and also possesses the ability to metabolize 
it into the 3a-hydroxy-53-pregnan-20-one and to form the 203 and 20a-4-pregnen- 
3-one in vitvo (Clemens & Estergreen, 1982). These metabolites have also been 
isolated in vivo together with 3a-hydroxy-5a-pregnan-20-one, 33-hydroxy-53- 
pregnan-20-one and 20a-hydroxy-5a-pregnan-3-one (Lin, Estergreen, Moss, Willet 
& Shimoda, 1978).
In vivo metabolism of progesterone by bovine muscle indicated 46% conversion,
principally to the products 5a-pregnane-3, 20-dione, 20B-hydroxy-4-pregnen- 
3-one and 3a-hydroxy-5$-pregnan-20-one (Lin et al, 1978).
Metabolism of progesterone to products other than hormone precursors has 
also been noted in the corpus luteum of the cow. Its ability to produce 
substantial quantities of 20B-hydroxy-4-pregnen-3-one has long been known 
(Hayano et al, 1954) although a function for this metabolite has yet to be 
established. While these reduction reactions generally lead to the production 
of more polar steroids, the products are still essentially hydrophobic and 
would not,therefore,be displaced readily from plasma proteins to enable 
filtration and excretion via the kidneys. The hydroxylated metabolites are 
made hydrophilic through glycoside formation or esterification in the liver 
or intestinal wall, most commonly with glucuronic acid derived from uridine 
diphosphoglucuronic acid (Isselbacker, 1956) or sulphate from adenosine 31- 
phosphate-5’-phosphosulphate (Robbins & Lipman, 1956). The enzymes involved 
are the glucuronyl transferases and the sulphokinases and these form the 
glucosiduronates (glucuronides) and sulphates respectively. The glucuronides 
are readily filtered by the kidney and excreted in urine without reabsorption 
at a rate similar to creatinine: sulphates are eliminated more slowly.
1.5.4. Excretion of Progesterone and its Metabolites
In an experiment involving administration of (ll+C)-progesterone to a 
pregnant lactating, dairy cow, 45%, 1.7% and 0.03% of the radioactive : 
material was recovered in faeces, urine and milk respectively (Williams, 1962). 
Similar observations were made in a study of six lactating, non-pregnant cows 
and four steers where 50% and 12% were found in faeces and 2.0% and 1.2% in 
urine for the cows and steers respectively: an additional 0.25% was removed 
with the milk (Estergreen, Lin, Martin et al, 1977). The main excretion route 
of progesterone appears to be through the liver and bile to the faeces since 
far larger quantities of radioactivity were found in bile and faeces than ’ 
urine and in liver compared with kidney (Estergreen et al, 1977).
1.6. THE MEASUREMENT OF PROGESTERONE IN COWS MILK
A range of hormones have been found in the milk of the dairy cow (see 
Foote, 1979; Richards, 1979; Pope & Swinburne, 1930; Sack, 1980; Strbak,
1985) and these include the major ovarian hormones progesterone (McCracken, 
1963) and oestradiol(Turner, 1958). It has been widely reported that during 
the oestrous cycle milk concentrations of both progesterone (Fig.1.lb; Heap, 
Gwyn, Laing & Walters, 1973; Hoffmann & Hamburger, 1973; Schiavo, Matuszczak, 
Oltenacu & Foote, 1975; Lamming & Bulman, 1976; Pope, Majzlik, Ball & Leaver, 
1976) and oestradiol-173 (Monk, Erb & Mollet, 1975; Erb, Chew & Keller, 1977; 
Gyawu & Pope, 1983; Abe^wardene, Hathorn & Glencross, 1984) correlate well 
with those in peripheral plasma and thus with the functional status of the 
ovary. Thus, although the most common means of evaluating the functional 
status of the ovary of farm animals has been through the determination of 
steroid hormone levels in blood, an alternative non-invasive procedure is 
possible for lactating animals. The practical significance of this lies in 
the ease with which large numbers of milk samples can be collected by 
dairymen during the normal milking period without causing discomfort to the 
cow: this contrast with blood sampling, for which veterinary or technical 
input would inevitably be required.
Although the assay of oestradiol-173 in milk has provided a useful research 
tool in the investigation of events associated with follicular development 
(Erb et al, 1977; MacDonald, Sauer & Watson, 1982; Abeywardene et a l , 1984), 
in contrast with progesterone determination, its application to the monitoring 
of oestrous cycle events has not become common practice, in part because its 
low concentrations in milk (0-10pg/m£ range: Glencross, Abeywardene, Corney & 
Morris, 1981; MacDonald, Sauer, Watson & Foulkes, 1982) militate against the 
use of simple assay protocols.
1.6.1. The Occurence of Progesterone and its Metabolites in Milk
Progesterone in cows blood is largely derived from the corpus luteum.
Studies involving the intravenous injection of (llfC)progesterone into lactating 
cows indicated that concentrations of radiolabel in milk accounted for only 
0.03- 0.25% of that administered (Miller et'al3 1963; Estergreen et al, 1977) 
indicating that milk forms a very minor excretory route for progesterone and 
its metabolites.
Steady state intravenous infusion studies have indicated that mammary 
extraction of labelled progesterone could vary from nil to 24.4% in lactation 
but could be as high as 84.3% in non-lactating animals when blood flow was 
low (Heap et al, 1975). Comparison of the concentration of labelled compounds 
in mammary arterial and venous blood indicated that in particular circumstances 
mammary metabolism could be substantial: total ether extractable radioactivity 
represented by progesterone was reduced from 79% to 64% respectively in one 
cow and from 72% to 11% respectively in another (in which mammary blood flow 
was low). The same study indicated that in milk 90%-of the ether extractable 
radioactivity was associated with authentic progesterone and about 1 0% with a 
component less polar than progesterone: the latter component was thought to 
correspond with 5a-pregnanedione, a compound identified in milk as representing 
the major unconjugated progesterone metabolite by others using in vitro tracer 
studies (Purdy et al, 1980) or gas chromatography (Darling, Laing & Harkness, 
1974). The predominance of 5a reduced metabolites in milk (Darling et al, 1974; 
Purdy et al, 1980) indicates that these are derived, at least in part, from 
mammary metabolism since the liver, the major site of metabolism, produces 
exclusively metabolites of 53 configuration (Purdy et al, 1980; Clemens & 
Estergreen, 1982).
Reports of the proportion of progesterone metabolites represented as conju­
gated steroids (non ether-extractable) vary from 45% (Heap et al, 1975) and 
15% (Purdy et al, 1980) to as low as 1% (Estergreen et al, 1977). The reasons 
for these large differences remain unexplained but are unlikely to be due to 
differences in extraction procedure: differences in stage of oestrous cycle 
or pregnancy are not stated in the latter two studies and could partly
account for the disparities. Although the conjugated metabolites may well 
represent a substantial proportion of the progestin content of the milk, 
their nature has not been reported.
1.6.2. The Determination of Progesterone in Milk by Saturation Analysis
Progesterone was first reported to occur in milk by McCracken (1963) who 
used ultra-violet absorption methods for its estimation. Gupta (1967) confirmed 
its presence using gas liquid chromatography (GLC) and Darling, Kelly, Laing 
& Harkness (1972) made a definite identification using gas chromatography and 
mass spectrometry. Subsequent to these studies concentrations of progesterone 
in milk have, for routine purposes, been determined exclusively by saturation 
analysis (see section 1 .8 ): initially competitive protein binding assays were 
used (Laing & Heap, 1971; Schiavo et at, 1975) and later RIA (Heap et al,
1973; Hoffmann & Hamburger, 1973; Lamming & Bulman, 1976; Pope et al,
1976).
To ensure maximum cost—effectiveness of milk progesterone determinations 
in fertility management, assay methodology has become increasingly simplified. 
Although some laboratories continue to apply extraction and chromatographic 
procedures to milk samples prior to assay (Hoffmann et at, 1979), many 
laboratories perform RIA determinations by direct addition procedures: whole 
milk (Heap et al, 1976; Holdsworth, Chaplin & Booth, 1979; Bulman & Lamming, 
1979) or defatted milk (Pope et al, 1976; McCaughey & Gordon, 1979) is added 
to the assay system without prior extraction or purification. As a result 
procedures of this type clearly rely upon the specificity of the antiserum and 
constancy of non-specific binding effects to ensure accuracy. A number of labor­
atories have established the concentrations of progesterone which occur in the 
different types (fore, composite or strippings; section 1.6. 4) and fractions of milk 
(Pope et al, 1976) and from cows of varied reproductive status using extraction 
and chromatographic purification prior to assay by gas chromatography and/or 
RIA (Darling, Laing & Harkness, 1974; Ginther et al, 1974; Nuti et al, 1975). 
There have been no reports, however, in which authors using direct addition
procedures have evaluated their assays by comparison with extraction/purifi­
cation methods performed on the same samples. Despite this, there is a broad 
level of agreement between independent reports of concentrations by these 
different methods.
The majority of early studies of progesterone concentrations in milk 
involved extraction or extraction and chromatographic purification of 
progesterone prior to assay (Heap et at, 1973; Hoffmann & Hamburger, 1973;
Darling et at, 1974; Ginther, Nuti, Wentworth & Tyler, 1974; Nuti et at, 1975; 
Schiavo et at, 1975). These reports were largely concerned with determinations 
in whole milk samples from pregnant animals since pregnancy testing was a 
major application of the assay: concentrations between day 30-120 of pregnancy 
were reported to range between 5-15ng/m£ (quantitation by gas chromatography, 
values uncorrected for losses, Darling et at, 1974), 20-50ng/m£ (quantitation 
by gas chromatography and RIA, Nuti et at, 1975), 23-25ng/m£ (quantitation by 
RIA, Ginther et at, 1974) and 20-44ng/m£ (quantitation by competitive binding 
assay, Heap et at, 1973) when extraction and chromatographic purification were 
employed. When extraction alone was used prior to quantitation by RIA or 
competitive protein binding assay, concentrations ranged from between 7-22ng/m£ 
(Heap et at, 1973) to in excess of 30ng/m£ (Hoffmann & Hamburger, 1973). The 
limited studies carried out at that time on extracted composite whole milk 
samples -collected throughout the oestrous cycle indicated that follicular phase 
concentrations were about lng/m£ or less (Heap et at, 1973; Hoffmann & Hamburger, 
1973; Schiavo et at, 1975) rising to luteal phase concentrations varying between 
an average of 9ng/m£ (Schiavo et at, 1975) to about 30ng/m£ (Hoffman & Hamburger,
1973). Following extraction and isolation by chromatography, concentrations were 
found to be around 0.8ng/m£ during the follicular phase, rising to between 7 and 
12ng/m£ in the luteal phase (Nuti et at, 1975): no significant difference was 
found between estimation using two different RIA systems or GLC for quantitation.
Following this period it was found that determinations could be greatly 
simplified by direct addition of the whole milk sample to the RIA system thereby 
circumventing the extraction and purification steps (Heap et at, 1973; Heap
et at, 1976; Lamming & Bulman, 1976). A major oversight during this switch in 
procedures was that none of these authors had directly compared estimates on 
the same samples using "direct addition RIA" with those found following 
purification. This was probably overlooked partly because concentrations were 
in general agreement with those found previously: Bulman (1979) has compiled 
and compared values obtained by several laboratories when using direct addition 
procedures. In these studies, values for the majority of composite whole milk 
samples fell between 0-3ng/ra£ during the oestrous period, 10-30ng/m£ during 
the luteal phase and 12-40ng/m£ during early pregnancy (Holdsworth, Chaplin & 
Booth, 1979; Booth, Davies & Holdsworth, 1979; Bulman & Lamming, 1979).
I.6.3. Potential Sources of Interference with Progesterone Determination by 
Immunoassay
Of the steroids which have been identified in milk 5a-pregnanedione and to 
a lesser extent 5$-pregnanedione (Darling et al, 1974; Purdy et at, 1980) 
commonly show appreciable cross-reactivity against readily available anti­
progesterone sera (see section 1 .8 ). In vivo metabolic studies using 
(ll+C)progesterone (Estergreen et at, 1977) have allowed isolation of steroid 
fractions from milk with chromatographic properties like pregnanediones and 
mono-, di- and trihydroxylated progesterone metabolites: these represented
II.5%, 27.9% and 4.5% respectively of total radioactivity in milk compared with 
progesterone and could again constitute potential significant cross-reactants.
Of the steroids which have been specifically assayed in milk, oestradiol 
(MacDonald, Sauer, Watson & Foulkes, 1982; Glencross & Abeywardene, 1983), 
oestrone sulphate (Heap & Hamon, 1979; Holdsworth, Heap, Booth 8s Hamon, 1982), 
androstenedione (Gaiani, Chiesa, Mattioli, Nanetti & Galleali, 1984), 5a- 
androstline-3, 17-dione (Darling et at, 1974), testosterone (Gaiani et at, 1984) 
and cortisol (Schwalm & Tucker, 1978), would be expected to show low cross­
reactivity with the specific a^ntisera in use in the majority of 
laboratories and due to their low concentrations in milk are unlikely to 
influence determinations of progesterone by RIA.
It has been demonstrated that aqueous milk constituents have a considerable 
capacity to bind progesterone non-specifically and assumed that casein, by far 
the most abundant protein in milk (80%, see Renner, 1983) may be responsible 
for this effect. Tracer studies involving ultracentrifugation of milk have 
indicated that 80% of radio-labelled progesterone was contained in the lipid 
fraction, 19% in the pellet and less than 1% in the aqueous phase (Heap, 
Henville & Linzell, 1975). Thus, when milk samples are estimated by direct 
addition RIA this phenomenon presents a potential source of inaccuracy since 
radio-labelled progesterone will bind specifically to antibody and non- 
specifically to casein. In practice this problem may be overcome by addition 
of milk with negligible progesterone content (milk from an ovariectomised 
cow or a cow at oestrus) to the assay standards thereby producing equivalent 
non-specific binding in standards and test samples (Heap et at, 1973; Gadsby, 
Heap, Henville & Laing, 1974).
1.6.4. The Assay of Progesterone in Milk: Practical Considerations of Sampling 
• Since milk is not a homogenous body fluid a number of parameters have been 
investigated to evaluate and minimize possible sources of error in sampling 
and handling. These include the type of sample taken at milking, the fraction 
of milk assayed and, where appropriate, methods of sample storage.
Three alternative types of«' milk sample have been considered as practical, 
the first or fore-milk, composite milk (a representative sample taken from the 
whole milking) or the strippings (taken from the teat by hand following 
milking). Most research has been carried out using the composite sample since 
this is most representative (Schiavo et at, 1975; Heap et at, 1976; Lamming & 
Bulman, 1976; Pope et at, 1976) although fore-milk (Thibier, Fourbert & Farez, 
1976) and strippings (Hoffmann et at, 1976; van de Wiel et at, 1978) have been 
used by some groups in part because they better suit the particular management 
and milking systems in operation.
Between 80 and 87% of the progesterone content of milk is associated with 
the lipid fraction (Heap, Henville & Linzell, 1975; Pope et at, 1976) and in
keeping with the fat content of milk types (strippings > composite > fore;
Pope et at, 1976; Smith, 1959), the progesterone content is highest in the 
strippings, intermediate in composite milk and lowest in fore-milk (Schiavo 
et at, 1975; Pope et at, 1976). Although the fat content of milk may differ 
according to the udder quarter from which it is drawn and according to the 
time of day and the physiological status of the cow (Copeland, 1929; King,
1977; Dodd 8s Griffin, 1979), work by Schiavo et at (1975) and McCaughey 8s 
Gordon (1979) indicated that progesterone concentration did not differ 
significantly in milk taken from the four udder quarters irrespective of the 
stage of cycle. It has been found however that progesterone concentrations are 
significantly higher in milk taken at the evening milking than that taken in 
the morning (Heap et at, 1976; Batra, Pahwa, Suri & Pandey, 1930): it is not 
clear whether this was related to an increased secretion rate or to a higher
v. '
fat content of the milk during the evening (Heap et at, 1976).
There is a close positive correlation between the fat content of milk and 
its progesterone concentration (Hoffmann & Hamburger, 1973; Ginther, Nuti, 
Garcia, Wentworth & Tyler, 1976; Pope et at, 1976): this is perhaps to be 
expected since progesterone is thought to occur in milk as a result of 
diffusion from blood down a concentration gradient and that its higher 
concentration in milk than plasma is probably related to its high solubility 
in and effective dequestrationby milk lipids (Heap et at, 1975). Clearly this 
indicates that different concentration limits will need to be set when assaying 
luteal function in breeds producing milk of higher fat content (e.g. Guernsey 
and Jersey cattle; Pennington, Spahr 8s Lodge, 1981) or when fore-milk or 
strippings are assayed rather than composite milk.
The errors in interpretation of ovarian status as a result of large 
fluctuations in fat content of particular samples (e.g. due to decreased fat 
yield at oestrus or faulty sampling) may be avoided by the assay of progesterone 
in milk fat (Hoffmann et at, 1976; Claus 8s Rattenburger, 1979) or defatted milk 
(Pope et at, 1976; McCaughey 8s Gordon, 1979). The benefits accrued from these 
procedures must, however, be balanced against the extra time and effort
involved in preparing milk fat or defatted milk. The work of Lamming & Bulman 
(1976) indicates that although errors associated with fluctuations in milk 
fat content may be reduced by correcting for fat content only a small 
percentage of animals (3.2%) were displaced in category of ovarian status 
by not doing so: this percentage would probably be reduced if successive 
samples were being studied as an aid to the diagnosis of sub-fertility. 
Pennington et at (1976) have stressed that errors associated with fat content 
of whole milk will be less pronounced with a composite milk sample rather 
than fore-milk (see also Heap et at , 1976) or strippings and that although 
milk fat content normally varies by less than two fold (2.5 - 5%) a greater 
than ten fold change in progesterone concentrations occurs between the 
follicular and luteal phase of the cycle (<2ng/m£ to >2 0ng/ra£ respectively).
1.6.5. Preservation of Milk Samples
Milk samples may require to be stored before assay and storage frozen or 
at 4°C after the addition of preservative have been considered.
Storage at -10°C or -20°C has proved convenient (Ball & Pope, 1976) although 
after 3-6 months this may result in precipitation of casein micelles following 
thawing (Pope et at. 1976): the addition of EDTA solution to the sample may 
overcome this problem, however (Pope & Swinburne, 1980). Nuti, Wentworth, 
Karavolas, Tyler & Ginther (1975) and Oltenacu & Foote (1976) found small but 
non-significant changes in progesterone concentration during storage at -10°C 
for 1 0 - 12 months.
The use of various preservatives including potassium dichromate/mercuric 
chloride tablets (Lactabs Mk II: Heap et at, 1976; Lamming & Bulman, 1976;
Foote et at, 1979; McCaughey & Gordon, 1979), sodium azide (Pope et at, 1976), 
formalin (Bishop, Bond & Roberts, 1976), formaldehyde (Batra, Arora, Bachlaus 
& Pandey, 1979) and chloramphenicol (Hoffmann et at, 1974) have been reported 
and compared (Durdevic, Maksimovic, Stojic 8s Kercov, 1979) and found to enable 
storage of milk samples at 4°C for many months without significant alterations 
in progesterone content as determined by immunoassay. Of these, Lactab
treatment ( 1  tablet/2 0m£ milk) is perhaps the most convenient and commonly 
employed: potassium dichromate tablets (Lactab Mk III) have recently been
found to be equally effective (R.J. Holdsworth, personal communication).
1.6.6. The Diagnostic Value of Determinations of Progesterone in Milk
The relative ease of progesterone determination offered by RIA rapidly lead 
to the appreciation that its measurement in the milk of dairy cows provided an 
accurate and valuable tool in the assessment of the functional status of the 
corpus luteum and thus of reproductive events associated with and controlled 
by its secretions. Such determinations have enabled testing for pregnancy at 
21-24 days post AI (Laing & Heap, 1971; Heap et at, 1973; Heap, Holdsworth, 
Gadsby, Laing & Walters, 1976; Pennington, Spahr 8s Lodge, 1976; Pope et at ,
1976) and have highlighted problems associated with acyclicity and the timing 
of the postpartum return to ovarian cyclicity (Bulman 8s Lamming, 1978; Foote, 
Oltenacu, Kummerfeld, Smith, Riek & Braun, 1979; Giinzler, Rattenburger, Gorlach, 
Hahn, Hocke, Claus & Karg, 1979; van de Wiel, Kalis & Shah, 1979), the incidence 
and occurence of silent or missed oestrous periods (Lamming & Bulman, 1976;
Karg et at, 1980; Greve & Lehn-Jensen, 1980), the accuracy of behavioural oestrus 
detection (Hoffmann, Giinzler, Hamburger & Schmidt, 1976; Bulman 8s Lamming, 1979; 
Giinzler et at, 1979; McCaughey 8s Cooper, 1980; Oltner 8s Edqvist, 1981; Henriksen 
et at, 1982; Laitinen, Remes, Tenhunen, Hanninen & Alanko, 1985) and the 
occurence of early embryo mortality (Ball, 1978; Bulman 8s Lamming, 1978; Humblot, 
1982). The diagnosis of the anovulatory condition using this method and its 
ability to distinguish between follicular and luteal cysts enable the appropriate 
choice of hormone therapy to be made (Hoffmann et at, 1976; Lamming 8s Bulman, 
1976; Dobson, Rankin 8s Ward, 1977; Giinzler et at, 1979; van de Wiel et at, 1979). 
In addition the test may be used to confirm the accuracy of an oestrous observa­
tion if a milk sample is taken on the day of AI (Giinzler et at, 1979). Ball 8s 
Jackson (1979) took this a step further and used an appropriate milk sampling 
and testing regime to enable prediction of the timing of oestrus and thus of AI: 
this demonstrated that cows are capable of conceiving at the time of ovulation 
even if this is not precelded by observed oestrus. Giinzler et at (1979; have
indicated the possibility of applying progesterone assays to embryo transfer 
programmes since synchronisation of cycle stage and conception age is critical.
It is becoming clear that access to a simple and rapid progesterone test 
may help resolve some of the problems which arise in fertility management and 
which have emerged from the studies cited above. With regard to early post­
partum studies on ovarian activity, general agreement was found with earlier 
investigations involving palpation or determination of plasma progesterone 
concentrations (Labhsetwar, Tyler & Casida, 1963; Morrow, Roberts, McEntee 8s 
Gray, 1966; Pope, Gupta 8s Munro, 1969; Robertson, 1972; Glencross 8s Munro,
1974): the first ovulation normally took place around the 24th day postpartum 
and was often not prece[dbd\' by oestrous behaviour (Bulman 8s Lamming, 1978;
Foote et at, 1979; Giinzler et at, 1979; van de Wiel et at, 1979). Although it 
may not be desirable to inseminate at the first ovulation postpartum due to 
the likelihood of low fertility at this time, it is important to inseminate 
at the following and subsequent oestrous period,where appropriate, in order to 
achieve a mean calving interval of one year and to achieve and maintain a 
tight calving pattern. This requires that animals not pregnant to AI must be 
identified, ideally within 21 days to enable re-insemination at the next oestrous 
period. Similarly, sub-fertile animals must be correctly identified at an early 
stage postpartum so that appropriate action can be taken.
The incidence of early embryonic mortality, often considered to be of the 
order of 15-20% at around day 24 (see Gwazdauskas, Lineweaver & Vinson, 1981), 
may have been over-estimated due to problems associated with poor oestrous 
detection at AI or subsequent silent heat 21 days post AI: a more realistic 
figure may be of the order to 5-10% (Ball, 1978; Kummerfeld, Oltenacu 8: Foote, 
1978; Humblot, 1982).
Unfortunately, progesterone does not provide a specific positive test for 
pregnancy: although it is possible to determine non-pregnancy,by assay of a 
single sample taken at day 21-24, with near 100% accuracy, pregnancy estimations 
are only about 80% accurate (Hoffmann, Hamburger, Giinzler, Korndorfer 8s Lohoff, 
1974; Heap et at, 1976; Hoffmann et at, 1976; Pennington et at, 1976; Pope et at3
1976; van de Wiel, van Eldik, Koops, Postma & Oldenbroek, 1978; Booth, Davies 
& Holdsworth, 1979; Foote et at, 1979). False positive results may be due to 
an incidence of incorrect oestrous detection (luteal phase insemination), 
irregular cycle length, faulty milk sampling or embryonic death. There is 
currently no alternative early test for pregnancy in dairy cattle but the use 
of real time ultrasonic scanning devices presents a possibility for the future 
(Reeves, Rantanen& Hauser, 1984; von Kahn, 1985).' The'occurrence of 
oestrone sulphate in milk provides a specific test for pregnancy being a 
product of the conceptus but can only be performed with confidence after 105 
days of gestation (Heap & Hamon, 1979; Holdsworth, Heap, Booth & Hamon, 1982).
In the United Kingdom a commercial pregnancy testing service is offered by 
the Milk Marketing Board at a single central laboratory and is based on milk 
progesterone determination by RIA. Although this provides a valuable service 
the test is statistically most reliable if conducted between 22-26 days post 
AI (Holdsworth et at, 1979). This and the inevitable delays in communicating 
the results means that the non-pregnancy data is available too late for 
insemination 21 days after the first AI.
It is clear that the determination of progesterone concentrations in milk 
offers what is perhaps the only single aid by which the majority of fertility 
management problems can be assessed and possibly corrected. RIA is, however, 
fatally'flawed in that it is neither cheap nor fast enough or sufficiently 
simple to perform to be of value for the majority of its potential applications. 
The development of alternative non-isotopic immunoassays, based on principles 
similar to RIA, are a means by which these objections may be circumvented and 
may provide a means by which the test can be performed locally at a veterinary 
laboratory or, eventually, on the farm by the dairyman. Such methods will be 
discussed in a later section (1.9).
1.7. METHODS OF PROGESTERONE DETERMINATION
Prior to the late 1960’s, methods for the detection and estimation of 
progesterone in biological fluids and tissue were based upon its physico-
chemical properties and biological effects. These methods have been reviewed 
by van der Molen & Aakvaag (1967) and van der Molen (1979) and include 
determination of ultra-violet or (following derivatization) visible light 
absorption (Perlman & Cerceo, 1953; Hinsberg, Pelzer & Seuken, 1956; Short,
1958), fluorescence (Touchstone & Murawec, 1960; Heap, 1964), isotope labelling 
with isotope dilution (van der Molen, Riinnenbaum, Nishizawa, Kristen, Kirsch- 
baum, Wiest & Eik-Nes, 1965; Riondel, Tait, Gut & Little, 1965), and detection 
after gas-liquid chromatography (flame ionization, or, following derivatization, 
electron capture or nitrogen detection: Lurie, Villee & Reid, 1966; van der 
Molen Si Groen, 1967; Stabenfeld, Ewing, Patton & McDonald, 1969; Frith & 
Phillipou, 1981) and bioassay (effects on endometrium, ovary or the capacity 
to maintain pregnancy - McGinty, Anderson & McCullough, 1939; Hooker 8s Forbes, 
1949; Miyake 8c'Pincus, 1958; Miyake, 1962). Their use has, however, been limited 
to quantitative or semi-quantitative determinations or to quantitation of 
relatively small numbers of samples. This is due to the relatively low concen­
trations of progesterone in biological fluids combined with the lack of 
specificity and sensitivity of the methods or to the time and expertise required 
These methods are based on "reagent excess" principles (Ekins, 1976) since they 
rely on the use of an excess of specific reagent (chemical, physical or 
biological) which is converted by interaction with the hormone to give a 
detectable change directly proportional to the amount of hormone present.
Assays in most common use today, however, are based on a totally different 
principle, that of "saturation analysis" (Ekins, 1976).
1.8. THE PRINCIPLE OF SATURATION ANALYSIS AND ITS APPLICATION TO THE IMMUNOASSAY 
OF PROGESTERONE.
Assays based on the principle of saturation analysis utilize a specific 
reagent, present in a limited and defined quantity (usually less than the amount 
of analyte in the system) and observations are made of the proportion of analyte which, 
as a result of its interaction with the reagent attains altered characteristics (Ekins
1976). This principle was first exploited for the determination of insulin by
Berson and Yalow (1959) and of thyroxine by Ekins (1960) and was later adopted 
for the measurement of steroid hormones by methods more specifically termed 
competitive protein binding assay (CPBA: Murphy, 1967; Neill, Johansson & 
Knobil, 1967; Yoshimi & Lipsett, 1968) and radioimmunoassay (RIA: Abraham,
1969). The specific binding reagents in RIA are antibodies and in CPBA endo­
genous binding proteins such as corticosteroid-binding globulin. Although both 
procedures provided assays several orders of magnitude more sensitive than 
those using reagent excess, RIA soon proved to be the method of choice for the 
determination of steroids in biological fluids since it provided a higher 
degree of accuracy, precision, specificity and sensitivity than CPBA (van der 
Molen, 1979; Fotherby, 1979). This enabled reliable measurements of some 
hormones in body fluids and tissues to be made for the first time and is still 
the most widely used method for progesterone determination.
Immunoassays based on the saturation analysis principle require the 
provision of three components, a) a limited and constant quantity of antibody 
specific for the analyte, b) a limited and constant quantity of labelled 
analyte and c) standard quantities of analyte for calibration purposes (or 
unknown quantities of analyte in the test sample). When the three components 
are mixed, labelled and unlabelled analyte compete for the limited (saturable) 
number of antibody binding sites: since each test contains the same amount of 
antibody and labelled analyte, the greater the quantity of unlabelled analyte 
present the smaller will be the quantity of labelled analyte binding to the 
antibody. A fourth requirement for the assay is d) the availability of a means 
of distinguishing between and quantitating free labelled analyte and that bound 
to antibody: standard amounts of analyte thus enable calibration curves to be 
constructed from these data and quantitation of analyte in the unknown sample 
by interpolation. The components a), b) and d) are worthy of further consider­
ation and are discussed below in the context of progesterone determination.
1.8.1. The Production and Characteristics of Progesterone Antibodies
The determination of progesterone by immunoassay requires the availability 
of antibodies which bind progesterone with specificity and preferably high 
avidity. Progesterone, being a hap.ten, is not immunogenic in its own right 
(in common with most molecules of molecular weight <4,000 Daltons; Kellie, 
Lichman, Samarajeewa, 1979) and antiserum production requires conjugation 
of a progesterone, derivative with a carrier protein such as albumin (Erlanger, 
Borek, Beiser & Lieberman, 1957b) prior to immunization of the host animal.
The first generation of such steroid immunogens were fashioned by utilizing 
one of the primary functional groups (at C-3 or C-20) to form a derivative, 
usually containing a carboxylic acid group, which could subsequently be coval­
ently conjugated by amide bond formation to the e-amino groups of lysine 
in a protein (Beiser, Erlanger, Agate & Lieberman, 1959; Niswender & Midgley,
1970). Antisera raised by injection of these immunogens were generally of low 
specificity, however. Subsequent suggestions that a carboxylic acid (or 
alternative reactive residue) be introduced at a site remote to the functional 
group (i.e. in ring B or C: Lindner, Perel & Friedlander, 1971) to avoid steric 
hindrance of the distinctive features of the steroid, lead to the formation 
of antibodies of increased specificity (Niswender & Midgley, 1970; Kohen et at, 
1975; Niswender, Nett, Meyer 8s Hagerman, 1975). The length of the chemical 
bridge between hapten and carrier protein may for similar reasons be expected 
to influence antiserum specificity: the optimum length would appear to be 4-6 
carbon atoms (Bermudez, Coronado, Mijares et at, 1975; Robinson, Morris, Piall, 
Aherne 8s Marks, 1975). The avoidance of conjugation of positions on the steroid 
which are prone to major metabolic transformation may reduce the possibility 
of producing antisera cross-reacting with such metabolites (Kohen et at, 1975).
Reactive derivatives of progestins suitable for conjugation to protein 
include oximes derived from ketonic groups, heraisuccinates and acid chlorides 
from hydroxyl groups and thioether alkanoic acids from halogenated or a, 
unsaturated ketones. Anti-progesterone sera have thus been raised against 
progesterone derivatives linked to carrier protein via O-carboxymethyloxime
at C-l (Kohen et at, 1975) or C-3 (Niswender, 1973), carboxymethyl- or 
carboxyethyl thioether at C- 6  or C-7 (Lindner, Perel, Friedlander & Zeitlin, 
1972; Bauminger, Lindner 8s Weinstein, 1973), hemisuccinate, chloroformate 
or glucuronide at C-ll (Lindner et at, 1972; Furr, 1973; Niswender,
1973; Corrie, Ratcliffe & MacPherson, 1982), hemisuccinate at C-12 
(Stupnicki 8s Kula, 1980) and hemisuccinate at C-20 or C-21 (Erlanger et at,
1959). Superior and comparable specificity has generally been obtained using 
conjugates linked via the C-7, C-ll (Kohen et at, 1975; Niswender et at, 1975) 
or C-12 (Stupnicki 8s Kula, 1980) position. The progesterone derivatives 
required for conjugation at C-7 and C-12 are neither cheap nor readily 
available. The converse is true of lla-hydroxyprogestercne (the usual starting 
material for C-ll conjugation) which is a readily produced microbiological 
metabolite of progesterone (Peterson, Murray, Epstein et at, 1952) and so has 
become the most often used derivative for production'of anti-progesterone sera. 
Generally this has been linked via a hemisuccinate bridge to the carrier 
protein (Thorneycroft 8s Stone, 1972; Lindner et at, 1972; Furr, 1973) and 
antisera so produced cross-react to the largest extent (>50%) with 
lla-hydroxyprogesterone (Thorneycroft 8s Stone, 1972; Furr, 1973) which 
fortunately is not known to occur in significant concentrations in mammalian 
blood (Kohen et at , 1975). Significant (2-20%) cross-reactions against the 5a 
and 53 pregnane-3, 20-diones and to a lesser extent with monohydroxy pregnanes 
and pregnenes has been noted by some (Thorneycroft 8s Stone, 1972; Furr, 1973; 
Fotherby, 1979).
Methods used for covalently linking carboxy or amino steroid derivatives to 
carrier proteins have been extensively reviewed (Kellie et at, 1975; Kohen 
et at, 1975; Niswender et at, 1975; Butler, 1977; Pratt, 1978) and principally 
involve condensation with e-amino groups of lysine residues or 8 or Y-carboxyl 
groups of aspartic or glutamic acid, respectively. The condensation of carboxy­
lic and. amino groups has been achieved by two principal methods, the mixed 
anhydride reaction (Erlanger, Borek, Beiser 8s Lieberman, 1957a) and the 
carbodiimide reaction (Sheehan 8s Hess, 1955; Kurzer 8s Douraghi-Zadeh, 1967).
Where chlorocarbonate derivatives are used the Schotten-Baumann reaction 
enables condensation with amino residues to be simply performed (Erlanger 
et al, 1957a).
A diverse range of carrier proteins have been used in the formation of 
immunogens including keyhole limpet haemocyanin, thyroglobulin and albumins 
from various species or synthetic macromolecules such as poly-L-lysine (James 
& Jeffcoate, 1974; Pratt, 1978). Although bovine serum albumin has been 
commonly employed it has been stressed that the latter would not be the 
carrier of choice if species phylogenetically similar to the bovine were 
being immunized (sheep or goats) since this may lead to an attenuated response 
related to inter-species tolerance (Lescowitz, 1972): ovalbumin provides a 
useful alternative carrier for these species.
Although antibodies are produced by transformed ^ -lymphocytes (plasma cells) 
in response to immunization it is important that lymphocytes are not exposed 
directly to the immunogen since this may give rise to tolerance (Boak, Kolsch 
& Mitchinson, 1969) : it is preferable that exposure of the j§j-lymphocyte to 
the immunogen is achieved through presentation by the macrophage (Boak, Kolsch 
8s Mitchinson, 1969). Slow release of immunogen such as achieved through intra­
muscular, subcutaneous or intradermal injection has proved particularly 
effective for antiserum production (see Hurn, 1974). Satisfactory anti-steroid 
serum production necessitates the injection of an adjuvant with the immunogen 
since this induces non-specific proliferation of lymphocytes derived from 
bone-marrow (Roitt, Greaves, Torringiani et at3 1969).
It has proved possible to raise antisera against all of the steroid hormones 
and many of their metabolites, although the success of the immunization 
procedures and the binding properties of the resultant antibodies have been 
highly variable. Differences between species and individual animals have been 
found. The adjuvant, the dose and the purity of the immunogen, its route of 
administration and the timing of repeat innoculations and subsequent blood 
samples have been found to give rise to differences in response (Hurn 8c Landon, 
1971; Hunter, 1978; Abraham, 1974; Parker, 1976; Hunter 8s Corrie, 1983).
Blood taken 7-10 days after booster injection is assessed for titre, 
specificity and avidity of binding. Antibody titre is that dilution of anti- 
serum giving rise to 50% binding when incubated with a stated amount of 
labelled analyte alone. Low titre is not, however, indicative of a poor anti­
serum; quality is assessed following an estimation of the avidity of binding, 
which governs the sensitivity and detection limit of the assay and the
specificity of binding which indicates the extent to which structurally similar
steroids may interfere with the assay.
The binding of analyte to antibody proceeds in accordance with the Law of 
Mass Action (see Ekins, 1974),
thus H + Ab?=— ^ H Ab at equilibrium ^  = K
iHJIAbJ Kd
Where H = hapten or analyte; Ab = antibody; H.Ab= hapten-antibody complex; 
Ka + Kd = rates of association and dissociation respectively of 
the complex;
K = the equilibrium constant or avidity of the antiserum.
Ekins (1976) has demonstrated that the theoretical lower limit of detection
0
in saturation analysis is of the order of —  (e is the relative error of the
K
response determination), thus the greater the affinity of binding the lower 
the detection limit. The determination of the equilibrium constant is complicated 
by the heterogeneity of the polyclonal antibody population but estimations 
may be made by applying Scatchard or Michaelis-Menton analysis (see Buller, 
Schrader & O'Malley, 1976) to data obtained by determining the quantity of 
free and bound analyte following addition of increasing amounts of labelled 
steroid to a fixed amount of antibody.
Tests of antiserum specificity are performed in order to evaluate if, or to 
what extent, samples may require to be purified before assay and is investigated 
by estimation of the extent to which potential cross-reactants compete with 
labelled analyte for antibody binding sites. This is expressed as a percentage 
of the competition obtained with unlabelled analyte. Two of the more commonly 
employed methods of describing cross-reactions are (i) in terms of the ratio of 
amount of analyte to cross-reactant required to give rise to a 50% displacement of
labelled analyte (CR5 0 : Abraham, 1969) or (ii) the displacement of labelled 
analyte produced by a fixed mass of analyte or cross-reactant (De Lauzon, 
Cittanova, Desfosses & Jayle, 1973). The fixed-mass test is to be preferred 
since in the first method, binding inhibition curves of the analyte and 
cross-reactant are not parallel (Rodbard & Lewald, 1970) and the concentrations 
of cross-reactant used often fall outside the physiological range of concen­
trations (De Lauzon et at, 1973). These methods require a prescience on the 
part of the investigator which may often be incomplete. Tests which involve 
addition of analyte to analtye-free samples or dilution of samples containing 
significant endogenous quantities of the "analyte" and subsequent evaluation 
of the linearity of estimates (recovery and parallelism experiments) provide 
additional information relating to the specificity of the assay in practice.
1.8.2. The Choice of Label
In saturation analysis, there is no requirement that the analyte and its 
labelled form be chemically identical. They do, however' have to compete 
for the same.antibody binding sites.and the labelled analyte should be- ' 
capable of detection and quhntitation by sensitive methods. In steroid 
immunoassay radiolabelling is most commonly used. '
Progesterone may be labelled internally by substitution of -^C or into 
the normal steroid structure (labelled analyte and analyte are chemically 
identical) or externally by conjugation with a compound, e.g. tyrosine
jnethyl ester or histamiqe, which may be iodinated before or after conju-
- 1 2 5 * *gation: I has been the radionuclide most often employed (Scarisbrick
& Cameron, 1975),
High specific activity radio-labelled analytes in conjunction with antibodies 
of high avidity enable a high degree of precision and sensitivity to be 
achieved in RIA. Although modern automatic and manual B and y-radiation counters
operate at high efficiency and are easy to use there are numerous, disad­
vantages to these forms of labelling. The .performance of RIA is limited to 
specialised licensed laboratories due to the high cost of counters and the 
regulations associated with the use of radio isotopes. Shortcomings relating 
to the use of 8-particle emitting isotopes are the comparatively low specific 
activity of 14C- and 3H-labelled analytes (long counting times required for 
high precision) and the high cost of liquid scintillator required for their 
determination. The 1 2 5I-labelled alternatives, however, have short half-lives 
and lack stability ("decay catastrophe"). Schall and Tenoso (1981) have reviewed 
the numerous alternatives to radio-labelling for use in immunoassays. These 
include use of bacteriophages (Andrieu, Manas & Dray, 1975), chemiluminescence 
precursors (Kohen, Kim, Lindner & Collins, 1981; Pazzagli, Kim, Messeri et at, 
1981; Kohen, Lindner & Gilad, 1983), fluorochromes (Soini & Hemmila, 1979; 
Allman, Short & James, 1981; Bacigalupo, Ins, Merini■ et at, 1983), enzymes 
(Engvall & Perlmann, 1971; Van Weemen & Schuurs, 1971; Dray, Andrieu & Renauld, 
1975), coenzymes (Schroeder, Carrico, Boguslaski & Christner, 1976), enzyme 
inhibitors (Finley* Williams & Lichti, 1980) enzyme substrates (Burd, Wang, 
Feeney et at, 1977; Pearson, Smith & Marks, 1984), metal atoms (Cais, Dani,
Elden et at, 1977), sol particles (Cambiaso, Leek, de Steenwinkel et at, 1977) 
and stable free radicals (Wei & Almirez, 1975). The widespread application of 
these labels is, however, dependent upon the development of detector technology 
that will enable instrumentation to become available at reasonable cost. The 
main exceptions are those methods in which enzyme activity is determined: the 
relative merits of such methods are described in section 1.9.
1.8.3. Distinction Between Free and Antibody Bound Analyte
The end-point of saturation analysis immunoassays involve discrimination 
between and quantitation of the relative proportion of analyte which is free 
and that which is bound to antibody: the practical and theoretical aspects of 
the means by which this may be achieved have been reviewed by several authors 
(Aubert, 1970; Rodbart & Catt, 1972; Hunter, 1973; Ratcliffe, 1978). . This
usually requires separation of the two species, although in very particular 
circumstances (homogeneous assays) where the quantifiable properties of the 
label are changed as a result of binding (see Boguslaski & Li, 1982) this may 
not be necessary. Although homogeneous assays offer much potential for the 
development of simple tests, in most forms they lack the sensitivity required 
for the determination of steroid hormones (Schuurs & Van Weemen, 1977) 
particularly where samples are measured without extraction and concentration. 
Estimation of label is also prone to interference from components of complex 
biological fluids such as serum or milk since by definition no free/bound 
separation or wash stages are employed. For these reasons these types of 
procedure are not considered further here.
An ideal separation method should enable precise and complete separation of 
the components and should not, as a result, interfere with the equilibrium 
attained by the primary binding reaction nor be affected by other components 
in the sample. The reagents and equipment should be cheap, readily available 
and should enable separation to be performed quickly and easily thereby allowing 
large numbers of samples to be processed.
Separation techniques are varied and rely on differences in molecular weight, 
charge, adsorption, solubility and precipitative properties between the bound 
and free fractions. Methods involving adsorption and precipitation of the free 
hormone (e.g. by addition of dextran coated charcoal: Abraham et at, 1971; 
Lindner et at, 1972; Niswender, 1973; Heap et at, 1976) have often been employed 
in the assay of progesterone by RIA: conditions must be optimized, however, 
since adsorption is highly dependent upon pH, temperature and contact time and 
may result in some stripping of analyte from antibody binding sites if low 
avidity sera are used (Abraham et at, 1971; Malvano & Rolleri, 1975; Runnenbaum,
1975). Adsorption methods rely on similarities in physical properties between 
the labelled and unlabelled free analyte to separate them from the bound forms. 
Such methods are, however, not well suited to enzymeimmunoassay where the 
molecular weight of the labelled and unlabelled hormone differ by orders of 
magnitude.
Immunoprecipitation methods, involving addition of a second antibody raised 
against the primary (analyte specific) antibody, are less prone to errors in 
quantitating the proportion of label in each fraction (misclassification errors) 
than adsorptive methods (Ratcliffe, 1.983.). Although this separation process used 
to require prolonged incubation to ensure complete precipitation,separation 
times may be reduced by attachment of the second antibody to a particulate 
solid phase (double antibody solid phase method) or by the use of an accelerator 
such as polyethylene glycol (Edwards, 1983). The attachment of primary antibody 
directly to a solid phase such as the walls of plastic test tubes (Catt &
Tregear, 1967; Gowan & Etches, 1979) or to particulate material such as cellulose 
microgranules (Dighe & Hunter, 1974) provide perhaps the most rapid and 
convenient means of separation, allowing short incubation periods and providing 
low misclassification errors (Wide, 1978). The immunoprecipitation and solid- 
phase primary antibody methods are both well suited to use with the majority of 
forms of label including enzymes.
1.8.4. Extraction Versus Direct Assay of Progesterone
In order to eliminate potential sources of interference, both non-specific 
(i.e.- not interfering directly with antibody-analyte binding) and from 
cross - reacting substances , solvent extraction procedures and chromatographic 
purification have traditionally been used prior to RIA. Extraction alone 
with a selective, non-polar solvent such as petroleum ether may be sufficient 
to eliminate more polar steroids which cross-react with progesterone (Dighe 
& Hunter, 1974). Where antisera are suitably specific to enable direct 
addition assays to be performed, non-specific interference such as may be caused 
through binding of progesterone to corticosteroid-binding globulin (in women) 
has been prevented either by performing the assay at reduced pH (Ratcliffe, 
Corrie, Dalzial & MacPherson, 1982) or by addition of reagents capable of 
displacing non-specifically bound progesterone: Danazol (McGinley 8c Casey,
1979), cortisol (Haynes, Concorran, Eastman & Doy, 1980) and 8-anilino-l- 
napthalene sulphonic acid (Ratcliffe et at, 1982). Such solutions have not,
however, been found to be applicable where non-specific binding was to other 
serum components such as albumin or lipoprotein (Pratt, 1978). Problems 
associated with non-specific binding in direct addition assays of progesterone 
in bovine plasma (Holdsworth, 1980) or milk (Heap et at, 1973; Heap et at,
1976), however,have not proved to be so severe as in human applications and 
such matrix effects have generally been circumvented by preparation of assay 
standards in analyte free preparations of the fluid under test.
1.9. ENZYMEIMMUNOASSAY
Although many forms of labelling have been considered for use in saturation 
analyses, the use of enzyme-labelled analyte provides the most convenient 
means by which the sensitivity and specificity of RIA can be brought within 
the reach of the small laboratory: saturation analyses using enzyme-labelled 
analytes are termed enzymeimmunoassays (EIA). The advantages of using enzyme 
as opposed to radio-label have been enumerated by several authors (Landon, 
Crookall & McGregor, 1975; Schuurs Sc van Weeman, 1977; O'Sullivan, Bridges & 
Marks, 1979; Blake & Gould, 1984) and include the innocuous nature, stability 
and low cost of the reagents and the ready availability of equipment required 
for end-point determinations: the potential for producing colorimetric end­
points which can be assessed by eye may be particularly valuable where 
quantitative or semiquantitative evaluation will suffice.
The use of EIA was first reported by Engvall and Perlmann (1971) and van 
Weemen & Schuurs (1971) and although such assays have since been developed 
for many steroid hormones (Table 1.1) and the majority of hormones associated 
with the reproductive process (van Weemen, Bosch, Dawson, van Hell & Schuurs, 
1978; Sauer, Cookson, MacDonald & Foulkes, 1982a), RIA has remained the 
preferred method (Schall & Fraser, 1983). The main exceptions to this are in 
the monitoring of drugs by homogeneous EIA (Schall 8c Fraser, 1983) and in 
screening for infectious diseases (Voller, Bartlett & Bidwell, 1978; Wardley 
8c Crowther, 1982). In the former case this is related to the relatively simple
TABLE 1.1 Application of EIA to the Determination of Steroid Hormonea
Hormone Enzyme
Label
Conjugation
Uethod
Hetero/
Homology
Body
Fluid
Assayed
Direct 
Addition or 
Extraction
Separation
Technique
Detection
Limit
(pg/tube)
Author
Cortisol 0-Gal HA homo plasma E DA, DASPc 100 Comoglio ft Celada, 1976
AP CDI hetero (b) serum D DA 1000 Kobayasbi e t a t , 1978
0-Gal UBae hetero (b) plasma D DA 200 Uonji & Castro, 1979
AP CDI homo plasma D DA 100 Ogihara e t a t , 1977
Oestradiol 0-Gal CDI hetero (b+s) - DA 25 Abuknesha Ic Exley, 1978
HRP Glut* homo serum E SPct 10 Sadeh e t a t , 1979
HRP UA homo ft hetero 
(b) ft (s)
- - DA - Van Weeman ft Schuurs, 1975
Oestriol HRP UA homo urine D PEG 140 Korhonen e t a t , 1980
AP CDI homo serum D DA I10 Otsuki e t a t , 1979
Oestrogens HRP UA homo serum D DASPc 30 Bosch e t a t , 1978a
(total) HRP UA homo plasma D PEG 30 Osterman e t a t , 1979
Progesterone 0-Gal. CDI homo - - DA 15 Dray e t a t , 1975
0-Gal NHSae hetero (b) plasma E DASPgb 20 Gros e t a t, 1978
0-Gal ? homo serum (p) E DA 25 Johmen e t a t , 1980
HRP UA homo plasma E SPso 125 Joyce e t a t , 1977a
HRP UA homo plasma E DA 10 Joyce e t a t, 1978
HRP UA homo plasma (b) E DASPc 50 Kamonpatana, 1979
0-Gal CDI homo plasma D DASPgb 55 Patricot e t a t , 1978
0-Gal CDI homo serum (e) E SPct 93 Seeger e t a t , 1979
Testosterone HRP UA hetero (s+b) serum E SPct - Bosch e t a t , 1978b
0-Gal NHSae hetero (b+s) 
+ homo
- - DA - Hosoda e t a t , 1979
HRP UA homo - - SPc 50 Rajowski e t a t , 1977
GA CDI homo serum E DA 250 Tateishi e t a t , 1977
ABBREVIATIONS
Enzyme - 0-Gal, 0-Galactosidase; AP, alkaline phosphate; HRP, horse raddish peroxidase; GA, glucoamylase;
* enzyme conjugated to antibody ('sandwich' technique or immunoenzymometric assay).
Conj. Math.- Glut., glutaraldehyde; UA, mixed anhydride; CDI, water soluble carbodiimide; UBae, maleimido benzoate 
active ester; NHSae, N-hydroxysuccinimide active ester.
Procedure - Homo, homologous assay (hapten linkage to immunogen is same as linkage to enzyme); hetero, heterologous 
assay (linkage differs, either in bridge (b) or site (s) of conjugation).
Body Fluid - Species is human except where indicated; bovine (b), equine (e) or porcine (p).
Direct Addition or Extraction - D, direct addition; E, hapten extracted prior to assay.
Separation Technique - SP, solid phase antibody; DA, double antibody; DASP, double antibody solid phase; PEG, polyethylene 
glycol precipitation; c, cellulose; s, sephadex; gb, glass balls; mt, microtitre plate; ct, coated tube; so, sepharose.
and rapid homogeneous assay procedures which are possible when analyte 
concentrations are relatively high (yg/m£ test fluid). In the latter there 
was a relatively low commitment to other types of assay prior to development 
of enzyme-label techniques.
With respect to steroid hormone assays, few laboratories have committed 
themselves to EIA and the necessary reagents have not become commercially 
available: this is related to several factors. Many endocrinology laboratories 
have considerable capital invested in radioisotope counting equipment and 
cannot immediately justify the change. Many heterogeneous EIA procedures offer 
little advantage in time and convenience over RIA (particularly where *^I- 
labelling is used). As a result EIA remains relatively untested and its 
potential advantages undeveloped. On the other hand, unspecialised laboratories 
which could justify the performance of steroid assays but baulk at the cost 
and regulatory strictures imposed by the use of isotopes may, for the above 
reasons, remain unconvinced that EIA procedures are simple or reliable enough 
to offer a viable alternative. Finally, EIA sensitivity has been poor compared 
with that achieved using tritium labelling because large differences may exist 
in the affinity of antibody binding with enzyme-labelled steroid as opposed 
to unlabelled steroid (van Weemen & Schuurs, 1975).
It is apparent, therefore,that to fully capitalize on the potential of EIA, 
assay performance (sensitivity, accuracy, precision) at least equivalent to 
that of RIA must be demonstrated along with a degree of practicability exceeding 
that of RIA. Problems associated with the attainment of these goals and how 
they may be circumvented are discussed below.
1.9.1. Sensitivity and Precision in Hapten EIA
It is not absolute sensitivity which is prime importance in the development 
of an assay but whether the assay is sufficiently sensitive to detect clinically 
significant changes in the concentration of analyte. The assay of ovarian 
steroid hormones does, however, make demands on assay sensitivity since their 
concentration in tissues or body fluids may fall below the limit of detection
of a particular assay. Such demands are particularly apparent where direct 
addition procedures are preferred (i.e. the analyte is not extracted from 
the sample prior to assay and cannot therefore be concentrated) and where it 
may be desirable to minimize sample volume in order to limit non-specific 
interference.
The factors which influence sensitivity of EIA parallel those in RIA in 
most respects, sensitivity being essentially limited by avidity of antibody 
for analyte; and by the magnitude and nature of errors incurred in the 
measurement of the response. A fundamental objective in assay design should 
therefore be to maximize precision of measurement through the range of analyte 
concentrations designated as clinically important (Ekins, 1976).
Sensitivity has been variously defined by numerous analysts and has been 
discussed in the context of EIA (van der Waart & Schuurs, 1977). . .
-The limit of detection of an assay may be. defined as the smallest 
amount of analyte giving risfe to a response significantly different. 
from zero at the 95% confidence limit (Abraham, 1975). Expressions giving a 
useful indication of the sensitivity of the dose-response curve include the 
slope of the calibration curve at a defined concentration of analyte (Yalow 
& Berson, 1968; Ekins, 1974) and the concentration of analyte resulting in a 
defined reduction in binding (e.g. 50%; Feldman & Rodbard, 1971; Bolton & 
Hunter, -1973;. An assessment of the proportion of label bound in the presence 
of a defined mass of analyte enables useful comparisons to be made during assay 
optimization where a maximal response is required at that concentration.
Ekins (1976) has stressed the importance of precision of determination 
irrespective of which expression is used. The precision component 
is related to the size of the signal, manipulative errors such as occur in 
preparation and addition of solutions and misclassification errors associated 
with incomplete separation of free from bound label (Hunter, 1978).
1.9.2. The Characteristics of the Antiserum and Label: Homologous and Heterolo­
gous EIA
No reports have been found of studies investigating directly the effect of
the avidity between antibody and enzyme-labelled analyte on the sensitivity 
of EIA. Experience with RIA, however, would indicate that antibodies of highest 
avidity for analyte would enable attainment of maximum sensitivity: sensitivity 
would be expected to decrease when the affinity for labelled analyte was 
significantly higher or lower than that for unlabelled analyte (Ekins, Newman 
& O'Riordan, 1968; Exley, 1978). Certainly, steroid RIA utilizing internal 
tritium labelling has commonly been shown to give rise to assays of sensitivity 
(as assessed both by limit of detection and calibration curve slope) superior 
to EIA’s employing labels formed from steroid derivatives identical to those 
used in producing the immunogen (i.e. homologous label). This phenomenon was 
first demonstrated for the EIA of oestrogens (van Weemen & Schuurs,
1975 & 1976). This reduced sensitivity is thought to arise as a result
of a higher binding affinity for the enzyme - labelled analyte than for 
the analyte itself. This arises because the antigenic determinant of the 
steroid immunogen consists of not only the steroid but also the chemical 
bridge of its derivative and the lysine residue (and adjacent amino acids of 
the protein) to which it is covalently attached (Gilby & Jeffcoate, 1973; 
Jeffcoate, Gilby & Edwards, 1973).
Steroid-enzyme conjugates in which the same steroid derivative was used 
to couple with lysine residues on the enzyme as on the carrier protein would 
thus be expected to possess near identical antigenic determinants to those of 
the immunogen. As a result, a higher antibody binding affinity for the steroid- 
enzyme conjugate would be anticipated than for the steroid hormone and the 
latter would not compete so effectively for antibody binding sites. An analo­
gous reduction in sensitivity arises from the use of steroids externally 
labelled with 125i (Cameron, Scarisbrick, Morris et at, 1974).
Attempts have been made to reduce affinity for the labelled analyte by 
attaching the enzyme to a different carbon atom on the steroid nucleus (site 
heterology) or at the same carbon atom but using a different bridge (bridge
heterology) or a combination of the two. These approaches have been effective 
in increasing sensitivity of EIA for oestradiol (van Weemen & Schuurs, 1975 
& 1976 ; Exley & Abuknesha, 1977), cortisol (Arakawa et at, 1979) and testost­
erone (Bosch, Stevens, van Wijngaarden & Schuurs, 1978a; Hosoda, Yoshida, Sakai 
et at, 1980) although no comparisons of sensitivity were made with RIA.
Several authors have, however, noted decreased assay specificity in hetero­
logous systems particularly when site or site and bridge heterology was used 
(van Weemen & Schuurs, 1975; van Weemen, Bosch, Dawson et at, 1978; Hosoda 
et at, 1980): this can be explained in terms of steric hindrance' of important 
antigenic determinants on the steroid-enzyme conjugate permitting preferential 
binding to less specific molecules in the antibody population.
EIA's for progesterone have largely been of the homologous type (Dray et at, 
1975; Joyce et at, 1977 & 1978a; Nakao, 1980):only preliminary investigations 
of heterologous systems have been made (Gros,Flecheux-& Dray,1978; Joyce,Read &
l
Riad-Fahmy,1978b).
Proof of the general applicability of particular heterologous combinations 
would obviously require demonstration of sensitivity comparable with that 
produced using RIA (tritium label) using a large number of antisera. In the 
particular case of progesterone EIA, the heterologous conjugate would usefully 
be compatible with progesterone Ha-hemisuccinate antisera since in the short 
term these are most widely available. Any improvement in sensitivity should 
not, however, be at the expense of specificity.
1.9.3. The Choice of Enzyme and Substrate
Numerous criteria have been cited as important in the selection of a 
particular enzyme for use in EIA (Landon et at, 1975; Schuurs & van Weeman,
1977). Of importance to assay sensitivity are enzyme specific activity and the 
sensitivity of detection of the product since these directly determine the size 
of signal at the assay end-point: the smaller the quantity of label which can 
be used and subsequently measured with precision, the greater will be the 
potential sensitivity (Yalow & Berson, 1968; Ekins, 1976). Only enzymes which
are available in a highly purified state should be used since protein impurities 
can also give rise to antigenic products. Of practical importance are availa­
bility, cost, the stability of the enzyme (and its conjugate), the speed and 
ease of estimation of enzyme activity and the safety of the reagents used. The 
enzyme chosen should preferably be absent from the test sample as should
■ ' npotential modulators of its activity. In practice, however, such sources of 
interference can usually be eliminated during the assay when free and bound 
enzyme-label are separated.
Although few enzymes fulfill all these criteria several have been employed 
in steroid immunoassays and these include 8-galactosidase (from E. col-i) , 
alkaline phosphatase (from calf intestinal mucosa), penicillinase (from B.cereus) 
glucoamylase (from Rhtzopus niveu§ and horse radish peroxidase (van Weemen & 
Schuurs, 1972; Dray et at, 1975; Tateishi, Yamamoto, Ogihara & Hayashi, 1977; 
Kobayashi, Ogihara, Amitane et at, 1978; Joshi, Shah & Sudhama, 1979). These 
can all be assayed with great sensitivity of the same order of magnitude and 
are available commercially at high purity and reasonable cost.
For optimum end-point determination, the choice of substrate may be a matter of 
compromise. For alkaline phosphatase (from calf intestine mucosa) phenyl phos­
phate gives a higher maximum velocity than any other substrate but the product, 
phenol, has a relatively low extinctijb2 coefficient. Para-nitrophenyl phosphate 
provides greater sensitivity of detection since its product p-nitrophenol has 
a far higher extinction coefficient than phenol (Bowers, Kelly & McComb, 1967). 
Although availability of equipment may dictate that colorimetric end-points 
are used, 3-galactosidase, alkaline phosphatase and peroxidase may also be 
assayed using substrates with fluorescent products. This may increase the 
sensitivity of enzyme detection by an order of magnitude (van der Waart &
Schuurs, 1977; Ishikawa & Kato, 1978; Arakawa, Maeda & Tsuji, 1979).
1.9.4. Methods of Formation of Steroid-Enzyme Conjugates
The coupling of steroids to enzymes can be achieved using procedures 
identical to those used in formation of immunogens (Schuurs & van Weeman, 1977;
a) Carbodiimide reaction
0 R ’N=C=NR2 0 H
H.pten-C? (Ca^odli^ide^ _'HEnzyme
OH -H20
(eg.progesterone 
hemisuccinate)
Enzyme-NH2
b) Mixed anhydride reaction.
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Fig.1.6 Summary of the carbodiimide and mixed anhydride reactions
O ’Sullivan et at, 1979; Sauer et at, 1982a). In the majority of instances 
attachment to the enzyme has been through formation of peptide bonds between 
the carboxyl group of a steroid derivative and e-araino groups of lysine 
residues of the enzyme. The condensation reaction has almost exclusively 
involved use of the mixed anhydride or the carbodiimide method (see Sauer et at, 
1982a): both methods (Fig. 1.6) have been used in the formation of progesterone 
conjugates with either 3-galactosidase or horse radish peroxidase. 8-Galacto- 
sidase linked to progesterone lla-hemisuccinate using the carbodiimide method 
provided the label first used in progesterone EIA (Dray et at, 1975) and 
similar procedures have been adopted in other laboratories (Patricot, Poggi & 
Revol, 1978; Seeger, Thurow, Haede & Knapp, 1979; Nakao & Kawata, 1980). In 
contrast Joyce, Read & Fahmy (1977 ) used progesteronella-hemisuccinate-peroxidase 
conjugate as label, prepared by the mixed anhydride procedure: their reaction 
conditions were subsequently refined (Dawson, Denisson & van Weemen, 1978;
Joyce, Othick, Read & Riad-Fahmy, 1981) and adopted by others (Kamonpatana, 
van de Wiel, Koops et at, 1979).
In producing enzyme-labelled analytes to provide maximum sensitivity in 
heterogeneous EIA it is of utmost importance that the immunoreactivity of the 
analyte and the catalytic activity of the enzyme remain unaltered. These aims 
may be achieved by the use of conjugation methods which avoid reaction between
the condensation reagents and the enzyme (minimizing co-conjugation) and by 
incorporation of analyte in such a way that binding with antibody will not be 
subsequently sterically hindered.
It might be anticipated that the use of water soluble carbodiimides for 
the condensation of progesterone derivatives with enzymes would result in 
appreciable loss of enzyme activity since the reagent is normally used in 
appreciable excess ( 1 0 0 times the steroid concentration) and in the presence 
of the enzyme. Dray et at (1975), however, reported recovery of 89% of enzyme 
activity following conjugation of progesterone lld-hemisuccinate with 
3-galactosidase: others using this method of conjugation did not report a 
recovery rate (Patricot et at, 1978; Seeger et at, 1979; Nakao, 1980; Nakao,
& Kawata, 1980). In contrast, when a similar procedure was used for conjugation 
of oestradiol-173-6-(Q-carboxymethyl)oxime, with 3-galactosidase, Exley and 
Abuknesha (1977) reported appreciable loss of enzyme activity which necessi­
tated the use of affinity chromatography for removal of denatured enzyme.
Formation of steroid mixed anhydrides on the other hand necessitates 
anhydrous conditions and subsequent addition of this reactive intermediate to 
aqueous enzyme should circumvent the possibility of "activation" and thus 
polymerization of the enzyme: in theory then, this method should be preferable 
to the carbodiimide procedure. The enzyme activity of progesterone-enzyme 
conjugates formed by the mixed anhydride procedure has not generally been 
reported, although Comoglio and Celada (1975) and Arakawa et at (1979) reported 
values of 80% and 40% of the original activity for conjugation of cortisol 
derivatives with 3-galactosidase and peroxidase respectively. It is not clear 
which is the conjugation method of choice since both give rise to some loss of 
enzyme activity. Both methods would also appear to be inefficient in incorpor­
ation of steroids into the enzyme. Dray et at (1975) reported that use of a 
1 0 0 molar excess of progesterone lla-hemisuccinate resulted in conjugation of 
only 26% of 3-galactosidase molecules by the carbodiimide method. Joyce et at 
(1977), using the mixed anhydride procedure, reported that only six steroid 
molecules were incorporated into peroxidase when a fifty molar excess of
derivative was employed. Similarly, with other haptens, a 1000 fold molar excess of 
hapten was required at conjugation to produce conjugates of sufficient immuno- 
reactivity when the mixed anhydride procedure was used (Comoglio & Celada,
1975; Al-Bassam, O ’Sullivan, Bridges & Marks, 1979). In theory, optimum immuno- 
reactivity and specific activity (enzyme activity/mol steroid) would be 
obtained by incorporation of one progesterone molecule per enzyme (Exley & 
Abuknesha, 1977).
For optimum sensitivity it is essential that excess unreacted analyte 
is removed following conjugation. With progesterone conjugates it has 
been widely reported that this can be adequately achieved by dialysis and/or 
gel filtration. The presence of unconjugated enzyme has not generally presented 
a problem in heterogeneous EIA since unconjugated enzyme can be washed away when 
free and bound analyte are separated.
1.9.5. Separation of Free from Antibody-Bound Label
Separation of free from antibody bound enzyme-label may be achieved in 
several ways (see Table 1.2.). The method most commonly employed in steroid 
EIA has been double antibody precipitation (see Table 1.1.). Although simpler 
to perform and involving fewer steps, solid phase procedures have proven less 
popular, possibly because they have been less tried and tested in RIA procedures.
Since all reagents remain in solution until the precipitating second antibody 
is added the double antibody method offers.the advantage of better availability 
of primary antibody to the other reagents: as a result, antibody binding proceeds
more rapidly. It has been suggested that this may result in assays of improved 
sensitivity (Joyce et al, 1978a) although this has not proved to be a 
general finding (Arakawa et al, 1979; van Weemen et al, 1979).
In the diagnosis of infectious diseases by immunoenzymoraetric methods (enzyme- 
linked immunosorbent assay, ELISA) the well walls of disposable plastic micro- 
titre plates (96 wells per pla.te) have been used as the solid phase and have 
proved to be the most convenient and popular means of separation (Voller,
Bidwell, Huldt & Engvall, 1974; Voller, Bidwell & Bartlett, 1976a,b). Although
Table 1 .2 Methods of Separating Bound from Free Label
1. Polyethylene glycol precipitation (Osterman et al3 1979)
2. Double antibody precipitation (Comoglio & Celada, 1976; Joyce et al3 1978a)
3. Double antibody solid-phase (Comoglio & Celada, 1976; Bosch et al3 1978b)
4. Solid-phase primary antibody:
Agarose, cellulose, magnetisable cellulose (covalent binding: Engvall
& Perlmann, 1971; Kato et als 1975; Guesdon & Avrameas, 1977; Joyce 
et al3 1977; Turkes et al3 1982) .
Polycarbonate-coated, polystyrene or nylon balls (covalent or passive 
binding: Miranda et al3 1977; Smith & Gehle, 1977; Hendry & Herrman,
1980).
Polystyrene test tubes (passive binding: Engvall & Perlmann, 1972;
Stimson & Sinclair, 1974; Voller et al3 1975).
Polystyrene or polyvinyl microtitre plates (passive binding: Voller
et al3 1976a, 1976b; Sauer et al3 1982a).
this method had not previously been applied to the assay of haptens, it shows 
great potential where large numbers of determinations are to be performed. 
Problems associated with well-to-well variations in antibody binding have been 
noted by a number of investigators, however (Denmark & Chesum, 1978a & 1978b; 
Halliday & Wisdom, 1978; Standefer & Saunders, 1978; Burt, Carter 8s Kricka,
1979; Kricka, Carter, Burt et al, 1980) and these must be resolved if micro- 
titre plates are to be used for the reliable quantitation of steroid hormones.
1.9.6. Non-Specific Effects and EIA Performance
Non-specific adsorption of enzyme-1abel, interference with specific binding 
and factors interfering with determination of enzyme activity may be expected 
to considerably reduce assay performance. Such influences have not generally 
been reported in steroid EIA, however, since the majority of procedures involve 
extraction of the analyte prior to assay (Table 1.1).
The adoption of adequate wash procedures in direct addition assays should, 
however, eliminate the influence of endogenous enzyme, modulators of activity 
or non-specific binding of the label to the assay tube if enzyme activity is 
measured in the bound fraction (Schuurs & van Weemen, 1977). The inclusion of 
detergent or high concentrations of salt or protein (gelatin or bovine serum 
albumin) in buffers used during wash procedures or at the immuno-incubation stage 
respectively have been reported as effective in reducing or circumventing non­
specific binding (Engvall & Perlmann, 1971; Engvall, Jonsson & Perlmann, 1971; 
Engvall & Ruoslahti, 1979; Saunders, 1979). It has been long recognised that 
endogenous steroid binding proteins interfere with the direct RIA of plasma 
steroids by competing with specific antibody to bind the steroid (see 
section 1.8.4). Although there have been few reports of direct EIA’s 
of steroids in plasma, problems associated with EIA of progesterone 
(Riad-Fahmy, Read, Joyce & Walker, 1981) and cortisol (Ogihara, Miyai, Nishi 
et al, 1977) were reported to be appreciably reduced by use of lowered pH of the 
immunoreaction and prior heating of the sample■, respectively.
Since milk represents a rich source of potentially interfering substances
including lipids, binding proteins (casein) and enzymes (see Renner, 1983) the 
direct measurement of steroids in milk may require particularly rigorous wash 
procedures. Two of the most commonly used enzymes in EIA, alkaline phosphatase 
and peroxidase (catalase) are present in milk in the fat globule membrane 
and in whey, respectively. The latter represents 1% of whey proteins (Renner, 
1983). The concentration of both these enzymes has been reported to increase 
during disorders of milk secretion (Andrews & Alichanidis, 1975; Bingham & 
Kalan, 1967).
1.9.7. Limitations of Existing Progesterone EIA Methods and Potential for 
Improvement
With few exceptions steroid EIA procedures reported up to the early 1980’s 
either represent procedures in which the steroid had been extracted prior to 
assay or model systems.not tested or fully validated by the assay of samples 
(see Table 1.1.). Direct addition procedures for progesterone determination in 
human plasma (Patricot et al, 1978) and cream (at dilution) from cows milk 
(Nakao & Kawata, 1980) have, however, been reported but full validation details 
were not provided in either case. The data obtained for progesterone determina­
tion in cream indicated that only 50% of the progesterone content was 
detected but no explanation of the discrepancy was offered.
The main shortcomings of current progesterone EIA's are related to poor 
sensitivity and lack of practical advantages compared with RIA.
Although Dray .et. al (1975) reported an EIA for progesterone which was 
comparable in sensitivity with RIA both in terms of limit of detection and 
slope of standard curve it is apparent from reports by others using the same 
procedures (Gros, Flecheux & Dray, 1978; Patricot et al, 1978; Nakao, 1980; 
Seeger et al, 1979) that this may have been an exception to the general case. 
Typically, these homologous procedures together with that developed by Joyce 
et al (1978a) provide calibration curves with limits of detection of the same 
order as those using 3H-labelled progesterone but of much reduced slope. This 
is considered to limit severely the possibility of developing reliable, simple
EIA systems.
In previous sections, numerous economic advantages have been described which 
justify the investigation of EIA techniques to develop the means for performing 
estimations of progesterone concentrations in milk. Improvements permitting 
extension of its use to the veterinary practice or possibly to the farm itself 
would enable prediction of the time of oestrus, pregnancy diagnosis and assess­
ment of ovarian status to be rapidly performed.
Development of microtitre plate procedures for steroid EIA would considerably 
simplify the speed and ease with which all stages of EIA (pipetting, separation 
of free from bound label and washing the bound phase) can be performed. Such 
procedures could be automated through the availability of multi-channel 
dispensers and automatic microtitre plate readers. Dramatic improvements in 
sensitivity through judicious use of heterologous systems may enable further 
extension of the areas of application if they facilitate the development of 
assays, the end-point of which can be assessed by eye.
1.10. OBJECTIVES OF STUDY
The objectives of this study were (a) primarily to develop a simple and 
reliable enzymeimmunoassay for progesterone in milk and investigate the factors 
affecting its sensitivity and (b) to investigate the application of such a test 
to the breeding of dairy cattle by artificial insemination.
CHAPTER 2:
MATERIALS AND GENERAL METHODS
2.1. MATERIALS AND REAGENTS.
All reagents were of an analytical grade unless otherwise specified.
2.1.1. General Reagents
Hydrochloric, sulphuric, acetic, citric (H2O), formic, boric and 
diethylbarbituric acids, sodium bicarbonate, sodium chloride, cupric 
sulphate (5H2O) , potassium sodium (+)-tartrate (4^0) , ci^-sodium hydrogen 
orthophosphate (I2H2O), sodium dihydrogen orthophosphate (2H2O), tris 
(hydroxymethyl)aminomethane , sodium acetate (3H2O), trt-sodium citrate 
(2H2O), ammonium sulphate, Folin and Ciocalteau’s phenol reagent, molecular 
sieve (type 3A), microcrystalline cellulose and all organic solvents were 
obtained from BDH Chemicals Ltd (Poole). Sodium azide, 2-mercaptoethanol, 
sodium ethylmercurithiosalicylate (Merthiolate), 6,9-diamino-2-ethoxyacridine 
lactate (Rivanol), polyoxyethylenesorbitan monolaureate (Tween 20), chicken 
egg albumin (ovalbumin, grade V), diethanolamine and activated charcoal 
(untreated powder) were obtained from the Sigma Chemical Company Ltd 
(Poole). Bovine serum albumin (BSA, puriss) was purchased from Koch-Light 
Laboratories Ltd (Haverhill), gelatin and Freunds adjuvant (complete and 
incomplete) from Difco Ltd (West Molesey, Surrey) and Decon 90 from 
Scientific Supplies Ltd (London). Plastic "cling" film was supplied by 
Payne Scientific Apparatus (Croydon).
2.1.2. Water
Water was softened (Aldous & Stamp Ltd, Beckenham), glass-distilled 
and deionized (Elgastat B102, Elga Group, High Wycombe) prior to use and 
is subsequently referred to as deionized water.
2.1.3. Unlabelled Steroids
lla-hydroxyprogesterone 11-hemisuccinate (progesterone lla-hemisuccinate) 
and lla-hydroxyprogesterone 11-hemimaleate (progesterone lla-hemimaleate)
were synthesized as described in sections 3.2.1a. and 3.2.1b. respectively. 
lla-Hydroxyprogesterone 11-3-D-glucuronide (progesterone lla-glucuronide; 
Corrie et al, 1981a) was a gift from Dr J.E.T. Corrie (MRC Immunoassay Team, 
Edinburgh). Progesterone (pure) was purchased from Koch-Light Laboratories 
(Colnbrook) and all other steroids from Steraloids Ltd (Croydon).
2.1.4. Tritium and Carbon-14 Labelled Steroids
(1,2,6,7-3H)Progesterone (80Ci/mmol) and (1,4-1 4C)succinic anhydride 
(80mCi/mmol) were obtained from Amersham International PLC (Amersham) and 
(11+C)formaldehyde (53mCi/mmol) from New England Nuclear Ltd (Southampton). 
Progesterone 11a-(1,4-11+C)hemisuccinate was prepared as described in section 
3.2.1a.
2.1.5. Reagents for Chemical Condensation Reaction
N,N*-dicyclohexylcarbodiimide, N-hydroxysuccinimide, succinic and maleic 
anhydrides, sodium cyanoborohydride, cyanogen bromide and nickel (II) chloride 
(6H2O) were purchased from the Sigma Chemical Company, tso-butylchloroformate, 
pyridine, tri-n-butylamine and dimethylformamide from BDH Chemicals Ltd and 
N,N’-disuccinimidyl carbonate from the Aldrich Chemical Co. Ltd (Gillingham).
2.1.6. Enzymes and Enzyme Assay
E, colt 3-galactosidase (grade VIII), alkaline phosphatase from calf 
intestinal mucosa (type VII-T), horseradish peroxidase (peroxidase, type VI) 
and B. ceveus penicillinase (type 1) and their respective substrates and 
chromogens 0-nitrophenyl-3-D-galactopyranoside, p-nitrophenyl phosphate, 
hydrogen peroxide (30%) and c-phenylenediamine (dihydrochloride) and phenoxy- 
methylpenicillinic acid (penicillin-V), hydrolyzed starch (potato) and iodine 
were all obtained from the Sigma Chemical Company.
2.1.7. Antisera
Antisera were produced using either progesterone lla-hemisuccinate-BSA or
progesterone lla-hemisuccinate-ovalbumin conjugate as immunogen as detailed 
in Table 2.1.
Table 2.1 Details of antiprogesterone sera.
Antiserum Code Species Immunogen Source*
S
Method of
•y-globulin
Preparation
G711/12 Goat Progesterone 11a- 
hemisuccinate-BSA
NIRD1 Rivanol
AF18/3 Sheep If
2
MMB ft
R54/10/5 It ft IRAD3 ft
HP/E/645 111C ft Progesterone lla- 
hemisuccinate-ovalbumin
GUILDHAY4 ft
S1509/16 ft tt CBC <NH4>2S°4
S360/10 ft ft 11 tt
S263/10 It 11 11 tt
* See Glossary for full institute and establishment names. 1 - 4 = Gifts from 
1. Dr. G.S. Pope; 2. Mr. R.G. Holdsworth; 3. Ms. E. Watson; 4. Mr. B.A. Morris.
5. = Produced as described in section 2.3.1.a) and 2.3.l.b).
5 See section 2.3.l.e) and 2.3.1.f).
2.1.8. Buffer Solutions
All buffers and aqueous solutions were prepared in deionized water (see 
section 2.1.2.). • .
a) Phosphate based buffers. Phosphate buffers (0.1M, pH7.0) were prepared 
with disodium hydrogen orthophosphate and sodium dihydrogen orthophosphate 
with sodium chloride (0.9% w/v; PS buffer), sodium azide (0.1% w/v; PAS buffer) 
and gelatin (0.1% w/v; PAS-gelatin buffer) added. PMS and PMS-gelatin buffers 
were prepared in the same manner but contained sodium ethylmercurithiosalicylate 
(Merthiolate; 0.01% w/v) as preservative instead of sodium azide.
b) Tris (hydroxymethy I) amindmethane (Tris). TAS buffer was prepared 
with Tris (O.lM or 1M)containing sodium chloride (0.9% w/v) and sodium azide 
(0.1% w/v) and was adjusted to pH 8.5 or pH 9.0 with HC1 (conc.).
o) Diethanolamine. DAM buffer was prepared with diethanolamine (1M) and 
contained magnesium chloride (O.SmM) and sodium azide (0.1% w/v) and was 
adjusted to pH 9.8 with HC1 (conc.).
d) Britton-Robinson. (See Dawson, Elliot, Elliot & Jones, 1974). A 
1 litre solution of citric acid (0.031M), potassium dihydrogen phosphate 
(0.0286M), boric acid (0.0286M) and diethylbarbituric acid (0.0286M) was 
prepared and 100ml of the solution titrated against sodium hydroxide sol­
ution (0.2M) to give the required pH. The solution was diluted to provide 
the appropriate molarity and the pH adjusted if required.
e) Citrate. Citric acid solution (O.lM) was titrated against tri-sodium 
citrate solution (0.1M) to provide the appropriate pH.
f) Acetate. Sodium acetate solution (O.lM) was titrated against acetic 
acid (O.lM) to provide the appropriate pH. For preparing antibody solutions 
for coating to microtitre plate wells, a stock solution (0.1M, pH 5.0) was 
prepared, stored frozen and thawed as required. On dilution to the working 
concentration (l.mM or 0.17mM) it was not generally necessary to correct 
the pH.
2.1.9. Substrate Solutions for Determination of Enzyme Activity
Concentrations of substrates and chromogens were optimized as described 
in section 4.3. All substrate solutions were prepared on the day of use.
a) B-Galactosidase. O-Nitrophenyl-ft-D-galactopyranoside (10mM) was 
prepared in PAS-gelatin buffer, pH 7.0,containing magnesium chloride (0.01M) 
and mercaptoethanol (O.lM).
b) Alkaline phosphatase. p-Nitrophenyl phosphate (15mM) was prepared in 
DEM buffer, pH 9.8 and stored in the dark until used.
a) Peroxidase. The substrate/chromogen solution contained hydrogen 
peroxide (7.1mM) and o-phenylenediamine (22.1mM) and was prepared in PMS- 
gelatin buffer.,pH 6.0 and stored in the dark until used.
d) Penicillinase. The substrate/indicator reagent was prepared 15 minutes 
before use by addition of iodine solution (15mM, 0.75ml), starch solution 
(2% w/v, 6.5ml) and penicillin-V (12.5mM in PS buffer, 0.65ml) to 58.5ml of 
PS buffer pH 7.0. Stock iodine solution (80mM prepared in 3.2M potassium 
iodide) was stored in an amber bottle at room temperature (20 - 22°C) and 
diluted in PS buffer as appropriate on the day. Starch solution (2%) was 
prepared fresh daily by boiling hydrolysed starch for 2 - 3  minutes in 
PS buffer.
2.1.10. Progesterone Standard Solutions for Immunoassays 
Progesterone (100yg/ml methanol) was added (0.1ml/20ml) to whole milk
collected from an ovariectomised cow (ovX milk) and preserved as described 
in section 2.3.7. This solution was further diluted with the same milk to 
provide standards (milk standards) containing 0-80ng of progesterone/ml. 
Buffer standards were prepared in PAS-gelatin buffer in the same manner.
2.1.11. Microtitre Plates
Microtitre plates were purchased from four sources; Falcon polyvinyl 
chloride (PVC) plates from Becton & Dickinson (Oxford), Flow PVC (flat 
bottom, high activated) and polystyrene (sterile, flat bottom) plates from 
Flow Laboratories Ltd. (Rickmansworth), Dynatech PVC (M29) and polystyrene 
(M129B) plates from Dynatech Laboratories Ltd. (Billingshurst) and NUNC 
polystyrene plates (Immunoplate type IF) from GIBCO (Uxbridge).
2.2. EQUIPMENT.
2.2.1. Liquid Handling
All repetitive pipetting was performed using positive displacement
pipettes manufactured by SMI Ltd. (Alpha Laboratories, Eastleigh),
Soccorex Ltd. (Camlab Ltd., Cambridge) or Brand Instruments Ltd. 
(Transferpettor, A.R. Horwell Ltd., London). A BCL 500 dispenser (BCL Ltd. 
Lewes) was used for repetitive dispensing of aqueous reagents (50 - 500yl) 
and a Nichiryo dispenser (Chemlab Instruments Ltd. Hornchurch) for dispen­
sing solvents or scintillation cocktails. An 8-channel peristaltic 
dispenser (Micro Compu-Pet Multi-Dilutor, General Diagnostics, Abingdon) 
was used for addition of antibody solutions or PAS-gelatin buffer to wells 
of microtitre plates as appropriate.
2.2.2. Centrifugation
An MSE super minor centrifuge (MSE Ltd., Crawley) was used for the 
majority of procedures; larger samples (>500ml) were centrifuged using an 
MSE Coolspin.
2.2.3. Photometry
Absorbance determination was performed using a Cecil CE292 spectro­
photometer (Cecil Instruments, Cambridge) fitted with an autosampling 
attachment. A flow cell (10mm path length, 70yZ- capacity) was installed to 
enable continuous monitoring of effluent from chromatography columns. A 
Dynatech MR580 plate reader (Dynatech Laboratories) was used for in situ 
absorbance measurements of solutions in microtitre plate wells: the bases
of wells were wiped clean and dry with a soft absorbent tissue beforehand.
2.2.4. Freeze Drying
An SB4 Laboratory Freeze Dryer (Chemlabs Ltd., Ilford) was used for all 
freeze drying processes. Samples were shell-frozen where possible over a 
liquid nitrogen bath.
2.2.5. Sample Mixing
Samples were vortex mixed as appropriate either singly or in batches 
using a Rotamixer (Scientific Supplies Ltd.) or V100 Multivortex Mixer 
(Denley Instruments, Billingshurst) respectively.
2.2.6. Dialysis
o
Dialysis procedures were performed at 4 C in knotted Visking tubing 
(4" inflated diameter; Scientific Instruments Ltd., London) with constant 
stirring provided by a magnetic stirrer (Voss Ltd., Maldon) and follower.
2.3. METHODS.
2.3.1. Antibody Production and Purification
a) Formation of immunogen. Progesterone lla-hemisuccinate-ovalbumin con­
jugate was used as immunogen and was prepared by a modification of the direct 
active ester procedure (section 3.2. 4.a ). N-hydroxysuccinimide (550ymol 
in 1ml dry dioxan ) and dicyclohexylcarbodiimide (550ymol in 1ml dry dioxan) 
were added to progesterone lla-hemisuccinate (500ymol in 2ml dry dioxan), 
the mixture stirred for 1 hour at room temperature (20 - 22°C) and acetic 
acid (34yl = 250 ymol) added. After stirring for a further 15 minutes, the 
insoluble by-product dicyclohexylurea was removed by centrifugation (2,0 0 0g 
for 10 minutes). The active ester solution (3.7ml) was slowly added to a 
continuously stirred ovalbumin solution (500mg; ll.lymol, dissolved in 50ml 
PS buffer) to which 25ml distilled water and 25ml dioxan were added (to 
maintain solution of buffer salts and the active ester) and stirring con­
tinued for a further 3 hours. The products were shell frozen in a conical 
flask (250ml) and then freeze dried. Addition of deionized water (8ml) to 
the lyophilysate revealed that a large proportion of the conjugate was 
insoluble. To facilitate removal of unconjugated steriod, the insoluble 
component was separated by centrifugation (1600g for 10 minutes) and the
pellet washed with 3 x 100ml methanol over a glass Buchner funnel before 
drying under vacuum. Purification of the soluble component was achieved 
by passage through a Sephadex G25 column (swollen in distilled water, 50ml 
bed volume) and elution with distilled water. The fraction eluting at the 
void volume was freeze dried and mixed with the dried insoluble fraction. 
The white powder (0.463g) constituted the progesterone lla-hemisuccinate- 
ovalbumin immunogen.
b) Immunization of sheep and collection of blood samples. The immunogen 
was prepared for inoculation in an emulsion of sterile saline (0.9%) and 
Freunds complete (primary inoculation) or incomplete (subsequent "boost" 
inoculations) adjuvant in a ratio of 1:3 v/v using a Silverson laboratory 
homogenizer (Silverson Ltd., Chesham) at full speed for ten minutes. Inoc­
ulations (0.5ml), two per limb, were by deep intramuscular injections of 
the emulsion through a 20g x 1^" needle, (4ml in total, containing 2mg or 
lmg of immunogen/animal for primary and boost inoculations respectively).
In the forelegs, the inoculation was made into the triceps muscle of the 
upturned sheep and in the hindlegs, into the medial aspect of the quadriceps 
femoris. Booster injections were given at intervals of one to three months 
and blood ('MSSOml) collected 7 - 1 0  days later from the jugular vein, via
a 12g x 2\" needle and plastic tube, into a plastic centrifuge bottle. The 
blood was allowed to clot and the clot to contract (1 - 2  hours at room 
temperature + 1 hour at 37°C) before separation of the antiserum follow­
ing centrifugation (Coolspin, 2,600g for 1 hour).
c) Assessment of antiserum titre. Antiserum titre is defined as the
3
dilution of antiserum at which 50% of ( H) progesterone is bound in the
absence of competing steroid. This was determined by incubation of serial
3dilutions of antiserum with ( H) progesterone in accordance with the RIA 
procedure described below (section 2.3.4.).
d) Absorption of carrier-prdtein antibodies from antisera. A procedure 
modified from that of Thorneycroft et al (1970) was used. Aliquots of antiserum 
(100 yl) were placed in conical glass test tubes and ovalbumin or BSA solut­
ion (10 yl in 1M TAS buffer pH 8.5), over the concentration range 0.125 - 
64mg/ml, added. The tubes were stoppered and incubated for 1 hour at 37°C
and a further 3 days at 4°C before separation of the immunoprecipitate by 
centrifugation (15 minutes at 1600g). The supernatant was aspirated off and 
the pellet resuspended and washed with 0.1M PAS pH 7.0 (4ml). Following 
centrifugation and removal of the supernatantf the wash cycle was repeated 
and the protein pellet dissolved in 0.5M sodium hydroxide solution (1ml, 
containing 0.1% sodium azide). The concentration of carrier protein which 
gave rise to maximum antibody precipitation (the point of equivalence) was 
subsequently determined either by quantitative determination of protein 
concentration by the method of Lowry et al (1951), using standards prepared 
in 0.5M NaOH solution (section 2.3.2.) or relatively by comparison of 
estimates of absorbance of the NaOH solutions at 280nm. Larger batches of 
antiserum for use in EIA and RIA were subsequently absorbed in an identical 
fashion by addition of the equivalent quantity of protein. Following centri­
fugation the supernatant was retained and stored at -20°C until required.
e) Preparation of the y-globulin fraction of antisera using 63 9-diamino-2- 
ethoxyacridine lactate (Rivanol). The treatment of sera with Rivanol at an
appropriate pH (Thorneycroft et al, 1970) results in precipitation of the 
majority of serum proteins leaving the globulins in solution (Horejsi and 
Smetana, 1956).
Treatment of goat or sheep antiserum with 0.4% Rivanol in O.lM PAS 
(pH 6 , 7 and 8) or TAS (pH 7 and 8 ) buffer (4 volumes) was found to provide 
maximum recovery of antiprogesterone T-globulin (by RIA) with the minimum of 
contamination by other serum proteins (assessed by polyacrylamide gel electro­
phoresis) when performed at pH 9.0 (pH range 6 - 1 0  tested) in the manner
described by Sauer, Cookson, MacDonald and Foulkes (1982a). Y-Globulin 
fractions of the carrier-protein-absorbed antisera detailed in table 2 . 1  were 
prepared by addition,whilst mixing, of 0.4% Rivanol (4 vol) in O.lM TAS 
buffer (pH 9.0) at room temperature (20 - 22°C). After 0.5 hour, precipit­
ated proteins were separated by centrifugation (3,000g, 0.5 hour) and the 
supernatant applied to a Sepha dex G25 column (bed volume ^ lOx supernatant 
volume) to enable removal of Rivanol. Elution with 0.01M phosphate buffer 
pH 7.0 containing 0.02% sodium azide enabled collection of they -globulin 
fraction at the void volume as detected by monitoring absorbance at 280nm. 
Y-Globulin solutions were stored frozen (-20°C) until required.
f) Preparation of the y-globulin fraction of antisera by ammonium 
sulphate precipitation. The method used was essentially that described by 
Garvey, Cremer and Sussdorf (1977). Carrier-protein-absorbed antiserum 
( 2 vol) was dispensed into a conical test tube and the level of the meniscus 
marked. Saturated ammonium sulphate solution (1 vol) was added dropwise, 
with continuous vortex mixing, to this and the preparation further mixed at 
intervals of 10 minutes. After 30 minutes the Y-globulin precipitate was 
separated by centrifugation (5 minutes at 1600g) and the supernatant aspirated 
off. The pellet was loosened by vortex mixing, dissolved in deionized water 
to the mark and the precipitation procedure repeated twice. The resulting 
Y-globulin solution was stored frozen (-20°C) until required.
2.3.2. Determination of Protein Concentrations,
The method used was essentially that of Lowry, Rosebrough, Farr and 
Randall (1951). The following reagents were required for the assay:
Solution A: Sodium carbonate solution (2% w/v) was prepared in O.lM sodium
hydroxide containing sodium azide (0.1%) and stored at 4°C 
until required.
Solution B: Cupric sulphate (SH^O) solution (0.5% w/v) was prepared fresh on
the day of use in potassium sodium (+)tartrate solution (1% w/v). 
Solution C: Solution A (100ml) mixed with solution B (2ml) on the day of use. 
Solution D: Folin-Ciocalteau reagent (2ml) diluted 1:2 in deionized water 
on the day of use.
Standard solutions of protein (BSA) in the range 0 - lOOyg/ml were prepared 
in PAS buffer or, for the assay of sodium hydroxide-hydrolysed protein, in 
sodium hydroxide solution (0.5M) and stored at 4°C until required. To deter­
mine protein concentrations, 2ml of solution C was added to 0.2ml of standard 
solution or sample, vortex mixed and left at room temperature (20 - 22°C) for 
a minimum of 10 minutes. Solution D (0.2ml) was then added, with immediate 
mixing and the samples left at room temperature for 30 minutes. Absorbance 
values were subsequently determined at 750:nm and protein concentrations of 
the samples determined by interpolation from the calibration curve calculated 
by linear regression.
2.3.3. Determination of Radioactivity
Radioactivity was determined using a Tricarb Model B2450 liquid scintil­
lation spectrometer (Packard Instruments Ltd., Caversham, Berkshire) with a 
radium-226 external standard. Quench correction was performed automatically 
by the external standard channels ratio method. The radioactivity of tritium 
or carbon-14-labelled compounds was measured in glass scintillation vials 
(20ml capacity) following addition of an appropriate scintillation fluid (7ml) 
to each vial: the scintillation cocktails and solubilizers used were obtained
from Packard Instruments Ltd. Hydrophilic radio labels in buffer solution 
(0.05 - 1.0ml) were counted in Instagel (xylene-based scintillation cocktail) 
or, following treatment with Soluene-350 (lml/0.01 - 0.2ml sample) for 3 hours 
at room temperature (21 - 23°C), in Toluene Scintillator (5g of 2,5- 
diphenyloxazole and O.lg of 1,4-Di-2-(5-phenyloxazolyl)-benzene per litre of 
toluene). Hydrophobic radiolabels in buffer solutions (0 . 0 1  - 1 .0ml) were
counted in Toluene Scintillator following mechanical shaking (1 hour minimum; 
shaking incubator, Mickle Ltd., Gomshall) to ensure complete partition and, 
in the case of progesterone RIA supernatants, dissociation of the steriod - 
antibody complex. Radioactivity adsorbed to bisected polyvinyl microtitre 
plate wells was counted in Filter Count (1, 2, 4-trimethylbenzene-based 
cocktail) following an incubation at room temperature for at least 24 hours: 
polystyrene wells were dissolved and counted in Toluene Scintillator.
2.3.4. Radioimmunoassay
RIA was performed in a manner similar to that described by Heap et al
(1976). Standards (lOyl, in quadruplicate) or samples (lOyl, in duplicate)
3
were pipetted into polystyrene test tubes. ( H)Progesterone: in PAS-gelatin 
buffer (200V11, = 7pg progesterone) and anti-progesterone y-globulin (lOOyl, 
equivalent to lOOPl of a 1/15,000 dilution of antiserum) in PAS-gelatin 
buffer were then added. The tubes were mixed and incubated overnight at 
4°C. Ice-cold PAS-gelatin buffer (500yl) was added to each tube and free 
( H)Pr°ges'terone separated from bound by the addition of dextran-coated 
charcoal suspension (200yl, containing 6.25mg charcoal/ml and 0.625mg dextran/ 
ml) in PAS-gelatin buffer at 4°C. After 10 minutes at 4°C,the tubes were 
centrifuged at l,600g (5 minutes), the supernatant poured into scintillation 
vials and the radioactivity determined following extraction into Toluene 
Scintillator (7ml). Concentrations of progesterone in the samples were 
determined by interpolation from the calibration curve fitted manually to 
the standard points with the aid of a flexible plastic curve.
2.3.5. Enzymeimmunoassay
Assays were based on the saturation analysis principle and were performed 
by addition of standard or sample and enzyme-labelled progesterone to micro­
titre plate wells previously coated with antibody. The competitive procedure
was performed under specified conditions and antibody-bound enzyme label 
quantified colorimetrically after rinsing away unbound label. Specific 
details are delineated in appropriate sections (Chapters 5, 6 and 7) since 
investigation of these procedures was a subject of this thesis.
2.3.6. Statistics and Analysis of Data
The variance ratio test and students "t" test (see Snedecor and Cochran,
1967) were used to establish the significance of differences between experi­
mental data.
a) Conventional linear regression analysis t This was used to describe the 
line of best fit where appropriate but was only applied when one parameter 
was determined experimentally: a pre-programmed calculator (Munroe, Model 
1930, New Jersey, USA) was used for this purpose.
b) Weighted linear regression with errors in X and Y. ' Conventional linear 
regression is inappropriate for the comparison of two methods since two
critical assumptions are made. The first is that the relative size of the
errors are constant for all regions of the calibration curve. The second
is that errors of measurement are made in only one of the variables (Y).
Munson and Rodbard (1982) have described a method using a weighted linear 
regression assuming error in both procedures which enables correction for 
variations in X and Y: this method has therefore been used in the present
studies and is described briefly below. Data were processed in this manner 
by microcomputer (Commodore PET 2001) using a BASIC programme written by 
Dr. J.A. Foulkes. (See appendix 2. for full details.)
1. Calculation of corrected slope (b) and intercept (a). The method 
compensates for non-uniformity of variance by using statistical weighting: 
each point is assigned a weight based on its predicted reliability and 
statistical comparisons then based on the weighted sums of squares (SS^):
SS = Z.W. (Y. - bX. - a ) 2 equation 1
W  1 1 1 1
and X^ are the i'th X and Y values, a is the intercept and b the slope
2 2
of the best fitting line. The weighting W. = 1/cr where a is the
i
variance of the appropriate Y value.
With errors in both Y and X,the appropriate weighted sum of squares (3S^ )
7 ba
is given by:
SSU = E. (Y. - bX. - a ) 2 ba i i i
2 ,2 2
° Y + b ° X 
i i
equation 2
and the slope by:
b = (b2 - X/b1) - (4 A + (b2 - A/b^ )
equation 3
X = a 2 / a 2 : where each method has equal and uniform y x H
error, A = 1 .
b^ = regression slope of Y on X
b = the reciprocal of the slope for the X on Y regression.
A
The sign of the root is determined by the sign of the correlation
coefficient. In the current application the variance in any technique
was calculated from its coefficient of variation.
Knowledge of the slope b enables calculation of the intercept a:
a = Y - bX, where X, Y are the mean X and Y values.
2 . Compatibility of weighted regression of methods with the line of
identity. An F-ratio (F„ „) based on the "extra sum-of-squares" prin---------  2 ,n - 2 .
ciple was used to compare the weighted regression described by equation 2
above with the line of identity (slope = 1 , intercept = 0 ).
F _ = (SS, - SS )/2
2 ,n- 2  ba res j.* a*  — ----- -^-- equation 4
SS /(n - 2) 
res
F0 n __ g = the critical value of the F-statistic with 2 (the number2
of parameters fixed = a and b) and n - 2 degrees of freedom: the sig­
nificance of F at the appropriate probability level was established by
reference to tables (Snedecor and Cochran, 1967).
SS^a = the sum of squares for a particular value of slope and intercept 
SSres = the mean square residual or minimum (residual) sum of squares.
2.3.7. Milk Samples: Collection, Treatment and Storage
Unless otherwise stated, milk samples were taken from the collection jar
or an appropriate vessel following agitation of the complete milking and
preserved by addition of a potassium dichromate tablet (Lactab Mk III,
Thompson & Capper Ltd., Runcorn; 1 tablet/20ml milk). Samples were stored 
o
at 4 C until required. Sodium azide solution (20% w/v in PAS-gelatin
buffer; 5yl/ml milk), was used as preservative in earlier studies.
2.3.8. Cleaning of Glassware
Glassware was washed by immersion in Decon 90 (2.5% v/v) for 24 hours, 
rinsed with tap water, then immersed in dilute technical grade hydrochloric 
acid (1% v/v) for 24 hours before rinsing in three changes of tap water, 
three changes of distilled water and drying inverted in an oven.
CHAPTER 3:
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CHAPTER 3. CONJUGATION OF PROGESTERONE DERIVATIVES WITH ENZYMES
3.1 INTRODUCTION
Ideally, methods for the synthesis of enzyme-labelled analyte for use in 
EIA should produce conjugates in which all enzyme molecules are coupled 
with analyte. In addition,there should be no enzyme co-conjugation or 
reduction of catalytic activity.
The carbodiimide (Goodfriend, Levine and Fasman, 1964) and mixed anhy­
dride (Erlanger et- al, 1957a and 1957b) methods have been most commonly 
employed to form hapten-enzyme conjugates. Representative procedures for 
condensation using carbodiimides have been described by Dray et al (1975) 
and Exley and Abuknesha (1977) for EIA of progesterone and oestradiol-17 3 
respectively and using mixed anhydrides by AlBassamgt al (1979) and Joyce 
et al (1981) for EIA of methotrexate and progesterone. To evalr- 
uate their efficacy, preliminary studies were made in which each of these 
methods was followed to produce homologous enzyme-conjugates with progester­
one lla-hemisuccinate. Alternative procedures (below) were found to be more 
effective, however, and are described in detail.
Synthesis of the N-hydroxysuccinimide or p-nitrophenol ester of steroid 
carboxylic acid derivatives should enable ready conjugation with primary 
amine groups of enzymes since such intermediates are commonly used to form 
amide bonds in peptide synthesis: such ester formation is achieved through
use of the condensation reagent dicyclohexylcarbodiimide (Bodansky, 1960; 
Anderson, Zimmerman and Callaghan, 1964).
It has previously been shown that esters of N-hydroxysuccinimide; in 
particular may be isolated from the condensation reagent in a pure form 
(e.g. N-succinimidyl 3-(4-hydroxyphenyl)propionate, Bolton and Hunter 1973 
dithiobis(succinimidyl propionate), Lomant and Fairbanks, 1976) and conju­
gated in aqua with proteins at neutral pH (Lomant and Fairbanks, 1976): the
absence of condensation reagent thus potentially allows conjugation with 
enzymes without inducing co-conjugation or denaturation. Conjugation with 
protein will occur with unhindered N-terminal amino or e-amino groups of 
lysine to form an amide bond, N-hydroxysuccinimide being eliminated (Bolton 
and Hunter, 1973).
The use of the N-hydroxysuccinimide ester (active ester) of progesteronen- 
hemisuccinate for the formation of conjugates with enzymes was therefore 
investigated. The suggested reactions involved are shown in Fig. 3.1. 
Similarly, the preparation of heterologous enzyme conjugates with progest- 
terone lia-glucuronide, progesterone lla-hemimaleate and progesterone 3- 
carboxymethyloxime was also investigated. 3-Galactosidase was chosen for 
initial studies since it had proved successful in the EIA of progesterone 
(Dray et at, 1975) and oestradiol-173 (Exley and Abuknesha, 1977) and is not 
present in milk. In later work, alkaline phosphatase, peroxidase and penicil­
linase were also employed.
Although generally dicyclohexylcarbodiimide has been used for the 
production of N-hydroxysuccinimide esters, it has been reported to produce 
toxic effects when in routine use: these include sensitization of the skin
and eyes (Sigma Chemical Co.). Ogura, Kobayashi, Shimizu, Kawabe and Takeda 
(1979) have shown that N,N ’-disuccihimidyl carbonate could be more conveniently 
and safely used to produce N-hydroxysuccinimide esters of N-substituted 
amino acids and peptides. Its use fox' the synthesis of such esters of 
progesterone carboxylic acid derivatives was therefore investigated and 
compared with esterification using the carbodiimide procedure. An outline 
of the expected reaction is illustrated in Fig. 3.2.
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Fig. 3.1. Formation of 3-galactosidase-progesterone conjugates by the 
N-hydroxysuccinimide ester method.
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Fig. 3.2. Proposed reaction summary for the synthesis of steriod active
esters using N,N*-disuccinimidyl carbonate and subsequent form­
ation of steriod-enzyme conjugates.
RCOOH = progesterone lla-hemisuccinate or progesterone lloc-glucuronide.
3.2 METHODS
The organic solvents used for all chemical syntheses and conjugation 
procedures were dried before use by addition of molecular sieve.
3.2.1. Formation of Carboxylated Progesterone Derivatives
14a) Progesterone llo.-( Ohemisuoctnate. Since it is not available 
commercially, a radiolabelled derivative of progesterone lla-hemisuccinate 
was formed to enable the degree of steroid incorporation into the enzyme and 
thus the efficiency of the reaction to be ascertained. The synthesis was 
performed using a modification of the method of Furr (1973): the concen­
trations of the reagents was increased, otherwise a poor yield resulted.
14
lla-Hydroxyprogesterone (330mg), succinic anhydride (lOOmg), ( C)succinic' 
anhydride (50mCi; 80mCi/mmol) and pyridine (300yl) were heated in a loosely- 
capped conical glass test tube on a sandbath at 90°C for 24 hours. To 
decompose any residual anhydride, the tarry residue was dissolved in 
methanol (2ml) and the methanol subsequently evaporated under a stream of 
nitrogen for 1 hour at 90°C. The products were dissolved in diethyl ether 
(3 x 2.5ml) and extracted with sodium bicarbonate solution (5% w/v, 4 x 10ml). 
The pooled aqueous fractions were acidified with sulphuric acid (6M) to 
pH 4.0 and immediately extracted into diethyl ether. After dehydration over 
anhydrous sodium sulphate, the ether extract was dried down under a stream
14
of nitrogen and progesterone lla-( C)hemisuccinate subsequently crystal­
lised from ethanol:water (70:30 v/v). On recrystallisation a yield, by 
weight, of 57% of the theoretical maximum was found. The melting point was 
determined to be 154°C.
b) Progesterone lla-hemimaleate. lla-Hydroxyprogesterone (lg), maleic 
anhydride (3.0g) and tri-rc-butylamine (0.5ml) were dissolved in dimethyl- 
formamide (DMF, 1ml) and heated in a loosely-capped conical glass test-tube 
on a sandbath at 90°C for 24 hours. The residue was dissolved in chloroform/
methanol (9:1 v/v, 10ml), the volume reduced under a stream of nitrogen and 
the oily residue transferred to a separating funnel with further chloroform/ 
methanol. The solution was washed with acetic acid (0.1M, 3 x 25ml) and the 
organic phase extracted with sodium bicarbonate solution (5% w/v, 3 x 25ml). 
The pooled aqueous phases were acidified (pH 4.0) with hydrochloric acid (3M) 
and extracted with chloroform/methanol (9:1 v/v, 3 x 75ml). The pooled 
organic phase was evaporated under a stream of nitrogen to a volume of appro­
ximately 5ml, from which white crystals of progesterone lla-hemimaleate 
separated. The crystals were washed with cold acetone (5ml, -20°C) over 
filter paper (Whatman No. 1) and recrystallised from methanol/water 
(70/30 v/v): the yield by weight was 43.3% of the theoretical maximum.
3.2.2. Formation and Isolation of N-Hydroxysuccinimide Esters (Active Esters)
of Carboxylated Progesterone Derivatives
24
a) Progesterone 11 a-( C)hemisuccinate. The crystallised progesterone 
14
lla-( C)hemisuccinate (43mg) was dissolved in dioxan (1ml) and N-hydroxy-
succinimide (12.5mg) and dicyclohexylcarbodiimide (23.8mg) added. The
mixture was stirred at 25°C for 30 minutes and the by-product dicyclohexylurea
removed by washing through a sintered glass funnel with 3 x 3ml dioxan. The
clear filtfate was dried under a stream of nitrogen and the residue dissolved
in a minimum volume of dichloromethane at 35°C. Addition of cold diethyl-
ether allowed crystallization of the N-hydroxysuccinimide ester of progest- 
14 o
erone 1 1a-( c) hemisuccinate. A melting point of 195 - 197 C was found 
after recrystallization, (yield 62.6% by weight of the theoretical maximum) 
and a molecular weight of 528.27 determined (Dr. D. Manning, NIRD, Shinfield) 
for the M + 1 ion by mass spectrometry using ammonia chemical ionization.
The formula was confirmed as ^29^37N^8 ^  elemental analysis (Dr. F.B.Strauss, 
Microanalytical Laboratory, Oxford) and the specific activity determined as
373.2 x 10 dpm/mol (33nCi/mol) by liquid scintillation spectrometry 
(Toluene Scintillator).
b) Progesterone 11 a-hemimaleate and -progesterone 3-carboxymethyloxime.
The esters of these compounds were formed in a manner identical to that 
described for progesterone lla-hemisuccinate. it was possible to crystallize 
only relatively small quantities of these products ( 1 0  - 2 0mg) due to the 
formation of stable oils and the products were not further characterized.
3.2.3. Use of Isolated (Crystallized) Active Esters to form Conjugates with 
3-Galactosidase and Peroxidase
3-Galactosidase solution was dialysed overnight at 4°C against PS buffer 
(1000 vols). Aliquots (0.1ml) of the resulting solution (5.1nmol 3-galacto- 
sidase/ml) were dispensed into glass test tubes containing a magnetic follower. 
The steroid active ester in dimethylformamide solution was slowly added 
(10yl:concentration range 0.114 - 114 ymol/ral) to provide a 2 - 2000 fold molar 
excess of steroid. The mixture was stirred continuously for 1 hour at room 
temperature and after removal of excess unreacted steroid by dialysis at 4°C 
against PAS buffer (3 x 31 over 3 days), was chromatographed on 10 x 1cm 
columns of G25 Sephadex in PAS buffer. Conjugates were collected as a 
single peak at the void volume as observed by continuous monitoring of 
eluate absorbance at 280nm: a Cecilspectrophotometer fitted with a flow
cell was used for this purpose. Conjugates were stored at 4°C following 
addition of gelatin solution (10% w/v in PAS buffer) to a final concentrat­
ion of 0.1% w/v. An identical procedure was used for formation of peroxidase- 
progesterone lla-hemisuccinate conjugates but PMS buffer was substituted for 
PAS buffer.
3.2.4. Use of Active Esters without Isolation (Direct Procedure) to form 
Conjugates with Enzymes
a) Alkaline Phosphatase,  penicillinase and $-galactosidase. Difficulties
encountered in purifying active esters of progesterone derivatives because 
of the formation of stable oils prompted the use of the active esters 
immediately following the removal of the by-product dicyclohexylurea. Since 
only a 10% molar excess of dicyclohexyl carbodiimide reagent was used in the 
formation of the active ester (commonly a 1 0 0-fold excess of reagent is used 
in the direct carbodiimide conjugation procedure: Dray et al3 1975) co­
conjugation or denaturation of enzyme was likely to be small but was further 
limited by reaction of unreacted carbodiimide with acetic acid. A represent­
ative procedure for conjugating progesterone derivatives with alkalihe phos­
phatase, penicillinase and latterly 3-galactosidase is described below: for
higher molar ratios of steroid:enzyme the concentration of steroid solution 
was adjusted appropriately.
Enzyme solution (lOOnmol/ml) was dialysed against PS buffer (11) for 24 
hours at 4°C and adjusted to a concentration of 5mg/ml (50nmol/ml) with PS 
buffer prior to use. N-hydroxysuccinimide (llOnmol in 20yl dry dioxan) and 
dicyclohexylcarbodiimide (llOnmol in 20yl dry dioxan) were added to progest­
erone lla-glucuronide (lOOnmol in 20yl dry dioxan) and stirred for one hour 
at room temperature. Unreacted dicyclohexylcarbodiimide was inactivated by 
addition of acetic acid (50nmol in 20yl dry dioxan). After a further 15 
minutes, the insoluble by-product dicyclohexylurea was removed by centrifug­
ation (2,OOOg for 10 minutes). One hundred per cent conversion of progester­
one to '’active ester” was assumed. Steroid solution (40yl) was slowly added 
to enzyme in PS buffer (500yl) to provide a molar steroid excess of 2:1.
The mixture was stirred for 2 hours at room temperature before dialysing at 
4°C against 4 changes of 3 litres of PAS buffer over 4 days. The conjugate 
solution was finally passed down a .Sephadex G25 column, eluting with PAS 
buffer to remove any remaining free steroid. Gelatin solution (10% w/v in 
PAS buffer) was then added to a final concentration of 0.1% w/v.
o
Conjugate was stored at 4 C and under these conditions has been shown 
to be stable for at least one year. Loss of enzyme activity was less than 
1% and no significant alteration in the performance of the conjugates in 
EIA was found before or after dialysis, indicating that minimal release of 
steroid by hydrolysis had occurred.
b) Use of UsN'—disuccinimidy I carbonate in the formation of active 
esters for direct conjugation with atkatine phosphatase. Alkaline phospha­
tase solution (lOOnmol/ml) was dialysed against PS buffer (11) for 24 hours 
at 4°C and the volume adjusted to a concentration of 50nmol/ml with PS 
buffer prior to use. Disuccinimidyl carbonate (880nmol in 20yl acetonitrile) 
and pyridine (880nmol in 2 0yl acetonitrile) were added to solutions of
14
progesterone derivative (progesterone 11a-( C)hemisuccinate or progesterone
lla-giucuronide; 800nmol in 2 0 juLacetonitrile) and stirred for 2 hours at
room temperature (21°C) before addition of acetic acid (400nmol in 20yl
acetonitrile): the reaction mixture was stirred for a further 0.5 hours.
The active esters so formed were added slowly to aliquots of enzyme (0.16ml;
8nmol) in volumes appropriate to the molar excess required (see table 3.4)
and the mixture stirred continuously for a further 2 hours. Conjugates
were then purified by dialysis and gel filtration and stored in the manner
described previously, (section 3.2.4.a ). For comparison, a further series
of conjugates were prepared in parallel using dicyclohexylcarbodiimide to
form the active ester in the manner described previously (section 3.2.4 .a ): 
14
progesterone llot-( C)hemisuccinate was used at 5:1, 10:1 and 20:1 molar 
steroid excess and progesterone lla-glucuronide at a 2 : 1  molar excess.
The formation of active ester with time was monitored by periodic removal 
of aliquots (5yl or 2juL) of each reaction mixture and application to pre­
coated silica gel TLC plates (20 x 20cm, layer thickness 0.25mm; Merck 
6 0 F 2 5 4 ’ BDH Ltd.): the adsorbent contained a fluorescence indicator.
The samples were chromatographed for 1 hour in the solvent system chloroform: 
ethyl acetate’.methanol (40:10:50 by. volume) and the components located by 
visualization of fluorescence quenching at 254nm (UV lamp UVSL-58; Scientific 
Supplies Ltd.) scraped from the plate with a scalpel and extracted into 
methanol (1ml, glucuronide components) or acetonitrile (1ml, hemisuccinate 
components). The extent of conversion to the active ester was estimated 
by liquid scintillation spectrometry (Toluene Scintillator * 7ml) in the 
case of the hemisuccinate or UV adsorption at 240nm (Perkin Elmer 552 
spectrophotometer) for the glucuronide. The percentage conversion to the 
active ester was calculated from the total radioactivity or UV adsorbing 
material in the TLC components associated with steroid. The availability 
of crystalline reference material allowed identification of progesterone 1 1a 
hemisuccinate active ester, but the location of the progesterone 
lla-glucuronide equivalent was presumed by elimination of the other known 
components: the reaction mixture excluding steroid was run separately for 
this purpose. An unidentified minor component (R^0.52) was formed by both 
procedures as a product of glucuronide active ester synthesis: this 
was assumed ta.be a steroid and was included in the quantification of total 
steroid (above).
3.2.5. Preparation of Peroxidase Conjugates with Progesterone lla-glucuronide 
using the Mixed Anhydride Procedure 
Particular difficulty was experienced in forming peroxidase conjugates 
with progesterone lla-glucuronide as evinced by their poor immunoreactivity 
and low binding in EIA. By these criteria conjugates formed by the direct 
active ester procedure (section 3.2.4.a ) were no more effective than those 
formed by a modified mixed anhydride procedure below, although higher molar 
excesses were required for the latter method (25, 125 and 250-fold rather
than 20 and 40-fold). Since use of the mixed anhydride procedure at a 
125-fold molar steroid excess provided a conjugate sufficiently immuno- 
reactive to be used at a dilution which would enable a practical. number 
of assays to be performed,this conjugate was used in subsequent comparative 
EIA’s. The procedure described below was modified from that of Al- Bassam 
et al3 (1979): more concentrated reagents were necessary to enable economic
use to be made of the limited supply of progesterone lla-glucuronide.
Progesterone lla-glucuronide (2.0mg; 3.93ymol) was dissolved in dioxan 
(75yl), tri-n-butylamine (3.93ymol in 25yl dioxan-) added and the mixture 
cooled to 10°C before addition of tso-butyl chloroformate (3.93ymol in 25yl 
dioxan ). The mixture was stirred for 30 minutes at 10°C and an aliquot 
(50 yL) slowly added to a stirred solution of peroxidase (12.5nmol; 0.5mg 
in 0.1ml of 0.1M sodium bicarbonate buffer, pH 8.2)and allowed to react 
for 3 hours at 10°C,then overnight at 4°C,before dialysis and gel fil­
tration against PMS buffer and storage in the manner described previously 
(section 3.2.4.a)).
3.2.6. Assessment of Enzyme-labelled Steroids
a) Estimation of enzyme activity. Enzyme activity following conjug­
ation was compared with that of the original enzyme: the relative quantity 
of product formed by a fixed mass of enzyme conjugate (in lOyl of approp­
riate buffer) was compared with that produced by the same mass of enzyme 
over the same period. The mass of conjugate or enzyme was estimated by 
determination of protein concentrations. Assays were performed in test 
tubes or microtitre plates using the appropriate condition described in 
section 4.3.
b) Performance in EIA. The performance of conjugates in EIA was 
evaluated by comparison of the relative degree of binding of fixed masses
of conjugate with antibody adsorbed to microtitre plate wells and by assess-
ment of the degree to which binding was inhibited by the presence of 
competing progesterone: such tests were performed using milk standards
and the protocol appropriate to the particular enzyme (see section 6 .2 .1 .).
c) Estimation of the molar incorporation of steroid per enzyme molecule.
Molar incorporation of steroid was only assessed in specific cases. Where
14
progesterone lla-( C)hemisuccinate was used,this was performed by deter­
mination of the radioactivity of aliquots of conjugate of known concentration 
(digested in soluene, 1ml) in Toluene Scintillator by liquid scintillation 
spectrometry.
For some preparations a comparison was made between conjugates by 
determining their potency in RIA: the ability of a fixed mass of the
3conjugate, relative to progesterone, to inhibit antibody binding of ( H)- 
progesterone enabled an estimate to be made by interpolation from an RIA 
calibration curve using progesterone standards prepared in buffer.
A spectrophotometric procedure based on the method described by 
Erlanger et al (1957a) proved useful for the determination of incorporation 
of progesterone lla-glucuronide into alkaline phosphatase conjugate.
Doubling dilutions of progesterone lla-glucuronide solution were prepared 
(30 - 1.875yM) and the solutions scanned twice (PS buffer reference) over 
the wavelength range 190 - 290nm (Perkin Elmer 552 spectrophotometer): 
maximum absorbance was found to be at 248nm. Plotting mean relative peak 
heights (y, range 67 - 962mm) at 248nm against steroid concentration (x) 
enabled a calibration curve to be fitted (y = 31.8x + 3.771,r = 0.9999). 
Similarly, following adjustment of the protein concentration of progester­
one lla-glucuronide-alkaline phosphatase conjugate solutions to equal that 
of the alkaline phosphatase solution used for reference (see below), the 
conjugates were scanned, peak heights at 248nm determined and the equiv­
alent steroid concentrations calculated by interpolation from the calib-
ration curve. The molar steroid incorporation per enzyme was calculated 
knowing the molar concentrations of the enzyme and steroid components of 
the conjugate. Since sodium azide interferes strongly with this procedure, 
if such estimations are to be made, dialysis and gel filtration procedures 
should be performed using PS buffer.
Whichever procedure was used, molar concentrations of enzyme were 
calculated following estimation of protein concentration by the method of 
Lowry et al (1951; see section 2.3.2.).
3.3 RESULTS .
3.3.1. The Properties of Progesterone llq-hemisuccinate-enzyme Conjugates,
Formed using Established Mixed Anhydride and Carbodiimide Procedures 
The mixed anhydride procedure was used to conjugate progesterone 
lla-hemisuccinate with peroxidase and 3 -galactosidase according to the 
methods described by Joyce et at (1981) and A1 Bassam et al (1979) respect­
ively. The methods of Dray $t al (1975) and Exley and Abuknesha (1977) were used 
to form conjugates with $-galactosidase by the carbodiimide procedure.
Conjugates prepared by these procedures proved to be ineffective in EIA 
when applied in this laboratory and table 3.1 illustrates why this
may have been the case. In the best preparations (conjugates 8 and 37) their
3
limited ability to inhibit ( H)progesterone binding in RIA indicated that 
less than one in ten enzyme molecules were conjugated with progesterone 
despite being formed using a high molar excess of steroid (1477 and 2500 
fold).
Subsequent observations substantiated the indication that incorpor­
ation of progesterone derivative into enzyme was low: using a cellulose-
linked antibody system (Bolton, Dighe and Hunter, 1975) as described by 
Sauer, Foulkes and Cookson (1981), only conjugate 8 provided 
EIA calibration curves but a relatively large mass of label (200ng) was
required to provide detectable binding to antibody. Furthermore, although 
loss of enzyme activity did not exceed 50%, the carbodiimide procedure of 
Dray et al (1975) and Exley and Abuknesha (1977) gave rise to substantial- 
enzyme co-conjugation as indicated by the considerable degree of turbidity 
produced at conjugation.
Table 3.1. Properties of conjugates of progesterone lla-hemisuccinate with
Enzyme
3-galactosidase and peroxidase prepared following published procedure
a b c
Conjugate Condensation* Steroid Enzyme Potency Steroid
No. Reaction Ratio Activity in RIA 
(mol/mol Recovery (yg) 
enzyme) /(% -of 
original
Incorpor­
ation
(mol/mol
enzyme)
Peroxidase l MA (A) 50 108 0.46 0 . 0 0 1
?! 2 I! ?! 1 0 0 80 1.25 0 . 0 0 1
3-galactosidase 3 CDI (B) 74 99 0 . 0 0 0 . 0 0 0
If 5 ?! !! • 296 114 1.25 0.007
?! 7 ! ! !! 887 90 0.24 0.034
?! 8 !! !! 1477 54 0 . 1 0 0.080
n 17 !! (C) 500 50 0.25 0.034
tf 35 MA (D) 500 53 0.85 0.008
if 36 1! ?! 1500 50 0.80 0 . 0 1 0
tt 37 ! ! !! 2500 59 0 . 2 1 0.080
a) The ratio of steroid:enzyme in the reaction mixture. ■ ■
b) The mass of conjugate giving rise to the same % inhibition of ( H)progesterone 
binding as 5pg progesterone.
c) Calculated as described in section 3.2.6 .c) from potency data.
Enzyme activities for peroxidase and 8“galactosidase were determined as described 
by Joyce et al (1977) and Exley and Abuknesha (1978).
* The protocols followed were those of A, Joyce et al, 1981; B, Exley and 
Abuknesha, 1977; C, Dray et al, 1975; D, Al Bassam et al, 1979.
MA — Mixed anhydride procedure CDI = carbodiimide procedure.
3.3.2. The Properties of Progesterone lla-hemisuccinate- B-Galactosidase
Conjugates formed using Isolated Active Ester
The first requirements in the evaluation of the conjugation procedure 
using isolated active ester (section 3.2.3.) were to establish the effici­
ency of the reaction with enzyme, its effect on enzyme activity and the 
value of such conjugates in EIA. No assumptions were made initially regard­
ing the reaction efficiency or the degree of conjugation required to 
produce conjugates useful in EIA: a wide range of molar excess of steroid:
enzymes were therefore used in this study (2 : 1 - 2 ,0 0 0 :1) The character-
istics• of the conjugates formed are shown in table 3.2.
Table 3.,2 Molar Incorporation of Progesterone llx-hemisuccinate into
3-Galactosidase and Enzyme Activity of the Resulting Conjugates
Conjugate
No.
Molar Ratio of Molar Ratio of 
Progesterone:Enzyme Progesterone to Enzyme:- 
in Conjugation Radioactivity RIA Binding 
Reaction Mixture Determination Inhibition
Enzyme Activity of 
Conjugates (% of 
Original Activity)
56 0 0 0 . 0 1 103.4
52 2 2 . 0 0 . 0 2 104.4
58 2 0 7.9 0.15 1 1 1 . 1
59 1 0 0 48.6 0.27 91.6
60 2 0 0 87.7 0.34 82.4
61 500 104.4 1.16 62.6
62 2 0 0 0 107.0 0.83 2 2 . 6
Low molar ratios of steroid to enzyme in the reaction mixture produced 
substantial incorporation as determined by radioactivity measurements and at 
high molar ratios approached the theoretical maximum of 1 20 (116 lysine 
e-amino groups and 4 N-terminal amino groups: Craven et olI<> 1965).
Enzyme activity was not appreciably reduced by the active ester procedure 
except when the enzyme was highly conjugated, i.e. when the molar excess of 
steroid exceeded 100-fold. This may be due to alterations occurring at the
enzyme active site when incorporation occurred near this position or to 
allosteric effects.
Quantities of conjugate equivalent to 5 - 15 pg of progesterone (by 
RIA) resulted in sufficient binding of enzyme-label to antibody for cali­
bration curves to be produced by EIA. A comparison of curves produced using 
the most effective homologous 3-galactosidase conjugate (prepared with a 
25:1 molar excess of steroid) with that produced using liquid phase RIA is 
shown in Fig. 3.3.
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Fig. 3.3 Comparison of homologous EIA (A-A) and RIA (□-□) calibration curves. 
The EIA was performed at 40 C on polyvinyl microtitre plates (G711/12 antiserum 
adsorbed at 1 / 2 0 0 0  dilution) using 8-galactosidase conjugate (2 0ng/well) pre­
pared using a 25:1 molar excess of steroid.
Progesterone standards were prepared in milk.
B/Bq = the quantity of label bound to antibody in the presence of competing 
progesterone (B) as per cent of that bound in the absence of competing 
progesterone (Bq ).
3.3.3. The Influence of Direct Conjugation Method Conditions on Enzyme
Activity of Alkaline Phosphatase 
a) Reaction solvent effects. Aliquots of dialysed alkaline phosphatase
solution, diluted for use in conjugation (4.2mg/ml PS buffer), were added 
to glass reaction vials (1ml capacity) containing magnetic followers. A 
range of volumes of dioxan were subsequently added and the solutions stirred 
for 2 hours at room temperature to reproduce conjugation conditions. The 
solutions were then diluted to the same final concentration of enzyme (50ng/ 
ml) and the enzyme activity of 1 0yl aliquots (in octruplet), placed in 
microtitre plate wells and estimated in the manner described (section 4.3.5.). 
Volume ratios of dioxan to enzyme solution of 0:1, 1:60, 1:12, 1:3, 1:1 
and 2 : 1  resulted in percent enzyme activity recoveries of 1 0 0 (control),
100.4, 94.5, 97.9, 85.1, and 86.4 respectively indicating that the conju­
gation conditions caused appreciable loss of enzyme activity only when a 
high proportion of dioxan was used (^ 50%). Under the latter conditions, 
a precipitate of enzyme was formed (buffer controls became only slightly 
hazy) which readily dissolved on dilution in buffer. Clearly dioxan could 
be used at up to 25% v/v without appreciable loss of enzyme activity.
b) The relative concentration of reagents. As in all chemical reactions, 
the relative concentrations of the reagents will influence the probability 
of molecular interaction and thus the reaction rate and would be expected 
to increase with increased concentration. The use of a high proportion of 
organic solvent may increase the solubility of the steroid in the reaction 
mixture but as shown in the previous section, may also result in enzyme 
denaturation. The possibility of localised and therefore non-uniform 
conjugation of steroid with enzyme arises if the active ester solution is 
too concentrated or is added too quickly to the enzyme solution.
A single concentration of alkaline phosphatase (5rag/ml) was used to 
investigate the influence of relative active ester solution volume on 
subsequent formation of conjugate: the former was as concentrated as could
practicably be readily reproduced,., following dialysis, from commercially 
available alkaline phosphatase preparations. A 2:1 molar excess of
progesterone lla-glucuronide was used throughout since this had been shown 
to provide calibration curves of greatest sensitivity (section 6.3.2.). 
Progesterone lla-glucuronide active ester solution was prepared in dioxan 
as described previously (section 3.2.4 .a ), diluted in dioxan to contain 
50nmol in the required volumes and added slowly to stirred aliquots of 
alkaline phosphatase to form conjugates in the usual way (section 3.2.4a ).
Table 3.3 describes the relative enzyme activity of the conjugates, their 
ability to bind with antibody adsorbed to microtitre plates and their per­
formance in EIA (performed at 21°C).
Table 3.3 The Influence of the Relative Volumes of Progesterone lla-glucur­
onide Active Ester and Alkaline Phosphatase Solutions on the
Formation and Properties of Conjugates
Conjugate
No.
Vol Enzyme 
Vol Steroid 
'(Ul)
: Enzyme0 
b Activity 
Recovered 
(%)
Relative
Bo d
(%)
B50/B0
(%)
173 500:5 96 1 0 0 44
174 500:50 91 1 0 2 43
175 500:125 87 91 44
176 500:250 87 79 43
a: 25nmol alkaline phosphatase (2.5mg) contained in 500U1 PS buffer, 
b: 50nmol progesterone lla-glucuronideactive ester in given volume (100% 
conversion to active ester assumed). 
c: % of original enzyme activity.
d: Binding of conjugate (20ng/well) to antibody (G711/12, 1/8000 dilution)
in the absence of progesterone ( B q ) relative to conjugate 173 ( B q  = 100%)
e: B = binding of conjugate in the presence of 50pg progesterone.
50
Loss of enzyme activity as a result of conjugation increased with 
increasing proportions of active ester solution from 4% to a maximum of 
13% and was greater than that associated with the solvent alone (see section
3.3.2.a ). The apparent degree of binding of conjugate to antibody in the 
absence of competing steroid (B^) similarly decreased as the proportion of 
steroid solution used for its formation increased although the sensitivity
potential (B _/B ) was unaffected. This implies that either conjugation ou o .
efficiency decreased with increased dioxan volume (a higher proportion of 
enzyme remained unconjugated) or the apparent reduction in binding was a 
result of lower enzyme activity of the conjugate. The validity of the 
latter argument could be assessed by evaluation of the binding inhibition 
caused by the conjugates in RIA.
Whatever the cause of the relative differences,it would appear approp­
riate to prepare conjugates by addition of active ester solution to enzymes 
at a maximum volume proportion of 1 to 1 0 .
I t
3.3.4. Comparison of N,N -Disuccinimidylcarbonate (DSC) and N,N -Dicyclohexyl 
Carbodiimide/N-hydroxysuccinimide (DCC) for the Direct Formation of 
Alkaline Phosphatase Conjugates
14
Conjugates of progesterone 11a-( C)hemisuccinate and progesterone 
lla-glucuronide with alkaline phosphatase were prepared using DCC or DSC to 
form the active esters as previously described (section 3.2.4.a) and 3.2.4.b) 
respectively).
TLC of aliquots of the reaction mixture during formation of the active
14esters provided Revalues for progesterone lla-( C)hemisuccinate and its
active ester of 0.61 and 0.79 respectively and for progesterone lla-glucuronide
and its active ester of 0.34 and 0.62. The time courses of active ester form-
14
ation are shown in Fig. 3.4. In the case of progesterone lla-( C)hemi- 
succinate the DCC procedure gave rise to more rapid formation of active 
ester over the full period of study (100 minutes): by 100 minutes 48%
conversion to the active ester was achieved compared with 34% for the DSC 
method. The initial rates of formation of active ester were similar for 
both methods and significant quantities were formed in the time between 
initiation of the reaction and first transfer of an aliquot of the mixture
to the TLC plate (1 minute). Formation of the active ester of progesterone 
lla-glucuronide was assessed at 1 hour by quantitative spectrophotometry and 
was similar for both procedures, 51% and 53% by the DSC and DCC procedures
respectively.
50
40
Conversion of 
steroid to active 
ester (%)
30
2 0
10
0 1 2 0 60 100
Reaction time (minutes)
14
Fig. 3.4 The formation with time of active esters of progesterone 11a-( C) 
hemisuccinate (a ,«) and at a single time point for progesterone lla-glucuronide 
(a »0> using DCC (±-A, A) or DSC (•-- •, o) .
Components' of the reaction mixture were separated by TLC and the proportion 
of total steroid associated with the active ester determined by use of UV 
spectrophotometry (240nm) for the glucuronides (a, o) and by liquid scint­
illation spectrometry for the hemisuccinates (▲, •).
Table 3.4 shows the characteristics of the conjugates prepared using 
active esters synthesized by the two methods. For both procedures, loss of 
enzyme activity as a result of conjugation was minimal. The immunoreact- 
ivity of the conjugates in RIA largely reflected the actual molar excess 
of steroid added to enzyme and thus the relative extent of active ester 
formation since,as previously mentioned,the molar excess was initially based
on an assumed 1 0 0% conversion of progesterone derivative to active ester. 
Thus, when hemisuccinate-linked conjugates were formed using a 5 or 10-fold 
molar excess of active ester, incorporation following use of the DCC method 
was approximately twice that using DSC. This difference was not apparent 
at a 2 0 -fold molar excess, however, and may reflect conjugation with all the 
most accessible amino residues under these conditions. Assessment of the 
degree of conjugation by RIA binding inhibition studies or by evaluation in 
EIA gave rise to similar conclusions although values were less than obtained 
by determination of radioactivity (table 3.4): this is in keeping with
findings in earlier studies using 3-galactosidase (table 3.2) and the indic­
ation that steric hindrance may in part be responsible. Later studies dem­
onstrated that the attainment of equilibrium would be unlikely in EIA under 
these conditions (section 6.3.4.a)) which suggests that equilibrium would be 
unlikely here: this would also contribute to underestimation of the steroid
content of the enzyme.
In the case of glucuronide-linked conjugates incorporation was assessed 
only in relative terms by RIA binding inhibition and performance in EIA, 
although for comparison, spectrophotometric estimations have been included on 
conjugates prepared on a separate occasion. Data are limited to comparison 
of conjugates formed using a 4:1, 7:1 and 14:1 excess of active ester by 
DSC with a single conjugate formed at a 10:1 excess using DCC. The DCC 
conjugate (1 0 :1) showed a similar degree of incorporation to that formed 
using DSC at a 4 fold molar excess of active ester when assessed by RIA 
binding inhibition, implying that at conjugation,less active ester was 
actually present when formed by DCC (table 3.4).
Although there was little difference between procedures in the yield of 
glucuronide active ester, yield was lower for the hemisuccinate active 
ester by the DSC procedure. It.is the performance of the conjugates in EIA,. 
however, which is most important. In this respect, the glucuronide-linked
o
CO
Q
3
P
3
3
O
XZ
P
3
o
>»
•o
•Ha
•H
3
•H
O
0 
3CO
•rl
1
tOD
3
•rl
01
3
-d
0)a
po
to
CO
3
P
3
bfl
3
•o
3
O
O
«H
O
01
0
•H
P
01 
•H 
P 
(1) 
P  
O 
3
p
3
xi
o
o
xitr*
CO
3
rH
a
H
«H
0
01 
P 
3 
p  
01 
to
3
5>
•H
P
O
<3
3
O
3TJ
O
P
ft
O
P
o
o
Q
(1)
•3
•Ha
•H
3
•H
O
0 
301 
5>>
X
0
p
•a
>>
.3
153
\
3
•a
•Ha
•rl
•rl
•3
O
XI 
P 
3 
OiH
>>
K
3XZ
O
rH
o
>»
0
•rl
*3
1
53
rH
*
<M Ow CQ\ /-s.
3 CfcS
•H W'-'
CQ
3
3
3
3a X3
p \0 0 QSH CQ O
P <
3 V-/
ft
>» >»
3 P pa •H 3
>» > >N •H 0
3 P O
W O 3< 33
. 3a 
>» 
N 
• 3 
to
+ O3 a 
o \
•H P  
P  3 
3 3 
P r-I 
O 3 
ft > 
P 'rl 
O 3 
O 3* 
3 W
O
3
TO
•rl
3
O
P
3
0
3
rH
bfl
P
O
co
53
3
P
3
3
•rl
O
O
3
3
•rla
3
xi
o
I
3r-l
3
3
0 
P 
3 
P
01 
3 
hfl 
O 
P 
ft
3 P  
P  3 
CO 3 
bfl 
O 
P 
ft
rH 
' Oa
•3
o
.3
P
3
S
3>
"3 *H 
•rl P  
O 3
ftO CS3
P
P
3
3
ft
CO
bfl
3 3
•rl O
*3 -H 
3 P
•rl p '
CQ .Q 
•H
<. xi M 3 
«  W
!>» 3 
P  O 
•rl -H 
> p
3 S 
O P 
•H 3 
•3 P  
3 3 
OS ft
P
3
P
CO 3 
P
•3
•H
O P
P
3
P
3 
O
3 *H 
P  
01 3
CO M bfl
3 3
P O i-»
3 X 3  
<H W  O
O O
S
3
P
3
bfl • 
3 O
a” 5
o
o
CO 00 in ci O CO 01 cq • 1
rH l> t> cq >*’ rH
1
CO CO CO m CO cq CO CO
Cl in cq t> in rH m cq cq
o in in rH rH rH rH t> CO rH
rH in co CO rH cq in o CO | 1
rH rH rH o rH rH o’ o rH O
CO CO CO o m m in 01 t> rH CO
00 Cl 01 o o o o o> 01 0) 01 00
rH rH rH
cq
o*
cq
co
CD m in cq in l>
cq co rH in o rH CO o
o o* rH O o* cq o O* o o’
CO CO 00 co CO CO
rH CO 01 CO cq o
• • • • • •
rH cq cq o rH CO
o
o
Q
CO
53
O
o
Q
CO
53.
CO
53
o o U O O O O O O
CO CO CO CQ CO CO O O O
Q Q Q Q Q Q Q Q Q
CO
53
CO
53
CO
53
3
rH
O
3
rH
o
3
iH
O
3
iH
o
3r—I
o
3
rH
a
w o
cq
in o
rH
Ocq
cq
CO in CO r> 00 01 O rH rH in CO
00 00 00 00 00 oo 00 01 01 00 01 01
rH rH rH rH rH rH rH rH rH rH rH rH
Fo
r 
le
ge
nd
 
pl
ea
se
 
se
e 
ov
er
.
Table 3.4 (cont).
Conjugates 195 and 196 were prepared in an identical manner to 183 - 185 
and 181 but on a separate occasion.
■f
Calculated as described in section 3.2.5.C .
- Not determined.
* EIA was performed using polystyrene plates (NUNC; antiserum G711/12 
globulin preparation, 1/8000 dilution) in the manner described in 
section 7.2.2.b using 5ng of conjugate/well.
B Q = amount of enzyme-labelled progesterone bound to antibody in the absence 
of competing progesterone. Values are expressed as optical density 
change/h (AOD/h).
B50^B0 = amount of label bound in the presence of 50pg of competing pro­
gesterone as percent of BQ value.
conjugate formed using DSC and a 4:1 molar excess of steroid provided the
most sensitive calibration curve as indicated by B^/B. values (Table 3.4).
50 0
The small differences in sensitivity between conjugates formed using the 
same derivative are likely to reflect differences in the degree of
conjugation (see section 6.3.3.).
It can be seen that the immunoreactivity (= steroid incorporation by 
RIA) of the glucuronide conjugates is far lower than that of the hemisuccin­
ate conjugates formed using the same molar excess (Table 3.4). This would 
be expected if bridge recognition and therefore the binding affinity was 
lower with the glucuronide bridge (see section 6.3.2.). Additionally, it 
cannot be discounted that differences in the degree of incorporation may 
play a minor role. Although some reservations are justified about the use 
of spectrophotometric measurements for absolute determinations of incor­
poration rate (Erlanger et al 1957a) this method showed 2 - 3  times lower 
incorporation for glucuronide conjugates (195 and 196) than equivalent 
hemisuccinate conjugates (182 and 184) assessed by radioactivity determin­
ation (Table 3.4). Spectrophotometric determinations were not performed for 
the latter.
3.4 DISCUSSION
The preliminary studies reported in Table 3.1 and those by others 
(Dray et al, 1976; Commoglio and Celada, 1976; Exley and Abuknesha, 1977;
Joyce et al, 1977; Al Bassam et al, 1979) clearly indicate that a large molar 
excess of hapten is required to produce effective conjugates using the 
mixed anhydride and carbodiimide procedures even though it may be necessary 
to incorporate only one per enzyme molecule.
Data from the RIA binding inhibition studies enabled comparison of the 
degree of incorporation of progesterone into 3-galactosidase using the 
active ester procedure (Table 3.2), with that obtained previously by other 
methods (Table 3.1). This indicated that conjugation proceeded more 
readily using the active ester method since a higher degree of substitution 
was achieved using lower molar excess. Comparison of conjugate 60 (Table 3.2) 
with conjugates 7, 17 and 36 (Table 3.1) indicates that the active ester 
procedure was an order of magnitude more efficient than the carbodiimide or 
mixed anhydride procedures. This is in keeping with the data of Comoglio 
and Celada (1975) who used the mixed anhydride procedure to form steroid 
enzyme conjugates and Exley and Abuknesha (1978) who used the carbodiimide 
method. These groups estimated the degree of conjugation by radioactivity 
incorporation and RIA determinations on hydrolysed conjugates, respectively: 
the degree of incorporation was at best one tenth that reported here using 
the active ester procedure at approximately equivalent molar excess of 
steroid.
Previous reports of the use of steroid active esters for this purpose 
have not provided details of the efficiency of substitution into the 
enzyme (Gros et dl3 1978; Hosoda, Sakai, Yoshida and Nambara, 1979).
When used for conjugation with proteins (e.g. BSA for which a 50 fold 
molar steroid excess would be usual) for the formation of immunogens, 
efficient incorporation is generally anticipated with the mixed anhydride
procedure (Erlanger et ai3 1957a): for particular enzymes, reduced effic­
iency may be related to the accessibility of e-amino residues. Al Bassam 
et at (1979) reported that a 2,500 molar excess was optimal for the form­
ation of methotrexate conjugates with 3-galactosidase.
Substantially lower molar steroid incorporation was recorded by RIA 
binding inhibition than by radioactivity incorporation, a phenomenon also 
reported by Comoglio and Celada (1975). Clearly the only progesterone 
molecules detected by immunoassay are those located at sites on the enzyme 
molecule which do not sterically hinder antibody binding.
It has been stated that optimum sensitivity in EIA is in part depen­
dent on achieving a low (around 1:1) degree of incorporation (Exley and 
Abuknesha, 1977; Joyce et al, 1978a). From the findings here, however, this 
would only be true where all conjugated steroid was immunologically detect­
able.
Although EIA calibration curves produced using the homologous conju­
gates (hemisuccinate bridge) were markedly less sensitive than RIA (Fig. 3.3) 
the performance of the EIA proved adequate for preliminary application to 
the direct measurement of progesterone in milk and enabled corpus luteum 
function to be monitored in dairy cows (see section 8.3.1.).
The necessary adoption of the direct active ester conjugation procedure 
(as opposed to use of crystallized esters) for formation of heterologous 
conjugates gave rise to minimal effects on the catalytic activity of alka­
line phosphatase (Table 3.3). The main disadvantage of such direct pro­
cedures (as with the carbodiimide and mixed anhydride procedures) is that 
the molar excess of reactive steroid added to enzyme is unknown. For 
conjugation procedures performed using this method 1 0 0% conversion to 
active ester was assumed, although clearly this was not reached in practice 
(Fig. 3.3).
I
N,N -disuccinimidyl carbonate was demonstrated to provide a practical
alternative to dicyclohexylcarbodiimide and N-hydroxysuccinimide for the 
formation of active esters and may prove to be less hazardous for general 
use.
3.5 CONCLUSIONS
1. Use of active esters of progesterone derivatives whether isolated or 
added directly enabled efficient formation of enzyme-labelled progesterone 
with minimal loss of enzyme activity. The binding characteristics of 
these labelled steroids with antibody commended them for use in EIA.
2. Disuccinimidyl carbonate provided a more convenient and arguably safer 
alternative to carbodiimide and N-hydroxysuccinimide for the synthesis 
of active esters.
CHAPTER A:
THE ENZYMES USED AS I flBFIS: . 
OPTIMIZATION OF ASSAY PRnCFDIIRF.S
CHAPTER 4. THE ENZYMES USED AS LABELS: OPTIMIZATION OF ASSAY PROCEDURES
4.1 INTRODUCTION
Alkaline phosphatase, 3-galactosidase, penicillinase and peroxidase were 
assessed for their usefulness in microtitre plate EIA since they have 
previously been applied successfully in steroid EIA (see section 1.9.3.): 
only 3-galactosidase (Dray et al3 1975) and peroxidase (Joyce et al3 1977) 
have been used in the assay of progesterone, however.
The properties of enzymes used in these studies are shown in Table 4.1. 
The enzyme preparations were of the highest purity and specific activity 
commercially available. Colorimetric assays for these enzymes were adapted 
for use in microtitre plates from test-tube procedures described by Joyce 
et al3 (1977, peroxidase), Novick (1962, penicillinase), Exley and Abuknesha 
(1978; 3 -galactosidase) and McComb and Bowers (1972, alkaline phosphatase).
The main objective was to optimize substrate and chromogen concentrations 
to ensure, where possible, the attainment of zero-order kinetics (reaction 
velocity independent of substrate concentration) over the normal assay 
period. This is particularly critical for microtitre plate procedures since 
the volume of substrate which may be added is limited by the small size of 
the wells (maximum volume 0.3 - 0.4ml). Since in EIA the mass of enzyme 
bound in each well will depend on the degree of competition,it is also 
important that product formation should increase linearly with the mass of 
enzyme present. Maximum sensitivity in EIA should be attained when minimum 
concentrations of label are used and full advantage of this will be achieved 
when assay conditions subsequently permit substrate conversion at maximum 
velocity. The reactions catalysed by the four enzymes are outlined in 
Fig. 4.1.
In the case of alkaline phosphatase and 3“galactosidase, assay optimiz­
ation procedures were considerably simplified by the availability of chromo- 
genic substrates.
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A number of amino and phenolic chromogens may act as hydrogen donors in 
the reduction of hydrogen peroxide by peroxidase (Saunders et 1964) and 
the resulting spectral shift provides a sensitive means of monitoring 
peroxidase activity: <?-phenylenediamine (oPD) was used here.
Two chromogenic substrates have been reported for penicillinase but 
neither were considered to be suitable for the present application.
N-(2-furyl)acryloyl penicillin (Durkin, Dmitrienko and Viswanatha, 1977) 
gives rise to spectral changes outside the visible range (330nm) and which 
could not be quantitated on the plate reader using standard optical filters.
The other, 3-(2,4-dinitrostyryl)-(6R, 7R)-7-(2-thienylacetamido)-ceph-3-em- 
4-carboxylic acid (O’Callaghan, Morris, Kirby and Shingler, 1972) was shown 
to be hydrolysed too slowly by penicillinase from B. osreus to be of pract­
ical value. An iodometric assay developed from that described by Novick 
(1962) was therefore used. This procedure has also been modified by Shah 
and Joshi (1982) for use in a microtitre plate EIA but this involved a two 
step method in which the end-point was attained in a test tube: this was
considered to be impractical and retrograde in the present application.
The Novick method depends on the reduction of iodine by penicilloic acid 
but not by penicillin, as indicated by decolorization of starch/iodine 
reagent.
4.2 METHODS
For all assays absorbance readings were made in situ using a "through- 
the-wellM automatic microtitre plate reader. Use of a suitable dispenser 
(BCL 500) enabled substrate to be added to wells already containing enzyme 
solution at essentially the same rate at which the wells were read ( 96 wells/
1 .2  minutes): thus termination of the enzyme reaction was considered
unnecessary.
All assays were performed in a similar manner in microtitre plate wells.
Enzyme solutions were diluted in the appropriate buffer (PAS-gelatin; for 
peroxidase, PMS-gelatin) to provide the desired concentrations and an ali­
quot (IOjuL) added to the wells with a positive displacement pipette prior 
to addition of substrate or substrate/chromogen solution. Substrate sol­
utions were prepared (see section 2 .1 .8 .) over an appropriate range of 
concentrations: in addition, for peroxidase, a range of chromogen concen­
trations were investigated using a fixed substrate concentration. Each 
variable was estimated in quadruplicate. Substrate solutions (200^1) were 
added rapidly to enzyme in the wells and the plate covered with a lid and 
transferred to a covered water bath at 40°C (21°C - 24°C in the dark for 
peroxidase). Incubations took place on a grid over which the water level 
was adjusted to enable immersion of the base of the wells by 1 - 2mm.
Product formation was monitored by reading the plate .at appropriate inter­
vals: values were corrected for substrate blanks. Table 4.2 summarizes
assay conditions and the reagents used.
4.3 RESULTS
4.3.1. g-Galactosidase
Concentrations of o-nitrophenyl- g-D-galactopyranoside (o-NPG) below L.6mg/ml 
(5.3mM)were found to be reaction-rate limiting (Fig. 4.2a) and a concen­
tration of lOmM was used for all subsequent work. The reaction rate was 
found to be non-linear irrespective of the mass of enzyme used (Fig.4.2b): 
however, a linear relationship between reaction rate (absorbance at fixed 
time) and quantity of enzyme present.was demonstrated (Fig. 4.2c, r = 0.9998, 
y = 0.112x+ 0.025). A reduction in reaction rate as a result of non­
immersion of wells during incubation was clearly demonstrated (Fig.4.2b) 
and arises from slower attainment of equilibrium temperature (see section 
5.2.5.a ).
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Fig. 4.2 The assay of g-galactosidase (n = 4 for all estimations).
a) The influence of substrate concentration on reaction rate at 40 C. 
g-Galactosidaso (3.2ng) was incubated with o-nitrophonyl-/3-D-galactopyranoside 
(<?NPG) at the concentration indicated.
b) The reaction rate of /J-galactosidaso (0.8ng, a - a ; l.Gng a-a; 3.2ng ■ -«)
incubated at 40°C with ONPG (lOmM). Plate wells were incubated either in 
contact with (---) or immediately above (--- ) water in the bath.
c) The relationship between the mass of enzyme and relative reaction rate 
(15 minute incubation) with oNPG (lOmM) at 40°C.
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Fig. 4.3 The assay of alkaline phosphatase (n = 4 for all estimations)
a) The influence of substrate concentration on reaction rate at 40°C.
Alkaline phosphatase (0.2ng) was incubated with p-nitrophcnylphosphate (pNPP) 
at the concentrations indicated.
b) The relationship between the mass of enzyme and relative reaction rate 
(1 hour incubation): pNPP was used at 5, 10 and 15mM.
c) The relative reaction rute of alkaline phosphatase (0.4ng) incubated at 
23 C (.-■), 37 °C (o-o) 40°C (A-A) and 4 5°C (a  -  a ) with pNPP ( 15,nM) .
4.3.2. Alkaline Phosphatase
The maximum reaction rate was achieved using p-nitrophenylphosphate at 
a concentration of 30mM (Fig. 4.3a). Further studies indicated that the 
reaction rate retained linearity over a range of enzyme concentrations 
(Fig. 4.3b) using 5, 10 or 15mM substrate (r = 0.998, 0.999 and 0.999 
respectively): thus,although the latter concentration gave rise to a 
12% lower reaction rate than 30mM, it was used at 15mM for all' subsequent 
work to reduce reagent.cost. Comparison of incubation temperatures bet­
ween 25°C and 45°C indicated that 40°C was optimal since,for incubation 
periods in excess of 40 minutes, the reaction rate declined at higher 
temperature (Fig. 4.3c).
4.3.3. Peroxidase
The concentration ranges of OPD and H O  chosen for the studies des-
A A
cribed here were selected on the basis of an initial "latin square" experi­
ment using a fixed mass of enzyme (lng). Subsequent experiments were per­
formed using a closer range of concentrations of both chromogen and sub­
strate and indicated that the reaction rate was maximal using 22.1mM <?PD 
(Fig. 4.4a) and 7.1mM H202 (Fig. 4.4b): higher concentrations of either
reagent resulted in an apparent inhibition of enzyme activity. The 
reaction rates were non-linear, possibly as a result of limiting substrate 
concentrations: similar complex kinetics have been reported elsewhere
(Groome, 1980; Porstmann, Porstmann and Nugel, 1981). Using the optimal 
concentrations, however, reaction rates did increase linearly with increas­
ing mass of enzyme (Fig.4.4c; y = 6.785x - 0.034 and r = 0.9995 for a 
40 minute incubation period).
4.3.4. Penicillinase
The initial absorbance of the reagent is dictated by the concentration 
of iodine and this was adjusted to provide a value of 1 .2  (see section 2.1.9d ).
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Fig. 4.4 The assay of peroxidase. All assays were performed at ambient temperature (20 - 
22°C; n ■ 4 for all estimations).
a) The influence of o-phenylenediamine (oPD) concentration on enzyme activity. Peroxidase
(0.5ng/well) was Incubated with hydrogen peroxide (7.1mlf) and the chromogen OPD at the
concentrations Indicated.
b) The influence of substrate concentration on enzyme activity. Peroxidase (0.2ng/well) was 
incubated with <?PD (22.1mll) and hydrogen'peroxide at the concentrations indicated.
c) The relationship between the mass of peroxidase and relative reaction rate. Peroxidase
was incubated with oPD (22.1mU) and hydrogen peroxide (7.1ml() for IS minutes (■-■) or
45 minutes (•-•).
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Fig. 4.5 The assay of penicillinase. All assays were performed at 40°C (n c 4 for all 
estimations).
a) Reduction of starch/iodine reagent as a result of autolysis of peniclllin-V. Starch/iodine 
reagent, prepared as described in table 4.2, was added to aliquots (lOpl) of penicillin-V 
solution to provide the final concentration indicated.
b) Penicillin-V concentration and catalytic reaction rate. Penicillin-V hydrolysis by 
penicillinase (20pg) at concentrations of 122yM (a-a), 245yM (a - a ) ,  489yU (o-o) and 979pJ4 
(□-0)was determined by reduction of starch/iodine reagent. All volumes are corrected 
for autolysls. The autolysis value as % of initial absorbance (^ 1.2) of the starch/iodine 
reagent is expressed where appropriate.
c) The relationship between the mass of penicillinase and relative enzyme reaction rate. 
Incubation periods at a substrate concentration of 122pli (m-m) were 30, 45 or 60 minutes, 
and at 245pM (a— A), 45 minutes.
Phenoxymethylpenicillinic acid (penicillin-V). was used as substrate since 
this is most rapidly hydrolysed by B. oereus penicillinase (Citri, 1971): 
the reaction has been described as providing zero-order kinetics (Citri,
1971).
The main problem associated with the method was development of a 
substantial substrate blank at high substrate concentrations (Fig. 4.5a), 
a phenomenon also observed with benzylpenicillin. This prevented its use 
with the starch/iodine system at concentrations likeiy to provide zero- 
order kinetics.
Only substrates concentrations of 122yM and 245yM gave rise to accept­
ably low degrees of autolysis (at 45 minutes, 3% and 9% respectively of the 
initial blank value) when compared with enzyme hydrolysis (Fig. 4.5b).
Although enzyme activity was substrate-limited at these concentrations, 
it was considered that either would enable end-point determinations in EIA.
The greater enzyme-induced reduction in absorbance using 245yM rather than 
122yM was balanced against a 6 % increase in autolysis and as a consequence 
the latter was used in subsequent studies.
A lag-phase was noted at all substrate concentrations (Fig. 4.5b): This
is not associated with the enzyme but with a limiting starch/iodine reduction 
rate (Novick, 1962). Despite this, a linear relationship was demonstrated 
between reaction rate and the mass of enzyme using substrate concentrations 
of 122yM (r = 0.999, y = 58.78x - 0.091) and 245yM (r= 0.999, y = 48.47x +
0.012) at incubation periods of 1 hour and 0.75 hour respectively (Fig.4.5c). 
Lack of linearity for shorter incubation periods was assumed to be assoc­
iated with the greater proportional influence of the lag-phase.
4 ‘3.5. Summary of Selected Assay Conditions
Table 4.2 summarises the conditions selected for the assay of the four 
enzymes in EIA. The wavelength selected for absorbance determination was
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dictated by the filters available in the microtitre plate reader and were 
at or close to the wavelength of maximum absorbance as determined spectro- 
photometrically (Cecil CE292).
Table 4.3 Comparison of the Relative Sensitivity of Detection of 
g-Galactosidase, Alkaline Phosphatase, Peroxidase and 
Penicillinase Assayed.in Microtitre Plates
Enzyme AOD/ng/h AOD/f.mol/h
3-Galactosidase 0.458 0.247
Alkaline Phosphatase 2.48 0.248
Peroxidase 9.923 0.397
Penicillinase 58.8 1.764
Values were calculated from data in Figs. 4.2.C., 4.3.b., 4.4.c. and 4.5.c.
Enzymes were assayed under conditions described in Table 4.2.
AOD = change in optical density. This represents the product of the enzyme 
specific activity and the extinction coefficient of the product.
4.4 DISCUSSION
From the data shown in Figs. 4.2c, 4.3b, 4.4c and 4.5c, it was possible
to compare the sensitivity of detection of the four enzymes in terms of
absorbance change per unit time for a given mass of enzyme (Table 4.3).
The low (<1 f.mol) quantities of enzyme which may be detected were 
within those anticipated for use as label in EIA: the quantity of
tritium label used in progesterone RIA would be of the order of 10 - 50 
f.mol /test (A 3 - 15pg/test).
It is clear that penicillinase may be detected with greatest sensit­
ivity (precision was similar for all enzymes, ^ 1% c.v.) when considered 
both in terms of mass and molar quantities of enzyme: the possibility
clearly exists that the sensitivity may be further improved by use of a
substrate (preferably chromogenic) less prone to autolysis in order that 
the maximum reaction velocity may be approached. Similarly, sensitivity of 
detection may be further improved for the other three enzymes by use of 
fluorogenic substrates (see section 1.9.3.), although these are of no 
practical interest for the intended application. A system has recently 
been described, however, which enables the product signal of the alkaline 
phosphatase-catalysed reaction to be Lcolprimetrically amplified, by up to a 
hundred-fold (Self, 1982) and this may be of value in reducing the mass of 
conjugate required, the time taken to perform the assay or in providing a more 
readily visualised product for semi-quantitative applications.
Enzyme detection limits should not solely dictate the preferred 
enzyme for use in EIA and the properties of these enzymes when conjugated 
with progesterone are considered in Chapter 6 .
4.5 CONCLUSIONS
1. It was possible to assay the four enzymes in microtitre plate wells
by addition of a single reagent: a linear relationship between reaction
rate and enzyme mass was noted in each case.
2. Low f.mol detection limits were attained indicating the suitability of 
the enzymes for use in microtitre plate EIA.
3. The sensitivity of detection of the enzymes was in the order 
penicillinase > peroxidase > alkaline phosphatase > 3-galactosidase.
CHAPTER 5:
SEPARATION OF FREE FROM ROUND ENZYME L A B E L ; 
THE USE OF MICROTITRE PIATFS
CHAPTER 5. SEPARATION OF FREE FROM BOUND ENZYME LABEL: THE USE OF
MICROTITRE PLATES.
5.1 INTRODUCTION
In preliminary studies of separation procedures in EIA, solid-phase 
primary antibody (covalently attached to microcrystalline cellulose or 
passively adsorbed to microtitre plates) were compared with double antibody 
precipitation techniques. At this stage of assay development methods of 
end-point determination all involved manual spectrophotometric procedures 
in the manner described by Sauer, Foulkes and Cookson (1981). It became 
clear at this time that use of microtitre plates, although far from perfect, 
presented a major advantage over the other procedures in that manipulative 
stages were considerably simplified. The rigid form of the 96 well plates 
enabled manual pipetting stages and separation and wash steps to be per­
formed with greater speed and facility.
"Through-the-well” microtitre plate readers (colorimeters) have 
subsequently become available which enable sequential, rapid (96 wells/
1 .2  minutes) and automatic determination of absorbance vn situ thereby 
eliminating a major rate-limiting step in EIA. It was therefore decided 
to concentrate on the development of microtitre plate methods.
It was apparent from other preliminary studies that major shortcomings 
in the microtitre plate procedure required resolution if this was to become 
a practicable, reliable quantitative procedure. Their major limitations 
were their variable and low adsorptive capacity for antibody.
The use of microtitre plate wells as immunoadsorbent in enzyme- 
immunometric assays has been reported to give rise to variable results 
(Denmark and Chessum, 1978a and 1978b). Discrepancies have been ascribed 
to variations in the adsorptive properties of single or groups of wells 
as a result of inconstancy in manufacture or in incubation conditions 
either at adsorption or during the immunoassay (Denmark and Chessum 1978a & b 
Burt, Carter and Kricka, 1979; Kricka et at, 1980).
Measurement of precision and extent of adsorption of y-globulin is
facilitated by the use of labelled y-globulin and avoids the introduction
of errors associated with indirect procedures. Application of 
125
I-labelled y-globulin for these purposes has been widely reported
(Pesce, Ford, Gaizutis and Poliak, 1977; Salonen and Vaheri, 1979;-
Cantarero, Butler and Osborne, 1980). The introduction of a large '
(electron-withdrawing) atom such as iodine would be expected to induce
conformational changes and alter the isoelectric point of the y-globulin
(Hunter, 1978), however and this might influence the adsorption process.
The validity of using such a label in the investigation of adsorption must
14
therefore be held in question; ( C)Y-globulin was used in the 
present study. This was formed at neutral pH by the reductive methylation 
technique applied by Jentoft and Dearborn (1980) to the labelling of BSA. 
This involved minimal perturbation of protein structure since the substi­
tuted methyl groups are relatively small and the net charge distribution 
of the protein is not altered (Jentoft and Dearborn, 1979; Tack and 
Wilder, 1981).
Microtitre plates are not available in plastics containing functional 
groups allowing the formation of chemical bonds with antibody. Reliance 
has therefore been placed on passive adsorption to the well surface. The 
use of antibody immobilized on the surface of polystyrene in this way for 
immunoassay was first reported by Catt and Tregear (1967). Few details of 
the studies involved in arriving at the conditions described as "optimal” 
for the passive adsorption of antibody were reported, however. The 
process involved incubation of plastic tubes containing antibody solution 
(unspecified buffer at pH 9 - 10) for a suitable period. Engvall et al 
(1971) reported the use of a carbonate buffer (0.1M, pH 9.8) for the same 
purpose: the coated tubes were subsequently used in EIA. Similar con-
ditions have become the norm in both EIA and RIA, however, despite the 
apparent inefficiency of the adsorption process (Parsons, 1981).
The process of protein adsorption to hydrophobic amorphous polymers 
such as polystyrene and PVC is thought to involve hydrophobic bonding 
(Morrissey, 1977). In aqueous solution hydrogen bonds, hydrophobic and 
ionic interactions dictate the structural conformation of proteins so 
that hydrophilic amino acids are presented at the protein surface and 
hydrophobic amino acids to the interior. During the process of adsorption, 
water molecules ordered around specific regions of the protein and the 
solid surface must be displaced and conformational changes occur in the 
protein to enable bonding between hydrophobic nuclei (Kochwa, Litwak, 
Rosenfield and Leonard, 1977). Once formed, such hydrophobic bonding is 
thought to be virtually irreversible (Parsons, 1981).
2
The relatively small surface area of microtitre plate wells ( ^240mm ) 
necessitates identification of optimum conditions if efficient use is to 
be made of antisera and sufficient antibody is to be adsorbed to provide 
a practicable assay: the investigation of such conditions are described
in this chapter.
The adsorption of caprine and ovine anti-progesterone y-globulin to 
PVC and polystyrene microtitre plates was investigated. PVC plates were 
used in the earliest studies since they provided higher and less variable 
adsorption properties than concurrent polystyrene plates. High performance 
polystyrene plates (NUNC) subsequently became available and their charact­
eristics justified comparison with PVC plates.
Adsorbed antibody was initially quant^jfTedUi by subsequent assessment
3
of ( H)progesterone binding since equilibrium was attained within a few 
hours and fewer incubation stages were involved in which errors could be 
introduced. Later studies involved use of enzyme-labelled progesterone
14.
or direct measurement of C-labelled y-globulin.
The performance of assays in test tubes permits rapid and uniform attain­
ment of particular assay temperatures since they can be immersed in a water bath 
at the required temperature. The manner of construction and dimensions of 
microtitre plates, particularly those in polystyrene, do not readily 
permit such procedures. Furthermore, the use of oven incubations is not 
recommended since heat transfer is relatively slow and may not be evenly 
distributed across the plate. The occurrence and extent of between-well 
variation in heat transfer rate was therefore investigated since this 
could give rise to imprecision during y-globulin adsorption and subse­
quently during EIA.
5.2 METHODS
5.2.1. Carbon-14 Labelling of Anti^-Progesterone y-Globulin
The method used was adapted from methods described by Jentoft and 
Dearborn (1979 and 1980) for the reductive methylation of e-amino groups 
of lysine residues and a-amino terminus of BSA: the reaction readily
proceeds at neutral pH.
r n h3+
t! NaCNBH
RNH2 + CH2 = 0 -5=^ RNH - CH2 0H^3=r- RN = CH2  —  RNH - CHg
Further reaction of the secondary amino group occurs at high molar ratios
of formaldehyde to amine (e.g. 6 :1): reduction using sodium cyanoborohydride
then forms the dimethyl derivative.
The y-globulin fraction of BSA-absorbed goat anti-progesterone serum
(G711/12) was prepared by the Rivanol procedure (section 2.3.l.d and 2.3.1.e ),
dialysed against 0.1M PS buffer, pH 7.5 (1000 vol) and the protein content
determined. Sodium cyanoborohydride (1.4mg, 22ymol) was weighed into a
screw capped glass bottle containing a magnetic stirring bar and freshly
prepared nickel chloride suspension (IM in 0.1M PS buffer pH 7.5, lOyl e
lOymol), anti-progesterone y-globulin solution (1.682mg in 0.9ml = O.Ollymol
or 0.814ymol lysine residues*) and C-formaldehyde solution (4.7ymol:
250yCi in 0.1ml 0.1M PS buffer pH 7.5) added. The mixture was then
stirred in the capped vessel for 2 hours at room temperature (21°C).
Following dialysis of the mixture at 4°C overnight against 0.1M PS buffer
pH 7.5, it was applied to a Sephadex G25 column (bed volume 10ml). The 
14
C-labelled y-globulin fraction was eluted with 0.1M PAS buffer pH 7.0, 
collected manually at the void volume following spectrophotometric 
detection at 280nm and stored frozen (-20°C) in 1ml aliquots.
Following determination of the protein concentration (recovery 98%) 
and radioactivity (5yl aliquots counted in 10ml Instagel) of the y-globulin
14
fraction an incorporation of 0.77 mol C/mol lysine and specific activity 
of 3.01 Ci/mmol IgG were calculated.* Comparison of binding characteristics 
of this and the unsubstituted y-globulin in RIA revealed no substantial 
differences.
5.2.2. Plate Coating Procedure
The y-globulin fraction of the antiserum was diluted in the appropriate 
buffer, 2 0 0 yl aliquots added to each microtitre plate well using an 8- 
channel peristaltic dispenser and the plate covered with a lid. Following 
incubation for 3 hours either on a grid in a water bath (base of wells 
1 - 2mm below water surface) at 40°C or at room temperature (in a draught 
free environment away from point sources of heat), the plate was emptied, 
tapped dry over absorbent paper and 250yl (PVC plates) or 350yl (poly­
styrene plates) of PAS-gelatin buffer added and the plate sealed with 
plastic film. Plates were stored for a minimum of 16 hours at 4°C before 
use. To facilitate incubations in water, a small hole was cut in each 
corner of PVC plates to prevent floating.
* For the purpose of these calculations the y-globulin preparation was 
assumed to be pure IgG. Since data for caprine or ovine I gG were not 
available these figures are based on data for human IgG, molecular 
weight 153,000 Daltons (Sober, 1970) and lysine content 74mol lysine/ 
mol IgG.
5.2,3. The Adsorption of Caprine Y-Globulin to PVC (Dynatech) Plates
The carrier protein-absorbed y-globulin fraction of anti-progesterone 
serum was used for all experiments and the final dilution based on the 
original antiserum volume.
a) Duration and temperature of incubation with y-globulin. The 
y-globulin fraction of the antiserum (G711/12) was diluted to 1/200 in
0.01M PAS buffer and 200yl aliquots dispensed into quadruplet wells of
microtitre plates in sequence, such that all incubation periods (0.5, 1,
2, 3, 4, 5, 6 , 9, 21 and 24 hours) were completed at the same time. The 
plates were incubated covered with a plate lid for the specified time at 
room temperature or in a water bath maintained at 35°C or 40°C.
b) The pH of the coating buffer. The y-globulin solution (G711/12) 
was diluted to 1/200 in 0.1M PAS at pH 5,6, 7 or 8 or in 0.1M carbonate 
buffer at pH 9 and 10 and 200yl aliquots dispensed into octuplet wells.
The plate was covered with a plate lid and incubated for 3 hours at 40°C 
in a water bath.
c) The molarity of the coating buffer. The y-globulin (G711/12) was 
diluted to 1/200 in acetate buffer pH 5.0 (0.001, 0.01, 0.05, 0.1 and 0.5M) 
and 200yl aliquots dispensed into octuplet wells. The plate was covered 
with a plate lid and incubated for 3 hours at 40°C in a water bath. PAS 
buffer was not used in this study since phosphate ions do not provide
effective buffering at pH 5.0.
In experiments a, b and c, plates were emptied after the incubation
period, tapped dry, PAS-gelatin buffer (250yl) added to all wells and the
plates left covered overnight at 4°C. Plates were then emptied, washed
3
once with PAS-gelatin buffer (250yl) and ( H)progesterone (15pg = 8,000dpm 
in 200yl PAS-gelatin buffer) added to each well. The plates were incu­
bated at 4°C for 24 hours (a) or 40°C for 3 hours (b and c). Wells were
then emptied, washed with PAS gelatin buffer (x3), separated using scissors 
and the radioactivity bound determined by liquid scintillation counting 
following extraction of each well in Toluene Scintillator (7ml).
5.2.4. The Adsorption of Ovine y-Globulin to Polystyrene (NUNC) or PVC 
(Dynatech) Plates using a Universal Buffer
The y-globulin fraction of ovine antiserum S10823/24, prepared by 
ammonium sulphate precipitation (see section 2.3.1.f)), was diluted (1/800) 
in Britton/Robinson buffer over a range of pH values (2.5, 4.0, 5.0, 6.0,
7.0, 8.0 9.0 or 10.0) or at pH 4.0 over a range of molarities (0.5, 1.6,
4.0, 13, 40 or 120mM, total of all solute molecules) and 200yl aliquots 
added to quadruplet wells. y-Globulin diluted in ImM acetate buffer at 
pH 4.0 and pH 5.0 was used to prepare control wells. - The y-globulin was 
adsorbed following incubation for 3 hours at 40°C in the manner described 
in section 5.2.2. The degree of adsorption was subsequently determined 
following incubation (3 hours at 40°C) with progesterone lla-glucuronide- 
alkaline phosphatase conjugate (5ng: prepared with a 50:1 molar excess 
of steroid) in the presence of ovX milk (lOyl) in the manner described 
for EIA (section 7.2.2.b)).
5.2.5. Sources of Variability
a) Between-well variations in temperature equilibration rate. Micro­
titre plates containing 200yl of PAS gelatin buffer per well were cooled 
to 4°C prior to transfer to a water bath fitted with a lid. A thermo­
couple (nickel chrome/nickel aluminium; Radiospares, London) was placed 
into the specified well at the start of the incubation period and the 
plate allowed to attain equilibrium temperature (40°C). The plates were 
arranged such that the base of each well was either just above (2 - 3mm) 
or just below (2-3mm) the water surface. The attainment of 40°C in the
"above water’1 wells necessitated an increase in water bath temperature to 
43°C. Temperature changes were monitored by a chart recorder which was 
calibrated to enable determination of the time taken to raise the well
contents from 20°C to within 0.5° of 40°C.
14b) The adsorption of C-labelled y-globulin: the influence of
detergent pre-'Wash. Dynatech, Flow and Falcon PVC microtitre plates were
washed at room temperature with either Tween 20 (0.05% v/v for 1 hour) or
Decon 90 (2.5% v/v, overnight), rinsed in tap water,then soaked in dilute
HC1 (1% v/v for 1 hour), rinsed (x 3 each) with tap water then distilled
14
water and finally dried in air. ( C)Anti-progesterone y-globulin (G711/12, 
716ng/ml at 1/4000 dilution, 200yi in ImM acetate buffer pH 5.0) was 
added at the appropriate dilutions ( =1/4000, 1/8000, 1/16,000), 
each to 30 wells of a plate. Coating buffer alone
was added to two wells in each group to provide blanks . The plates were 
covered with lids and incubated at 40°C for 2 hours in a water bath such 
that the base of each well was 1 - 2mm below the water surface. The wells 
were then emptied, tapped dry, washed with distilled water (250y1) , 
tapped dry, PAS-gelatin buffer (250yl) added to half of the wells in each 
group and the other half left dry: the plates were stored covered at
4°C overnight (20 hours). They were then emptied, tapped dry, each well 
separated and bisected with scissors and placed in a scintillation vial.
The mass of y-globulin adsorbed to each well was determined by liquid 
scintillation counting after additions of Filter Count scintillator (7ml) 
as described (section 2.3.3.).
c) The sources of polystyrene and PVC plates. Polystyrene microtitre 
plates manufactured by Dynatech, Flow and NUNC, and PVC microtitre plates 
by Dynatech, Falcon and Flow were used to assess between-brand variability 
in precision of adsprption of caprine y-globulin to wells. Two plates of 
each type were assessed. PVC plates were washed in Decon 90 prior to use 
(see section 5.2.5.b ).
Adsorption of anti-progesterone y-globulin (G711/12, diluted 1/4000.in 
0.17 mM acetate buffer, pH 5.0) to the 96 wells of each plate was performed 
at room temperature (21°C) for 3 hours in the manner described in section
5.2.2. Assessment of adsorption was performed following incubation (3 hours 
at 21°C) with progesterone lla-glucuronide-alkaline phosphatase conjugate 
(20ng, prepared with a 2:1 molar excess of steroid) in the manner described 
for EIA (section 7.2.2.b)). The four corner wells of each plate were used 
to provide a mean substrate blank value (no conjugate added).
5.3 RESULTS
5.3.1. The Adsorption of Caprine y-Globulin to Plate Wells
a) PVC plates: the influence of time, temperature, pH and buffer
molarity. The influence of these variables on the adsorption process are
shown in Fig.5.1. The study of the influence of buffer pH employed buffer
.1 . 2.4
x
a
•O I 2.0
■o
c
3
o
JO
3.0
4)
COb
®
0.
2.6
as
•— *
0.001
incubation time (hrs) buffer pH buffer molarity
Fig.5.1. Effect of A, incubation duration and temperature (25°C, o-o;
30 C, a -a ; 35°C, ■-■; 4O°C,0-Q); B, pH and C, buffer molarity on adsorp­
tion of caprine y-globulin (G711/12) on to PVC (Dynatech) microtitre plate 
wells. Values are mean of 4 determinations (A) or 8 determinations (B and 
C) ±1 sd.
systems (pH 9 and 10) similar to those used by Catt and Tregear (1967) and 
adapted for use in EIA by Engvall et al (1971) and Voller et al (1976a).
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It was clear from these studies that the adsorption process was virtually 
complete within 1 hour and that a small increase in the total adsorbed could 
be achieved by incubating above ambient temperature (Fig. 5.1.a). For all 
subsequent studies the adsorption process was performed for 3 hours at 40°C
in a water bath or at room temperature: although less y-globulin was
adsorbed, the latter procedure was chosen for subsequent use since it enabled 
large numbers of plates to be prepared. Maximal adsorption was obtained at 
pH 5.0 (Fig. 5.1b) in ImM acetate buffer (Fig.5.1c).
b) PVC and -polystyrene plates: the influence of different buffer ions.
The higher degree of adsorption achieved using acetate rather than phosphate 
buffer suggested a buffer ion effect: this was investigated by comparing
the efficacy of 3 buffer systems at pH 5.0 in promoting antibody adsorption 
to both polyvinyl (Dynatech) and polystyrene (NUNC) plates as described in 
table 5.1. Adsorption using acetate buffer was highest at the lowest mol­
arity used (0.17mM) and at this molarity was appreciably greater than that 
achieved using the other buffer systems at any molarity (see table 5.1 for 
significance).
5.3.2. The Adsorption of Ovine y-Globulin to Polystyrene (NUNC) or PVC 
(Dynatech) Plates using a Universal Buffer 
The adsorption of ovine y-globulin was examined in a similar manner to 
that for caprine y-globulin since the possibility of between-species differ­
ences could not be ignored. A universal buffer (Britton/Robinson buffer, 
effective pH range 2.5 - 12.0) was used to investigate the influence of pH 
since this eliminated the possible variable effect of different solute 
molecules on the process. A similar pattern emerged to that with caprine 
y-globulin (Fig.5.1), maximum adsorption occuring at pH 5 for polystyrene 
plates and at pH 4 - 5 for PVC plates (Fig.5.2a). At the lowest buffer 
molarity used (0.5mM solute, pH 4.0; Fig.5.2b) adsorption was higher than
Op
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l 
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y 
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05
nm
)
achieved with acetate (lmM) at pH 4.0 or 5.0 for both types of plate. The 
apparent reduction of adsorption seen at pH 2.5 may have been a result of 
antibody denaturation.
Using both ovine (Fig.5.2) and caprine (table 5.1) y-globulins under 
identical conditions, a higher degree of adsorption was achieved with poly­
styrene (NUNC) than PVC (Dynatech) plates.
1.0
0.8
0.6
0.4
0.2
106 82 4
pH
0.5 1.6 4.0 13.0 40 120
Total Buffer Molarity (mM), pH 4.
Fig. 5.2 The influence of pH (a) and buffer molarity (b) on the adsorption 
of ovine anti-progesterone y-globulin (S10823/24) from Britton/
Robinson buffer to polystyrene (---, NUNC) or PVC (---, Dynatech)
plate wells.
For b, controls were included on the polystyrene (o,«) and polyvinyl fc,A) 
plates consisting of the y-globulin diluted in lmM acetate buffer at pH 4.0 
(#,a) and pH 5.0 (o ,a ).
5.3.3. Sources of Variability
a) Betueen-well variations in temperature equilibration rate. The time
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taken to raise the temperature of buffer (200yl) contained in plate wells 
from 20°C to 40°C was monitored using a thermocouple. It was seen that the 
time to equilibrate varied considerably between wells and that immersion of 
the wells to a depth of 2 - 3mm reduced the mean time taken by 49% for 
polystyrene plates and by 86% for PVC (table 5.2). The latter took cons­
iderably less time to reach equilibrium since the PVC plate wells are 
substantially thinner.
PVC plates were subsequently used to investigate the precision of 
adsorption of Y-globulin since they enabled rapid temperature equilibration
and initial studies indicated the attainment of better overall precision.
14b) The adsorption of C-labelled y -globulin: the influence of deter­
gent prewash. In preliminary studies pre-washing of PVC plates with deter­
gent (Tween 20, 0.05% v/v) to remove possible impurities on the surface of 
the wells caused an insignificant reduction (4%) in adsorption of y-globulin 
to wells but lowered (F = 4.8, p <0.01) the coefficient of variation in EIA 
(cv = 2.9%, n = 288) compared with untreated plates (cv = 6.0%,
n = 288) when assessed by use of progesterone lla-hemisuccinate-B-
14galactosidase label. A comparison of the adsorption of( C)y-globulin to 
three types of PVC plate pre-washed with Tween 20 or Decon 90 was therefore 
made.
A highly significant increase in adsorption (p< 0.001) was seen in all 
cases when plates were pre-washed with Decon 90 rather than Tween 20 (Fig.5.3) 
accompanied by an overall improvement in imprecision of adsorption, from 3.9 
to 1.7%, 3.3 to 1.2% and 5.4 to 2.1% (Tween 20 vs Decon 90) for Dynatech,
Flow and Falcon plates respectively. The subsequent degree of desorption 
of y-globulin following the standard addition of PAS-gelatin buffer (gelatin 
is included to block unoccupied adsorption sites) for 16 hours was low for 
all types of plate but was higher for Decon 90 treated than Tween 20 treated 
plates: this effect was more marked at higher antibody dilutions. The
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Fig. 5.3 Comparison of adsorption of ( C) anti-progesterone y-globulin to 
Dynatech, Flow or Falcon PVC plates following a pre-wash with Tween 20 (— -) 
or Decon 90 (---) .
Following y-globulin adsorption, plates were emptied and stored empty (0) or 
containing 250yl of PAS gelatin buffer (a ) for 20 hours at 4 C before asses­
sment of the degree of adsorption by liquid scintillation spectrometry. 
Values represent the mean ± sd dpm (n = 15).
Table 5.4 Comparison of the Adsorption of Caprine y-Globulin to Polystyrene 
and PVC Microtitre Plates from Various Sources
Plate PVC PLATES POLYSTYRENE PLATES
Manufacturer No. Dynatech Falcon Flow Dynatech Flow NUNC
Mean 1. 0.847 1.051 0.745 1.068 0.714 1.396
Absorbance (4.7) (6.0) (5.9) (9.2) (9.0) (4.7)
(cv%)
2. - 1.230 0.998 0.971 0.850 1.498
(6.1) (5.1) (9.4) (16.5) (4.3)
Anti-progesterone y-globulin (G711/12) was adsorbed to the wells of two plates 
of each type and the extent and precision of adsorption to each type determined 
as for EIA following subsequent incubation with progesterone lla-glucuronide- 
alkaline phosphatase conjugate. Absorbance values represent the mean for 
92 wells. - = not performed.
mean desorption values ranged from 0.1 to 5.2% of the total adsorbed 
(table 5.3). The proportion of y-globulin adsorbed decreased with increas­
ing concentration and at a dilution of 1/16,000 (PAS-gelatin treatedwells) 
was 69.4 - 1.9% and 84.4 - 4.1% of the total added for Tween 20 and Decon 
90 pre-washed plates respectively (table 5.3). The results were further 
analysed to establish if there was a difference between adsorption to wells 
on the edge of the plate compared with those interior. When mean binding 
for four edge wells was compared for each treatment and antibody dilution 
with that of the block of 12 adjacent interior wells (e.g. wells 1A - ID 
vs the matrix of wells 2.B - 2D to 4B - 4D)^  no significant difference was 
found for any position.
q) The sources of 'polystyrene and PVC plates. The degree and precision 
of adsorption of caprine y-globulin to various plate types was compared 
indirectly by incubation with progesterone lla-glucuronide-alkaline 
phosphatase conjugate (table 5.4) subsequent to adsorption. Only poly­
styrene plates manufactured by NUNC produced higher and more precise 
adsorption than the washed PVC plates: only NUNC plates were avail­
able with a manufacturers maximum specification for C.V.. for adsorption 
(not to exceed - 10%).
5.4 DISCUSSION
The dependence of the adsorption process on the buffer system used as 
well as the pH and molarity demonstrated the importance of establishing 
optima if efficient use is to be made of y-globulin preparations. The 
literature has revealed little comparable data on this subject.
For solid phase RIA, Crosignani, Nakamura, Hovland and Mishell (1970) 
showed a similar relationship between buffer molarity and the adsorption 
of rabbit antiserum to polypropylene discs at pH 9,2 to that found here.
An influence of pH, dependent upon the buffer system used, was also 
demonstrated (maximum adsorption at pH 7.8) although a limited pH range
(7 - 9.8) was investigated.
The study of Oreskes and Singer (1961) was limited to comparison of 
T-globulin adsorption (human) at pH's 3.98 and 9.01, making general conc­
lusions regarding pH optima difficult. Adsorption was higher at pH 9.01, 
close to the isoelectric point of human y-globulin. They therefore argued 
that such conditions would be conducive to maximum binding since inter- 
molecular repulsion would be minimized and allow closer packing on the 
plastic surface.
Isoelectric point determinations were not performed here on sheep and 
goat y-globulins and such data /were not found in the literature. It would 
be anticipated, however, that a net positive charge would be induced on 
y-globulin from most species at the pH optimum 4 - 5 found here: this may
enable coulombic attraction to the net negative charge on the plastic sur­
face (the negative component of the surface electrical double layer; 
Leininger, Cooper, Epstein, Falb and Grode, 1966; Fuerstenau, 1971) as a 
preliminary to formation of stronger hydrophobic bonds. The probability 
is that, at particular pH values, different portions of. the y-globulin or 
y-globulin sub-classes will have differing net charges and thus may influ­
ence whether, for instance, the Fq or F ^  portion of the antibody attaches 
to the plastic surface. Attachment of the F end may result in a subse­
quent reduction of antigen binding due to steric hinderance.
Incubation at room temperature for 3 hours was found to provide a 
practical compromise for adsorption of ovine or caprine y-globulin to 
large numbers of plates.
Use of 0.17mM acetate coating buffer pH 4 - 5 ensured maximum binding 
of y-globulin for both polystyrene and PVC plates and enabled antisera to 
be used at dilutions (e.g. 1/4000 for G711/12) of the same order as for 
RIA (-1/15,000; see section 2.3.4.). It was clear, therefore, that the 
carbonate/bicarbonate buffer (pH 9.6) widely adopted and recommended for
ELISA procedures by Voller et al (1976a) is not appropriate for optimal 
adsorption of all protein preparations. This presumably reflects the lack 
of comprehensive data published on this subject.
No evidence was found to indicate that differences occurred in the 
amount of y-globulin adsorbed to edge wells compared with interior wells.
It was therefore concluded that the adsorption achieved for PVC plates 
was acceptable both in terms of the extent and precision when a Decon 90 
pre-wash was used. Subsequent desorption of y-globulin on storage was 
minimal, in keeping with the findings of Cantarero etal (1980). The 
mechanism by which this wash procedure (a standard procedure for glassware, 
recommended by the detergent manufacturers) induced increased adsorption- 
is not clear. It is possible that putative inhibiting substances are 
removed from the plastic surface or that trace quantities of detergent 
remain adsorbed on the plastic and facilitate exposure of hydrophobic 
regions of the y-globulin to the plastic surface.
Although it can be seen from table 5.4 that it is necessary to be 
selective about the type of plates used,it is clear that precision of the 
order of 5% (cv) can be attained under conditions appropriate to EIA.
This.was considered acceptable for the current application of EIA of 
progesterone in milk.
The precision and degree of adsorption was highest with NUNC poly­
styrene plates: these are y-irradiated at manufacture and this may be
responsible for the apparent enhancement of adsorption compared with other 
brands of polystyrene plate. Since, additionally, these did not 
require pre-washing,they were used for the EIA procedure finally adopted 
(see chapter 7.).
5.5 CONCLUSIONS
1. The highest degree and precision of y-globulin adsorption was achieved
with NUNC polystyrene plates: although pre-washed Dynatech PVC plates
attained a similar degree of precision the total y-globulin adsorbed was 
lower.
2. Adsorption of y-globulin to PVC and polystyrene plates was maximised by 
use of acetate buffer of low molarity and pH,enabling economic use to be 
made of valuable antisera.
3. Incubation of microtitre plates above ambient temperature gave rise to 
marked between-well differences in the time taken for equilibrium tem­
perature to be reached. Differences for PVC plates were minimal when 
the bases of wells were below the water surface of the water bath.
CHAPTER 6:
INFLUENCES ON MILK PROGESTERONE ETA"SFWSTTTVtTY
CHAPTER 6. INFLUENCES ON MILK PROGESTERONE EIA SENSITIVITY
6.1 INTRODUCTION
Practical considerations dictate the sensitivity and working range of 
calibration curves required for microtitre plate EIA of progesterone. The 
concentration of progesterone in whole milk ranges from less than lng/ml 
during the follicular phase of the oestrous cycle to 20 - 40ng/ml in the 
luteal phase or during pregnancy.
The limited capacity of microtitre plate wells (300 - 400yl) dictates 
that the size of the milk sample assayed must be restricted. A volume of 
lOyl has commonly been used in RIA (Heap et al3 1976) and this has been used 
throughout these studies. This indicates a requirement for a limit of 
detection for EIA of lOpg/well (= lng/ml) or better.
The majority of applications of EIA for progesterone in milk (see section 
1.6) require that samples from cows in the follicular-phase of the oestrous 
cycle be readily distinguishable from those of the luteal phase or preg­
nancy. A discriminatory level of 4.5ng/ml milk has been determined by RIA 
(Holdsworth et al3 1979). Visual classification of samples following EIA 
requires maximization of the absorbance difference between the end-point for 
samples containing between 0 - lng/ml and those containing 4.5ng/ml.
Two main measures of sensitivity have been used to allow conditions
influencing sensitivity to be compared: 1) the b 5q /b q value, the quantity
of labelled progesterone bound in the presence of 50pg progesterone (lOyl
of milk containing 5ng/ml) per well (B__) compared with that bound in the50
absence of progesterone (Brt) and 2) the ED__, the dose of progesteroneO 50
effective in reducing binding of label in the absence of progesterone (Bq ) 
by 50%. The influence of milk on antibody binding of progesterone dictated 
that EIA performance was in all cases assessed in the presence of ovX milk 
or with progesterone standards prepared in milk.
The Law of Mass Action dictates that the limit of detection in EIA, as 
in RIA, is proportional to the mean equilibrium constant of the antibody
population : antisera with the highest avidity for progesterone will thus 
provide the most sensitive assays. Maximum sensitivity will only be achieved, 
however, where the binding affinity for progesterone and labelled-progesterone 
are similar (Ekins et at, 1968).
It has been shown in RIA that equilibrium constants may increase with 
decreasing temperature (Berson and Yalow, 1959; Abraham, Swerdloff, Tulchinsky 
and O'Dell, 1971; Malvano and Rolleri, 1975). For this reason, RIAs have 
traditionally been performed at 4°C: the low molecular weight of steroids
ensures that equilibrium is attained within a few hours. Keene et at (1976) 
have shown, however, that this increase in equilibrium constant would only 
be expected where the binding reaction involved a large enthalpy component. 
This indicates the importance of establishing the appropriate incubation 
temperature for a given antiserum: clearly, particular antisera may be
used at higher temperature without loss of sensitivity and the assay thereby 
performed more quickly.
It has long been assumed that the binding affinity of antisera for 
homologous enzyme-labelled steroids are generally higher than those for the 
free steroid and that assay sensitivity may be reduced as a result: equil­
ibrium constants for the binding of the former have not, however, been
determined*. The molecular weight of enzyme-labelled progesterone may be
v . . .
100 - 1000 fold greater than progesterone and this together with the use
of solid-phase antibody would be expected to reduce the reaction rate. In
the majority of current studies microtitre plate EIAs have been performed
at temperatures above 4°C to increase binding rates.
To study assay equilibration times at various temperatures and the 
influence of incubation time and temperature on assay sensitivity, the time- 
course of label binding to antibody coated plates in the presence and 
absence of competing progesterone at various temperatures was investigated.
The former was to enable determination of equilibrium constants in subse­
quent experiments. Conjugates of progesterone lla-glucuronide with alkaline
phosphatase,3-galactosidase and peroxidase were used for this study.
The y-globulin fraction constitutes about 11% of plasma protein
(Armstrong, Budka and Morrison, 1947) and it might be expected that of these
only 1% would be specific for a particular antigen (Parsons, 1981). The
2small surface area of microtitre plate wells (^ 240mm ) therefore dictates 
that the antibody fraction be isolated prior to adsorption in order to 
ensure that specific antibodies constitute a reasonable proportion of the 
total protein adsorbed. This enables more efficient use to be made of anti­
sera and may allow utilization of previously unusable low titre antisera.
Two simple procedures were used here enabling much extraneous protein to be 
removed; a) absorption of carrier-protein antibodies by titration against 
the carrier protein and b) isolation of the y-globulin fraction using 
ammonium sulphate or Rivanol (see section 2.3.1.). In addition to removal 
of some y-globulin which is not specific for progesterone, the absorption 
process a) has been shown to bring about a substantial reduction in non­
specific binding in EIAs using peroxidase as label (Riad-Fahmy,
Read and Turkes, 1983). It is not clear whether this applies to other 
enzyme systems.
The necessity for this absorption process was therefore investigated 
with alkaline phosphatase conjugates using four anti-progesterone sera from 
which y-globulin had been prepared with and without prior absorption of 
carrier-protein antibodies.
6.2 METHODS
6.2.1. Standard EIA Procedure
PVC microtitre plates (Dynatech) were pre-washed with Decon 90 (see 
section 5.2.5b ) and coated with the y-globulin fraction (as section 2.1.7.) 
of the particular antiserum in the manner described previously (section 5.2.2.)
EIA incubation stages were performed in a water bath with the base of the 
wells immersed 2 - 3mm below the water surface.
Microtitre plates previously coated with antibody were emptied, shaken 
dry and blotted. Whole milk standards were allowed to come to room temper­
ature and thoroughly mixed before use. Standards (lOyl, containing 0 - 5000pg 
progesterone) were pipetted into replicate wells and conjugate, diluted as 
appropriate in PAS-gelatin* buffer (200yl), added at ambient temperature.
Blank values were determined by addition of buffer alone to duplicate wells 
containing lOyl of the zero progesterone standard. The plates were covered 
with a plate lid and incubated at 40°C in a covered water bath for 3 hours 
before gently agitating, emptying and washing 3 times with PAS-gelatin* 
buffer (250yl/well). The appropriate substrate solution (see section 2.1.9.) 
was added to each well (200yl) and the plates incubated for 1 hour at 40°C 
(20°C for peroxidase) in a tfater bath. The absorbance of each well was 
recorded directly at the appropriate wavelength (see section 4.3.5., table 
4.2) using an automatic plate reader.
6.2.2. The Characteristics and Selection of the Enzyme-Conjugates Used
All enzyme-steroid conjugates were prepared using a range (minimum 3) 
of molar excesses of steroid (2 - 250 fold). The progesterone 11a- 
hemisuccinate and lla-hemimaleate conjugates with 3-galactosidase were 
prepared using the isolated active-ester procedure (section 3.2.3 ) and the 
progesterone lla-glucuronide-peroxidase conjugates were prepared using the 
mixed anhydride procedure (section 3.2.5.). All other conjugates with 
penicillinase, alkaline phosphatase, 3-galactosidase and peroxidase were
* PMS-gelatin buffer was used for peroxidase conjugates.
produced by the direct active ester procedure (section 3.2.4a ). For each
type, the conjugate with the degree of steroid incorporation providing
maximum sensitivity was selected. Its working dilution was established
by screening for sensitivity (B_rt/B_) over a range of concentrations
5U U
(5 - lOOOng conjugate/ml buffer) using microtitre plates coated with 
serial dilutions of the particular anti-progesterone y-globulin (at 
between 1/800 - 1/25,000 dilution of original serum in M  or 0.17mM acetate 
buffer pH 5.0; see section 5.2.2.). EIA was performed as described in 
section 6.2.1. Since all antisera used in these studies were raised against 
progesterone 11a-hemisuccinate conjugated to carrier protein (section 2.1.7.) 
enzyme labels other than progesterone lla-hemisuccinate-renzyme are termed 
heterologous.
6.2.3. The Characteristics of the Antiserum and its Condition of Use
a) Binding kinetics and the influence of time and temperature. PVC 
(Dynatech) microtitre plates, pre-coated with anti-progesterone y-globulin 
(G711/12 at 1/8000 dilution, section 5.2.2.), were emptied, tapped dry and 
refilled with PAS-gelatin (or PMS-gelatin for peroxidase EIA) buffer (200yl) 
and allowed to attain the required temperature (4°C, 21°C and 40°C) in a 
water bath or a cold room: a single plate was used for each conjugate at 
the specified temperature. Buffer was aspirated from triplicate wells at 
time intervals appropriate to the incubation period required (0 - 26 hours 
or 0 - 7  days, longest incubation first): following addition of milk
standard (lOyl, containing 0 - 300pg progesterone) and conjugate (200yl) 
the wells were re-sealed with plastic film and the incubation period con­
tinued. At the end of the study period (26 hours at 40°C or room temper­
ature or 7 days at 4°C), all wells were emptied simultaneously, washed and 
enzyme activity determined as described (section 6.2.1.).
The long incubation periods at elevated temperatures involved in this
study necessitated an investigation of antibody and enzyme conjugate stab­
ility over the relevant periods. There was no significant loss of binding 
capacity of antibody coated microtitre plate wells following incubation 
with PAS-gelatin buffer under appropriate conditions of time and temperature 
(determined following subsequent incubation with progesterone lla-glucuronide- 
alkaline phosphatase conjugate in the normal manner). Loss of enzyme activity 
of the conjugates, whilst appreciable at the longest incubation period at 
21°C and 40°C (6 - 11%) was not considered sufficient to influence the 
outcome of the experiment.
b) The purity of the antibody preparation, y-Globulin preparations of 
absorbed and non-absorbed antisera were prepared by the methods outlined in 
section 2.1.7. and 2.3.1. and on dilution, were equivalent in terms of the 
original antiserum volume. Absorbed and non-absorbed antisera were tested 
on the same plate, a different plate being used for each antiserum. Non­
specific and specific binding studies (i and ii below) were performed 
simultaneously on the same plate, using a half plate for each.
i) Non-specific binding. Absorbed and non-absorbed anti-progesterone 
y-globulin preparations of G711/12 (1/2,000 dilution), AF18/3 (1/3,000 dilut­
ion) HP/S/645111C (1/3,000 dilution) and R54/10/5 (1/3,000 dilution) were 
adsorbed onto microtitre plate wells (3 rows of 8 wells for each preparation). 
Alkaline phosphatase (10, 20 or 40ng in 200yl of PAS-gelatin buffer) was 
added to 6 (2 blank wells in the row) or 8 wells for each antibody prep­
aration and the plates treated as for EIA (see section 6.2.1.).
ii) Specific binding. Absorbed or non-absorbed anti-progesterone 
y-globulin preparations of G711/12 (1/2,000, 1/4,000 and 1/8,000 dilution), 
AF18/3, HI&fe45-lllC and R54/10/5 (each at 1/3,000, 1/6,000 and 1/9,000 
dilution) were adsorbed onto plate wells (n = 8 for each preparation and 
dilution). Alkaline phosphatase conjugate (prepared with a 50:1 molar 
excess of steroid) was added to each well (10ng/200yl) and the plates treated 
as for EIA.
For both i) and ii) the incubations to determine enzyme activity were 
performed for 30 minutes or in one case (R54/10/5 antiserum), due to high 
binding activity, for 12 minutes.
6.3 RESULTS
6.3.1. The Method of Producing Enzyme-Progesterone Conjugates
The necessity for using efficient condensation reactions such as the 
"active ester" procedure which apparently minimizes formation of enzyme- 
enzyme conjugates or enzyme denaturation has been discussed in chapter 3.
In addition to circumventing the formation of denatured conjugated 
enzyme it is necessary to ensure that the enzyme-labelled progesterone is 
free from unconjugated progesterone derivative since this will reduce 
assay sensitivity. For all conjugates described here this has been achieved 
by extensive dialysis (3 - 4 changes of buffer) and subsequent gel filtr­
ation. Although it was still possible to remove free progesterone deriv­
atives with further dialysis, the quantity detected by RIA in the dialysate 
indicated that this would be unlikely to interfere with the performance of 
the EIA at the working dilution of the conjugate. This suggests that the 
free progesterone derivative might bind to the enzyme to some extent and 
this limits its rate of elimination during gel filtration and dialysis. 
Simpson and Wright (1977) have reported that dialysis is less effective at 
removal of free steroid from protein conjugates than gel filtration, possibly 
due to reduced membrane permeability to hydrophobic molecules. The use of 
extensive gel filtration rather than dialysis may therefore be appropriate.
6.3.2. Heterologous Systems and the Influence of the Enzyme and the 
Antiserum
As predicted by other studies (van Weemen and Schuurs, 1975) antisera 
derived using progesterone lla-hemisuccinate-BSA as immunogen gave rise to
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Fig. 6.1 Gomparison of EIA calibration curves using homologous and heter­
ologous conjugates. Calibration curves produced using homologous progesterone 
lla-hemisuecinate conjugates with 3-galactosidase (•-•) are compared with 
heterologous progesterone lla-hemimaleate (o-o), progesterone 3-carboxy- 
methyloxime (□-□) and progesterone lla-glucuronide (■-■) conjugates. Values 
are mean ± sd of four determinations. Conjugates were prepared using a 
25 molar (A) or 250 molar (B; 200 molar for hemimaleate) excess of steroid. 
y-Globulin from antiserum G711/12 was used at 1/2000 dilution: the mass
of conjugates used are detailed in Table 6.1.
* Excluded from calibration curve mean cv determinations (see text) since 
this value was within 2sd of the mean substrate blank.
Table 6.1 The Influence of Site and Bridge Heterology and the Degree of Steroid
to Anti-Progesterone lla-Hemisuccinate y-Globulin
Conjugate
No.
Bridge Position 
and Type
Molar Ratio 
Steroid:Enzyme 
at Conjugation
Mass 
Conjugate 
used in 
EIA (ng/well)
Bq Value 
Absorbance 
Units
ED50
Pg
104 lla-hemisuccinate 25:1 12 0.320 875
105 lla-hemisuccinate 250:1 10 0.487 1220
101 lla-hemimaleate 25:1 21 0.389 380
90 lla-hemimaleate 200:1 40 0.412 216
110 3-carboxymethyloxime 25:1 136 0.217 100
111 3-carboxymethyloxime 250:1 11 0.247 230
114 lla-glucuronide 25:1 102 0.109 56
115 lla-glucuronide • 250:1 10 0.156 87
EIA was performed in the manner described in Fig. 6.1 and E D ^  values 
interpolated from the calibration curves.
EDgQ = dose of progesterone effective in reducing label binding by 50%.
insensitive EIA calibration curves when used with homologous (progesterone 
lla-hemisuccinate) enzyme conjugates (section 3.3.2.), presumably as a result 
of bridge recognition (Fig. 6.1). The maximum progesterone concentration 
anticipated in cow's milk during the luteal phase or pregnancy (about 
40ng/ml, 400pg/10yl) would only reduce conjugate binding by 40% (Fig. 6.1a; 
progesterone lla-hemisuccinate conjugate). Furthermore, only one of several 
antisera tested (G711/12) provided sufficient sensitivity to be useful in 
EIA (Table 6.2). The properties of enzymes conjugated with four progesterone 
derivatives (structures shown in Fig. 6.2) were therefore compared to 
assess the ability of heterologous systems to improve assay sensitivity 
(Fig. 6.1) and to reduce reliance of EIA on the availability of exceptional 
antisera (Table 6.2).
Fig. 6.2 Comparison of structures of progesterone derivatives used to form 
enzyme conjugates: A, progesterone lla-hemisuccinate; B, progesterone
lla-hemimaleate; C, progesterone 3-carboxymethyloxime and D, progesterone 
lla-glucuronide.
The different slopes and EDcr. values of calibration curves using bridge5U
(hemimaleate or glucuronide) or bridge and site heterology (3-carboxymethyl- 
oxime)are demonstrated in Fig. 6.1 and Table 6.1. Since coefficients of 
variation (cv) throughout the calibration curves fell within the same range 
(mean cv's 3.6% - 5.8%) it is clear that with this antiserum (G711/12),
Enz.-Nhrs^°^N^
C D
Table 6.2 The Influence of Heterology, the Enzyme Label and the Antl8erum on the Degree of Label Binding (BQ)
and Assay Sensitivity (BSQ/BQ)
LABEL 8-GALACTOSIDASE ALKALINE PEROXIDASE PENICILLINASE (3H)PROGESTERONE
PHOSPHATASE
BRIDGE HS GLU HU CMO HS GLU HS GLU GLU
Molar Excess Steroid 25:1 250:1 25:1 25:1 2:1 2:1 2.5:1 125:1 5:1 -
at Conjugation 
Mass Label/Well (ng) 6.4 33 21 136 5 20 46 150 0.5 7.5pg
ANTISERUM 
R54/10/5 B0 0.323 0.197 0.588 0.280 0.739 0.172 1.021 0.984 0.343 39%
B50/B0 <*> 94 86 105 87 94 70 94 83 47 49
HP/^645111C B 0.352 0.137 1.180 0.172 0.822 0.256 0.213 0.334 0.519 48%
B5(/ Bo <» 103 84 104 90 92 81 92 78 43 67
AF18/3 Bo 0.356 0.196 0.684 0.132 0.838 0.274 0.956 0.184 0.512 31%
B50/B0 (%> 92 64 83 91 48 84 51 6.0 26
G711/12 Bo 0.178 0.206 0.276 0.205 0.764 0.279 0.770 0.206 1.177 60%
B50/B0 «>. " 81 58 65 83 71 54 79 33 39 35
S1509/16 Bo - 0.164 _ 0.264 1.083 0.502 - - 0.665 50%
B50/B0 «> - ' 75 - ■ 83 90 58 - - 23 30
S360/10 B0 - 0.126
_ 0.165 0.811 0.471 - - 0.523 79%
^ o  «> - 87 - 83 91 56 - - 29 52
S263/10 Bo
- 0.247 _ 0.398 0.999 0.438 - - 0.964 77%
B50/B0 <*> - 83 79 88 64 - - 45 50
EIA was performed at 40°C (section 6.2.1.)
DatawtSt derived in the manner described In section 6.2.2: B^ (optical density) values are mean ± sd of 4 determin­
ations.
Bq values were normalized to A optical density/h. For RIA, BQ represents % of total label bound.
HS, GLU, HU and CUO signify bridge types lla-hemisuccinate, lla-glucuronide, lla-hemimaleate and 3(0-carboxymethyl)oxime. 
- ° not tested.
assay sensitivity was improved through use of heterology in the order 
glucuronide > 3-carboxymethyloxime > hemimaleate > hemisuccinate. With 
the exception of the hemimaleate conjugate, greater assay sensitivity was 
achieved with conjugates prepared with a 25 rather than a 250 molar excess 
of steroid. Conjugates produced using the lower excess necessitated use of 
a greater quantity of conjugate to provide an equivalent degree of binding 
(table 6.1). Comparison of EDgQ values provided by hemisuccinate and 
glucuronide-linked conjugates emphasize the improvement in sensitivity 
obtained irrespective of the steroid:enzyme ratio used at conjugation: 
hemisuccinate conjugates required at least ten times the quantity of com­
peting progesterone to provide an equivalent drop in label binding.
Although these results clearly demonstrate the ability of the glucur­
onide bridge to substantially improve assay sensitivity, the general 
applicability of this approach would require that the conjugates be tested 
with several antisera.
Progesterone derivatives conjugated with 3-galactosidase, alkaline
phosphatase, peroxidase and penicillinase were examined by EIA using seven
antisera raised against progesterone IIofr-hemisuccinate conjugated with BSA
or ovalbumin (see section 2.1.7.). The sensitivity (B /B_ values) for
50 0
conjugates of each type at the dilution of y-globulin providing maximum
sensitivity are shown in table 6.2. A minimum B^ value of 0.10 0D was
required to ensure that discrimination was maintained between the Be/% value50
and the substrate blank. Irrespective of the enzyme label, the glucuronide 
conjugates provided sensitivity comparable with or often better than that 
of RIA. The exceptions to this were antisera R54/10/5 and HP/S/6451IIC 
which gave low sensitivity in RIA and poor sensitivity in EIA.
B-Galactosidase was the only enzyme conjugated with each of the pro­
gesterone derivatives: bridge recognition was least evident with the
glucuronide conjugate, irrespective of the antiserum used. Glucuronide-
linked conjugates of peroxidase and alkaline phosphatase likewise gave 
greater sensitivity than the homologous conjugates.
6.3.3. The Molar Ratio of Steroid:Enzyme Required at Conjugation and the 
Mass of Conjugate Required for EIA
The data in Table 6.2 were derived following screening of conjugates 
produced using steroid molar excesses ranging from 2:1 to 250:1 (see section
6.2.2.). In each case the conjugate selected was that giving rise to the 
greatest sensitivity: the optimum steroid:enzyme ratios at conjugation
varied widely. It was clear, therefore, that the optimum excess of a 
particular derivative required at conjugation was largely dependent on the 
enzyme and to a lesser extent on the derivative used.
A smaller mass of homologous conjugate was generally required to pro­
duce similar or greater label binding than the heterologous equivalent 
and was associated with lower apparent binding affinity for the latter.
In the case of the progesterone lla-glucuronide conjugates of peroxidase 
andB-galactosidase, a large excess of steroid was required to produce con­
jugates giving an acceptable without requiring large (microgramme) 
quantities of conjugate.
For all conjugates there was an inverse relationship between assay 
sensitivity and both the molar excess of steroid used to form the conjugate 
and the mass of conjugate required for EIA. This is demonstrated by data 
derived using progesterone lla-glucuronide-alkaline phosphatase conjugates 
(Fig. 6.3).
6.3.4. The Characteristics of the Antiserum and its Conditions of Use
a) Binding kinetics and the influence of time and temperature. Fig. 6.4 
shows label binding in the absence of competing progesterone over a period 
of 0.5 hours to 26 hours at 21°C and 40°C and 4 hours to 7 days at 4°C.
10 50 100
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Fig. 6.3 The influence of quantity of conjugate and degree of conjugation 
on the sensitivity of microtitre plate EIA for progesterone in whole milk.
Microtitre plates were coated with anti-progesterone y-globulin (G711/12 at 
1/4000 dilution) and EIA performed using a 3 hour incubation at 40°C. Pro­
gesterone lla-glucuronide was conjugated with alkaline phosphatase using a 
molar steroid excess of 2:1 (A-A), 10:1 (■-■) or 50:1 (•-•) at conjugation. 
Sensitivity was expressed as B,.q/Bq (%). Values are mean ± sd of 3 
determinations.
Binding appeared to be biphasic, with a rapid initial uptake of label.
There was, however, no consistent indication that equilibrium had been 
attained after the longest incubation period: the possible consequences of
this in EIA are discussed in section 7.4. The question of determination of 
equilibrium constants was not therefore pursued further.
Assay sensitivities at different incubation times and temperatures are 
shown in Fig. 6.5. Evidence for an effect of incubation period on assay 
sensitivity was only seen for assays using peroxidase label, in which 
sensitivity apparently decreased with increasing time. This difference may 
arise as a result of the impractically low degree of binding attained 
(compare absorbance.values in Fig. 6.4).
INCUBATION TIME AT 21°C OR 4 0°C (HOURS)
2626
0-6
s
a
8
0-5
0-4
0-3
0*2
INCUBATION TIME AT 4°C (DAYS)
Fig. 6.4 The binding kinetics at 4°C (d-cj), 21°C (a-a) or 40°C (o-o) of 
progesterone lla-glucuronide conjugated with a) S-galactosidase (lOng/well), 
b) alkaline phosphatase (lOng/well) and c) peroxidase (50ng/well) to anti­
progesterone y-globulin adsorbed on PVC microtitre plates: conjugates were
prepared with a 50:1, 2:1 and 125:1 molar excess of steroid respectively. 
Optical density values are the mean of 3 determinations and represent binding 
in the absence of competing progesterone.
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Fig. 6.5 The influence of incubation time and temperature (4°C, 21°C,
a-A; 40 C o-o) on the sensitivity of EIA (Bcr/Bn) usinS a) 3-galactosidase
b) alkaline phosphatase and c) peroxidase as label. Conjugates were prepared 
as described in Fig. 6.4. Values are the mean ± sd of three determinations.
For alkaline phosphatase and 3-galactosidase labels the sensitivity was 
greatest at 4°C and lowest at 40°C irrespective of the period of incubation 
(Fig. 6.5): peroxidase label was not tested at.4 °C.. At 4°C, however, unac-
ceptably long incubation periods were required to obtain a satisfactory degree 
of binding (Fig. 6.4). Performance of the (EIA at room temperature (21°C) rep­
resented a compromise between the two and enabled good sensitivity (Fig. 6.5) and 
an acceptable degree of binding (Fig. 6.4) to be achieved within a reason­
able incubation period (3 hours) and indicated the possibility of performing 
the assay without the use of an incubator or water bath.
b) The purity of the antibody prepccration. The total recovery of pro­
gesterone antibodies following absorption and preparation of the y-globulin
3fraction was evaluated through their ability to bind H-labelled progester­
one in RIA and following adsorption to plate wells, alkaline phosphatase- 
labelled progesterone lla-glucuronide in EIA. Non-specific binding was 
assessed by measuring binding of unconjugated alkaline phosphatase to anti­
progesterone y-globulin. RIA indicated that loss of specific antibody 
during absorption was minimal since there was no significant difference 
between antibody dilution curves obtained using absorbed and non-absorbed 
y-globulin.
Binding of alkaline phosphatase (lOng) to protein-absorbed anti­
progesterone y-globulin (Fig. 6.6) and expressed as % of specific binding 
(Fig. 6.7) of alkaline phosphatase conjugate (lOng) was low for all prep­
arations (G711/12, 3.5%; AF18/3, 5.4%; HP/S/645IIIC, 3.4% and R54/10/5, 2.1%) 
but generally higher than for non-absorbed y-globulin preparations (G711/12,
2.4%; AF 18/3, 3.4%; HP/S/645IIIC, 2.6% and R54/10/5, 1.5%). Non-specific 
binding values (%) were corrected to account for a 33% difference between 
the specific activity of the conjugate and the subsequently purchased 
unconjugated enzyme.
6.3.5. The Choice of Enzyme as Label
/
The enzyme assay optimization data detailed in section 4.3 (table 4.3)
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Fig. 6 . 6  Binding of unconjugated alkaline phosphatase (non-specific binding) 
to absorbed (A-a) and non-absorbed (□-□) y-globulin preparations. Values 
represent means ±sd optical density (n = 8 or, when lOng enzyme was used, n = 6 ).
The significance of differences between non-specific binding (expressed 
as % of specific binding of conjugated alkaline phosphatase at the same anti­
body dilution, from Fig. 6.7) for protein absorbed and non-absorbed antisera 
was calculated for wells containing lOng enzyme. 1 = t significant, p
< 0.01; 2 = t significant, p < 0.05; 3 = F significant, p < 0.01; 4 = F 
significant p < 0.005.
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Fig. 6.7 Binding of progesterone 11orglucuronide-alkaline phosphatase con­
jugate (lOng) to protein absorbed (a -A) and non-absorbed (n-d) y-globulin 
preparations. Values represent mean ± sd optical density (n = 8).
demonstrated that the sensitivity of detection of the enzymes is in the
order penicillinase > peroxidase > alkaline phosphatase > 3 -galactosidase.
Using data derived from EIA using enzyme conjugates with progesterone
11a-glucuronide (table 6 .2 ), it is clear that for particular antisera
penicillinase generally produced the highest sensitivity (lowest B / B -
50 0
values) and 3-galactosidase the lowest sensitivity. Alkaline phosphatase 
and peroxidase performed in a similar manner to each other. The generally 
poor sensitivity obtained using conjugates with other progesterone deriv­
atives indicated that comparisons between enzymes using these conjugates 
would be of little interest.
6.4 DISCUSSION
The problems of achieving the maximum sensitivity possible with a particular
antiserum owing to bridge recognition were introduced in a previous section
(1.9.2.). Although only limited investigations have been made in this area
in the context of EIA of progesterone (Joyce et at, 1978b; Gros et at, 1978),
research demonstrating its importance in attaining sensitive RIA’s using 
125
I-labelling has been extensive (Cameron et at, 1974; Allen and Redshaw,
1978; Corrie et at, 1982). Similarly, in the EIA of oestrogens (van Weemen 
and Schuurs, 1975 and 1976; Exley and Abuknesha, 1977), corticosteroids 
(Arakawa et at, 1979; Hosoda, Kobayashi, Miyairi and Nambara, 1981; Hosoda, 
Kobayashi and Nambara, 1983) and testosterone (Bosch et at,1978a; Hosada, 
Yoshida, Sakai, Miyairi and Nambara> 1980) this phenomenon has been widely 
investigated although no hard and fast rules relating to the general applic­
ability of heterologous combinations has emerged.
Despite this problem, anti-progesterone sera have been produced which 
have either provided sensitive homologous assays or enabled specific heter­
ologous combinations to be effective (see Riad-Fahmy et at, 1981): there
have, however, been no investigations published demonstrating the suitability
of particular EIA systems for more than one antiserum. The results presented 
here indicate the suitability of the llo^hemisuccinate (immunogen bridge)/ 
lla-glucuronide (label bridge) heterologous combination for the EIA of pro­
gesterone. This confirms the findings of Corrie et at (1981b) who used the
125same combination in an RIA using I-labelled progesterone llar-glucuronide- 
tyramine.
Prior preliminary investigations by Gros et at (1978) indicated that 
improvements in progesterone EIA sensitivity may be achieved using the 
Hot -hemi male ate :■ bridge. Although their findings were confirmed here, the 
increase in sensitivity achieved was relatively small and only applied to a. 
few of the antisera tested: Joyce et at (1978b)reported minimal details of their 
investigations of bridge and site heterology but indicated that use of 
hemiphthalate, dimethylsuccinate and hexahydrohemiphthalate bridges only 
gave rise to minor improvements in sensitivity. This group have reported 
the use of sensitive homologous EIA procedures (Joyce et at, 1981) but their 
method implies that a pre-incubation period was required, as with the heter­
ologous procedure of Gros et at (1978), prior to addition of label in order 
to attain the required sensitivity: no comparison was made between EIA and
RIA calibration curves. The more recent report of Munro and Stabenfeldt 
(1984) confirms the finding (Fig. 6.1) that the carboxymethyloxime bridge 
could be usefully employed.
Van de Wiel and Hoops (1982) have provided the only example of a highly 
sensitive heterologous EIA using antibody raised against a progesterone 
derivative (7a-hydroxyprogesterone-7-carboxyethylthioether) other than 
progesterone lla-hemisuccinate. This was used in conjunction with 63- 
hydroxyprogesterone-6-hemisuccinate-peroxidase.
It is not clear why the glucuronide bridge is recognized less than others 
by the antisera tested: being cyclic and relatively hydrophilic in nature,
many structural dissimilarities to the hemisuccinate are apparent. The RIA
work of Corrie, Ratcliffe and Macpherson (1982) indicates that branching of 
the bridge in close proximity to the steroid may be responsible. In an 
investigation of twelve bridge-heterologous EIA systems for 11-deoxycortisol, 
Hosoda et al (1983) concluded that an important characteristic for sensitivity 
was that the enzyme label bridge should be shorter than that of the immunogen: 
EIA's lacked sensitivity if longer bridges were used. The former relation­
ship would also apply to the hemisuccinate/glucuronide combination. Of 
possibly greater importance in the present study are the characteristic 
groups near the steroid structure. The hemimaleate bridge was well recog­
nized by the antisera and has an ester link, common to the immunogen, for 
attachment to the steroid: in contrast, the glucuronide is joined by a
hemiacetal group (see Fig. 3.2). This view is. supported by the findings
of Nordblom, Counsell and England (1984) who employed-an ether link for the
125
immunogen and an ester for the I-label in a bridge heterologous (position 
113) RIA for androstenedione.
Differences in the degree of incorporation of steroid may make some 
small contribution to differences in sensitivity seen between different 
heterologous conjugates. Since it was not possible to accurately determine 
incorporation for the heterologous conjugates, however, no conclusions could 
be drawn on this point: radio-labelled derivatives were not available and
spectrophotometric determinations (see section 3.2.6c) or estimations of 
unconjugated e-amino residues (Fields, 1971) were found to be insufficiently 
reliable to detect small differences in incorporation.
The inverse relationship between assay sensitivity and both the relative 
degree of incorporation of steroid per enzyme and the mass of conjugate used 
in the assay (Fig. 6.3) are to be wholly expected since increasing either 
the mass of conjugate or its degree of derivitization will increase the 
relative probability of label interaction with the antibody. As a conse­
quence, a high concentration of unlabelled progesterone would be required to
give an equivalent degree of binding inhibition. The former relationship
has been a common finding in both RIA (Berson andYalow, 1968) and EIA
(Turkes, Turkes, Joyce, Read and Riad-Fahmy, 1979; Van de Wiel, Kamonpatana,
Ngramsurijaroy, Koops and Singhajan, 1982). The increased sensitivity
achieved with dilution is restricted by the ability to detect the label and
was a limiting factor for many of the conjugates assessed using B__/Brt
50 0
estimates.
The limit of detection of the assay is restrained in a more fundamental 
way by the equilibrium constant of the particular antiserum and in theory is 
proportional to the concentration 1/K (Ekins, 1976). The significance 
of this in EIA remains obscure since equilibrium constants have not been 
reported for such applications elsewhere. They could not be determined here 
because the study performed (Fig. 6.4) failed to demonstrate that equili­
brium had been attained.
Clearly, the speed with which a non-equilibrium assay may be performed 
(see section 6.3.4.) will be dictated in part by the time taken for a 
detectable degree of label binding to be achieved over the range of analyte 
concentrations. Thus, although faster assays may be achieved either by 
increasing assay temperature, the mass of conjugate used or the molar 
incorporation ratio this would be at the sacrifice of sensitivity.
Fig. 6 . 8  describes events which may explain the slow nature of conjugate 
binding to antibody in EIA in the presence of milk. Initially, the con­
jugate would have ready access to antibody binding sites but enzymes, such 
as alkaline phosphatase, being membrane associated (see Renner, 1983) and 
having steroid moieties attached, would be predisposed to incorporation into 
the fat globule: the fat globules would, in due course, rise to the surface
of the medium to form a lipid layer apart from the antibody. Similar events 
would occur with free progesterone but its faster diffusion rate would 
enable more rapid binding with antibodies before separation into the lipid
layer. The issue is further complicated by the association of progesterone 
with milk proteins (Heap et att 1975; Pope et al, 1976).
▲ ▲
Fig. 6 . 8  Schematic representation of equilibria probably occurring during 
microtitre plate EIA of progesterone in milk.
See text for further explanations.
*• = progesterone molecules; CT = enzyme-progesterone conjugate; fat
globule;
QQQ= 1:LPid layer; = antibody molecule; = wall of microtitre 
plate well.
Non-specific binding was found to be low (~ 5%) for the alkaline phos­
phatase EIA: the small changes caused by carrier-protein absorption of the
four antisera were of no practical significance (Fig. 6 .6 ). Further studies 
(see section 7.3.4c ) indicated that the‘degree of non-specific binding of 
alkaline phosphatase to anti-progesterone y-globulin was of a similar order 
to binding of conjugate to ’'normal'1 y-globulin. These findings 
contrast with the data of Riad-Fahmy et at (1983) who found that absorption 
reduced non-specific binding of progesterone lla-hemisuccinate-peroxidase to 
solid phase antibody preparations by 90% or more to levels similar to 
those observed here with or without absorption: their findings run contrary
to accepted views concerning antibody specificity and remain unexplained.
It would be anticipated that further improvements in assay performance 
may be attained by use of affinity purified antibody preparations as suggested 
by Ishikawa, Imagawa, Yoshitake et al (1982)since this should enable isolation 
of the specific antibody population. Limited investigation of this approach 
were unsuccessful, however, due to continuous leakage of free steroid from 
the immunoadsorbent (progesterone lla-hemisuccinate or progesterone 1 1a- 
hemimaleate linked to Sepharose).
The highest sensitivity with antiserum G711/12 was achieved by per­
forming EIA at 4°C (Fig. 6.5). Incubation at 21°C (ambient temperature) 
proved more practical, however, and provided adequate sensitivity.
Improved EIA sensitivity at reduced incubation temperature would 
similarly, be anticipated for other conjugate/antibody combinations 
investigated and described in table 6 .2 . In the original homologous 
EIA (Fig. 3.3 ) a high incubation temperature (40°C) was required to
ensure adequate binding of enzyme label to antibody-coated microtitre plates, 
the binding rate being temperature dependent. The use of ambient temper­
ature incubations subsequently became a practicable proposition when 
optimized procedures increased adsorption of antibody to microtitre plate 
wells (see chapter 5). These studies also revealed that under the majority 
of conditions the EIA was a non-equilibrium procedure: the literature
implies, by omission,that hapten EIAs will attain equilibrium within a 
similar period to RIA. Consideration of the size of the label alone, 
however, would argue against this.
Two factors contribute to the differing EIA sensitivities achieved for 
the four enzymes tested; the detection limit and the molecular weight of 
the enzymes (30,000, 40,000, 100,000 and 540,000 Daltons for penicillinase, 
peroxidase, alkaline phosphatase and 3-galactosidase, respectively). Since 
diffusion rate is inversely proportioned to molecular weight (Graham's Law) 
it would be expected that the enzyme-conjugate of lowest molecular weight would
give rise to the highest proportion of label bound to antibody per unit time. 
Together, these factors would allow a smaller mass of label to be used in 
EIA and thus greater sensitivity to be achieved. The high molecular weight 
and lower specific activity of 8 -galactosidase conjugates may explain the 
necessity to use a relatively large mass in EIA (Table 6.2). The findings 
using the heterologous peroxidase conjugates may appear contrary to this 
connection between sensitivity and enzyme molecular weight/detection limit: 
the large mass of conjugate required in this case (Table 6.2) must, however, 
be viewed in the light of its apparently poor immunoreactivity which may 
have resulted from inefficient coupling (see section 3.2.5.). For this 
reason.and because of the potentially mutagenic or carcinogenic 
nature of the chromogens used for its determination (Voogt et at, 1980; 
Yolken, 1982) peroxidase was not considered further.
Progesterone lla-glucuronide-alkaline phosphatase conjugate provided 
more than adequate sensitivity and was used in all further validation studies 
of the milk progesterone EIA. This was largely because the assay was 
simpler to perform than that using the more sensitive penicillinase conjug­
ates. Penicillinase may, however, prove to be well suited for assays where 
greater sensitivity is a pre-requisite: obviously the availability of a
suitable chromogenic substrate would greatly facilitate its application.
6.5 CONCLUSIONS
1. The heterologous combination of 11a-hemisuccinate (immunogen bridge)/ 
lla-glucuronide (label bridge) greatly reduced the problem of bridge 
recognition and several antisera provided EIA's of comparable sensit­
ivity to RIA.
2. Performance of EIA at low temperature (4°C) gave rise to highest sens­
itivity but incubation at ambient temperature ( 21°C) proved more 
practical and provided sufficient sensitivity. Binding equilibrium was 
not attained under the conditions investigated.
Convenience and high sensitivity of detection recommended alkaline 
phosphatase as the label for further development and EIA validation, 
although penicillinase provided greater sensitivity.
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CHAPTER 7. THE ADOPTED HETEROLOGOUS EIA: THE VALIDATION OF EIA USING
PROGESTERONE 11a-GLUCURONIDE-ALKALINE PHOSPHATASE AS LABEL
7.1 INTRODUCTION
Two of the microtitre plate EIA procedures described in the previous 
chapter were applied to the measurement of progesterone in milk samples.
The first was an homologous assay using the lla-hemisuccinate bridge between 
the steroid and protein in both the immunogen and the enzyme (8-galactosi- 
dase)-labelled steroid. This assay lacked the sensitivity and precision 
required for widespread use and so is not further considered in this 
chapter: it did, however, provide a useful means of evaluating the pract­
icality of EIA for routine assessment of reproductive status in the dairy 
cow. This aspect is considered in chapter 8 .
The second procedure, an heterologous assay, was developed to overcome 
these shortcomings and employed progesterone lloc-glucuronide-alkaline 
phosphatase as label: the full validation of this assay is described here.
Direct RIA of progesterone in milk is widely accepted for monitor­
ing luteal functions in dairy cattle. Although it provides a useful refer­
ence method against which direct EIA can be judged, there is little pub­
lished data relating specifically to its validation. Generally accepted 
validation procedures, including establishing recovery of added progester­
one, linearity of response on dilution of the sample and comparison with a 
method involving isolation of the analyte prior to assay have not all been 
performed in any single study. Investigation of recovery and linearity of 
response have involved small numbers of samples and so provide no clear 
indications of between-sample variation in non-specific effects noted in 
some laboratories (Heap et al, 1976, Pennington et at9 1976; Holdsworth 
et ata 1979; Stevens et at9 1981): comparative studies involving chromato­
graphic isolation of progesterone prior to RIA have not been reported.
It is a well established principle of assay validation that estimations
by new procedures should be compared with an established method, this pref­
erably being based on a different principle of analysis. For steroid immuno­
assays, it has been suggested that the combined procedures of gas chroma­
tography and mass spectrometry (GC/MS) attain suitable specificity and 
sensitivity to provide a reference method (Gaskell, Brownsey and Groom, 1984) 
although such facilities are only available in highly specialised laborat­
ories .
A practical alternative reference procedure to GC/MS was developed for 
the assay of progesterone in milk. This involved the extraction of steroids 
from milk and the use of HPLC to separate progesterone in these extracts from 
steroids, especially those of similar chemical structure to progesterone.
RIA, using antiserum of high and known specificity, allowed quantitation of 
the isolated progesterone. The procedure enabled combination of the specif­
icity of HPLC and RIA without loss of sensitivity and comparison of results 
with those obtained by EIA.
Methods have been described for the extraction of progesterone from 
whole milk by partitioning into organic solvents including petroleum spirit 
(Hoffmann and Hamburger, 1973) or diethyl ether(Heap et al3 1975; Nuti et 
at3 1975): to avoid gel formation pre-treatment with ethanol (95%) may also
be used to precipitate protein prior to extraction (Estergreen et at3 1977). 
These methods were assessed initially and compared with a solid phase part­
ition procedure using octadecylsilane-bonded silica (ODS). ODS has been 
applied to the extraction of steroids from urine (Shackleton and Whitney, 
1980; Heikkinen, Fotsis and Adlercreutz, 1981) and plasma (Heikkinen et alj 
1981; Cannel, Galligan, Mortimer and Thomas, 1982) but only a model outline 
procedure has been described for its use in the extraction of milk
(Axelson and Sahlberg, 1981). ODS extraction offers the possibility of 
achieving a high degree of concentration of steroids from milk without the 
requirement for large volumes of solvent.
ODS extraction was used by Axelson and Sahlberg (1981) to achieve effic­
ient recovery of steroids (92% for progesterone) and their conjugated meta­
bolites from large volumes of milk (2 - 5ml). The procedure was simplified 
to facilitate the handling of large numbers of samples with minimal proces­
sing and without the use of elaborate reservoirs to maintain sample temper­
ature (64°C) during extraction.
Although there are much published data regarding the separation of 
progesterone from broad groups of steroids by HPLC (Allenmark, Sonberg, 
Hammar and Lindstrdm, 1981; Walters, Foster and Cottrell, 1981; Kessler, 1982 
Sugara, Yamanaka, Takeda and Tsuruta, 1982; Huang, Ke, Hwang and Lo, 1983; 
Eibs and Schoneshofer, 1984) there are relatively few which demonstrate 
resolution of closely related steroids (Lin, Heftman and Hunter, 1980;
Purdy et al3 1980; Purdy, Durocher, Moore and Rao,1981): this is necessary 
to ensure the specificity essential to this application. Purdy et: at (1980;
1981) described the separation of ten pregnane and pregnene derivatives by 
gradient elution using a Chromegabond Diol (silica with bonded dihydroxy- 
lated carbon chains) column but the system failed to resolve 5$-pregnane-3, 
20-dione from progesterone. Using a silica column with isocratic elution 
(0.2% ethanol in dichloromethane) good resolution was shown between 5a and 
53-pregnane-3, 20-dione and progesterone although other steroids were not 
tested (Purdy et at3 1981). The isocratic system described by Lin et at 
(1980) used a silica column which provided excellent resolution of progest­
erone from eight closely related steroids and formed the starting point for 
the method developed here.
7.2 MATERIALS AND METHODS
7.2.1. Extraction and Isolation of Progesterone from Milk
a) Mifk samptes. Milk from an ovariectomized cow (ovX milk) was used ip 
the development of solvent and ODS extraction procedures following addition
of progesterone (to concentrations of 0 - 50ng/ml) as previously described
3
(section 2.1.10).. For recovery purposes ( H)progesterone, (0.9ng in 50yl 
5
methanol: 5 x 10 dpm) was added to aliquots (15ml) of these and all samples
used in subsequent HPLC studies (section 7.3.4h ) and allowed to equilibrate 
o
at 4 C overnight before use.
b) Solvents. All solvents were of analytical reagent grade with the 
exception of dichloromethane (HPLC grade). HPLC mobile phases were degassed 
before use by sonication (Sonicleaner Type 6441, Dawe Instruments Ltd., 
London) under reduced pressure.
c) HPLC equipment. System A comprised an ACS 351 pump and a Pye.
Unicam PU 4020 (8yl flow cell) UV detector (Applied Chromatography Supplies, 
Luton) and System B, a Spectroflow 400 pump and 757 (12yl flow cell)
UV detector (Kratos Instruments Ltd., Manchester). Samples were intro­
duced either via a Rheodyne 7125 (20 yl sample loop) or, when column back- 
flushing was used, a Valeo C10U (lOOyl sample loop) injection valv.e (Alltech 
Associates, Carnforth) . TJie 5ym Partisil columns (300 x 2mm) used in pre­
liminary studies were packed by Mr. L. Howells (Central Veterinary 
Laboratory,• Weybridge). The two columns (125 x 5mm) adopted for later use 
were packed with 3ym spherical silica and performed in a near identical 
manner: the RoSiL (Alltech Associates) column was packed by Mr. L. Howells
and the Hypersil column was packed commercially (H ichrom Ltd., Reading).
Elution of steroids from the column was monitored at 280nm with the aid 
of a potentiometric chart recorder (Servoscribe RE 541.2, Smith Industries 
Ltd). Where appropriate, precise retention times were determined using an 
integrator/plotter (CI-10B LDC Milton Roy, Stone) to monitor the detector 
signal (minimum time interval registered O.Olmin).
d) Extraction into organic solvents. Aliquots (200yl) of ovX milk con-
3
taining ( H)progesterone were dispensed in triplicate into glass test tubes 
(4ml capacity), petroleum spirit (40° - 60°C b.p.), diethyl ether or methanol
(2ml or 3ml) added (Transferpipettor, A.R. Horwell Ltd.; London) and the 
tubes closed with polyethylene stoppers. The tubes were mixed for 10 minutes 
(Multi-vortex mixer).
Samples extracted with methanol were centrifuged (1600g for 10 minutes),
o
the supernatant decanted into glass scintillation vials, dried at 60 C under 
nitrogen and PAS buffer (0.5ml) added. The aqueous phase of the other tubes 
was frozen in solid carbon dioxide/industrial methylated spirit and the 
supernatant poured into glass scintillation vials and evaporated at 60°C 
under nitrogen. Scintillator (Instagel, 7ml) was added to all vials and 
after shaking for 1 hour, the radioactivity in the extract determined in the 
manner described previously (section 2.3.3.).
e) Extraction using octadecylsilane bonded silica (ODS) columns. 
Commercially-available Baker-10 ODS columns (Linton Products Ltd., Harlow,
UK) consisting of a polypropylene syringe barrel pre-packed with ODS (O.lg 
for 1ml columns: 0.5g for 6ml columns) sandwiched between 20ym porosity 
polyethylene sinters were employed: these columns obviated the need for a
separate sample reservoir. Their use in conjunction with a Baker 10 mani­
fold (Linton Products) enabled 10 columns to be run simultaneously using 
reduced pressure to control the flow rate.
Columns were primed by passage of 2 x 2ml (1ml colums) or 2 x 5ml(6ml 
columns) of methanol and the same volumes of deionized water prior to use: 
care was taken to ensure that they were not dried after water addition since 
this markedly reduces subsequent flow of aqueous samples. The maximum total 
volume of hot milk (heated at 64°C for a minimum of 10 minutes) passed through 
each 1ml and 6ml column was 3ml and 15ml at a maximum flow rate of 
0.5ml/min or l.Oml/min respectively. After passage of milk samples; columns 
were washed with 2 x 2ml or 2 x 5ml hot water (64°C) and finally sucked dry 
prior to elution of progesterone into either scintillation vials (for direct 
radioactivity determination) or into conical glass test tubes with 1ml
(lml columns) or 3 x 0.5ml (6ml columns) of methanol. Elution was shown
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to be complete by determination of ( H)progesterone (in Instagel or 
Toluene Scintillator, see section 2.3.3.) in the milk sample, extracted 
milk and milk extract and examination of further fractions following elut­
ion with chloroform/methanol (1:1 v/v, lml). Tubes containing methanol 
extract were left overnight at -20°C and the lipids which precipitated were 
separated by centrifugation (1600g, 10 minutes). The extracts were aspir­
ated into screw-capped glass vials (2ml capacity), dried down under nitrogen, 
redissolved in the HPLC mobile phase (ethanol, 1% v/v in dichloromethane;
0.7ml) and stored at -20°C until required. The recovery of progesterone 
was determined by comparison of radioactivity (Toluene Scintillator) in 
duplicate aliquots of milk sample (X dpm in 0.1mi)with those in the extract 
(Y dpm in 5yl) . For an extract of a 15ml milk sample dissolved in 0.7ml mobile
phase, recovery = Y x 140 x 100%
X x 150
f) Isolation of progesterone from milk extracts by HPLC.- Isolation of
progesterone from milk sample extracts (lOOyl) was achieved using
system A and the 3ym RoSiL column set up for column back-flushing. The
mobile phase (1% v/v ethanol in dichloromethane) was used at a flow rate
of 2ml/minute. Following collection of the progesterone fraction into
screw-capped vials (2ml capacity), in accordance with its pre-determined
retention time (t 2.17 minutes, collection period 1.97 minutes to 2.47 
R
minutes), the column was backflushed for 6 minutes before injection of the
onext sample. The progesterone fraction was dried down at 60 C under a
stream of nitrogen, redissolved in PAS gelatin buffer (0.7ml) and stored
at -20°C until required for progesterone assay by RIA (section 2.3.4.) or
heterologous EIA: buffer standards were used in each case. Determination
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of ( H)progesterone in aliquots (5yl) of the fraction allowed percent 
recovery to be calculated (see section 7.2.1e)). Progesterone concentrat­
ions were compared with those obtained by direct RIA (see section 2.3.4.)
and EIA (section 7.2.2b)) of the milk samples.
7.2.2. Enzyme Immunoassay
a) Preparation of antibody-coated microtitre plates. Polystyrene plate 
wells (NUNC plates) were coated with anti-progesterone y-globulin (G711/12, 
1/8000 dilution in 0.17mM acetate buffer, pH 5.0) at room temperature as 
described in section 5.2.2.
b) EIA procedure. Progesterone lla-glucuronide-alkaline phosphatase 
conjugate (No. 151) was used. This was prepared with a 2:1 molar excess of 
steroid at conjugation as described in section 3.2.4.a.
Whole milk standards and samples were allowed to come to room temper­
ature (20 - 22°C) and thoroughly mixed before assay. Standards (lOyl, con­
taining 0 - 800pg progesterone) or samples (1 0yl) were added to duplicate 
wells. Conjugate diluted in PAS-gelatin buffer (200yl; 20ng/well) was then 
added at ambient temperature. Blank values were determined by addition of 
buffer alone to duplicate wells containing 1 0 yl of the zero progesterone 
standard. The plates were covered with a plate lid and incubated at 
ambient temperature for 3 hours in a covered plastic box lined with damp 
paper before emptying and washing 3 times with PAS-gelatin buffer (350yl/ 
well) at 40°C delivered from an 8-channel peristaltic dispenser. Substrate 
(p-nitrophenylphosphate, 15mM in DEM buffer) was added to each well (200yl) 
and the plates were incubated for 1 hour at 40°C in a waterbath on a grid 
at water level. The absorbance (405nm) of each well was recorded directly 
using an automatic plate reader. The progesterone concentration in each 
sample was estimated by interpolation from the calibration curve derived 
from each plate.
c) Statistical analysis of results. When assay techniques were com­
pared, weighted linear regressions were calculated assuming error in both 
procedures: slopes and intercepts were corrected after estimating the
variance in each technique from their coefficients of variation and their 
compatibility with a line of identity (slope = 1 , intercept = 0 ) using an 
F-ratio based on the "extra sum-of-squares" principle (Munson and Rodbard,
1982) as described in section 2.3.6.
7.3 RESULTS
7.3.1. Extraction of Progesterone by Solvent Partition
3
The recovery of ( H)progesterone following extraction from milk using 
methanol, petroleum spirit or diethyl ether is shown in table 7 .1 .
3 4" 4* -
Table 7.1 The Recovery of ( H)Progesterone : (8877 - 85dpm: mean - s.d. = 16pg)
Added to Triplicate Milk Samples (0.2ml) Following Extraction or
Partition with Methanol, Petroleum Spirit or Diethyl Ether
Solvent Methanol Petroleum Spirit Diethyl Ether
Solvent 2 3 2 3 2 3
Volume (ml)
% Recovery 90.2 - 1.8 92.7 - 0.3 43.4 - 2.1 74.5 - 4.5 92.2 - 2.4 82.3 - 1.7
(mean - s.d.)
Gel formation arose with extraction using 2ml of petroleum ether but this 
was considerably reduced with 3ml of solvent. Since gel formation was 
minimal with diethyl ether, however, there would be no advantage in using 
methanol precipitation of proteins prior to extraction.
7.3.2. Extraction of Progesterone using ODS Columns
a) Effect of flow rate. In preliminary studies milk samples (containing
3 -50,000dpm ( H)progesterone = 90pg and 50ng progesterone/ml milk) were
diluted 1:3 with 0.15M sodium chloride solution (at 64°C) as described by
Axelson and Sahlberg (1981). For the passage of a single lml aliquot of
diluted milk through lml columns at approximate flow rates of 0.5, 1.0 and
2 .0ml/minute, progesterone recovery in the methanol eluate was found to be
89.9%, 80.7% and 74.5% respectively: the remainder was found in the extra­
cted milk (11.0%, 20.4% and 20.3% respectively). Similarly, for extraction
of undiluted milk (lml) at a flow rate of 0.5ml/minute, 92% recovery was
achieved in the methanol eluate with 8 .8% remaining unextracted.
b) Adsorptive capacity of golumns. To estimate the efficiency of 
extraction of larger volumes of milk, duplicate milk samples (progesterone 
concentration 38ng/ml), either diluted 1:3 as in the previous section (9 x
lml aliquots/column) or undiluted (3 x lml aliquots/column), were passed
3
through lml columns (mean flow rate 0.5ml/minute) and residual ( H)progest-
erone recovered in each aliquot determined after extraction. Reduced
extraction was noted with successive aliquots. For undiluted milk, mean 
3
unextracted ( H)progesterone represented 3.5%, 4.1% and 8.5% of the total
in the three respective fractions and the mean recovery on elution with
methanol (lml) was 8 8%. Similarly, for the 9 successive aliquots of
diluted milk, 4.5%, 4.8%, 4.4%, 4.6%, 8.1%, 6.3%, 5.8%, 9.0% and 10.3%
3
(means) respectively remained unextracted, with 88.5% of ( H)progesterone 
recovered on elution with methanol.
Scaling up by use of 6ml ODS columns for the extraction of 15ml of
undiluted milk at a flow rate of approximately lml/minute gave rise to a
+ + -J.
mean - sd recovery (n = 5) of 77.4 - 5% and 79.1 - 2.8% for samples con­
taining a concentration of 0 and 50ng/ml respectively of added urtlabelled 
progesterone.
a) Use of ODS-extraated ultra high temperature-treated (UHT.) milk for the 
preparation of progesterone standards. Progesterone standards, prepared in 
the manner described previously (section 2.1.10.) using ovX milk, UHT milk 
from a commercial source and UHT milk previously extracted by the ODS method, 
were assayed in quadruplet by EIA. The calibration curves produced are 
shown in Fig. 7.1 and indicate that endogenous progesterone concentrations 
were lowest in the extracted milk: interpolation from the extracted milk
calibration curve indicated that the "0” standard for the ovX milk and UHT
milk contained lng progesterone/ml.( lOpg/well) and 16ng progesterone/ml 
(160pg/well) respectively.
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Fig. 7.1 Comparison of EIA calibration curves using progesterone standards 
prepared in ovX milk (•-•), UHT milk (o-o) and ODS-column extracted UHT 
milk (▲-▲). Values are mean ± s.d. of 4 determinations.
7.3.3. The Isolation of Progesterone from Steroid Mixtures by HPLC
a) Mixtures in solvent. The separation of progesterone from seven 
structurally related steroids (5a- and 53-pregnane-3, 20-dione; 3 3-hydroxy- 
5-pregnen-20-one; 3 3-hydroxy-5a-pregnan-20-one; 20 3-hydroxy-4-pregnen-3-one 
11B-hydroxy-4-pregnene-3, 20-dione and 17-hydroxy-4-pregnene-3, 20-dione) 
prepared in 1% ethanol in dichloromethane on a 3|im spherical silica column 
(system B) was investigated using four solvent systems comprising of
0.5%, 1%, 2.5% and 5% ethanol (v/v) in dichloromethane at a flow rate of 
lml/minute. As shown in Fig. 7.2,only the lower polarity systems(0.5% and 
1% ethanol) provided good resolution; base line resolution of all the
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Fig. 7.2 Separation of steroids by HPLC (system B; 3ym Hypersil column), 
using ethanol in dichloromethane as eluting solvent at concentration a) 0.5% 
b) 1% c) 2.5% d) 5% and a flow rate of lml/min. Peaks represent 1) 5a-pregnane-3, 
20-dione; 2) 5 B-pregnane-3, 20-dione; 3) progesterone; 4) 3$-hydroxy-5-pregnen- 
20-one; 5) 3$-hydroxy-5a-pregnan-20-one; 6 ) 17-hydroxy-4-pregnene-3, 20-dione;
7) 20B-hydroxy-4-pregnen-3-one; and 8) 11B-hydroxy-4-pregnene-3, 20-dione.
Steroids were dissolved in 1% ethanol in dichloromethane at concentrations of;
1 - 2, 25yg/ml; 3 - 6 , 50yg/ml; 7, 100^g/ml; 8 , 42.5yg/ml. The sample size 
was 20yl. Chromatogram e) demonstrates use of 1% ethanol in dichloromethane 
at a flow rate of 2ml/minute.
steroids was attained with 0.5% ethanol. Ethanol at 1% was chosen as 
optimal for the isolation of progesterone, however, since it ensured high 
resolution from the 5 a- and 5 3-pregnane-3, 20-diones and 3 3-hydroxy-5- 
pregnen-20-one in less time than with 0.5% ethanol; retention times for 
progesterone were 2.9 minutes and 5.9 minutes respectively (Figs. 7.2a 
and 7.2b). The nature of the additional peaks x and y (Fig. 7.2a) found 
using 0.5% ethanol is unknown: they may represent the summation of small 
quantities of impurity present in some or all of the steroid preparations, 
since neither was detected in substantial quantity when steroids were 
chromatographed individually. Resolution was little affected by use of 
1% ethanol at a flow rate of 2ml/minute compared with that at lml/ 
minute : elution profiles were virtually superimposable when plotted 
at chart speeds of lOmm/minute (Fig. 7.2e) and 5mm/minute (Fig. 7.2b) 
respectively. Clearly it was possible to isolate progesterone within 
2 minutes of injection of sample on to the column.
b) Mixtures in milk extract. To take advantage of the rapid separ­
ation capability of this sytem for the isolation of progesterone from milk 
extracts a column backflushing system was used in subsequent experiments. 
This arrangement enabled reversal of eluate flow across the column (3ym 
RoSiL) alone immediately the progesterone fraction was eluted and collected 
samples could thus be rapidly chromatographed whilst minimizing carry 
over of slow running components to the next sample. Comparison of the 
retention times (mean - s.d.) for progesterone when 100VGL of the 8 steroid 
mixture (described in the legend of Fig. 7.2, at a tenth concentration) 
prepared either in mobile phase or ODS extract of ovX milk was injected on 
to the column (flow rate 2ml/minute) revealed no appreciable difference: 
values were 2.22 - 0.06 min (n = 3) and 2.17 - 0.02 min (n = 4). U.V. 
absorbing (280nm) substances were eluted from the backflushing column in 
less than three times the retention time of progesterone. Chromatography
+ 3
of the milk extract (- the steroid mixture) containing ( H)progesterone
( 30,000dpm/100yl s 54pg) enabled an estimation of recovery of progesterone
to be made using the backflush procedure. Following injection of lOOyl
of extract three fractions were collected, from 0 - 2min, 2 - 2 . 4  min
(progesterone fraction) and during backflushing from 2.4 - 7 min: mean -
3
s.d. (n = 3) ( H)progesterone recovered in these fractions represented 
+ ■}•
5.8 - 0.5%, 85 - 1.5% and 8.24 - 1.4% respectively for samples containing
+ + +
the steroid mixture and 5.5 - 0.3%, 8 6 .1  - 2.8% and 11.9 -1.2% respectively
for samples without the mixture added.
7.3.4. Validation of EIA
a) Assay sens'it'iV'Lty. The sensitivity of the RIA and EIA procedures 
are defined in Table 7.2 in terms of both limit of detection (Abraham, 1969) 
and the mid-point of the calibration curve (Feldman and Rodbard, 1971). 
Values shown were from calibration curves using standards prepared in milk 
or PAS-gelatin buffer (Figs. 7.3a and 7.3b).
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Fig. 7.3 Calibration curves for EIA (a ) and RIA (•) using standards prep­
ared in milk (a) or buffer (b). For EIA, mean B/BQ values ± s.d. and CV (--
for 8 (a) or 6 (b) consecutive assays are shown. Values for a single RIA . 
calibration curve are included* for comparison. Mean absorbance values in 
the absence of competing progesterone (B ) fell within the ranges 0.659 - 
0.894 (a) and 0.624 - 1.017 (b). °
Table 7.2 Assay Sensitivities
EIA R IA
Limit of detection* Calibration curve Limit of detection* Calibration curve
Standards (confidence limit) mid-pointf (confidence limit) mid-pointf
Whole milk 5pg(95% ) 24 pg 5 pg (99%) 40 pg
PAS-gelatin 2 Pg (99%) 10  Pg 5 pg (99%) 2 0  pg
Data were derived from the calibration curves described in Fig. 7.3.
* Smallest quantity of progesterone measured which gives rise to a response 
significantly different from zero (Abraham, 1969). Confidence limits were 
derived from the appropriate t statistic.
f The mass of progesterone required to produce a 50% reduction in label 
binding (Feldman and Rodbard, 1971).
b) Precision of adsorption of antibody to plate wells. The enzyme- 
labelled steroid conjugate, diluted in PAS-gelatin buffer (20ng/200yl), 
was added to 8 8 wells on each of 6 plates previously coated with anti­
progesterone y-globulin: 8 wells in the centre of the plates received 
buffer alone to provide blank values. The plates were treated as described 
for EIA and the standard deviation (sd) of the optical densities of the 8 8  
wells calculated for each plate. The mean within-plate coefficient of 
variation (CV) for the 6 plates was 5.1% (range 4.1 - 7.9%). The mean 
optical density calculated for the wells at the outside of each of the 6  
plates did not differ significantly from the mean value for the remaining 
wells.
c) Blank Values. The binding of enzyme-progesterone conjugate to "non- 
immune" y-globulin and enzyme to anti-progesterone y-globulin was tested
to investigate non-specific binding in the microtitre plate system. Each 
of 2 plates was coated with both anti-progesterone y-globulin ( 2 x 4  rows 
of 8 wells) and non-immune y-globulin (4 rows of 8 wells). Milk samples 
(lOpl; n =  8) containing high ( > 15ng/ml) concentrations of progesterone 
were added in quadruplicate to each group of 4 rows on one plate and milk 
samples (1 0yl; n = 8) containing low ( < 5ng/ml) concentrations of progest­
erone to the other plate. Alkaline phosphatase in PAS-gelatin buffer 
(40ng/200yl) was added to one group of wells containing anti-progesterone 
Y-globulin on each plate and conjugate in PAS-gelatin buffer (40ng/200yl) 
to the remaining groups containing anti-progesterone or non-immune 
Y-globulin. The plates were treated as described for EIA and the non- 
specific binding of conjugate or enzyme expressed as a percentage (- sd) of 
the specific binding seen in the presence of the high or low concentrations 
of progesterone in milk. Conjugate binding to the non-rimmune y-globulin
■f*
was 4.4 - 1.2% and 2.15 - 0.61% in the high and low samples respectively 
and enzyme binding to the specific antibody was 6.1- 1.2% and 2.5 - 0.8%.
d) EIA drift. Repeated duplicate estimations (1 - 12) were made of the 
progesterone concentration in each of 3 milk samples arranged in sequence 
across a microtitre plate. The slope and intercept obtained by least 
squares regression analysis of the progesterone concentrations determined 
(y) for each sample against order of application to the plates (x = 1 to 1 2) 
were compared with 0 slope and intercept at the mean sample concentration 
by the F-ratio test. At means - sd of 2.6 - 0.13ng/ml, y = 0.015x + 2.505 
(F = 0.619); at 7.8 - 0.4ng/ml, y = 0.021x + 7.970 (F = 0.150); and at
28.4 - 3.1ng/ml, y = -0.360x + 30.758 (F = 1.026). There was no signific­
ant difference for any sample.
e) Within and between assay precision. Milk samples were assayed by 
EIA and 9 samples, found to contain between 15 and 30ng progesterone/ml 
of milk, were combined to form a ’’high" quality control. Nine samples 
found to contain<5ng/ml were similarly combined ("low" quality control). 
Equal volumes of the 2 pools were mixed to provide a "medium" quality 
control. The 3 quality controls were assayed in duplicate at 5 different 
positions on each of 8 microtitre plates during the course of a routine 
assay and the mean and standard deviation calculated for each to allow the 
within-assay coefficient of variation (CV) to be determined.(Table 7.3).
A mean duplicate determination from each quality control on each plate 
was selected using random numbers tables and the mean between-assay CV 
calculated by repeating the exercise a further 4 times (Table 7.3). The 
between-assay precision (CV) of calibration curves obtained using either 
milk or PAS-gelatin standards are shown in Figs. 7.3a and 7.3b
respectively.
f) Precision of RIA. The RIA (section 2.3.4.) was performed in
batches of 56 or 64 tubes to enable synchronisation of charcoal addition
and centrifugation. Replicate estimates of quality control samples assayed 
in duplicate within each batch (n = 5) or between batches (n = 8) allowed 
within-and between-batch CV to be calculated (Table 7.3).
Table 7.3 Within- and Between-Assay Precision for EIA and RIA and for RIA
Performed at the Milk Marketing Board (MMB) at Low (L), Medium (M)
and High (H) Concentrations of Progesterone in Milk
Mean within-assay precision Mean between -assay precision
EIA (n = 40) RIA (n =  5) R IA (M M B ) (n =  24) EIA (n = 40) RIA (m =  8 ) R IA  (M M B ) (« =  40)
control ng/ml C V (% ) ng/ml C V (% ) ng/ml CV (% ) ng/ml C V (% ) ng/ml C V (% ) ng/ml CV (% )
L 3-2 1 1 0 1-6 140 3-2 1 2 1 1-9 11 -3
M 1 1-2 16-7 6 -6 7-2 I I I 16-6 8-1 10 I
H 17-7 9-7 12 8 1 2-2 150 13-4 17 4 15 6 140 8 -2 14-6 14-1
Overall mean CV 12-5 l i t 14-8 9 .9
For comparison, data were also derived from RIAs run routinely by the 
Milk Marketing Board (MMB). Milk samples submitted to them for pregnancy 
testing in a 1 week period and found to contain >9ng progesterone/ml were 
pooled to provide a quality control sample. Eight assays, each including 
3 quality control determinations, were selected using random numbers tables 
from 34 assays conducted in 1 week and the mean within-assay CV calculated 
(Table 7.3). The between-assay CV was calculated from 40 values selected 
at random from assays performed during the same period (Table 7.3).
g) Cross-reactivity, Cross-reactivity was defined as the molar quantity 
of steroid, relative to progesterone (mol progesterone/mol steroid) required 
to reduce label binding by 50% (Abraham, 1969). Values for various steroids 
(dissolved in PAS-gelatin buffer) with the antiserum (G711/12) are presented 
in Table 7.4.
Table 7.4 Specificity of Antisera
Steroid*
Cross-reaction (%)
R IA f ETAf RIAJ 
at M M B
4-Pregnene-3,20-dione 1 0 0 1 0 0 1 0 0
4-Androstene-3,20-dione < 0 0 3 0 04 <0-30
5a-Pregnane-3,20-dione 1-30 2-80 2 -0 0
5|3-Pregnane-3,20-dione 6-80 8 -0 0 — § :
17-Hydroxy-4-pregnene-3,20-dione 3-60 11-3 0-40
3P-Hydroxy-5-pregnen-20-one 005 0-40 1-50
11P, 17a,21 -Trihydroxy-4-pregnene-3,20-dione < 0 0 3 0-06 <0-30
11 p,21-Dihydroxy-4-pregnene-3,20-dione 1-60 0-80 <0-30
3P-Hydroxy-5-androsten-17-one 003 0-03 — §
11 a-Hydroxy-4-pregnene-3,20-dione 75-80 — § 44-00
21-Hydroxy-4-pregnene-3,20-dione - § 5-80 4-00
17p-Hydroxy-4-androsten-3-one - § - § 0-35
20a-Hydroxy-4-pregnen-3-one - § H 8 0-35
Cross-reactivity is defined as the molar quantity of steroid, relative to progesterone (mol.
progesterone/mol steroid) required to reduce label binding by 50%.
*IU P A C -IU B  (1967) revised tentative rules for steroid nomenclature, 
f  Antiserum G 71 i /12.
$ Antiserum AF18/3 (data of Sheldrick, Mitchell &  Flint, 1980).
—§Not tested.
h) Comparison of EIA of miVk. and HPLC isolates, Whole milk samples
(n = 25) were selected using a random numbers table from samples collected
3
on a routine basis. ( H)progesterone was added to each sample prior to 
extraction and HPLC as described in section 7.2.1.
The mean - s.d. recovery of the progesterone tracer after ODS column 
extraction of the 25 milk samples examined was 78.8 - 4.5%. The recovery 
after HPLC and redissolving the progesterone fraction in PAS-gelatin buffer 
was 52.8 - 10.4%.
Progesterone concentrations were determined both before and after 
extraction and purification and were corrected for procedural losses. Com­
parisons of results from EIA with those from RIA before (r = 0.933) and
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Fig. 7.4 Linear regression of progesterone concentrations in milk determined 
by EIA and RIA a) before and b) after extraction and isolation by HPLC and 
c) by EIA and d) RIA before and after extraction and purification by HPLC.
•---= line of regression, — ----  = line of identity.
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Fig. 7.5 Progesterone concentrations determined by RIA and EIA in 4 luteal- 
phase milk samples after dilution with ovX milk, for which regressions 
differed significantly from a line of identity (-- ).
after (r = 0.969) extraction were highly correlated and the slopes and 
intercepts did not differ significantly from 1 and 0 respectively (Figs.
7.4a and 7.4b) when the F-ratio test was applied. Linear regressions for 
EIA before and after extraction (r = 0.910) and RIA before and after 
extraction (r = 0.952) were also not significantly different from a line 
of identity (Figs. 7.4c and 7.4d).
i) Linearity of response. Ten milk samples shown to contain progest­
erone concentrations consistent with the luteal phase (^slOng/ml) by EIA 
were taken at random and serially diluted with milk from an ovariectomised 
cow. The diluted samples were assayed by both EIA and RIA and linear 
regressions calculated for each set of results against dilution. Correl­
ation coefficients fell within the range r = 0.984 to 0.999 for the RIA 
and r = 0.946 to 0.997 for the EIA. Correlation coefficients following 
linear regression of the results from EIA on those obtained by RIA were in 
the range r =  0.946 to 0.998. For 6 of the dilution series, analysis of 
the F-ratio showed no significant deviation from slope = 1 and intercept = 0 
significant differences were found in 4 of the series (Fig. 7.5) although 
good correlations were still exhibited (r = 0.967 to 0,997).
g) Analytical recovery of progesterone added to milk, samples. Proges­
terone was added to milk samples taken from 6 different cows during the 
oestrous period (endogenous progesterone <1.0ng/ml by EIA), in the manner 
described for the preparation of progesterone standards (section 2 .1 .1 0), 
to provide concentrations of 20ng/ml. The samples were diluted in milk 
from an ovariectomised cow to provide a range of concentrations (2 0 , 16,
12, 8 , 4, 2 and lng/ml). The samples were assayed by RIA and EIA and the 
mean concentrations and percentage recoveries of progesterone are shown in 
Table 7.5. Linear regressions of mean concentrations measured (y) on the 
values expected (x) gave y = l.OlOx - 0.784 and y = 1.026x - 0.718 for EIA 
(r =0.993) and RIA (r = 0.995) respectively.
Table 7.5 Mean Concentration (ng/ml milk) and Recovery of Progesterone
Added to Milk Samples (n - 6) from Oestrous Cows
Expected cone, 
of progesterone
EIA CBC R IA
Mean +  s.d.
Recovery
(%) Mean ±  s.d.
Recovery
(%)
. 2 0 20-6 +  4-5 103 20-9 +  10 105
16 14-5 +  3-4 91 14-6 ±  0-8 91
12 10-4 ±  2-3 87 11-3 +  1-0 94
8 7-3 +  0-8 91 7-2 +  0-5 90
4 3-3 +  0-8 83 3-5 +  0-3 8 8
2 1-8 +  0 - 6 92 1-8 +  0-1 90
7.4 DISCUSSION
A central objective of this study was to confirm that progesterone was 
the sole or major component measured in the EIA (and RIA) systems. This was 
achieved by comparison of progesterone concentrations measured before and 
after isolation by extraction and HPLC.
Both the solvent-partition and ODS column methods were efficient in the 
extraction of progesterone from milk. The former was only suitable for 
extraction of samples of relatively low volume due to the large relative 
volume of solvent, required if gel formation was to be avoided. For routine 
purposes, the ODS column extraction procedure provided a simple and practical 
alternative to solvent partitioning for relatively large volume (> 1ml) 
samples in large numbers, 15ml of milk being reduced to 1.5ml of methanol 
extract. The reduced recovery (77 - 79%) and increased variability (CV
3.5 - 6.4%) of extraction attained on scaling up the procedure to accom­
modate 15ml of milk was associated with difficulties in achieving uniform 
and steady flow rates between columns when ten columns were employed 
simultaneously: this effect could be considerably reduced by pre-filtrat-
ion of the milk samples.
A further application of the ODS extraction method was found in the
preparation of essentially progesterone-free milk from commercially avail­
able sources. This provided a suitable matrix in which to prepare milk 
standards (Fig. 7.1) and circumvented the necessity for using ovX milk or 
selected milk samples from cows at oestrus. Axelson and Sahlberg (1981) 
indicated that the quantitatively-important components of milk such as 
proteins and lipids remain essentially unaltered by ODS extraction.
The HPLC system described by Lin et al (1980) could not be readily 
adopted since the column used resulted in high back-pressures which exce­
eded the working range of the equipment available.
This practical problem necessitated that an alternative system be
contemplated. Based on data from commercially available columns of 5mm
diameter (Hichrom Ltd.)^ the total potential efficiency N of the two
Partisil columns used by Lin et al (1980) would approximate to 6,000 - 7,000
Vr 2theoretical plates, N : N =a (— ) , where Vr is the retention volume ofw
the peak, W is the peak width in volume and d is a constant dependent on the 
height at which peak width is measured. This calculation excludes any 
reduction in efficiency incurred by use of columns of such low (2mm) sub- 
optimal diameter (Knox, 1978). The type of column employed in the present 
study provided total column efficiencies of 10,000 - 12,000 theoretical 
plates and enabled full resolution of progesterone from all the steroids 
tested.
The main advantage of this system compared with that of Lin et al (1980) 
was the speed of separation: the retention times for progesterone were
2.17 minutes and 45 minutes respectively. Purdyet al (1981) have
described a similar system which provided good resolution of progesterone 
from 5a- and 53-pregnane-3, 20-dione and 3ot-hydroxy-5oc-pregnan-20-one but 
again progesterone exhibited a long retention time (^21 minutes). When 
used in the column backflush system it was possible to isolate progesterone 
and prepare the column for injection of the next sample within 10 minutes,
while minimizing the possibility of carry-over of slow running components 
from one sample to another.
The presence of milk has been shown to cause a significant depression 
in antibody-antigen binding and sensitivity in both RIA (Heap et al3 1976) 
and EIA (Sauer al3 1981; Chang and Estergreen, 1984) of progesterone 
and in recognition of this, standards are often prepared in milk. Indeed, 
variations in non-specific effects between samples have been reported 
(Heap et al3 1976; Pennington et al3 1976; Holdsworth et al3 1979; Stevens 
et al3 1981) although many descriptions of immunoassays for progesterone 
have made no reference to such an occurrence. This problem was illustrated 
in the present study when 10 samples shown to contain luteal-phase con­
centrations of progesterone were diluted with milk from an ovariectomized 
cow. All samples showed linear correlations with dilution when measured 
by RIA or EIA and when these results were compared. Four of the samples, 
however, showed significant variation from a line of identity between EIA 
and RIA (Fig. 7.5), indicating that the sample matrix had affected the 
concentration of progesterone perceived by one technique or the other. A 
similar effect was noted when progesterone was added to 6 milk samples 
taken from cows at oestrus. Although the mean recoveries of progesterone 
after further dilution with milk from an ovariectomized cow were close to 
those expected (Table 7.5), greater variation in the recovery of progester­
one from individual milk samples was seen with EIA than with RIA. In 
comparison, Chang and Estergreen (1984) reported recovery values between 
80and 88% but a high degree of variability (s.d. 26 - 71%). Although com­
parable recovery data for RIA are scarce or limited (Heap et al, 1976), 
recovery ranges have been reported by some laboratories and vary consider­
ably, e.g. 97 - 110% (Bulman and Lamming, 1978), 104 - 126% (van de Wiel 
et al3 1978); and 100 - 136% (Batra, Pahwa, Suri and Pandey, 1980).
An explanation for the variation seen, in EIA in particular might lie in 
the composition or structure of milk since the label used could interact 
with particular milk samples. The investigation of non-specific binding 
in 16 milk samples containing high or low concentrations of progesterone 
showed no evidence of individual non-specific binding effects and mean 
values of 2.15% and 4.4% were recorded in the presence of follicular and 
luteal-phase samples respectively: clearly endogenous alkaline phosphatase
also had little influence on the system. Equivalent studies with RIA 
have produced variable values as high as 20% (Holdsworth et al3 1979; 
Stevens et al3 1981).
Differences in cross-reactivity between RIA and EIA could produce 
similar discrepancies in values measured: the occurrence of progestagens
in milk has been investigated by Darling, Laing and Harkness (1974) but 
since the oxidative procedures employed would only allow broad classific­
ation, the influence of specific steroids is hard to discern. Cross­
reactivity studies were conducted using the criteria of Abraham (1969) 
but no large differences were found between EIA and RIA (Table 7.4) 
although Van Weemen and Schuurs (1975) and Van Weemen, Bosch, Dawson,
Van Hell and Schuurs (1978) have shown that the use of heterologous assay 
systems can increase cross-reactivity. Steric considerations, however, 
suggest that this is less likely to occur when the heterology involves 
the bridge itself, rather than the site of attachment of the bridge to 
the steroid. Darling et al (1974) and Purdy, Durocher, Moore and Rao 
(1980) showed that 5a- and 53-pregnane-3, 20-diones occur in milk but it 
is the suggested presence of progestagen conjugates (Heap, Henville and 
Linzell, 1975) that should give rise to concern since these are not defined 
and were not tested. The probable preponderance of conjugated metabolites 
in the aqueous phase of milk would enhance their interaction with the anti­
body in comparison with progesterone and their greater availability would
be accentuated by the non-equilibrium nature of EIA (section 6.3.4a; Sauer 
et al3 1982b; Morino, Nakao, Tsunoda and Kawata, 1984; Munro and Stabenfeldt 
1984). The importance of the "first come, first-served" principle (Pratt 
and Woldring, 1976) in non-equilibrium RIA and EIA has been demonstrated by 
a number of other investigators (Van Weemen et al3 1978; Vining, Compton 
and McGinley, 1981).
With these considerations in mind, it was necessary to demonstrate that 
progesterone was the milk component being measured by EIA. After correction 
for procedural losses, progesterone concentrations determined in 25 milk 
samples before and after extraction and isolation by HPLC were highly cor­
related for both EIA and RIA (r - 0.910 and 0.952: Figs. 7.4c and 7.4d).
In addition, results from the two techniques were closely correlated before 
(Fig.7.4a; r = 0.933) and after (Fig. 7.4b; r = 0.969) extraction and, 
most importantly, none of the regressions differed significantly from a 
line of identity, indicating that progesterone was the major component in 
milk measured by both RIA and EIA.
The use of microtitre plates to provide both a solid-phase support for 
the antibody and a vessel to contain the assay greatly facilitates its 
application in unsophisticated laboratories. Previous studies (Kricka et 
al3 1980) have found evidence for variation in the adsorption of antibody 
to plates (CV = 5.2 - 30%). Although similar problems were originally 
encountered with both polyvinyl and polystyrene plates (see chapter 5), the 
use of plates specifically manufactured for immunoassay and attention to 
detail in ensuring a stable environment during antibody coating and incu­
bation resulted in acceptable precision (CV = 5.1%). In particular, no 
evidence was seen of preferential binding to wells at the edge of the plate 
(see Kricka et al3 1980). The within-and between-assay precision of EIA 
were 12.5 and 14.8% respectively and compared favourably with values for 
RIA both in this study (Table 7.3) and others (Heap et al3 1976; Holdsworth
et al3 1979; van de Wiel, Kalis and Shah, 1979; Batra et al3 1980).
Bulman and Lamming (1978), however, have given details of an RIA with 
greater precision (CVs = 8.9% and 10.3%).
If standards and 40 samples are assayed in duplicate on a microtitre 
plate, about 15 minutes will elapse between introduction of the first sample 
and addition of the conjugate. Munro and Stabenfeldt (1984),using 50yl of 
antibody per well to coat the plate and a 50yl sample, found that this 
resulted in a systematic variation in the value determined for a sample 
depending on the time of addition to the plate ("drift"), presumably 
because the earlier the addition, the greater the time for contact between 
the sample and antibody. Since the microtitre plate EIAs described do not 
attain equilibrium (Sauer et al3 1982b; Munro and Stabenfeldt, 1984), this 
presents a potential source of error. The use of 200yl of antibody to 
coat the plate and only lOyl of the sample apparently prevented drift in 
the present application, however.
CONCLUSIONS
1. Rapid extraction of progesterone from milk samples was achieved by use 
of ODS columns. Milk extracted in this way provided a suitable matrix 
for the preparation of EIA standards.
2. HPLC of milk extracts using a 3ym silica column and isocratic elution 
enabled separation of progesterone from steroids of similar chemical 
structure.
3. The precision, sensitivity and accuracy of EIA was shown to rival that 
of RIA. Its simplicity and safety in use commend its application to 
the solution of practical problems in the management of reproductive 
performance of dairy cattle.
CHAPTER 8: 
APPLICATIONS OF PROOFSTFRONF FIA
8.1 INTRODUCTION
The value of measuring milk progesterone concentrations by RIA in 
determining causes of reproductive failure is widely established and has 
been discussed (see section 1.6.6.). However, the use of radioisotopes 
restricts RIA services to licensed specialized laboratories and severely 
limits its practical value. The only routine application of this approach 
to the management of reproductive performance has been a postal pregnancy- 
testing service (Booth and Holdsworth, 1976). The development of EIA 
procedures described in previous chapters has removed these restrictions 
and the present study exploits some of the possibilities revealed by RIA.
Two EIA procedures have been used in the present studies. The relat­
ively insensitive homologous assay, with progesterone lla-hemisuccinate-8 
-galactosidase as label, was used to investigate the value of daily meas­
urements of progesterone concentration in cow's milk as a means of pre­
dicting the appropriate time for Al. The use of a second, sensitive 
heterologous EIA, employing progesterone lla-glucuronide-alkaline phospha­
tase as label was investigated as a simple means of pregnancy testing and 
for monitoring corpus luteum function during hormone treatment for oestrus 
synchronization.
Monitoring corpus luteum function during hormone administration for 
oestrus synchronization enabled the efficacy of treatment to be evaluated. 
The progesterone-releasing intravaginal device (PRID) used here has been 
promoted for oestrus synchronization and may initiate ovarian activity in 
the post-partum anoestrus animal: their administration for twelve days
has found acceptance as a means of. reducing days to conception and improv­
ing pregnancy rates (Drew, 1982). Using this treatment, however, Gyawu 
et al (1980) found that where the devices were fitted late in the oestrous 
cycle no conception occurred. This may result from prolonged exposure of 
the developing follicle to progesterone, leading to abnormalities of the
ovum (Van Niekerk and Belonge, 1970) or to early embryonic mortality 
(Wishart and Young, 1974). Further, the oestradiol benzoate capsule 
normally attached to the PRID may not be luteolytic (Seguin, 1979). The 
object of this particular study was to assess whether a seven-day admini­
stration of PRID with a single intra-muscular injection of cloprostenol 
24 hours before PRID removal could achieve precise synchronization and a 
satisfactory conception rate.
8.2 MATERIALS AND METHODS
8.2.1. Application of the Homologous EIA to Oestrus Prediction and the 
Timing of Al
a) Preparation of antibody-ooated microtitre plates. PVC plates 
(Dynatech) were coated with anti-progesterone y-globulin (G711/12, 1/4,000 
dilution, ImM acetate buffer pH 5.0) at 40°C as described in section 5.2.2.
b) Homologous EIA. Progesterone lla-hemisuccinate-8-galactosidase con­
jugate (No. 98) was used, prepared as described in section 3.2.3, with a 
20:1 molar excess of steroid at conjugation. All pipetting stages were per­
formed at 4°C in a cold room. Milk progesterone standards were preserved 
using sodium azide (0.1%).
Standards (10 UL) ormilk samples(lOyl) from animals under test were 
drawn up using a diluter/dispenser (IMV, L ’Aigle, France) and washed into 
the wells of the plate with conjugate (190yl in PAS-gelatin buffer, 10ng/ 
well). Blank values were determined by addition of buffer alone to dupli­
cate wells containing zero progesterone standards. The plates were covered 
with a lid and after incubation for 3 hours at 40°C in a water bath,the 
wells were emptied and washed three times with PAS-gelatin buffer (250yl). 
The degree of binding of enzyme conjugate to the antibody-coated wells was 
determined by addition of freshly-prepared substrate (o-nitrophenyl-3-D- 
galactopyranoside, 200yl; 3mg/ml) in PAS-gelatin buffer containing 0.01M
magnesium chloride and 0.1M mercaptoethanol. Following an incubation 
period of 1 hour at 40°Cjthe optical density at 405nm was measured
directly through the wells using an automatic plate reader. The progester­
one concentration in each sample was estimated by interpolation from the 
calibration curve derived from each plate.
a) Cattle and the collection of milk samples for EIA, Cows (164 in 
total) which were at least 42 days post-calving were identified and randomly 
assigned to two similar sized groups (experimental and control) on each of 
four commercial farms. Morning milk samples were collected daily over a 
30 day period from animals in the experimental group (identified by use of
f
tail tape) and transported to the laboratory for progesterone determination 
on the same day by EIA. The stockmen were instructed to agitate the milk 
jars before taking the representative sample (15 to 20ml) into polystyrene 
vials (Dilu-vial; Elkay Products Ltd., Basingstoke), pre-labelled with the 
cow's number.
d) Al of cattle. Milk progesterone concentrations were determined by 
the afternoon following collection and results for each cow plotted daily. 
When two successive low values (below 5ng progesterone/ml milk) had been 
noted, the farm was contacted by telephone and arrangements made for the cow 
to be inseminated the following day by Cattle Breeding Centre inseminators. 
Cows in the control groups were similarly inseminated following observation 
of behavioural oestrus by the stockmen.
e) Pregnancy testing. Pregnancy testing was performed by EIA using milk 
samples taken from animals in both experimental and control groups 24 days 
after insemination. Progesterone concentrations greater than lOng/ml were 
taken to indicate pregnancy and those below to indicate a return to oestrus.
8.2.2. Use of the Heterologous EIA to Monitor Corpus Luteum Function 
Following Hormone Treatment for Oestrus Synchronization
a) EIA, NUNC polystyrene microtitre plate wells were coated with
y-globulin from antiserum G711/12 (see section 7.2.2a ) for use in EIA.
EIA was performed as described in section 7-.2.2b .
b) Cattle and hormone treatments. A group of 29 Friesian cows of 1st,
2nd and 3rd lactation was housed in winter and fed a conventional diet. The
average interval from previous calving to day 0 of treatment was 122.0 - 
27.1 days. Progesterone-releasing intravaginal devices (PRID, CEVA Ltd.), 
from which the gelatin capsules containing lOmg oestradiol benzoate had 
been removed, were introduced into the vagina of each cow (day 0). Six 
days later (day 6) each cow was injected intramuscularly with 500yizg cloprost-
enol (a synthetic analogue of prostaglandin F0 . ICI pic.). The devices' £ oc
were removed from the cows 24 hours later (day 7). Al was carried out 
using semen from a single ejaculate from a progeny-tested bull 48 hours
(day 9) and 72 hours (day 10) after PRID removal. All procedures were
carried out between 10am and noon.
o) Collection of nrllk samples for EIA. Milk samples were taken during 
the morning milking (0700 - 0900 hours) at 2 - 3 day intervals during the 
21 days preceding the introduction of the PRID and daily from the day 
before treatment began until day 16. Further milk samples were taken at 
21, 22, 24 and 25 days after Al to confirm pregnancy. The milk samples 
were taken from individual milk jars after agitation, preserved using 
Lactab Mk III (section 2.3.7.) and stored at 4°C until assayed by EIA.
EIA data were processed automatically by interfacing the plate reader with 
a microprocessor (Commodore PET 2001): progesterone concentrations were
interpolated from calibration curves calculated using a 4-parameter logis­
tic function (Rodbard, 1978). The BASIC programme was provided by 
Mr. A. Thomas ( see appendix 3.).
8.2.3. Heterologous EIA and Pregnancy Testing of Dairy Cows: Comparison
with Other Methods
a) EIA, NUNC polystyrene microtitre plate wells were coated with
y-globulin from antiserum G711/12 (see section 7.2.2a ) for use in EIA.
EIA was performed as described in section 7.2.2b .
b) Comparison with RIA, Milk samples (200) submitted to the MMB by 
commercial farms for pregnancy testing 22 - 26 days after service or by 
veterinary surgeons investigating herd fertility were assayed by the RIA 
in routine use at the MMB Veterinary Laboratory (Holdsworth, Chaplin and 
Booth, 1979) before transporting for re-assay by RIA (as section 2.3.4.).
The majority (168) were milk samples taken after agitation of the whole 
milking in the collecting jar; however, 32 were fore-milk samples collected 
by hand.
q) Confirmation by reference to catting data, A further 110 whole 
milk samples were obtained from cows in four commercial herdsi24 days 
after service and progesterone concentrations determined by EIA. The 
conclusions were subsequently verified from calving data.
d) Confirmation by palpation per rectum. The 29 cows involved in the 
oestrus synchronization experiment described previously (section 8.2.2.) 
were tested for pregnancy by progesterone determination:(EIA) of milk 
samples taken 21 - 25 days after first Al and subsequently at 8 weeks by 
palpation per rectum by a veterinary surgeon.
8.3 RESULTS
8.3.1. The Timing of Al: Comparison of Observed Oestrus with that Predicted
by Homologous EIA
A comparison of pregnancy rates following predicted and observed oestrus 
are shown in table 8.1. Examples of typical profiles of milk progesterone 
concentrations (farm B) determined by EIA and which formed the basis of the 
timing of Al in the experimental group are shown in Fig. 8.1. Of 82 cows 
in the experimental group, 80 were inseminated during the 30 day period of 
the trial and 50 gave positive pregnancy test results 24 days after insemi­
nation. Of the two animals not served,one was anoestrus and the other
failed to be inseminated although this was requested. In the control 
group, 58 of the 82 cattle were observed.at oestrus and inseminated during 
the same period: 39 were diagnosed pregnant at 24 days. There was thus
a gain in the number of cows in calf following intervention on the farms. 
Table 8.1 Number of Cows Served and Diagnosed Pregnant in Experimental
and Control Groups on Each Farm. Mean Calving to First Service 
Intervals are given in days.
Herd n
Experimental group
Pregnant on 
Served day 24
. Days to 
service n Served
Control group
Pregnant on 
day 24
Days to 
service
A 23 23 16 84-0 . 26 21 14 95-7
B 24 24 15 83-3 22 14 12 9 0 0
C 22 21 12 74-2 21 16 9 8 9 0
D 13 12 7 64-3 13 7 4 89-7
Total 82 80 50 78-3 82 58 39 91-7
(97-5%) (62-5%) (70-7%) (47-5%)
The intervals between calving and first service were recorded for each
cow: mean values for each herd showed significant decreases in the experi­
mental groups after logarithmic transformation to reduce the distortion 
resulting from long intervals in the control group.
Departures from the experimental protocol instigated by the stockmen 
necessitated re-allocation of animals before analysis of fertility data.
Of the 80 cows served in the experimental group, two were served twice as 
the stock man saw them bulling on a different day to that predicted: these
were excluded from further analysis. Ten cows in the experimental group 
were served at the stockman’s instigation and these were included with the 
control group for determination of conception rates resulting from insemin­
ation at either predicted or observed oestrus. One cow was served at pre­
dicted oestrus outside the 30-day study but was included, for the purpose 
of comparing fertility (table 8.2).
Thus, of the 69 cows served at the time predicted from progesterone
Table 8.2 Number of Cows Diagnosed Pregnant Following Service at Predicted
or Observed Oestrus
Herd Served
Predicted oestrus 
Pregnant on day 24 Days to service Served
Observed oestrus 
Pregnant on day 24 Days to service
A 18 13 86-1 25 17 90-2
B 24 15 83-3 14 12 78-9
C 18 11 72-7 19 11 85-4
D 9 5 64-5 9* 5 87-8
Total 69 .. 44 78-9 67 45 86-2
(63-8%) (67-2%)
* A tenth cow was served but was excluded from the analysis because the 24-day 
pregnancy diagnosis result was not available.
Fig» 8.1 Progesterone concentrations by homologous EIA determined in whole 
milk samples taken from individual cows on farm B. 0 Cow judged pregnant 
according to milk progesterone concentration 24 days after Al.
profiles, 44 (63.8%) were found to be pregnant by milk progesterone analysis; 
of the 67 cows inseminated at observed oestrus 45 (67.2%) were found to be 
pregnant (Table 8.2).
8.3.2. Use of the Heterologous EIA to Monitor Corpus Luteum Activity of 
Dairy Cows Following Treatment with Progesterone Releasing Intra- 
vaginal Devices (PRID) and Cloprostenol 
All cows showed patterns of milk progesterone concentration consistent 
with normal cyclic ovarian activity before treatment began (Fig. 8.2). The 
day of the cycle on which treatment began was defined retrospectively with 
the day of oestrus as the second day after the first measurement of a 
progesterone concentration below 5ng/ml milk. Profiles of progesterone concen­
trations suggested that during'treatment luteolysis occurred at the normal time: 
progesterone levels were maintained at between 5 to 15ng/ml until the day 
after PRID removal (day 8),, however, after which they declined within 24 hrs to 
levels consistent with the follicular phase (less than 2ng/ml) in all cows (Fig 8.2 
Milk progesterone levels were confirmed to be low for all cows on both 
days ( 9 and 10) on which Al was performed and for at least the following 
3 days. This was followed by rises in milk progesterone in 28 out of 
29 cows. On the basis of milk pregnancy testing at 21 to 25 days, 18/29 
(62%) cows were judged to have conceived to Al following synchronization.
The positive pregnancy tests were confirmed by rectal palpation 8 weeks 
after Al in 17 of the 18 animals; the remaining animal was sold. The 
pregnancy rate was 11/17 (64%) where PRID was inserted before day 11 of 
the cycle and 7/12 (58%) where treatment was begun after day 12 of the 
cycle. The pattern of progesterone rise in the 7 days following Al for 
cows which failed to conceive was similar to the pattern observed for the 
other animals and was consistent with the occurrence of ovulation and 
subsequent formation of a corpus luteum (Fig. 8.2). 
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Fig. 8.2 Progesterone concentrations in milk from individual cows follow­
ing initiation of treatment (day 0) at various stages of an oestrous cycle.
▼ PRID in, ▲ PRID out, v cloprostenol injection and ®  estimated day of 
cycle at initiation of treatment.
8.3.3. Heterologous EIA and Pregnancy Testing of Dairy Cows
a) Comparison with RIA. Progesterone concentrations determined in the 
200 milk samples by EIA and RIA and by RIA performed at the MMB were compared 
using linear regression equations calculated and corrected for error in both 
techniques as described previously (section 2.3.6): scatter was particularly
noti.able when high values were recorded. This was true when results from 
either the RIA or EIA were compared with those from the MMB RIA (r = 0.890 
and 0.833 respectively; Table 8.3). The MMB used 4.5ng/ml and l.Ong/ml in 
whole milk and fore-milk respectively to discriminate between samples from 
pregnant and non-pregnant animals at 22 - 26 days post-insemination. The 
comparisons above with concentrations determined at the MMB allowed equiv­
alent discrimination points to be determined for the RIA and EIA
Table 8.3 Regression of Results from EIA and RIA of 200 Milk Samples
Discrimination
r Regression F t point +  2  s.d.J
Whole milk (« =  168)
E IA  on M M B  R IA 0-901 y = 0-832* +  1-72 13 1 5-46 ±1-62
E IA  on R IA 0-838 y =  0-699* +  3-21 32-8
R IA  on M M B  R IA 0-905 y =  1-140* -  1-63 7-4 3-50 ±  0-69
Fore-milk (rt =  32)
E IA  on M M B  R IA 0-662 y =  1-579* -  0-555 15-6 1-02 +  0-31
E IA  on R IA 0-768 y =  1-365* +  0-815 2 0- 1
R IA  on M M B  R IA 0-901 y =  1-023* -  0-286 0-27* 0-74 +  0-15
All samples (« =  200)
E IA  on M M B  R IA 0-890 y =  0-831* +  2-00 15-3
E IA  on R IA 0-833 y =  0-702* +  3-36 38-6
R IA  on M M B  R IA 0-908 y =  1 -1 3 3 * -  1-45 8 - 2
•(■Calculated for the deviation from a line of identity: *not significantly different 
(P>0-25).
^Calculated from 4-5 ng/ml (whole milk) and 1 0 ng/ml (fore-milk) in the M M B  R IA  and 
standard deviations from the mean overall coefficients of variation observed in the 
individual assays (Table 3).
(Table 8.3). Results falling within two standard deviations of the dis­
criminating point were considered inconclusive. Excluding these, 129
samples were classified by the MMB RIA as indicating pregnancy and 63 non 
pregnancy. Conclusions from the EIA results coincided for 122 and 52
samples respectively, with 7 values in each case falling within 2 standard
deviations of the discriminating value. The figures from the RIA were 126
and 56, with 2 and 5 results inconclusive. Both the EIA and the RIA
produced 4 results that were at variance with conclusions drawn from the
MMB RIA and these are summarised in Table 8.4: three (no*s 145, 149, 154)
were fore-milk samples. Veterinary investigation of three of the five
apparent anomalies provided an indication of which conclusions were correct
(Table 8.4).
b) Comparison with palpation per rectum. In a separate experiment 
described in section 8.3.2., the milk progesterone determinations at 21 to
25 days post-AI showed 18 of 29 cows (62%) to have conceived following
oestrus synchronization. The positive pregnancy tests were confirmed by
Table 8.4 Progesterone Concentration (ng/ml) in Milk Samples Submitted to 
the MMB for which Different Conclusions were Reached on Repro­
ductive Status.
Sample no. M M B  R IA EIA R IA
Veterinary
examination
81 1-9 ( - ) 11-0 ( + ) 4-3 ( + ) Oestrus
108 3 0 ( - ) 7-3 ( + ) 5-1 ( + ) Luteal
145f 0-7 ( - ) 2-1 ( + ) 1-3 ( + )
149t 0-6 ( - ) 1-6 ( + ) 10 (?) Pregnant
154f 3-6 ( + ) 1-2 (?) 0 ( - )
tFore-milk samples
+  =  Luteal-phase or pregnant; — =  follicular phase; ? =  
within +  2 s.d. of discriminating level.
palpation per rectum 8 weeks after Al in 17 of the 18 cows: the other was
sold and further data were not available.
c) Confirmation using calving data. Calving dates were obtained from 
a further 110 cows in 4 commercial herds for which EIA had been used for 
pregnancy testing at 24 days after Al. Of 62 diagnoses of pregnancy, 58 
(93.5%) were shown to be compatible with subsequent calving data assuming 
a gestation length of 280 - 10 days (Salisbury and VanDemark , ,1961). The 
46 cows diagnosed non-pregnant were shown to have calved to a subsequent 
service, demonstrating that the conclusion was correct.
8.4 DISCUSSION
The progesterone concentrations determined through the oestrous cycle 
by the homologous EIA are illustrated by results obtained from cows in the 
experimental group in farm B (Fig. 8.1). The luteal phase concentrations 
were generally higher than those measured by RIA elsewhere (Hoffmann and 
Hamburger, 1973; van de Wiel et c&s 1978; Bulman and Lamming, 1979; Batra 
et al3 1980). Low.levels indicative of a return to oestrus were consist­
ently similar, however. The disparity seen at higher concentrations may
be explained in part by the different cross-reactivities exhibited when 
RIA and homologous EIA were compared using the same anti-progesterone 
Y-globulin preparation (see Sauer et al3 1982b, in reprint appendix). The 
higher levels may thus reflect the varying concentrations of other steroids 
during the oestrous cycle. This could also explain the detection of a 
transient peak of progesterone-like material around the time of oestrus in 
a number of cows (e.g. nos. 51, 247 and 251 in Fig. 8.1). The latter occur­
rences have been detected by others using RIA (Bulman and Lamming, 1979; 
Bloomfield, 1982); the nature of the substance, if not progesterone, has not 
been determined, however.
Although these anomalies did not affect the outcome of this particular 
application they raised serious questions as to specificity of the homolo­
gous assay. It was clear that this would not be acceptable where only 
single samples are taken (e.g. confirmation of follicular phase or preg­
nancy testing).
The results from the application of the homologous EIA suggested that the 
majority of cattle were fertile when inseminated three days after the 
regression of the corpus luteum had been identified by falling concentrat­
ion of milk progesterone. This conclusion confirmed the early work of Ball 
and Jackson (1979) who similarly determined the approach of oestrus by 
progesterone RIA but inseminated at both two and three days after the fall.
It may be implied that either most cows ovulate and are fertile at a 
closely defined time after natural luteolysis or that spermatozoa have a 
considerable life span after insemination. The results described here also 
suggest that the natural oestrous cycle can be monitored and successful 
insemination made at a time independent of behavioural observations. Under 
this procedure early indication may also be given of abnormalities of 
ovarian function that would preclude fertility.
The study employing the heterologous EIA to monitor corpus luteum
function during hormone treatment suggests that a short, seven day, treat­
ment with PRID combined with cloprostenol injection on the sixth day can 
achieve effective synchronization and satisfactory fertility in dairy cows 
following fixed time Al. Smith et al (1984) recently observed increased 
synchrony of oestrus with excellent fertility (70% pregnancy rate by pal­
pation per rectum) in heifers following a similar seven-day regimen in 
which prostaglandin was injected one day before PRID removal, compared with 
injection at the time of withdrawal. The uniformity of progesterone 
patterns about the time of insemination and the pregnancy rate achieved in 
this smaller group of cows is in full agreement with their work.
The use of the heterologous progesterone EIA enabled corpus luteum 
function to be clearly established throughout the treatment period. The 
erratic variations in progesterone concentrations observed occasionally 
using the homologous assay (Fig. 8.1) during the luteal phase and around 
oestrus in the oestrus prediction experiment were not observed for any 
animal in this study. This clearly indicated the greater reliability of 
the heterologous assays since the cyclic patterns and concentrations of 
progesterone in milk closely followed those established using RIA by other 
groups (Hoffmann and Hamburger, 1973; Bulman and Lamming, 1978; Batra et 
al3 1980) .
The combination of precision, specificity and accuracy demonstrated 
for the heterologous EIA allowed a ready distinction to be made between 
luteal and follicular-phase concentrations of progesterone in whole milk.
This was illustrated by the results obtained by assay of milk samples 
taken for pregnancy testing 22 - 26 days after service, although the correl­
ations between results from RIA and EIA for the 200 samples obtained from 
the Milk Marketing Board were lower (r = 0.890 for the MMB RIA and r = 0.833 
for the RIA performed here) than those seen when 25 milk samples were assayed 
here (r =0.933; Fig. 7.4a) as part of the validation study. The delay in
re-assaying samples may have allowed changes in the structure of milk to 
occur that affected the performance of the EIA more than the RIA. Some 
evidence is available for this since freshly prepared milk standards red­
uce binding in the calibration curve perceptibly more than standards 
prepared 1 month previously. This is a difficult phenomenon to investig­
ate as it would require that new standards be prepared from a fresh 
batch of milk whose composition may differ from the original and thus . 
allow no absolute control for the ageing process. Since milk samples 
submitted for assay will usually be of recent origin, it may be a wise 
precaution to renew milk standards at least at monthly intervals. This 
apparent difficulty did not, however, prevent a high degree of corres­
pondence between the conclusions drawn from the various assays. Such 
disparities as there were revolved around samples showing concentrations 
of progesterone near the discrimination points of the assays, so that one 
or other test was inconclusive. Only 5 samples (Table 8.4) produced res­
ults for which the deductions from the assays differed and 3 of these were 
fore-milk samples which have previously been shown to produce results that 
may be variable in some circumstances (Holdsworth, Booth, Sharman and 
Rattray, 1980). EIA of one of the two whole milk samples (No. 81) pro­
duced a value consistent with the luteal phase and was from a cow in 
which the occurrence of behavioural oestrus was confirmed by the veterin­
ary surgeon. Rectal palpation indicated that the other sample (No. 108) 
was correctly identified by EIA and RIA as being from a cow in the luteal 
phase. It remains possible that the single real discrepancy (No. 81) in 
this study represents detection of progesterone-like material seen in the 
earlier study (see section 8.3.1.). Preliminary investigations using the 
HPLC system described in section 7.2.If) indicated that sample No. 81 
contains a cross-reacting component which is more polar than progesterone: 
the backflush fraction of the sample extract produced considerable binding
Table 8.5 Potential Applications of the Heterologous Milk Progesterone EIA
APPLICATION SAMPLING PROTOCOL*
1. Establishing the onset of ovarian cyclicity At 7 day intervals, 
prior to day 42 post-parturn.
2. Estimating the period of oestrus (with At 2 day intervals,
observation of heat).
3. Prediction of optimum time for Al Daily from day 16 of the
(without observation of heat) i] oestrous cycle.
4. Confirmation of follicular phase pre-or Day of Al.
post-AI.
i) Assurance where oestrus behaviour is 
indistinct.
ii) Assessment of heat detection efficiency
At day 19 post Al and, if 
progesterone concentrations 
are high, every 2 days until 
day 25.
6. Pregnancy testing. 2 4 - 2 6  days post-AI.
7. To check phase of oestrous cycle prior to Day of intended treatment,
prostaglandin injection.
8. To establish precisely the stage of the 
oestrous cycle of donor and recipient 
prior to embryo transfer.
9. To estimate the efficacy of hormone At 6 - 10 days post-
treatment for superovulation. ovulation?
10. To enable assessment of ovarian At 7 day intervals,
dysfunction and objective administration 
of hormone therapy.
+
* day 0 = day of oestrus. For normally cycling cows, insemination on
the third day on which progesterone'concentrations are low (< 5.0ng/ml
whole milk) following measurement of high concentrations (> 5.0ng/ml).
? = to be determined.
Daily from day 16 - 17 of 
cycle prior to intended 
transfer.
5. Early detection of failure to conceive or 
maintain pregnancy prior to next oestrous 
period.
inhibition when assayed by EIA.
Calving data, however, obtained from a further 110 cows in 4 commercial 
herds, of which 62 were determined as producing a positive test result by 
EIA, showed no evidence of this phenomenon. The 4 cows that did not calve 
to the expected insemination returned to service and were re-inseminated 
31, 113, 160 and 161 days later. None of these intervals is compatible 
with a single cycle occurring after service and it is suggested that the 
luteal phase was prolonged in each of these cows. Similarly, no unexpect­
edly high values were seen during the follicular phase in the study 
(section 8.3.2.) in which oestrous cycles of 29 cows were monitored by EIA 
of milk samples taken each day.
These studies clearly indicate the value of the heterologous EIA in the 
m a n a g e m e n t  o f  reproductive performance of dairy cattle. Further applic­
ations are envisaged,many of which would be particularly appropriate if the 
assay was in a semi-quantitative form providing a visual end-point. Such 
applications are outlined in Table 8.5.
8.5 CONCLUSIONS
1. In cyclic cows, oestrus detection rates of 100 per cent may be achieved 
by monitoring milk progesterone concentrations. Using AI, the fertility 
of cows inseminated at oestrus periods predicted in this way is similar 
to that achieved at observed oestrus.
2. The homologous EIA was neither sensitive nor reliable enough for 
general application.
3. The heterologous EIA provided a fast, reliable and accurate means of 
pregnancy testing and monitoring corpus luteum activity.
CHAPTER 9:
GFNFRAI nTSCtJSSION. CONCLUSION AND PROSPECTS
CHAPTER 9. GENERAL DISCUSSION, CONCLUSION AND PROSPECTS
The present studies were aimed at providing a colorimetric direct EIA 
for progesterone in milk equivalent in performance to RIA. It was pre­
requisite that the assay be simple and sensitive enough to be adapted for 
use in a basic laboratory or in the farm office. Such a procedure would 
allow widespread application of the detailed knowledge of bovine reproductive 
physiology previously acquired through studies employing RIA.
These goals have been met as a result of the following achievements.
1. The synthesis of labels which were highly effective in EIA was made 
possible through the development of a new procedure enabling efficient 
condensation of steroid with enzyme without significant co-conjugation or 
denaturation of the enzyme. The procedure involved formation of an inter­
mediate N-hydroxysuccinimide ester of the steroid using dicyclohexylcarbo- 
diimide or disuccinimidyl carbonate. Such conjugates enabled, for the first 
time, development of a direct addition (homologous) EIA for progesterone in 
whole milk (see table 9.1).
2. The factors responsible for the poor sensitivity of the homologous EIA 
were thoroughly investigated. The most important of these were found to be 
the phenomenon of bridge recognition, the temperature at which the immuno­
assay was performed and the enzyme used as label. The problem of bridge 
recognition was solved by use of bridge heterology. A new approach was 
demonstrated to be highly effective and involved substitution of a glucuronide 
bridge for a hemisuccinate bridge to link the steroid and enzyme while 
retaining the progesterone lla-hemisuccinate antiserum: the improvements
in sensitivity derived were independent of the antiserum or enzyme label 
used. This had not been demonstrated for any other heterologous combination. 
It seems probable that the same bridge combination would prove useful for 
the EIA of other steroid hormones.
The use of efficient labelling procedures,optimized molar ratio of steroid
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enzyme at conjugation and optimized methods of antibody adsorption to microtitre 
plates enabled practical and economic benefit to be derived from the 
increased sensitivity achieved by performing EIA at ambient temperature 
rather than 40°C. It was previously necessary to use a high incubation temp­
erature (40°C) in order to ensure adequate label binding.
Alkaline phosphatase and penicillinase had not previously been used as 
labels in the EIA of progesterone and in these studies provided the most 
sensitive and suitable procedures. Of the four enzymes investigated,the 
assay for B-galactosidase was least sensitive. Difficulties in the efficient 
formation of heterologous conjugates with peroxidase, in combination with 
the potential toxicity associated with its assay, militated against further 
evaluation of its use in EIA. Alkaline phosphatase was selected for further 
development since, unlike penicillinase, a chromogenic substrate was avail­
able which greatly facilitated the enzyme assay. The optimum molar excess 
of steroid required for conjugate formation was dependent upon the enzyme 
used: it is. suggested that this is related to the relative accessibility
and reactivity of particular lysine e-amino residues. In contrast with 
conventional dogma, steric considerations dictate that the optimum molar 
incorporation ratio of steroid in a particular enzyme might not be 1:1, but 
will be influenced by the location and orientation of the most reactive 
residues as this will influence their subsequent ability to. bind with anti­
body.
3. Although microtitre plate wells have provided a convenient immuno­
sorbent for the determination of antigen and antibody concentrations in 
ELISA7their application to hapten EIA had not been established at the 
start of these investigations and is only now becoming accepted (Sauer et 
al3 1981; Foulkes et at3 1982; Sauer et al3 1982b; van de Wiel and Koops,
1982; Munro and Stabenfeldt, 1984; Tallon et al3 1984; Cleere, Gosling,
Morris et dl3 1985; Sauer, Foulkes, Worsfold and Morris, 1986). The
particular contributions made to the use of microtitre plates has been in 
establishing optimum conditions for passive adsorption of antibodies to the 
well surface and in demonstrating that this system is precise and accurate 
enough to allow quantitative determination of haptens.
The optimum molarity and pH of the buffer established for antibody, adsor­
ption (0.17mM acetate buffer, pH 5.0) was far removed from those generally 
used elsewhere (0.05M carbonate buffer, pH 9.6) and stressed* the importance 
of assessing optimum conditions for the adsorption of particular antibodies 
and antigens. At pH 4 - 5  Y~globulin would be expected to have a net 
positive charge facilitating coulombic (electrostatic) attraction to the 
well surface prior to the establishment of hydrophobic binding. Pre­
washing wells with detergent significantly increased the degree and precision 
of adsorption to polyvinyl. These conditions promoted more economic use of 
antisera and made possible more rapid assays .by increasing the quantity of 
antibody adsorbed. Cleere et al (1985) have shown that the degree and 
precision of adsorption of antibody can also be achieved by addition of 
progesterone antibody (rabbit) to wells pre-coated with anti-rabbit-IgG 
antibody.
4. The validity of the heterologous milk progesterone EIA has been estab­
lished: precision, sensitivity, analytical recovery and linearity of 
response of the assay compared favourably with RIA and other procedures 
described for milk progesterone EIA (table 9.1).
The EIA of progesterone isolated from milk enabled the specificity of 
the assay to be assessed. The ODS column method used for steroid extraction 
offered practical advantages over solvent partition procedures. The high 
resolution HPLC system developed enabled isolation of progesterone from 
milk extract in at least one tenth the time described in other procedures 
of comparable resolution.
5. The majority of EIA procedures previously employed for the assay of
progesterone in milk involved prior extraction of milk or a milk fraction 
(see table 9.1) and with one exception (van de Wiel and Koops, 1982), are 
homologous procedures, lacking sensitivity and offering few practical 
advantages over RIA.
The direct, heterologous microtitre plate EIA described in abstract by 
van de Wiel and Koops (1982, see table 9.1) and the heterologous assay 
described here show very similar specifications. More recently, Cleere et 
at (1985) have described a direct homologous microtitre plate assay of 
comparable performance, demonstrating that bridge recognition may not be a 
problem with particular antisera. The EIA described by van de Wiel and 
Koops (1982) provides an end-point (red/brown colour) giving a visual 
distinction between samples from different stages of the oestrous cycle and 
providing a semi-quantitative test. Although this can be achieved with the 
present test,the yellow end-point is not ideal and use of alternative 
chromogenic substrates such as described by McComb, Bowers and Posen (1979) 
could resolve this point.
6. The homologous EIA demonstrated the practicality of applying milk 
progesterone EIA on the day of sampling although unexpected results were 
found during the follicular phase. The heterologous assay eliminated this 
problem and proved to be as reliable as RIA when used for monitoring corpus 
luteum function in dairy cattle and for pregnancy testing. Practical 
applications envisaged for the assay are shown in Table 8.5. Some of 
these applications are relevant to the management of reproduction in 
sheep and pigs and preliminary studies indicate that the heterologous 
procedure may be readily adapted to the assay of whole blood and plasma 
samples from these species.
The heterologous EIA was designed for the assay of large numbers of 
samples (^ 30 - 150 samples per.day, assayed in duplicate) and the time 
taken for its performance 5 hours) reflects this. For smaller numbers 
of samples, shorter assay times could, be accommodated largely by increasing 
the mass of conjugate and the volume of milk used.in the assay .although 
this would involve a^compromise with assay sensitivity.
Adaptations of the heterologous assay have enabled quantitative and 
semi-quantitative visual tests’to become commercially available for use on- 
farm or at the veterinary practice: practical aspects of these tests, when
used by farmers,are currently being evaluated (B. Drew and P. Lane, personal 
communication) and trials are in progress aimed at providing an analysis of 
the cost benefits of the test when used regularly as part of a breeding 
management programme (B. Drew and J.A. Foulkes, personal communication.)
It must be recognised that problems will arise when the test is used for 
other than oestrus confirmation or pregnancy testing by individuals not 
conversant with the endocrine changes which form the basis of the particular 
application. In these circumstances, consultation with an informed veterin­
arian or livestock advisory officer would resolve the problem. In the 
longer term,the institution of courses within the regular curriculum at 
agricultural colleges would be appropriate. This would also ensure that 
new generations of dairy farmers are aware of how best to achieve the commer­
cial benefits arising from the close control of fertility.
EIAs such as developed in these studies are currently the most suitable 
and convenient means of progesterone assay for use in non-specialized lab­
oratories or on the farm; however, developments towards faster procedures 
involving fewer steps are inevitable. Alternative non-isotopic immuno­
assays involving luminescence or fluorescence measurements may provide equiv­
alent or greater sensitivity (Collins, 1984) but require sophisticated
equipment.
Simplification of EIA could be achieved by development of label dis­
placement EIA (use of pre-formed antibody-bound label) or homogeneous EIA, 
although existing procedures are generally of insufficient sensitivity for 
the present application. As hybridomas become increasingly used for anti­
body production, however, rapid screening techniques will improve the 
possibility of finding antibodies with properties which best suit these 
assay systems.
Other forms of immunoassay such as those based on the agglutination of 
gold sols (Leuvring, Thai, White and Schuurs, 1981) or release of liposome 
entrapped dye (OrConnel, Campbell, Fleming et al3 1985) will enable a 
visual end-point to be achieved without the use of enzymes but again,require 
further development to provide adequate sensitivity.
Ideally, however, progesterone determination would be made directly in 
the milk collection jar without intervention by the dairyman. The indicat­
ions are that biosensor technology may eventually provide such a procedure 
since the principle of using changes in evanescent wave patterns generated 
in coated optical sensors to detect molecular interactions (e.g. between 
antigen and antibody) has already been established (Albery, Hagget and 
Snook, 1986): such a system would have no requirements for labelled analyte.
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APPENDIX 1. THE MATERNAL RECOGNITION OF PREGNANCY.
In all mammals studied, progesterone is essential for the maintenance 
of early pregnancy and in most species, including the cow (Hawk, Brins- 
field, Turner, Whitmore & Norcross, 1963) it is also pre-requisite for 
the implantation or attachment of the conceptus (Davis & Ryan, 1972).
In cattle the continued presence of circulating progesterone is 
achieved by cessation of cyclic activity through prolongation of the 
lifespan of the corpus luteum formed in the cycle of conception. The 
means by which this is brought about has not been established: the 
corpus luteum of the cow is not simply retrieved by a foeto-placental 
luteotrophin as appears to be the case with primates (see Perry, Heap, 
Burton & Gadsby, 1976). Nevertheless, luteal maintenance is dependent 
upon the presence of the conceptus in the uterus since the cow does not 
undergo pseudo-pregnancy in the absence of conception after mating. From 
evidence derived from sheep, it would seem that if gonadotrophins 
originating from the conceptus do arise around this time their role may 
well be secondary to that of the pituitary hormones since hypophysectomy 
in early pregnancy promptly leads to the demise of the corpus luteum 
and pregnancy failure. (Denamur & Martinet, 1961; Denamur, 1968; Heap 
et al, 1979).
Although the nature of the signal emanating from the conceptus remains 
to be determined, a pattern of events associated with the maintenance of 
corpus luteum activity during early pregnancy has emerged.
A significant increase in plasma progesterone concentration in pregnant 
compared with non-pregnant cattle has been reported from as early as day 9 
after oestrus (Henricks, Lamont, Hill & Dickey, 1975; Bulman & Lamming, 
1978; Lukaszowska & Hansel, 1980) and the decline in concentrations 
normally seen by day 17-18 of the cycle does not occur (Shemesh, Ayalon 
& Lindner, 1968; Hansel & Echternkamp, 1972).
It has been shown that transfer of embryos (Betteridge, Mitchel, 
Englesome & Randall, 1976; Betteridge, Randall, Englesome & Sugden, 1984), 
embryonic homogenates (Northey & French, 1980), trophoblastic vesicles 
(Heyman, Camous, Meziou & Martal, 1984) or trophoblast cells (Plante, 
Bosquet, Guay & Goff, 1984) into the uterus of cyclic cows can result in 
extension of the lifespan of the corpus luteum. The embryonic signal
resulting in maintenance of luteal activity must, however, be present
prior to day 17 as shown by the transfer of bovine embryos to cows at
different stages of the cycle (Betteridge et at, 1976) and by flushing
embryos from the uterine tracts of cows at different stages of pregnancy 
(Northey & French, 1980; Dalla Porta & Humblot, 1983; Humblot & Dalla 
Porta, 1984).
Current 'in V'itro evidence indicates that the conceptus may exert a 
direct luteotrophic effect on the corpus luteum: conflicting data may 
perhaps be related to differences in sensitivity and specificity of the 
means of assessment. Using the rat seminal vesicle bioassay, Foster (1956) 
failed to show gonadotrophic activity in the blood and urine of pregnant 
cows. Lunnen & Foote (1967), however, showed a significant response in 
the rat ventral prostate bioassay with extracts of bovine maternal plasma 
and foetal cotyledons. Human chorionic gonadotrophin (HCG)-like activity 
has been detected in day 16 bovine blastocysts using a radioreceptor 
assay (Shemesh, 1980) and in maternal and foetal cotyledons using a 
radioreceptor assay or rat heydig cell and bovine granulosa cell bioassay 
(Ailenburg Si Shemesh, 1983). Similarly, Beal, Lukaszewska & Hansel (1981) 
have demonstrated the ability of day 18 bovine blastocyte homogenates and
extracts to stimulate progesterone synthesis by dispersed bovine luteal 
cells. The latter study indicated that the luteotrophic substance(s) 
was heat labile and since it had a molecular weight (by dialysis) less 
than 12,000 daltons that it was not LH. Subsequent studies by Henricks 
8s Poffenbarger (1984) using a highly specific mouse heydig cell bioassay 
confirmed that day 16-20 bovine conceptus do not contain LH activity or 
form it on incubation.
The corpus luteum is still capable of synthesizing progesterone 
■in V'i'tvo in response to incubation with LH at day 18 of the cycle as it 
is in pregnancy, indicating that it is not increased responsiveness to 
LH which is directly responsible for luteal maintenance (Lukaszowska 8e 
Hansel, 1980).
No clear pattern has yet emerged to indicate whether a luteotrophic or 
antiluteolytic signal is operating in vivo or whether such a signal 
operates directly on the corpus luteum or via the uterus or any 
combination of these routes. It is apparent, though, that at least part 
of the effect of the conceptus is expressed locally since the corpus 
luteum is more readily maintained on the side ipsilateral rather than 
contralateral to an isolated gravid horn (Del Campo, Rowe, French & 
Ginther, 1977; Ginther, 1981). Given the localized counter current 
mechanism described earlier for luteal regression it is to be expected 
that one of the factors involved in luteal maintenance would be of 
low molecular weight, lipid soluble (ease of diffusion through blood 
vessel walls) and rapidly metabolizable (localization of effect), - 
as is the luteolysin PGF2a*
It is thought that uterine release of PGF201 is responsible for 
luteolysis during the oestrous cycle. It appears that day 18 pregnant 
cows show diminished endometrial secretion of PGF201 (Lukaszowska &
Hansel, 1980; Thatcher et at, 1984) but it is not clear whether a 
mechanism involving depression of PGF201 concentrations reaching the 
ipsilateral corpus luteum via the ovarian vein occurs and is operating
in the prevention of luteolysis. Although Lukaszowska and Hansel (1980) 
found no differences between ovarian, arterial and jugular vein concentra­
tions of PGF20C, Thatcher et at (1984) found evidence for a small net 
reduction in ovarian arterial concentration in pregnant compared with 
non-pregnant cows.
Recent evidence has indicated a possible role for prostaglandins in 
abrogating the luteolytic influence of PGF20t in early pregnancy in cattle. 
These findings are in keeping with previous observations in various 
tissues that the different classes of prostaglandin such as the F and E 
series appear to have opposing effects in the same tissues (Kuehl, Cirillo, 
Hams & Humens, 1973). Work in sheep initially indicated that PGE2 may 
antagonize the luteolytic action of PGF201 in vivo and thus potentially 
act as an antiluteolysin (Henderson, Scaramuzzi & Baird, 1977; Pratt,
Butcher & Inskeep, 1977) and that higher concentrations of PGE2 are 
present in the utero-ovarian venous plasma of pregnant rather than non­
pregnant sheep at the time of maternal recognition of pregnancy (Silvia, 
Ottobre & Inskeep, 1984).
A similar function is plausible in cattle since secretion of progesterone 
by bovine luteal tissue in vitro is stimulated by PGE2 (Marsh, 1970) and 
intra-uterine infusion of PGE2 between days 9-21 of the cycle results in 
extension of corpus luteum function and in delayed onset of oestrus 
(Chenault, 1983; Gimenez & Henricks, 1983). The demonstration that bovine 
embryos possess a considerable capacity for the synthesis and secretion 
of PGE2 (Shemesh, Milaguir, Agalon & Hansel, 1979; Lewis, Thatcher, Bazer 
8s Curl, 1982) introduces the attractive theory that such secretions may 
be involved in a local pathway resulting in the maintenance of the function 
of the ipsilateral corpus luteum. Reports by Kimball and Lauderdale (1975) 
and Milvae and Hansel (1980) on the ability of PGEj and PGI2 respectively 
to increase plasma progesterone concentrations when administered in  vivo, 
however, serve as a caution as to the validity of such a theory 
given the lack of specificity of the prostaglandins in this effect.
In the pig, it is thought that oestrogens produced and secreted by 
the blastocyst play a major role in corpus luteum maintenance. Evidence 
has been compiled suggesting that blastocyst oestrogens may operate at 
the level of the uterus, the ovary and the hypothallamus or pituitary. 
Oestrogens have been shown to produce an antiluteolytic influence at 
the level of the uterus involving inhibition of secretion of PGF201 into 
the uterine vein. Additionally, luteotrophic affects have been demonstrated 
which may involve direct antagonism of the luteolytic influence of PGF20C 
in the corpus luteum, stimulation of LH release from the pituitary or both 
(see Heap, Flint & Gadsby, 1979).
It seems that blastocyst oestrogens are unlikely to play a similar 
role in pregnancy recognition in cattle,however. Although the bovine 
conceptus is capable of metabolizing steroids such as progesterone and 
androstenedione (Gadsby, 1982), conversion into oestrogens in vitro 
appears to be minimal when comparisons are made with porcine blastocysts 
(Shemesh et at, 1979; Gadsby, 1982; Eley, Thatcher, Bazer & Fields, 1983).
A direct luteotrophic effect of conceptus. oestrogens seems improbable, 
since, in contrast with the sow, administration of oestrogens during the 
bovine luteal phase results in shortening of the lifespan of the corpus 
luteum (Wiltbank, Ingalls & Rowden, 1961; Eley, Thatcher & Bazer, 1979).
Oestradiol levels have, however, been shown to be elevated in the 
uterine lumenal fluid and in uterine venous blood at the time of pregnancy 
recognition (Ford, Chenault, Christenson, Echternkamp & Ford, 1981). They 
may be responsible for the transient increase in uterine blood flow 
occuring at this time and which is associated only with the uterine horn 
containing the conceptus (Ford, Chenault 8c Echternkamp, 1979). It has 
been suggested that this effect may function to enhance transport of 
luteotrophin to the ovary bearing the corpus luteum.
Although numerous proteins or macromolecules have been isolated which 
are secreted by the bovine conceptus or temporarily associated with this 
critical early stage of pregnancy (Roberts 8s Parker, 1976; Laster, 1977;
Butler, Hamilton, Sasser, Ruder, Hass & Williams, 1982; Masters, Roberts, 
Lewis, Thatcher, Bazer & Godkin, 1982) they have not been demonstrated 
to influence ovarian function,nor has any other particular function 
been ascribed to them.
APPENDIX 2. BASIC PROGRAMMES FOR COMMODORE PET 2001 SERIES MICROPROCESSOR. 
Calculation of weighted linear regression with errors in X and Y.
i) Linear regression analysis: calculation of regression of X on Y then Y on
READY.
10 OPEN3', 4
12 PRINT" INPUT NO. OF PAIRS" INPUTS
15 DIMA<S)sDIME<S>sDING(S)sDIMD<S)
16 DIME <S) s DIMF (S).s DING (S) : DIMM (S) ; DIMR (S)
50 F0RN-1T0S2 PRINT"INPUT X , Y "sINPUTA(N),RCN) 
100 B-B+A (N ) s T—T-i-R (N )sC( N ) -A C N ) *.R (N ) s D-D+C (N )
150 E<N)=A<N)A2 : F = F + E < N)sG(N)=R€N)H=H+G< N)
200 NEXTN
250 I=(B*T)./Ss j=F-< (B--2) /S)
300 K-H~ ( (T--2) /S > s L- (D-- I) / ( (J-*|<) •-•0. 5)
350 M=<D-I.)/(F-((BA2)/S)) sN=(T-(M*B))/S 
361 F0RAC=1T03sPRINT£32NEXTAC
400 PR I NT "CORP. CQEFF„ ~"Ls PRINT£3, "CORR. CQEFF.— "L 
410 PRINT"SLOPE-"M :PRINT£3,"SLOPE-"M 
420 PRINT"INTERCEPT-"N s PRINT£3,"INTERCEPT-"N 
430 PRINT£3,
440 PRINT£3,
1120 PRINT 
READY.
ii) Weighted linear regression: calculation of corrected slope b) and 
intercept a).
READY.
2 0PEN3 4
5 PR I NT " REGRESS I ON WITH ERROR I N X St' Y "
7 INPUT"COMPARISON"; T$
10 INPUT"S.D.Y"?SY:VY-SY-2
20 INPUt"S.D.X"sSXsVX=SXA2
30 L=VY/VXsPRINt"L=--"L
40 INPUT"SLOPE Y ON X " ;;B1
50 INPUT"SLOPE X ON Y "5B3 s B2-1/B3
60 N 1 -(B2” (L/Bl))
70 N2- (N 1 + ( (4#L) -1- < N 1 •-•2) ) •" 0. 5) / 2 
80 PRINT"CORRECTED SLOPE-"N2 
90 I NPUT "MEAN X"i|X 
100 INPUT"MEAN Y" ; Y 
110 A-Y— (N2-X-X)
120 PRINT"INTERCEPT-"A 
130 PRINTA"="Y"-<"N2"*"X")"
132 PRINT£3,T$
133 PRINT£3,"CORR SL0PE-"N2,"CORR IMT-"A 
140 G0T05
READY.
APPENDIX 2. (cont.).
iii) Compatibility of weighted regression of methods with the line of 
identity (slope = 1, intercept = 0 ).
READY.
4 0PEN3 4
5 p r :s:n t ''f t e s t  f o r  l i n e a r i t y 1
6 PRINT£3, "F-TEST FOR LINEARITY1
7 I NPUT11CDMPARI SON11; TT
10 I NPUT11CORRECTEID SLOPE112 BL
20 I NPUT1 CORRECTED I NTERCEPT1 ? A
22 INPUT'S.. D. X"?SX
25 I NPUT11S „ D . Y"?SY
30 I NPUT1 NO . OF POI NTS112 N 1
35 T-OsSS-OnP-OsRR-O
40 F0RN-1T0N1 :
50 I NPUT11X Y 1 s X h Y
65 S=( <SY--2) + < (BL--2) (SXx-2) ) )
70 S S = ((<(Y - (X*BL) ) -A)A2 )/S )
95 R= ( (SY--2) + ( (1 •"••2) * <SX22) ) )
100 RR- ( ( ( < Y~ ( X* 1 > ) -0) -"•2 > /R )
104 T—T-i-SS
105 P=P+RR 
110 NEXT
120 F I - ((P-T)/2)
130 F2=(P/(Nl-2))
135 F-F1/F2
140 PR I NT " F= 11F , 11DF-2L11N 1 -2 
150 I NPUT11SIGNIFICANCE- 115 ST 
160 PRINT£3,TT
170 PR I NT£3, “ F=11F , 11DF-2& " |\|-2, ST 
ISO G0T07 
READY.
APPENDIX 3. BASIC PROGRAMME FOR COMMODORE PET 2001 SERIES MICROPROCESSOR.
Calculation of progesterone concentrations in samples using a four parameter 
logistic function (Rodbard, 1978).
READY/-.
2 PRINT" DATA STORE
3 PRINT" 7777777777
5 DIM A (12,9)sDIMZ <10,10)s0PEN2,6:PRINT"DATE"
6 I NF'UTDT x PR I NT " FILE NO " s IMPUTF
7 PRINT"BLANK ON ZERO AND RUN PLATE READER 
10 DIMD9(12)
20 BET£2 , ATs IFA7-"M"THEN50 
40 G0T020
50 PRINTATssF0RN-6700T08175
60 GET£2 . AT s A—ASC (A T ) s POKEN, A
80, IFST02THENPRINTAT? s NEXTNs GOTO 100
85 GOTO60
100 REM REMOVE OR
180 K=0sF0RN-6700T08160s A-F’EEK(N) s IFA-13THEN300 
190 P O K E (15200+K) ,As K-K+l 
300 NEXTN
305 REM REMOVE LETTERS
310 FORM-152007016555s A-PEEK(NTsIFA>64THENA-A~16
320 POKEN,AsNEXTN
355 FORN— 1521OTO16540STEP14
360 A-PEEK(N)siFA-32THEND1-0:6070380
370 Dl-A-48
380 D2—PEEK(N+1)-48 s D3-PEEK(N+3)-48
400 A-PEEEK (N+8) : IFA-32THEND8-2s G0T0470
410 D4-PEEK (N i-8) -48 s D5- (PEEK (M-i-10) -48) / 10
420 D 6 - (PEEK(N+11)-48)/100 s D 7 - (PEEK(N+12)-48)/1000
460 D8—D4+D5-I-D6-I-D7
470 D9-D1*10+D2
475 IFD8-2THENPRINTD9""D3 " OVER"sG0T0485 
480 PRINTD9""D 3""DS 
485 A(D9,D3)—DS
490 NEXTN '
500 PRINT"CONNECT.UP PRINTER THEN TYPE CONT"sSTOP 
505 D-0:Dl-OsD2=0sD3-0sD4=0sDb—0 
507 0PEN3,4
510 A - (A (1,2)+A (1,3))/2 
520 Z (1 , 2) - (A (1 ,4) -HA (1,5) ) /2 
530 Z (2,2)-(A (1» 6)+A (1,7))/2 
540 Z (3,2)=(A<2,1)+ A (2,2))/2 
550 Z(4,2)-(A(2,3)+A(2,4))/2 
560 Z (5 2). - (A (2 , 5) + A (2 , 6) ) /2 
570 Z (6,2)— (A (2,7)+A (2,S ))/2 
575 F0RN-lT06sREAD Z(N,1)
580 Z<N,3)=Z(N,2)-D 
590 Z(N,4)— Z (N ,3)/A 
600 Z (N ,5)-LOG(Z (N ,4)/(1-Z (N ,4)))
610 Z (N ,6) -LOG ( Z (N 1) )
620 Z (N,7)-Z (N,5)--2 
630 Z (N,S)-Z (M,6) •-•2 
640 Z(N,9)=Z(N,5)*Z(N,6)
650 Dl-Z (N , 6) +D1.
660 D2-Z(N,5)-i~D2 
670 D3-Z(N;8)+D3 
680 D4-Z(N,7)+D4 
690 D5-Z(N„9)+D5 
695 D6-D1/N:D7-D2/N 
700 NEXTN
730 El-D3~( (D1--2)/6)
790 E2-D4- ( (D2--2) /6)
APPENDIX 3. (cont.).
800 E3—D5~ < <Di*D2> /6‘)
810 B 1 =E3 /E 1 s C 1 --D7- (B 1 *D6) s B2==—B 1
.820 F’RINT£3, "&&&&&&&"D$"&&&&&&&&&5FILE$“F *&&&&&&&&&&" '
831 PRINT£3,"D1="D1"D2^"D2"D3="D3"D4="D4
832 PR I NT£3 , " D5= " D 5 1 D6= " 06 " D 7~ " D7
833 PR I NT£3, " E T=11E 1 " E2= " E2 " E3=11E3 
835 PRINT£3 n"A="A
840 PRINT"BETA="B1 , "B="B2s PRINT.£3, "BETA="B1 „ "B="B2 
860 PR I NT " Y=,! B 1 " X+ " C 1 s PR I NT£3 , " Y = " B 1 " X + " C 1
870 C2=(O-Cl)/Bis C3=EXP(C2)s PRINT"C="C3s PRINT£3,"LN C“ "C2,"C="C3
900 C4--E3/ ( (E1-X-E2) ■'■•0. 5) s F‘RINT£3, "CORR. C0EFF=,,C4
910 PR I NT " X " v11EXF'T -Y " , 1 DBS—Y " s PR I NT£3 M " X " , " EXPT-Y " , " OBS--Y "
915 DEF FNA (V) = (A-D) / ( 1+ ( (V/C3) •'•B2) ) +D 
920 F0RN=iTG7s Y <N> =FNA (2(N„ 1) )
930 PRINT£3.-Z (N. 1) ..Y(N) ,Z<N,2) :PRINTZ(N, 1) ,Y(N) ,Z(N.2)
950 NEXTN ~
960 DEF FNB (V) = ( ( ( ( (A-D) / (V-D) ) -1) < 1VB2) ) *C3)
965 PR'IMT£3 , "0* Dl&O. D2&M* □» D&DQSE&&&&& (NG/ML) "
970 !<=-1
980 FORN1 = 1TO12 s FGRN2=1T07STEP2
0 0 5  j.; ~.j_
1000 P 1 - A (N 1 , M2) s P2=A <N 1 , N2.+1) s M 1- (PI +P2) /2 
1010 IFM1< 0. 001THEN2000 
1015 IFM1-ATHEN2100 
1017 IFM1>ATHEN2200
1020 M2=FNB(M 1)sIFM2>2540THENM2=2550sIFM2<0THENM2=0
1021 PR I NT£3, P 1 " " F‘2 " " M 1!i " N2 " " N2/ 10 
1023 POKE(17000+K),N2/10
1025 NEXTN2 s MEX TN1
1090 PR I NT "LOAD1 CON FILE" AND ENTER COW NUMBERS"
1100 STOP .
2000 G0SUB3000!GOTO1025 
2100 GOSUB3100 sGOT01025 
2200 G0SUB3200sGOTO1025 
2300 G0SUB3000 s GOTO1080 
2400 G0SUB3100 s GOTO1080 
2500 60SUB3200 s GOTO1080
3000 PRINT£3,Pi""P2""Ml"""0.D=0"sRETURN 
3100 PRINT£3,P 1""P2""M 1"""D0SE=0" : RETURN 
3200 PRINT£3,P 1""P2""M 1"""DOSE<0"s K=K+1s RETURN 
5020 DATA 10,20,50,100,300,800 
READY*
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ABSTRACT
A sensitive enzymeimmunoassay has been developed for measuring progeste­
rone in unextracted bovine milk. An N-hydroxysuccinimide ester of 1 1 «*■ 
-hydroxyprogesterone 1I-hemisuccinate has been synthesised and used to 
form conjugates with p-galactosidase in buffer at pH 7.0. The degree of 
incorporation of progesterone into the enzyme was demonstrated using 
(1“^ -labelled steroid and by radioimmunoassay binding inhibition. 
Standard curves of comparable range and sensitivity to radioimmunoassay 
were obtained in the presence of whole milk taken from a cow at oestrus. 
These advances have allowed the development of a simple micro-titre 
plate enzymeimmunoassay of progesterone in whole milk and will be of 
particular value in determination of pregnancy, prediction of the day of 
oestrus and diagnosis of reproductive disorders.
INTRODUCTION
Radioimmunoassay (RIA) is widely used for determination of picogram 
quantities of steroid hormones in blood and milk but has remained confi­
ned to specialised laboratories. The concentration of progesterone in 
bovine milk has been used for prediction of the oestrus period (1) and 
in commercial diagnosis of pregnancy (2). Progesterone determination by 
enzymeimmunoassay (EIA) provides a simple procedure for examination of 
reproductive status requiring only a colorimeter for quantitation and 
presents the possibility of widespread application by eliminating radio­
isotopic hazards. If full advantage is to be'taken of such techniques 
and for large numbers of assays to be practicable, measurements must be 
possible without the need for prior extraction of steroids. EIA proced­
ures previously employed for steroid determination have not convincingly 
demonstrated their suitability for use in direct assays (3-5). Synthesis 
of an N-hydroxysuccinimide ester of 1 1 °**-hydroxyprogesterone 1 l-hemisucc- 
inate (1 I0** -hydroxy-4-pregnene-3, 20 dione 1 1-hemisuccinate) has enabled
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ready formation of well characterized progesterone-Ji-galactosidase conj­
ugates at pH 7.0 and eliminated side reactions associated with some 
conjugation techniques (6, 7). Conjugates produced by this mild and 
efficient procedure have allowed the development of an EIA for progeste­
rone in the presence of whole milk with standard curves of a sensitivity 
and range comparable with those obtained using RIA. This advance has 
enabled the technique to be further adapted to provide a simple micro 
-titre plate EIA for determination of progesterone in unextracted bovine 
milk.
MATERIALS AND METHODS
Preparation of 11°*--hydroxyprogesterone 1 1-(*^C)-hemisuccinoyl N-hydroxy 
-succinimide ester.
1 1 -Hydroxyprogesterone (330mg) , succinic anhydride (lOOmg), (*^C)- 
succinic anhydride (50mCi; 80-120mCi mmol-*; Radiochemical Centre, 
Amersham) and dried pyridine (300ix£) were heated in a loosely-capped 
conical glass test-tube on a sandbath at 90°C for 24 hours. The tarry 
residue was taken up in methanol (2ml) and evaporated at 90°C under a 
stream of nitrogen for 1 hour before extraction and crystallization of 
1 -hydroxyprogesterone (*^C)-11-hemisuccinate ("progesterone (*^C)~ 
hemisuccinate") from ethanol: water (70:30 v/v) (8). Following recryst­
allization, the "progesterone (*^C)-hemisuccinate" (43mg) was dissolved in 
dioxane (1ml) and N-hydroxysuccinimide (12.5mg) and dicyclohexylcarbodi- 
imide (23.8mg) added. The mixture was stirred at 25°C for 30 min and the 
by-product dicyclohexylurea removed by washing through a sintered glass 
funnel with 3 x 3ml dioxane. The clear filtrate was dried under a stream 
of nitrogen and the residue dissolved in a minimum volume of dichlorome- 
thane at 35°C. Addition of cold diethyl ether allowed crystallization 
of the 1 l«<-hydroxyprogesterone 1l-(*^C)-hemisuccinoyl N-hydroxysuccini­
mide ester. A melting point of 195 to 197°C was found after recrystalli­
zation and a molecular weight of 528.27 determined for the M + 1 ion by 
mass spectrometry using NH3 chemical ionization. The formula was confirmed 
at C29, H37, N, Os by elemental analysis (Dr F.B. Strauss, Microanalytical 
Laboratory, Oxford).
Preparation of progesterone-ft-galactosidase conjugates
^-Galactosidase (EC 3.2.1.23; Sigma type VI) was dialysed against 1,000 
vols 0.1M phosphate-buffered saline (pH 7.0) at 4°C to remove ammonium 
sulphate. Aliquots (I00fi£) containing 2.8mg protein ml-1 were placed in 
glass test-tubes and the N-hydroxysuccinimide ester of"progesterone (*^C) 
-hemisuccinate"in dimethylformamide added (1 0|i£:concentration range 60mg 
ml-* to 60ng ml “*. This provided molar ratios of progesterone to enzyme 
varying from 2,000 to 1 to 2 to 1. The reaction was allowed to proceed
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with stirring at room temperature for 1 hour. Conjugates were exhausti­
vely dialysed against three changes of three litres of 0.1M phosphate 
-buffered saline containing sodium azide (0.1% w/v) at pH 7.0 (PAS 
buffer) at 4°C before elution from 10 x 1cm columns of G25 Sephadex 
with PAS buffer to ensure removal of any remaining traces of unconjugated 
progesterone. The passage of conjugate at an elution volume of approxi­
mately 4ml was detected by absorbance at 280nm using a Cecil Spectro­
photometer with a flow cell fitted.
Determination of incorporation of progesterone into p-galactosidase
The protein content of the conjugates was measured (9) and their enzyme 
activities determined as described below for EIA. Specific activities 
were expressed as prnol o-nitrophenol produced mg protein-! min-! at 45°C 
and recorded as a percentage of the original enzyme activity. Samples of 
the N-hydroxysuccinimide ester of"progesterone (*^C)-hemisuccinate"were 
weighed and dissolved in dimethylformamide. Aliquots (5p£) were placed 
in scintillation vials, Toluene Scintillator (7ml;Packard) added and 
radioactivity determined as 73.2 x 103 dpm mmol-!. Soluene (1ml; Packard) 
was added to aliquots of purified conjugates and the radioactivity simil­
arly measured. The molar concentrations of enzyme present were calculated 
assuming a molecular weight of 540,000 (10) and the molar ratio of 
progesterone to enzyme determined. The progesterone contents of suitable 
dilutions of the conjugates were further measured by RIA binding inhibi­
tion and the molar ratio of immunologically apparent progesterone to 
enzyme calculated..
Test-tube EIA and RIA of progesterone
Progesterone-enzyme conjugate prepared using a 200 fold molar excess of 
steroid was used for the EIA. A range of progesterone standards in PAS 
buffer with gelatin (l.Og £-!; 100p£) and 20p£ whole milk taken from a cow 
at oestrus (containing a minimum level of progesterone) were added to 
polystyrene test-tubes and allowed to equilibrate for 1 hour at room temp­
erature. Enzyme-progesterone conjugate (25ng in 100p£ PAS-gelatin buffer; 
equivalent to 5pg progesterone by RIA) and I00p£ of bovine serum albumin 
-absorbed (11), cellulose-linked (12) goat anti-progesterone antiserum 
(1:1600 dilution in PAS-gelatin buffer) were then added and the tubes 
mixed. The antiserum (G711/12) was raised against an 11<*-hydroxyprogest­
erone 11-hemisuccinate-BSA conjugate (8). "Non-immune" goat serum linked 
to cellulose (1:1600 dilution) was used in place of anti-progesterone 
antiserum in the blank. The assay tubes were incubated at room tempera­
ture for 1 hour with shaking every 10 min and left for 16 hours at 4°C. 
PAS-gelatin buffer (3.5ml) was added at 4°C and the antibody-bound label 
separated by centrifugation (1600g for 10 min). Unbound progesterone and 
progesterone-enzyme conjugate were poured off and the tubes drained by 
inversion over absorptive paper. The activity of enzyme bound to antibody 
was determined by addition of freshly prepared o-nitrophenyl Jl-D-galacto- 
pyranoside (3mg ml**!) £n 200/Jt assay buffer (PAS-gelatin buffer containing 
0.01 M magnesium chloride and 0.1M mercaptoethanol) at 4°C. The tubes were 
mixed and incubated at 45°C for 1 hour, cooled to 4°C for 2 min and the 
reaction stopped by addition of 1M sodium carbonate (2ml) before centrif­
ugation (1600g for 10 min). The absorption of the supernatant at 450nm 
was determined with a Cecil CE 404-2 spectrophotometer and corrected for 
the non-immune serum blank.
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The radioimmunoassay was conducted by essentially the same procedure 
as the enzyme immunoassay, but with 100|x£ (I, 2, 6, 7-3H) progesterone 
(Radiochemical Centre, Amersham; 4000 dpm, 5-6pg) in PAS-gelatin buffer 
in place of enzyme-steroid conjugate. After overnight incubation in the 
presence of antibody, PAS-gelatin buffer was added (700p£) and the tubes 
mixed and centrifuged as before. Unbound progesterone was determined by 
pouring the supernatant into scintillation vials, extracting into Toluene 
Scintillator (7ml) for 1 hour and counting in a Packard B2450 scintilla­
tion spectrometer.
Micro-titre plate EIA and RIA of progesterone
Progesterone-enzyme conjugate was prepared using a 20 fold molar 
excess of steroid. BSA-absorbed rivanol-purified (11) goat anti­
progesterone gammaglobulin in 0.1M carbonate buffer, pH 9.6 (200\it; lOpig 
protein ml- *) was added to each well of a polystyrene micro-titre plate 
(Dynatech M129A) and incubated at 37°C for 3 hours. The wells were 
emptied by inversion, washed twice with PAS-gelatin buffer, drained and 
stored at -20°C until used. Whole milk taken from a cow at oestrus 
(10li£) and PAS-gelatin buffer containing progesterone standards (180p£) 
were added to the wells and incubated at 37°C for 1 hour. Enzyme- 
progesterone conjugate (150ng in 10p£; equivalent to 13pg progesterone 
by radioimmunoassay) was added and the plate incubated for a further 2 
hours. The wells were emptied, washed three times with PAS-gelatin buff­
er and inverted on absorptive paper. o-Nitrophenyl-JJ-D-galactopyranoside 
in assay buffer . (200pi£; 3mg ml-*) was added to each well and the plate 
incubated at 45°C for 1 hour. The reaction was stopped by dispensing the 
contents of each well into 1M sodium carbonate (2ml) and the absorbance 
determined at 405nm in a Cecil 404-2 spectrophotometer.
The micro-titre plate RIA was conducted by essentially the same 
procedure but with 4000 dpm (3H) progesterone per well in place of enzyme 
-steroid conjugate. After overnight incubation at 4°C free progesterone 
was determined by transferring well contents into scintillation vials and 
extracting and counting as described above.
RESULTS AND DISCUSSION
N-Hydroxysuccinimide esters of acyl-amino acids have previously been 
employed in the synthesis of peptides (13). The ability of the N-hydroxy 
-succinimide ester of"progesterone 11-hemisuccinate"to combine with 
^-galactosidase under mild conditions was demonstrated by both direct 
measurement of incorporated radioactivity and RIA binding inhibition 
(Table 1). Low molar ratios of progesterone to enzyme in the reaction 
mixture produced substantial incorporation. There was little increase 
when a 2000 rather than a 500 fold molar excess of steroid was employed.
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TABLE 1
Molar Incorporation of Progesterone into Jl-galactosidase
and Enzyme Activity of the Resulting Conjugates
Molar ratio of Enzyme activity of Molar ratio of
progesterone: enzyme conjugates (% of progesterone to enzyme:-
in conjugation original activity) Radioactivity Radioimmumo-
reaction mixture determination assay
0 103.4 0 0.01
2 104.4 2.0 0.02
20 111.1 7.9 0.15
100 91 .6 48.6 0.27
200 82.4 87.7 0.34
500 62.6 104.4 1.16
2000 22.6 107.0 0.83
Molar incorporation calculated from the radioactivity data approached the 
theoretical maximum of 116 molecules of progesterone per enzyme molecule 
that could be attached to lysine residues in the enzyme (10). Enzyme 
specific activity was not reduced by the conditions of the conjugation 
procedure but a reduction was seen when near maximal numbers of progest­
erone molecules were incorporated (Table 1). This could be explained 
either by alterations occurring at the active site of the enzyme when 
progesterone was added near this position or by allosteric effects 
induced when high levels of incorporation occurred. The only comparable 
data available (3) indicated that the mixed anhydride technique (14) was 
an order of magnitude less efficient at conjugating a steroid (cortisol) 
to J3-galactosidase than the N-hydroxysuccinimide ester method reported 
here. The carbodiimide reaction used by other groups to link steroid 
derivatives directly to ^-galactosidase (6, 7) has been shown to be 
inefficient: only 30% of jl-galactosidase was reported to be conjugated 
with estradiol-17B when a 20 - 50 fold excess of the steroid was employed 
(15). Furthermore, the procedure inevitably leads to considerable enzyme 
to enzyme conjugation.
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Radioimmunoassay of conjugates formed using the N-hydroxysuccinimide 
ester of"progesterone hemisuccinate"detected substantially lower molar 
incorporation ratios than did direct measurement of incorporated radio­
activity (Table 1): clearly, the only progesterone molecules detected by 
immunoassay are those situated at such positions in the enzyme molecule 
that antibody attachment is not sterically hindered. This is in keeping 
with earlier findings (3) that only 1 in 10 of the cortisol molecules 
incorporated into JB-galactosidase were detected by immunoassay. Claims 
that optimum sensitivity in EIA is in part dependant on achieving a low 
(around 1:1) molar ratio of progesterone to enzyme (4, 7) would only be 
true where all conjugated steroid was immunologically apparent as well 
as physically detectable. Immunological assessment of progesterone 
incorporation is,therefore, clearly of the greater relevance to the 
performance of an EIA.
The quantity of each conjugate used in the EIA procedure was based on 
its immunoreactivity and the amount of label used for both EIA and RIA 
was adjusted to be approximately equivalent. Quantities of conjugate 
equivalent to 5 - 15 pg progesterone resulted in sufficient enzyme 
activity binding to the antibody for standard curves to be produced by 
EIA. Their range and sensitivity was comparable with those seen following 
RIA using the same antibody dilution. The addition of whole milk from a 
cow at oestrus to the EIA system did not reduce the resolution of the 
standard curves and the results obtained were comparable with those from 
RIA performed under the same conditions (Figs. 1 and 2). The test-tube 
system (Fig. 1) had a within assay coefficient of variation of 3.2% for 
the EIA and 6.7% for the RIA. The limits of sensitivity at the 95% 
confidence level were 20 pg and 21 pg respectively. The micro-titre 
plate system (Fig. 2) showed a within assay coefficient of variation of
EI
A 
op
ti
ca
l 
de
ns
it
y 
(4
05
nm
) 
* 
EI
A 
op
ti
ca
l 
de
ns
it
y 
(4
05
nm
)
S T XI RO I X) m 5 1
F i g .  .1 Comparison of test-tube EIA (•-•) and RIA (O— o) standard 
curves in the presence of whole milk from a cow at oestrus. 
Values are mean of 6 determinations ± 2 SEM.
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4.7% for EIA and 2.7% for RIA, with limits of sensitivity of less than 5 
pg and 7.8 pg respectively at the 95% confidence level.
The particular solid phase antibody system employed in the EIA proce­
dure determined which steroid-enzyme conjugate provided optimal sensiti­
vity. Using the microgranular cellulose-linked antibody system in the
test-tube EIA, optimal sensitivity was achieved with a conjugate prepared 
using a 200 fold molar excess of steroid. This system required a quantity 
of conjugate (25 ng) immunologically equivalent to 5 pg progesterone per 
assay tube. It was found, however, that in the micro-titre plate EIA 
optimal sensitivity was obtained with a conjugate prepared using a 20 fold 
molar excess of steroid. The quantity of label required per well (130 ng) 
was equivalent to 13 pg progesterone. The variation seen may be partly 
explained by the different antibody concentration used in the two systems. 
In the micro-titre plate assay the quantity of antibody which passively 
adsorbs to the wells has a finite and comparatively low limit. This in 
turn limits the total amount of label which may be bound.
The techniques described in this study will enable the widespread use 
of progesterone assays for determination of reproductive status and the 
diagnosis of reproductive disorders. Such methods will be invaluable to 
small laboratories or in developing countries where radioimmunoassay would 
involve levels of capital expenditure too high for economic consideration. 
The arrangements necessary for the safe handling and disposal of isotopes 
are eliminated and equipment requirements greatly reduced. The micro- 
titre plate method in particular offers a sensitive and convenient assay 
which may be readily automated at comparitively low cost. The successful 
assay of progesterone in whole milk without prior extraction of steroid 
will be of particular value as an aid to farmers and veterinary practiti- 
ioners for pregnancy diagnosis in cattle and in the prediction of the
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day of ovulation, perhaps eventually allowing insemination without 
recourse to observation of oestrous behaviour.
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THE USE OF ENZYME IMMUNOASSAY FOR THE MEASUREMENT OF HORMONES WITH 
PARTICULAR REFERENCE TO THE DETERMINATION OF PROGESTERONE IN 
UNEXTRACTED WHOLE MILK
M.J. Sauer, A.D. Cookson, B.J. MacDonald, J.A. Foulkes
Ministry of Agriculture, Fisheries and Food, Cattle Breeding Centre, 
Church Lane, Shinfield, Reading, RG2 9BZ, United Kingdom
ABSTRACT
Prior to the development of enzymeimmunoassay (EIA) techniques, 
radioimmunoassays or radioreceptor assays were the most practical means by 
which hormone concentrations could be measured in large numbers of samples. 
EIA requires only simple colorimetry for quantitation and avoids the use 
of radioisotopes and associated counting equipment.
EIA’s have been developed for various trophic, thyroid and steroid 
hormones during the past six year. These developments should enable 
veterinary laboratories to monitor abnormal hormone secretion in.various 
disorders. Periodic assessment of progesterone levels can provide conside­
rable information regarding the reproductive status of an animal. Milk 
would be the sample of choice in many domestic species.
The use of EIA for the determination of hormones in biological fluids
and the methods by which hapten-enzyme conjugate may be formed are reviewed
and factors influencing EIA sensitivity discussed. The development of a
simple microtitre plate EIA for progesterone in unextracted whole milk is
described.
INTRODUCTION
Enzyme immunoassay (EIA) or enzyme linked immunosorbent assay (ELISA) 
techniques have been the subject of continuous intensive development sinco 
their use was first reported (Engvall and Perlmann, 1971; Van Weeman and 
Schuurs, 1971). In the veterinary field, however, the application of EIA 
has remained almost totally restricted to the investigation and detection 
of infectious diseases. This is reflected in the scope of topics reported 
at this meeting. Other areas of application should surely include residue 
determinations in tissues and body fluids (anabolic steroids, antibiotics 
etc.) in order to police legislation relating to meat inspection and 
testing for drugs in racing.
The measurement of hormones associated with growth, development and 
reproductive function have obvious value in the livestock industry and the 
use of EIA procedures for their determination would enable their routine 
assessment to become a practical proposition.
The hormone EIA's which are listed in Table 1 and the procedures 
which we shall later describe are quantitative, competitive immunoassay 
procedures analagous with radioimmunoassay (RIA). This paper will not
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consider the relative merits of the different methods by which enzymes can 
be employed as labels in EIA nor the merits of various enzymes used since 
these areas have been adequately reviewed by others (O’Sullivan et al, 1979; 
Oellerich, 1980; Scharpe et al, 1976; Schuurs and Van Weeraan, 1977). 
Attention will, however, be paid to the methods by which enzyrae-imraunogen 
conjugates may be made.
Table 1 illustrates hormones for which EIA's have been developed. It 
can be seen that interest in this procedure has remained largely confined 
to the human clinical sphere. Progesterone is an exception and is the only 
hormone to have been assayed in a number of species as well as in several 
body fluids. This is perhaps because the patterns of progesterone secretion 
provide a wealth of information on aspects of reproductive performance such 
as the occurrence of cyclical activity or ovulation, differential diagnosis 
of luteal or ovarian cysts and pregnancy diagnosis.
The sensitivity of EIA is in many cases comparable with that achieved 
using RIA although many of the hapten EIA procedures have involved extrac­
tion of the analyte before assay (Table 1). Where cross-reacting substances 
are likely to be present in the test sample, purification by means of 
extraction or even chromotography may be necessary: this obviously applies 
equally to RIA. If high specificity is not required, however, prior extrac­
tion of sample may not be essential for the EIA provided the conjugates 
used are of suitable purity and do not contain a substantial proportion of 
unconjugated enzyme or steroid,or conjugated but denatured enzyme since 
this may affect the sensitivity of the assay. We believe, therefore, that 
particularly where quantitative, direct-addition assays are to be performed 
the mode of preparation of the conjugate is of the utmost importance.
PREPARATION OF PROTEIN-ENZYME CONJUGATES
A number of conventional procedures are available for the conjugation 
of enzymes to proteins and these include the one-step (Avrameas, 1969) and 
two-step (Avrameas and Ternynck, 1971) gluteraldehyde methods, the period­
ate method (Nakane and Kawaoi, 1974) and the use of homobifunctional 
reagents such as N ,N '-o-phenylenedimaleiraide (Kato et al, 1975a). These 
methods have been reviewed by Kennedy et al (1976) and others at this 
symposium (Doel and Collen, 1981).
The nature of these reactions makes co-conjugation of either enzyme to 
enzyme or protein to protein almost inevitable. For this reason, the
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development of heterobifunctional reagents represents a major advance for 
production of enzyme-protein conjugates since they eliminate the possibility 
of co-conjugation of enzyme or protein.
Protein-enzyme conjugation using heteroblfunctional reagents
A number of heterobifunctional reagents have recently been developed 
which, as the name implies, contain two differing reactive groups. The reage­
nts reported up to now have reactivity towards sulphydryl groups at one end 
and towards amino groups at the other (fig. 1). Thus, in the first instance, 
if the reagent is reacted with a protein (or enzyme) which does not contain 
available sulphydryl groups no polymerzation can occur: if excess reagent 
is then removed (ie. by gel filtration or dialysis) the other protein may 
then be added in order that conjugation may proceed. If the second protein 
does not normally contain available sulphydryl residues it may be possible 
either to introduce them by chemical means (mercaptoimidation or mercapto- 
succinylation (Traut et al, 1973; Kato et al, 1975b) or by reduction of 
existing disulphide bridges (Kato et al, 1975a).
m-Maleimidobenzoyl-N-hydroxy
0 succinimide
R NHj
HS-R
N-succinimidyl 3-(2-pyridyl 
dithio) propionate q
-S-S-CH, -CH2 -fl4-'N
f {
SHR’ NH2R2 o*
Fig. 1 Conjugation using heterobifunctional reagents. R* and R3 
can be protein or hapten moieties.
Bifunctional compounds which have been employed in the preparation of 
protein-enzyme conjugates include m-maleimidobenzoyl-N-hydroxysucciniraide 
(MBS) for conjugation of enzymes with insulin (Kitagawa and Aikawa, 1976) 
and donkey anti-sheep IgG Fc fragment (O'Sullivan et al, 1978a), N-hydroxy­
succinimide esters of N-(4-carboxycyclohexylmethyl)-maleimide and N-(4- 
carboxyphenylmethyl)-Maleimide for conjugation with protein hormones 
(Hamada et al, 1978; Ishikawa et al, 1978) and N-succinimidyl 3-(2-pyridyl
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dithio) propionate (SPDP) for conjugation with protein A (Pain, D. and 
Surolia, A.)•
PREPARATION OF HAPTEN-ENZYME CONJUGATES
The preparation of enzyme-hapten conjugates for EIA has generally 
involved use of the standard mixed anhydride or carbodiimide procedures 
originally developed for linking haptens to protein carriers such as BSA 
for use in raising hapten antisera (fig. 2). In essence, the procedures 
give rise to the formation of peptide bonds between an acid group on the 
hapten or hapten derivative and lysine £-araino groups on the enzyme.
a) Carbodiimide reaction
■ 0  R 1N=C=NR2 O H
Ho„. „ (// (Carbodiimide! 11 •Hapten-C  — --- ^  Hapten-C-N-Enzyme
OH ~H20
(eg.progesterone 
hemisuccinate)
Enzyme-NHj
b) Mixed anhydride reaction.
/°
Hapten-c' DMF Hanti»n c' •?* "
OH Anhydrcaus naPten Hapten-C-N-Enzyme
+  condition^ 0 Enz-NH2
(CH^.CHC^-O-cf R '°-Ci 0 ^
R, C1 -"C1
iso-butyl chloroformate
OH 
J 0
Fig. 2 Summary of carbodiimide and mixed anhydride reactions.
The carbodiimide method
The basic water-soluble carbodiimide procedure has been use by a 
number of workers for producing enzyme-hapten conjugates (Table 1) but is 
losing favour since it inevitably results in co-conjugation of enzyme 
molecules. This is because it is not possible with currently available 
carbodiimide reagents to conjugate enzyme to hapten without the continued 
presence of excess carbodiimides since the intermediate o-acylurea is 
unstable (Kurzer and Douraghi-Zadeh, 1967).
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The mixed anhydride procedure
This procedure eliminates the possibility of co-conjugation of enzyme 
since the generation of the intermediate mixed anhydride is only possible 
under anhydrous conditions (fig. 2). When aqueous enzyme solution is added 
for conjugation enzyme carboxylic acid groups cannot themselves form 
anhydrides and the enzyme-mixed anhydride reaction prevails.
Although a within laboratory comparison of the different methods of 
conjugation has not been reported, it has been argued that the mixed 
anhydride procedure may not be so efficient as procedures utilising hapten 
"active esters" described later.
Homobifunctional reagents
Homobifunctional reagents such as dimethyl adipimate (fig. 3) may also 
be used for coupling haptens to enzymes (Al-Bassam et al, 1978; O'Sullivan 
et al, 1978b) but reaction conditions must be carefully selected to mini­
mize the inevitable co-conjugation of either enzyme or hapten.
dimethyl adipimate bisoxirane
Fig. 3 Conjugation using homobifunctional reagents. R' and R2 can 
be protein or hapten moieties.
Heterobifunctional reagents
haptens essentially without the hazards of co-conjugation (fig. 1). They 
have not found general application in the hapten hormone field largely 
because derivatives containing amino or sulphydryl groups are not generally
Specific for amino groups
OH-Hapten
CH2 -CHCH2 0(CH2 )4OCH2 CH-CH2
NH2 Enz.
hydroxyl and amino groups
N , N ' -o.-phenylenedimaleimide
sulphydryl groups
‘Heterobifunctional reagents may similarly be used for conjugating
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available or easily synthesised.
Heterobifunctional reagents have, however, found application in 
coupling certain drugs to enzymes: MBS has been used for coupling J3-gal- 
actosidase to Viomycin (Kitagawa et al, 1976) and N-(3-maleimidopropionyl 
glycyloxy) succinimide for coupling Viomycin, Gentamycin (Kitagawa et al, 
1978a) and Ampicillin (Kitagawa et al, 1978b) to ^ 3-galactosidase.
"Active ester" derivatives of haptens
The synthesis of reactive esters of haptens or hapten derivatives 
provides the basis for what may be the most convenient and efficient means 
of producing enzyme-hapten conjugates (fig. 4). These esters may be 
isolated and purified and thus used directly for conjugation with the 
enzyme under aqueous conditions and neutral pH. This eliminates the 
possibility of co-conjugation and enzyme denaturation (fig. 4). N-hydroxy- 
succinimide and p-nitrophenyl esters will readily react with primary, 
unhindered amino groups such as the £-amino groups of lysine to form a 
peptide bond:such reactions have been used for conjugating progesterone
1) N-hydroxy succinimide esters.
0 0
dicyclohexyl
carbodiimide
2) p-Nitrophenyl esters.
R'C-OH + HO -NOa
Enz.-NH2
3) m-Maleimidobenzoate esters
Reflux 
-HC1 '
0
maleimidobenzoyl chloride
Fig. 4 Active ester derivatives of haptens. R' represents the 
hapten portion.
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ll-hemisuccinate (Sauer et al, 1981) and testosterone derivatives (Hosada 
et al, 1979; 1980) to p-galactosidase and for conjugating oestrone sulphate 
6-hemisuccinate to BSA (Nambara et__al, 1980). Gros et al, (1978) have also 
used N-hydroxysuccinimide esters to link progesterone ll-hemisuccinate and 
progesterone 11-hemimaleate to /J-galactosidase but without prior purifica­
tion or isolation of the active ester (carbodiimide may therefore have been 
present when the enzyme was added). Monji and Castro (1979a) have isolated 
and purified m-Maleimidobenzoate esters of cortisol and cortisol derivati­
ves which they subsequently used to enable direct conjugation with the 
free sulphydryl residues of p-galactosidase in buffer at pH 7.0. These 
reports indicate that these active esters react with enzyme or protein in 
a near stoichiometric manner and result in only minimal loss of enzyme 
activity.
Typical procedure for coupling haptens to enzymes using N-hydroxysuccinimide 
esters
The formation of the N-hydroxysuccinimide ester of 11 -hydroxypro- 
gesterone ll-hemisuccinate (Sauer et al, 1981) provides a typical example 
of the means by which N-hydroxysucciniraide esters of carboxylated haptens 
or hapten derivatives may generally be made (fig. 5).
A slight molar excess (10-20%) of N-hydroxysucciniraide and dicyclo- 
hexylcarbodiimide was added to progesterone ll-hemisuccinate (43mg) and 
dissolved in a minimum volume of dry dioxane. The mixture was stirred at 
25°C for 30 mins and the insoluble by-product dicyclohexylurea removed by 
washing through a sintered glass funnel. The clear filtrate was dried under 
a stream of nitrogen and the residue dissolved in a minimum volume of 
dichloromethane at 35°C. Addition of cold diethyl ether allowed crystalli­
zation of the N-hydroxysuccinimide ester.
Progesterone-^-galactosidase conjugates were subsequently produced as 
described (Sauer et al, 1981) by addition of a suitable molar excess of the 
active ester (in a minimum volume of dry dimethylformamide) to /J-galactosi- 
dase* in 0.1M phosphate buffered saline, pH 7.0. The reaction was performed 
at room temperature with stirring for one hour before "exhaustive" dialysis 
against three changes of 3 litres of 0.1M phosphate-buffered saline 
containing sodium azide (0.1% w/v) at pH 7.0. Conjugates were then subjec­
ted to gel filtration (Sephadex G25) prior to assessment and subsequent 
use for EIA. The importance of extensive dialysis and gel filtration for
* see appendix
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11*<-MYDROXY PROGESTERONE
-cXl
u*
(t.4  C) SUCCINIC ANHYDRIOE
HOOC r (C H, l j  - c
Pyridin*
0O°C
t 1 --HYDROXY PROGESTERONE-11 HEMISUCCINATE
8 ) 8YXTBX3I8 OF P80GISTYXOXY "ACTIV* 8STM ".
u
°
L-V | Ma'j -c v
OICYClOHEXYlCARBODIIMlOE PROGESTERONE "ACTIVE ESTER"
N HYOROXYSUCCINIMIOE - (11** -hydroxyproQMttfona-tt-tomitueeinoylNAydroxyiuCCirwmid* Mttrl
N,N'DICYCLOHEXYL UR|
3) snrrHxsxs or enzyvx- paogxstsroni conjvgatx .
DN-O-^ CHjIjC^-O*.
PROGESTERONE "ACTIVE ESTER"
(11 •*  -ftydroxy p r o g n t t r o n r l  1 -ftfm ituccinovl 
•N*hydroxysoccm<mid« tstor)
(E.coli f  -GaiactoiidaM)
e n z y m e - n . ^ . (CHj 1j. ^ . u
ENZYME PROGESTERONE CONJUGATE
Fig. 5 Formation of /3-galactosidase-progesterone conjugates by the 
N-hydroxysuccinimide ester method.
the removal of unconjugated progesterone cannot be over-stressed: it is 
essential if a high degree of assay sensitivity is to be achieved. Even 
after dialysis against four changes of buffer (over 5 days), and gel filt­
ration followed by a final dialysis, we have still been able to detect 
immunoreactive material in the dialysate. By this stage, however, the 
quantity present would not be sufficient to interfere with the EIA at the 
conjugate dilution employed.
Several methods have been employed to assess the number of hapten 
molecules conjugated per enzyme and these include spectrophotometric methods 
(Erlanger et al, 1957), or analysis of free amino groups on the enzyme 
subsequent to conjugation (Fields, 1971). The most direct and perhaps least 
misleading approach is through the use of radioactively-labelled hapten 
(Abuknesha and Exley, 1978; Coraoglio and Celada, 3 976; Sauer et al, 1981).
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Using the latter method of assessment the N-hydroxysuccinimide ester method 
of conjugation was shown to be highly efficient, particularly at lower molar 
ratios (Table 2). Incorporation approaching the theoretical maximum of 116 
progesterone molecules per enzyme can be achieved (there being 116 lysine 
residues per £-galactosidase molecule; Craven et al, 1965) although high 
molar incorporation was found to result in loss of enzyme activity (Sauer 
et al, 1981). Determination of steroid incorporation by binding inhibition
TABLE 2 Molar incorporation of progesterone into p-galactosidase and
enzyme activity of the resulting conjugates.
Molax* ratio progesterone: 
enzyme in conjugation 
reaction mixture
.
Enzyme activity of 
conjugates (% of 
original activity)
Molar
progesteror
Radioactivity
determination
ratio of 
le to enzyme:
Radioimmunoassay
0 103.4 0 0.01
2 104.4 2.0 0.02
20 111.1 7.9 0.15
100 91.6 48.6 0.27
200 82.4 87.7 0.34
500 62.6 104.4 1.16
2000 22.6 107.0 0.83
tests detected substantially lower molar incorporation (see Table 2), 
indicating that the actual molar steroid incorporation may have little 
bearing on the sensitivity of an assay except where it can be shown that 
all conjugated steroid is immunologically apparent as well as physically 
detectable.
METHODS OF SEPARATION OF FREE FROM BOUND ENZYME CONJUGATE
The EIA's described in this paper (termed heterogenous EIA's) require 
separation of free from bound enzyme label following the immunoreaction in 
order to quantitate the unlabelled hapten or protein. Separation techniques 
which have been employed are generally methods adapted from RIA procedures. 
These include polyethylene glycol precipitation, double antibody precipita­
tion, double antibody solid phase and solid phase primary antibody techniques 
(Table 1). The use of dextran-coated charcoal for separation is probably the 
most widely used technique for hapten RIA but since absorption is based on 
the large difference in molecular weight (of the order of 200 fold) between 
free label and that bound to antibody it cannot be applied to EIA.
Where possible the use of solid phase antibodies (preferably primary
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antibodies) gives rise to the most convenient form of separation. Where 
particulate solid phases are used it has been necessary to employ a centri­
fugation stage. To avoid a centrifugation step, methods have been developed 
enabling magnetic solid phases to be prepared: materials used include 
polyacrylamide-agarose beads (Guesdon and Avrameas, 1977), ferric oxide 
particles (Hersch and Yaverbaum, 1975; Nye et al, 1976), cellulose (Ander­
son, 1978) and plastic coated steel balls (Smith and Gehle, 1977).
Using polystyrene test-tubes or polyvinyl or polystyrene microtitre 
plates coated with primary antibody, separation of free from bound enzyme- 
conjugate is achieved simply by pouring off the free fraction. The quantity 
of enzyme label bound may be simply determined by addition of substrate 
following an initial washing to remove residual free enzyme conjugate.
In this laboratory we have largely used solid phase separation techni­
ques, including primary antibody linked to microgranular cellulose. We now 
use microtitre plates in a progesterone enzymeimraunoassay (Sauer et al, 
1981) in what we believe is the first reported use of such plates in a 
hapten EIA. This procedure combines a convenient, simple and less tedious 
method with rapid assay and end-point determination - particularly when 
used in conjunction with an automatic plate reader such as the "twin beam" 
Dynatech MR 580.
MICROTITRE PLATE ENZYMEIMMUNOASSAY FOR PROGESTERONE
For the majority of quantitative coated test-tube or microtitre plate 
immunoassays it is essential to isolate the Y -globulin fraction of the 
antiserum prior to coating of tubes or microtitre plate wells. This enables 
significant antibody binding to be achieved at reasonable antibody dilution.
Antibody purification
* We have used BSA-absorbed (Thorneycroft et al, 1970) goat antiprogest­
erone serum (G711/12) raised against 11 cx-hydroxyprogesterone 11-hemisucc- 
inate-BSA for our assay. Adequate purification was achieved by treating the 
antiserum with 4 volumes of 0.4% Rivanol; this precipitates the majority of 
serum proteins leaving globulins in solution (Horejsi and Smetana, 1956). 
Thorneycroft et al, (1970) indicated the importance of pH in this purifica­
tion procedure and our results underline the point. The indications are 
that it is essential to establish not only the pH for the precipitation but 
also the volume of 0.4% Rivanol to be added, since these optima may vary 
from species to species. Goat antiserum was treated with 4 volumes of
p H 6  . 0
Fig. 6 
Rivanol.
a n d  0 
k g l o b u l i n s
■ m .t*
m m  ,r" '**** a l b u m i n
p H 7  . 0 p H 8 .0 p H 9 .0 p H l O . O
The effect of pH on the precipitation of serum proteins by
100
90
80
70
\ A60
50
40
30
20
10
1/10 1/20 1/40 1/80 1/160 1/320
antibody dilution (xlO2)
Fig. 7 Effect of pH on recovery of anti-progesterone ^-globulin 
from serum treated with Rivanol (pH 6.0, pH 7.0, pH 8.0,
a-a; pH 9.0, pH 10.0, untreated serum, O-O).
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buffered 0.4% Rivanol (0.1M phosphate or tris buffer, pH 6-10) for 15 
minutes at room temperature and then centrifuged. Rivanol was removed by 
Sephadex G-25 column chromatography (eluting with 0.005M phosphate buffer, 
pH 7.0) and the protein fraction freeze-dried and re-dissolved in deionized 
water to give a volume of 10 x that of the original serum. Polyacrylamide 
gel electrophoresis (fig. 6) and subsequent assessment of antibody titre 
(fig. 7) indicated that pH 9.0 was optimal and resulted in removal of the 
majority of other serum proteins. Antiserum treated in this way was subse­
quently used for binding to microtitre plates. When dilution curves 
obtained with the original antiserura were compared with those following 
treatment at pH 6-9, a small but similar drop in binding was seen consist­
ent with experimental losses. At pH 10, however, a further more substantial 
drop in binding was found, indicating a loss of If -globulins by treatment 
at this pH (fig. 7).
Adsorption of antibodies to microtitre plate wells
We have used Dynatech 96-well flat-bottomed polyvinyl’plates (M29A) 
and found that these gave more consistent binding than did the use of their 
polystyrene equivalent reported previously (Sauer et al, 1981). Binding of 
3H progesterone to the wells was used to assess the extent to which the 
anti-progesterone }f-globulin was adsorbed. At temperatures of 25, 30, 35 
and 40°C binding of f -globulin was virtually complete by one hour (fig. 8A). 
We eventually chose a 3hr incubation at 40°C to ensure good standardization.
3IorH *
'©X
3aa■o
■o
C3O£1
3
4)
C0u4) 2
a4)M0Ua 2
x
2‘ 0.00!5 6 7
buffer pH
:4 8 9 10
buffer molarityincubation time (hrs)
Fig. 8 Effect of A, incubation duration and temperature (25°C, G-G; 
30°C, i - i; 35°C, ■ - ■; 40°C, E-ti); B, pH and C, buffer molarity on adso­
rption of antibody onto microtitre plate wells. Values are mean of 4 
determinations (A) or 8 determinations (B and C) ± 2 SEM.
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The pH of the coating buffer had a considerable influence on binding 
of T  -globulin to the wells, maximum binding being achieved at pH 5.0 (Fig. 
8B). The influence of acetate buffer concentrations at pH 5.0 on binding of 
antibody to the wells is shown in fig. 8C. Buffer solutions were prepared 
in water which had undergone a primary deionization, glass distillation and 
further deionization prior to use. The highest binding levels were achieved 
using ImM buffer.
Later studies therefore used standard adsorption conditions: "y-globu-
lin diluted in ImM acetate buffer pH 5.0 (0.2ml), was added to each well 
and incubated at 40°C for 3 hrs. The plates were then inverted and sharply 
tapped to eject the residual antibody. The wells were washed once with 0.1M 
phosphate buffer (pH 7.0) containing sodium chloride (0.9% w/v), sodium 
azide (0.1% w/v) and 0.1% (w/v) gelatin (PAS-gelatin buffer) and then incu­
bated overnight at 4°C with the same buffer (250ji£) . Plates were stored in 
this condition at 4°C and further washed with PAS-gelatin buffer immediately 
prior to use for EIA.
Enzymeimmunoassay procedure
This assay procedure was developed to enable the determination of 
progesterone in milk by direct addition of whole milk to the assay system. 
Experiments to determine optimum conditions with regards antibody and enzyme 
conjugate dilutions were therefore carried out in the presence of whole milk 
Progesterone-p-galactosidase conjugate prepared using a 20 fold molar excess 
of steroid was used in subsequent EIA procedures unless otherwise indicated.
Standards were prepared by the dissolution of progesterone in whole 
milk (containing a minimum of endogenous progesterone) from a cow at oestrus 
These standards (lO^ u/) , or whole milk from test animals (lOyuf) were added to 
each well of an antibody-coated microtitre plate followed by 200yu/ of 
progesterone-enzyme conjugate suitably diluted in PAS-gelatin buffer. After 
a three hour incubation period at 40°C the wells were emptied and washed 
three times as above. The amount of enzyme conjugate bound was determined 
by addition of freshly prepared substrate, o-nitrophenyl ^3-D-galactopyrano- 
side (3mg ml-*) , in PAS-gelatin buffer containing 0.01M magnesium chloride 
and 0.1M mercaptoethanol. Following an incubation period of 1 hr at 45°C
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the optical density (OD) at 405nm was measured directly through the wells 
using a Dynatech MR580 automatic plate reader.
Selection of antibody and enzyme conjugate dilutions
A 1 hr period was chosen for incubating enzyme and substrate to mini­
mise time differences associated with substrate addition to the first and 
last well. This also enabled economical use to be made of antibody and 
conjugate. The antibody dilution at which wells were coated and the conju­
gate dilution used in the EIA procedure were determined on an empirical 
basis; account' was taken of the optical density achieved following binding 
in the absence of competing progesterone (Bo value) since this dictates 
the OD range measured in the standard curve.
Conjugate and antibody dilutions giving rise to acceptable standard 
curves were compared in order to assess their influence on the limits of 
detection. It can be seen from figs. 9A and 9B that neither parameter had
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Fig. 9 Effect of A, antibody dilution (at 1/400 conjugate dilution) 
and B, conjugate dilution (at 1/200 antibody dilution) on the sensiti­
vity of EIA standard curves. Values are mean of 4 determinations t'2 SEM.
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a dramatic effect over the ranges tried. In some respects this may not be 
surprising. The range of antibody dilutions indicated in fig. 9A would 
result in a quantity of antibody bound to the wells, which, if used in RIA 
would bind a maximum of lpg of 3H progesterone in the absence of competing 
steroid. Further reduction in the quantity of antibody bound to the wells 
would be unlikely to result in a substantial increase in sensitivity under 
the immunoassay conditions adopted here; the theoretical arguements applied 
to RIA by Ekins (1974) would suggest that by using such small quantities of 
antibody the system may already be operating around the limits of sensiti­
vity for the assay. At a 1/2000 antibody dilution (fig. 9A)a significant 
difference in binding of conjugate was shown between 0 and 10pg (p<0.05). 
No significant difference in the limit of detection was found between 
standard curves using the different conjugate dilutions.
In subsequent assays of progesterone in test milk samples each well 
was coated with anti-progesterone ^-globulin (1/2000 dilution = 0.6fig/we11) 
and conjugate (1/400 dilution; 135ng in 200jjZ PAS-gelatin buffer = 6pg of 
immunoreactive progesterone) added to 10/l£ of milk.
Comparative RIA systems
A microtitre plate RIA and a liquid phase RIA were developed to 
compare whole milk progesterone concentrations determined by RIA and EIA.
The microtitre plate RIA was carried out in essentially the same 
manner as the EIA procedure except that the plates were coated with Y*” 
globulin at 1/200 dilution. Following removal of the free steroid by 
washing as before, bound label was measured by cutting up the plates and 
counting individual wells in Toluene Scintillator (7ml, Packard).
The liquid phase RIA was carried out as follows:-
Whole milk standard (10p£; 0-300pg progesterone) was pipetted 
into polystyrene test tubes and 3H progesterone in PAS-gelatin buffer (100u£,
i
4,000 dpm = 6pg progesterone) and progesterone antiserum (200|iZ G711/12 at 
1/30,000 dilution in PAS-gelatin buffer) added. The tubes were mixed and 
incubated for 1 hr at room temperature and then overnight at 4°C. Free 3H 
progesterone was separated from bound by the addition of dextran-coated 
charcoal suspension (500p^, 2.5mg charcoal; "Separex” , Steranti, UK) in 
PAS-gelatin buffer at 4°C. After 6 mins at 4°C tubes were centrifuged at 
4,000gi(10 min) and the supernatant poured off into scintillation vials 
and counted following extraction into Toluene Scintillator (7ml).
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The application of EIA to the determination of milk progesterone
Fig. 10 shows a typical comparison between EIA standard curves prepar­
ed in the presence and absence of milk. It is apparent that milk caused a 
considerable drop in enzyme conjugate binding (21%), but even so the 
sensitivity of the curve was still lOpg/well at the 95% confidence limit. A 
similar drop in binding was noted for the microtitre plate RIA (fig. 11B). 
These EIA standard curves were not as sensitive as we have reported in a 
previous publication (Sauer et al, 1981); this may be due to the presence 
of slightly higher levels of endogenous progesterone in the "oestrus milk" 
sample used to prepare the standards. The milk used for these standards had 
been stored for about 5 months at 4°C in the presence of 0.1% sodium azide. 
Storage of the milk in this way had a minimal effect on progesterone conce­
ntrations when assayed by liquid phase RIA but may influence the stability 
of certain milk proteins over a period of several months: this may in turn 
influence conjugate binding to the antibody.
During November and December 1980, representative milk samples were
COW: 2 COW: 19520 *
15-
t r -»— t
22 24 26 28 30
Nov
24 26 28 30 422 2
Dec PecNov
SAMPLE DATE
Fig. 12 Comparison of progesterone concentrations in milk samples 
collected around the oestrus period. Samples were assayed by microtitre
plate EIA (A-A) and RIA (O O) and by liquid phase RIA # - #  . Values
are mean of 4 determinations.
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taken from the milk collection jars of two cows at the morning milking. 
Aliquots (1ml) were stored at 4°C in the presence of 0.1% sodium azide. The 
samples were assayed within three months by liquid phase RIA and subsequen­
tly by liquid phase RIA, microtitre plate RIA and microtitre plate EIA in 
August 1981. Results from samples collected around the oestrus period at 
which artificial insemination (Al) was carried out are illustrated in fig.
12.
A correspondence can be seen when comparing profiles obtained by the 
three methods. The long period of storage may have influenced the EIA results 
since protein precipitation occured in some of the samples. Such changes in 
milk constituents may conceivably have a greater influence on the binding 
of enzyme conjugate in the EIA system than the RIA system. A comparison of 
milk samples assayed after three months with those assayed after eight 
months revealed only minimal changes in progesterone concentration when 
examined by liquid phase RIA. A study of progesterone concentrations in 
fresh whole milk is currently being undertaken to resolve the differences 
observed between the EIA and RIA systems.
Clinical value of milk progesterone determinations in fertility control
Progesterone concentrations in milk have been shown to correlate clos­
ely with the growth and secretary function of the corpus luteum (Hoffmann 
et al, 1976; Laing and Heap, 1971; Pope et al, 1976): luteal function in 
cattle may therefore be conveniently monitored through determination of 
progesterone concentrations in milk rather than plasma, allowing sampling by 
lay personnel.
Analysis of progesterone in milk samples has been used for the investi­
gation of a number of physiological conditions. These include pregnancy 
diagnosis, enabling early re-submission of non-pregnant cows for service 
(Laing and Heap, 1971), confirmation of cyclic activity (Gunzler et al, 1979; 
Lamming and Bulman, 1976), accurate differential diagnosis of ovarian cysts 
(Hoffmann et al, 1976) and the confirmation and prediction of oestrus (Ball 
and Jackson, 1979; Gunzler et al, 1979). The latter application is of parti­
cular interest to the artificial insemination industry since it is now well 
established that in large herds the detection of oestrus can be a major 
problem (McCaughey and Cooper, 1980; Oltner and Edqvist, 1981) and can result 
in a considerable extension of the calving to conception interval. The econ­
omic losses involved can be considerable since a missed oestrus period will 
result in a delay of 21 days before subsequent Al and each day lost has been
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estimated to cost of the order of £1,50 in lost production.
Failure to detect oestrus can be a particular problem during the early 
post-partum period when "silent" oestrus periods may occur. Whether failure 
to detect oestrus is due to "silent" heat or management problems, a quick 
and simple progesterone test could circumvent the necessity for oestrus 
observation. Ball and Jackson (1979) used progesterone levels (measured 
by RIA) as the basis for determining when cattle should be inseminated. Sub­
sequent conception rates of animals in which oestrus was not observed demon­
strated the value of this approach. The potential of a suitable on-farm milk 
progesterone test in this respect is obvious. The microtitre plate EIA 
currently offers the quickest and most convenient means for determining 
progesterone concentrations directly in whole milk. The use of enzyme rather 
then isotopic labels offers the opportunity for further development of "dip­
stick" techniques for use by stockmen.
PRELIMINARY APPLICATION OF DIRECT EIA OF SERUM SAMPLES
In heifers and non-lactating cows it is obviously not possible to 
obtain a milk sample. Similarly, in other species such as the pig, sheep 
and horse,progesterone estimations would need to be carried out on blood 
samples under most circumstances, although saliva might be suitable. Prelim­
inary findings suggest that the microtitre plate procedure may be equally 
applicable to the assay of serum samples. Fig. 13 shows standard curves 
obtained using essentially the same conditions described for the direct assay 
of milk. Serum samples (10|x£) were taken from animals in which endogenous 
levels of progesterone should have been minimal. RIA standard curves are 
also shown for comparison (fig. 14). The results appear particularly prom­
ising in the pig since plasma progesterone concentrations during the oestrus 
cycle 'cover a similar range to those in bovine milk. The large depression 
in binding observed with the RIA standard curve in the presence of prepub­
ertal pig serum (fig. 13) could have arisen from the presence of endogenous 
progesterone or steroid binding globulins.
FACTORS INFLUENCING EIA SENSITIVITY
Discussions regarding the limits of sensitivity that may be achieved by 
hapten EIA have largely evolved from the development of steroid enzyme immun­
oassays. Two main factors have been considered important (given that the 
conjugative procedure is efficient and does not result in enzyme denaturation) 
namely,
i) the number of steroid molecules incorporated per molecule of enzyme and
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ii) the affinity of the antibody for the hapten relative to its affinity 
for the congugate.
i) The steroid: enzyme incoporation ratio aspect has been stressed by a
number of workers (Exley and Abuknesha, 1977; Joyce et al, 1977b). It has
been suggested, either on theoretical grounds (Exley and Abuknesha, 1977) 
or on the basis of experimental findings (Joyce et al, 1977a); Hosada et al,
1980), that the ratio of steroid : enzyme should be of the order of 1 : 1
for optimal sensitivity to be achieved. The findings of Joyce et al (1977b) 
indicated that with oestradiol - horse radish peroxidase conjugate, reducing 
the incorporation ratio from 11 : 1 to 2.6 : 1 gave rise to a 30% increase in 
sensitivity. No explanation was given as to how, by reducing the ratio by a 
further small degree (from 2.6 : 1 to 2.1 : 1) they achieved an increase in 
sensitivity of 70%. Their results indicate rather that the assay system was 
not optimised for particular conjugates. This is reinforced by their further 
observations that using an optimised double antibody separation technique 
rather than solid phase primary antibody, a 50 fold increase in sensitivity 
was achieved, considerably more than that realised by alteration in steroid 
incorporation ratios. More recent publications by this group (Joyce et al, 
1978; Turkes et al, 1979) better reflect the high degree of sensitivity 
which can be attained by using a heterologous EIA under optimum conditions. 
The work of Hosada et al (1980) does not enable conclusions to be drawn 
regarding the limits of detection achievable using conjugates with different 
steroid : enzyme ratios, particularly since they have not determined the 
degree of steroid incorporation in their enzyme conjugates.
The actual number of hapten molecules conjugated to an enzyme may be 
at least a magnitude higher than those which are accessible to antibody 
binding sites (Coraoglio and Celada, 1975; Hayashi et al, 1981; Korainami 
et al, 1980; Sauer et al, 1981). Since only conjugated hapten molecules 
which are not sterically hindered are likely to be of immunological signi­
ficance it is our view that for hapten EIA systems the total number of 
haptens incorporated may have little bearing on the absolute sensitivity of 
the system (the sensitivity will be appreciably reduced, however, when, as 
a result of very high steroid incorporation, a large proportion of the con­
jugated steroids are immunoreactive). Despite their arguements to the cont­
rary, this view is supported by the data of the Riad-Fahmy group. For their 
progesterone and testosterone EIA systems they have indicated that 20 - 50ng 
of steroid-horse radish peroxidase conjugate (1.2:1 steroid : enzyme
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incorporation ratio) proved optimal (Turkes et al, 1979 and 1980). Theoretical 
considerations argue against the possibility of realising the high degree of 
sensitivity which they have achieved (Joyce et al, 1978; Turkes et al, 1979) 
were all the steroid in this quantity of conjugate immunologically apparent: 
20 - 50ng of conjugate is approximately equivalent to 200 - 500pg of steroid, 
assuming a molecular weight for HRP of 40,000. Further, it has not been our 
experience that optimal sensitivity can be achieved using ^ 3-galactosidase- 
progesterone conjugates which contain of the order of one steroid molecule 
per molecule of p-galactosidase.It can be seen by comparison of figs. 15A 
and 15B that such low incorporation requires the use of considerably more 
conjugate per assay in order to achieve an acceptable degree of conjugate 
binding in the absence of competing steroid. Note that in fig. 15B the 5, 10 and 
20pg standards cannot be distinguished from the B0 value. In practise, where 
steric hinderance of conjugated hapten occurs it will be necessary to employ 
a conjugate with appreciably more hapten incorporated since only a fraction 
of these will be immunoreactive (Table 2).
ii) It is widely accepted that in an homologous hapten EIA system the affin­
ity of binding of enzyme conjugate to antibody is higher than that for native 
hapten since the same hapten derivative is used in forming the immunogen as 
is used for conjugating hapten to enzyme. This phonomenon was originally 
investigated for oestrogens by Van Weeman and Schuurs (1975) who argued that 
by employing 'site' or 'bridge' heterology more sensitive assays could be 
achieved. It can now be seen that similar improvements in sensitivity can be 
achieved by the use of more refined conjugation and separation techniques. In 
a practical sense, however, antibody avidity dictates that, for an homologous 
hapten-enzyme conjugate, very high concentrations of hapten are required in 
order to reduce enzyme label binding to blank values (10 - 100 times those re­
quired to reduce *Hlabel binding in a comparable RIA system to blank levels) 
even though the sensitivity achieved may still be very high (compare figs.
10 and 11).
A number of workers have investigated aspects of bridge and site heter­
ology in order to increase the sensitivity of steroid EIA's but with varying 
degrees of success (Van Weeman and Schuurs, 1975; Joyce et al, 1977b; Exley 
and Abuknesha, 1977; Dawson et al., 1979; Hosada et al, 1980). Different 
methods of assessing sensitivity have, however, made it difficult to compare 
their findings. Although increases in sensitivity have been achieved in some 
instances (Dawson et al, 1979; Van Weeman and Schuurs,1975) they may be 
accompanied by loss of specificity (Hosada et al, 1980)
The data of Dray and co-workers (Dray et al, 1975; Gros et al, 1978)
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appear conflicting. They indicate in one instance (Gros et al, 1978) that 
it is necessary to use bridge heterology (hemimaleate rather than hemisuc- 
cinate) to achieve similar dose response curves when comparing binding of 
tritium and enzyme-labelled progesterone whereas in a previous publication 
(Dray et al, 1975) an almost identical response was achieved using an homo­
logous system. We have found that such comparisons can be misleading since
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Fig. 15 Comparison of EIA standard curves (in the absence of milk) 
using progesterone hemisuccinate (A-A) or progesterone hemimaleate 
(•-•) conjugates prepared with a molar ratio of progesterone 
. derivative: J3-galactosidase of 25 : 1 (A) or 2.5 : 1 (B). Results are 
mean of 4 determinations ± 2 SEM. For A, Bo values t 2 SEM for the 
hemisuccinate (23ng conjugate/well) and hemimaleate (21ng/well) conju­
gates were 0.920 ± 0.055 OD and 0.784 ± 0.010 0D respectively. For B,
B0 values ± 2 SEM for the hemisuccinate (54ng conjugate/well) and 
hemimaleate (57ng conjugate/well) conjugates were 0.460 ± 0.015 OD 
and 0.331 t 0.011 OD respectively.
it cannot be assumed that assay conditions which are optimal for one conju­
gate are also optimal for the other or that conjugation efficiency is the 
same when using different hapten derivatives.We have compared J3-galactosidase 
conjugates of progesterone hemimaleate (heterologous) and progesterone hemi­
succinate (homologous); under the same conditions it was apparent, using 
conjugates prepared with a 25 : 1 molar steroid excess that greater sensitiv­
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ity was achieved using the hemimaleate conjugate (fig. 15A). Standard curves 
obtained using conjugates formed with a 2.5:1 steroid excess, however, showed 
no significant difference in sensitivity (fig. 15B).
SUMMARY
The fragmentary nature of the information which has been derived from 
investigations of heterology and the extent of hapten conjugation on the 
performance of EIA's is such that it is impossible to draw hard and fast 
conclusions about their influence on assay sensitivity. In general, where 
heterology has been introduced to effect increases in sensitivity little 
attention has been given to the degree of hapten incorporation achieved under 
these conditions (Van Weeman and Schuurs, 1975; Hosada et al, 1980). Increa­
ses or decreases in sensitivity under these circumstances may partly be 
attributed to differing degrees of steroid incorporation. Further, it has 
proved possible to achieve equally sensitive EIA's using homologous systems 
(Sauer et al, 1981; Turkes et al, 1979; Dray et al, 1975) as was previously 
thought possible only by using heterology (Joyce et al, 1977; Van Weeman and 
Schuurs, 1975). Closer attention to the elimination of free hapten following 
conjugation may have contributed to these improvements.
To our knowledge no studies have been performed under suitably compar­
able conditions to furnish evidence that for hapten assays an actual incor­
poration ratio of approximately 1 hapten per enzyme molecule does indeed 
result in standard curves of the greatest sensitivity. This arguement has a 
theoretical attraction which cannot be ignored but it does not take into 
account the extent to which incorporated haptens are sterically available 
for antibody binding. In future it would seem pertinent, when evaluating the 
influence of heterology on the sensitivity of EIA standard curves to consider 
concurrently the relationship between the total number of haptens incorpora­
ted into the enzyme and the number of haptens which are immunoreactive.
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Appendix
It is only recently that the Sigma Chemical Company have indicated in 
their catalogue that the grade IV E. Coli jB-galactosidase used in these 
studies is standardized by the addition of BSA. Since this would clearly be 
conjugated by the progesterone active ester and subsequently interfere with 
the assay, we now use the grade VIII product.
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USE OF MICROTITRE PLATE EIA FOR DIRECT 
DETERMINATION OF PROGESTERONE IN WHOLE 
MILK: APPLICATION OF HETEROLOGOUS 
SYSTEMS FOR IMPROVED SENSITIVITY
By M . J .  S a u e r , J .  A. F o u l k e s  a n d  P. M .  O n e i e l
M inistry o f  Agriculture, Fisheries and Food, Cattle Breeding Centre, Church Lane, Shinjield,
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SUMMARY
A n h om o lo g o u s  m ic ro t i t re  p la te  e n z y m e im m u n o a s s a y  (E IA )  for the  d irec t  
d e te r m in a t io n  o f  p ro g e s te ro n e  in w ho le  milk is d esc r ib e d .  A sp ec ts  o f  the  assay  
a re  d iscu ssed  in re la t io n  to p ro g es te ro n e  profiles o b ta in e d  from  severa l  cows over  
an  o e s t ro us  cycle. T h e  /3 -ga lac tos idasc  co n ju g a te  used w as  p r e p a r e d  from the  
1 la - h c m is u c c in a t e  de r iv a t iv e  o f  1 la -h y d ro x y p ro g e s te ro n e  a n d  w as  s u b ­
s e q u en t ly  c o m p a r e d  w ith  h e te ro lo go us  co n ju g a te s  p r e p a r e d  in a s im i la r  w ay  
us in g  1 l i r -h e m im a le a te ,  1 l a -g lu c u ro n i t l e  a n d  3 - (0 -c a rb o x y m e th y l )o x im e  
d eriva t ives .  T h e  p ro g es te ro n e  1 la -g lu c u ro n id e - /3 -g a lac to s id a se  c o n ju g a te  
p ro v id ed  s t a n d a r d  cu rves  w i th  th e  s teep es t  slope. A p p ro x im a te ly  V 10 th e  m ass  o f  
p ro g es te ro n e  (56 pg) w as  re q u i re d  to r ed u c e  c o n ju g a te  b in d in g  by  5 0 %  w h en  
c o m p a r e d  w ith  the  h o m o lo go us  h e m isu c c in a te  c o n ju g a te .  T h e  resu lts  sugges t  
th a t  the  use o f  a g lu c u ro n id e  b r id g e  for l ink ing  p ro g e s te ro n e  to e n zy m e  m a y  
re d u c e  ‘b r id g e - re c o g n i t io n ’ p h e n o m e n a  suffic iently  for a v isua l d is t in c t io n  to be 
m a d e  b e tw een  lu tea l  a n d  follicular p h a se  c o n c e n t ra t io n s  o f  p ro g es te ro ne .
INTRODUCTION
T h e  ana lys is  o f  p ro g es te ro n e  co n c e n t ra t io n s  in m ilk  is in v a lu ab le  for the in ves t ig a t io n  
o f  a n u m b e r  o f  r e p ro d u c t iv e  p a ra m e te r s  (L a in g  & H e a p ,  1971; H offm an  el al., 1976; 
L a m m in g  & B u lm a n ,  1976; Ball & J a c k s o n ,  1979; G u n z le r  1979). U n t i l  recen tly ,  
how ever,  such  an a ly se s  w ere  confined  to spec ia lized  lab o ra to r ie s  since  rad io -  
im m u n io a s sa y  (R IA )  w as the  on ly  p ra c t ic a b le  m e a n s  o f  p ro g es te ro n e  d e te r m in a t io n .  
E IA  p ro ce d u re s ,  deve lop ed  from th e  ear ly  w o rk  o f  E ngva ll  & P e r lm a n n  (1971) a n d  
V a n  W e e m a n  & S c h u u rs  (1971),  n ow  p ro v id e  a n  a l t e rn a t iv e  to R IA  a n d  h a v e  ra ised  
the  p ro sp ec t  o f  a p ro g es te ro n e  ana lys is  w h ic h  cou ld  be p e r fo rm ed  in an y  la b o r a to r y  o r  
even  o n -fa rm .  In  b o th  cases it is d e s i ra b le  for th e  assay  p ro c e d u r e  to be  s im p le  a n d  
involve no  s a m p le  p r e p a r a t io n ,  i.e. a n  a s say  ca r r ied  o u t  on  w ho le  milk w i th o u t  p r io r  
ex trac t io n  o f  s te ro id .  S u ch  a sy s tem  invo lv ing  the  use o f  m ic ro t i t re  p la te s  o r
M I C R O T I T R E  PL AT E EIA O F  P R O G E S T E R O N E 5 2 3
m ic ro g ra n u la r  ce llu lose-linked a n t i s e ru m  h as  been  d e sc r ib ed  p rev iously  (S auer ,  
Foulkes & C oo kson ,  1981; S a u e r  el al., 1982). T h e  m ic ro t i t re  p la te  m e th o d ,  how ever ,  
oilers m u c h  in te rm s  o f  speed  a n d  s im p l ic i ty  o f  o p e ra t io n  a n d  so h as  been  used for all 
o u r  su b s e q u e n t  s tud ies .  A l th o u g h  m ic ro t i t re  p la te  re ad e r s  a re  a v a i lab le  w h ich  will 
rap id ly  q u a n t i t a t e  e n zy m e  ac tiv ity  in situ, a  s im i la r  b u t  m o re  sensit ive  p la te  sys tem  
w o u ld  a llow  a v isua l d is t in c t io n  to be m a d e  b e tw een  lu tea l  a n d  fo l l icu la r-phase  levels 
o f  p roges te ro ne .
T h e  E IA  p ro c e d u re  de sc r ib e d  first in this  p a p e r  is te rm e d  h o m o lo g o u s  s ince  the  
p ro g es te ro n e  d e r iv a t iv e  co up led  to th e  en z y m e  is iden t ica l  to t h a t  u sed  for p r e p a r a t io n  
o f  the  im m u n o g e n  used in ra is in g  the  a n t i -p ro g e s te ro n e  s e ru m . G en e ra l ly ,  w hen  
h o m o lo go us  ex te rn a l ly - labe l led  s te ro ids  a re  used  in im m u n o a s sa y s  a n  overa l l  inc rease  
in the  b in d in g  affinity o f  the  a n t ib o d y  for th e m  is o b se rved  w h ich  is a ssoc ia ted  w ith  
ad d i t io n a l  recog n i t io n  o f  the  b r idg e  l ink ing  s te ro id  to label (S ca r isb r ick  & C a m e ro n ,  
1975). I t  h as  long  been  a p p re c ia te d  th a t  the  m a x im u m  sensit iv ity  a t t a in a b le  d ecreases  
w hen  a n t ib o d y  affinity for the  label is g rea t ly  d is s im ila r  to t h a t  for the  u n lab e l led  
an t ig e n  (E k ins ,  N e w m a n  & O ’R io rd a n ,  1968). T h is  w as  found  to ho ld  tru e  for l25I- 
b ascd  s te ro id  R IA  p ro ced u re s  (Allen & R e d sh a w ,  1978; C o rr ie ,  H u n te r  & 
M a e P h e r s o n ,  1981a; S tan cz y k  & G o e b e ls m a n n ,  1981) a n d  s te ro id  E IA  (V a n  W e e m a n  
& S c h u u rs ,  1975; Exley & A b u k n e sh a ,  1977; H o s a d a  el al., 1980) w h en  b o th  sys tem s 
were c o m p a r e d  w ith  R IA  using  5H - labe l lcd  s te ro ids .  T h e  effect o f  b r id ge  recognition  
can  be c o n s id e rab ly  re d u ce d  by ju d ic io u s  use o f  h e te ro log ou s  sys tem s  in w h ich  site o f  
a t t a c h m e n t  o f  the  e n z y m e  on  th e  s te ro id ,  th e  b r id g e  used o r  b o th  a re  a l te re d .  A l th o u g h  
the  h e te ro lo go us  sy s tem  finally a d o p te d  is often d e te r m in e d  on  a n  em p ir ic a l  basis, the 
w ork  o f  C o rr ie ,  Rateliffe & M a c P h e r s o n  (1981b) ,  u s ing  l2)I s te ro id  R IA  sys tem s, 
suggests  th a t  w h e re  a n t i s e ra  have  been  ra ised  a g a in s t  h e m isu c c in a te  der iva t iv es  the  
use o f  a g lu c u ro n id e  l inkage  a t  the  sa m e  site on  the  s te ro id  will gen e ra l ly  p rov ide  
c o n jug a tes  w ith  the  d e s i red  ch a rac te r i s t ic s  w i th o u t  the  n eed  for s u b s e q u e n t  selection  o f  
excep t iona l  a n t i se ra .  A co m p a r iso n  o f  four d if feren t co n ju g a te  sys tem s is d e sc r ib ed  
he re  w h ich  sugges ts  th a t  th e i r  find ings m a y  also  be a p p l ic a b le  to E I A  p ro ced u res .
U s in g  the  n o n -e q u i l ib r iu m  ho m o lo g o u s  m ic ro t i t re  p la te  E IA  for w ho le  m ilk  as 
d e sc r ib ed  below , it is a p p a r e n t  th a t  a l th o u g h  milk p ro g e s te ro n e  profiles o f  cows 
c o r re sp o n d  well w i th  those  d e te rm in e d  by  R IA ,  lu tea l  p h a se  c o n c e n t ra t io n s  are  
in v a r iab ly  o v e r -e s t im a te d  a n d  o ccas iona l t r a n s ie n t  (less th a n  one  d ay )  p ro g es te ro n e  
peaks m ay  a p p e a r  a ro u n d  oes t ru s  w hich  a re  no t  a p p a r e n t  u s ing  R IA .  In  a p re l im in a ry  
a t t e m p t  to e x p la in  these  differences w e h av e  in ves t ig a ted  the  c ross-reac t iv i ty  o f  various  
s te ro ids  in b o th  th e  E IA  a n d  R I A  sys tem s.  S ince  it has  been  sh o w n  th a t  the  d egree  o f  
c ross-reac t iv i ty  m a y  be sign ifican tly  a l te re d  in im m u n o a s s a y s  in w h ich  e q u i l ib r iu m  
has not been  a t t a in e d  (V in in g ,  C o m p to n  & M c G in ley ,  1981), the  ex tent o f  n o n ­
e q u i l ib r iu m  in this  sys tem  h as  also been  inves t iga ted .
MATERIALS ANl) METHODS
An lise rum
T h e  sa m e  a n t i s e ru m  ( G 7 1 1/12) w as used  for all E IA  a n d  R IA  p ro c e d u re s  a nd  was 
p re p a re d  by the m e th o d  o f  F u r r  (1973) us in g  p ro g es te ro n e  11 a ' -h em isucc ina te -B S A  as 
im m u n o g e n .
HRI TI SH VKTKRI NARY J O U R N A L ,  I 'Ml, (i
Preparation o f  steroid derivatives
1 lo r-hydro xy p ro gcs tc ron c  1 l -h e m isu c c in a te  (1*1 1 - 1 IS) a n d  I 1 a -h y d r o x y p ro -
g es te ron e  1 l - h c m im a lc a te  (P I  1 -H M ) w ere  p re p a r e d  by essen tia l ly  the s a m e  m ean s  
from 1 l t t - h y d ro x y p ro g e s te ro n e  (S tc ra lo ids ,  C ro y d o n ,  U K )  a n d  the  respec tive  acid 
a n h y d r id e s  (S a u e r  et al., 1981). 1 lo r -hy d ro xy p ro gcs tc ron c  1 l - g lu c u ro n id c  (P I  I-G ) was 
fo rm ed  by the  m e th o d  o f  C o rr ie  e ta l. (1981). P ro g e s te ro n e  3 -(0 -c a rb o x y m e th y l )o x im e  
( P 3 - C M O )  w as  p u rc h a s e d  from S tc ra lo ids .
T h e  N -h y d ro x y su cc in im id c  esters  o f  the  c a rb o x y la te d  s te ro ids  w ere  p r e p a r e d  in d ry  
d io x a n e  us ing  a d ic y c lo h ex y lc a rb o d i im id e  (S ig m a  C h e m ic a l  C o . ,  Poole, U K ) -  
m e d ia te d  c o n d e n sa t io n  reac t ion  as d esc r ib ed  by  S a u e r  et al. (1981). T h e  esters  o f  PI 1- 
H S  a n d  PI 1 -H M  w ere  p r e p a r e d  a n d  iso la ted  as c rys ta l l ine  p ro d u c ts  a n d  s to red  
d css ica tcd  un ti l  used for co n ju g a t io n  w ith  /3 -galac tosidase . T h e  esters  o f  P 3 - C M O  a n d  
P l l - G  w ere  used  d irec t ly  w i th o u t  p u r i f ica t io n  following a d d i t io n  o f  ace t ic  ac id  in 
d io x a n e  (m o la r  ra t io  s tero id :  ace t ic  ac id ,  1:0-5) to e l im in a te  u n re a c te d  c a rb o d i im id e  
a n d  fi l t ra tion  to re m o v e  the  b y -p ro d u c t  d icyc loh cxy lu rea .
Preparation o f  steroid-enzyme conjugates
T h e  /3 -galac tos idase  p r e p a r a t io n  w as  d ia ly scd  a g a in s t  0 1 M p h o sp h a te - sa l in e  buffer 
p H  7-0 before use. S o lu t ions  o f  the  N -h y d ro x y su c c in im id e  esters  in d ry  d io x a n e  w ere  
co n ju g a te d  d irec t ly  w ith  )3-galac tosidase  (g ra d e  V I I I ,  S ig m a - C h e m ic a l  C o .)  in 
p h o sp h a te -sa l in e  bufier  by  d ro p w ise  a d d i t io n  as desc r ib ed  by S a u e r  et al. (1981): a  25:1 
or 250:1 m o la r  excess o f  s te ro id  w a s  used .  O n e  h u n d r e d  p e rc e n t  convers ion  o f  P3- 
C M O  a n d  PI 1-G to the  esters  w as a s s u m e d .  T h e  vo lu m e  ra t io  o f /3 -g a la c to s id a se  in 
buffer to s te ro id  in d io x a n e  w as m a in ta in e d  a t  o r  ab o v e  10:1.
F ollow ing  c o n ju g a t io n  o f  s te ro id  w ith  en z y m e ,  u n c o n ju g a te d  s te ro id  was e l im in a te d  
by exh au s t iv e  d ia lysis  a n d  gel f i ltra tion  (S e p h a d e x  G 25) as p rev iously  d e sc r ib ed  
(S a u e r  et al., 1981) a n d  the  co n ju g a te s  s to red  a t  T C  in 0-1M p h o sp h a te -b u f ic rc d  sa l in e  
(p H  7-0) c o n ta in in g  0-1% (w /v)  s o d iu m  az id e  a n d  0-1% (w /v)  ge la t in  (P A S -g e la t in  
buffer).
Microtitre plate PI IA  procedure
T h e  wells o f  f ia t -b o t to m ed  polyvinyl p la te s  ( I )y n a te c h  M 29)  w ere  co a te d  w ith  the 
y -g lobu lin  fraction  o f  B S A -ab so rb cd  an t i -p ro g e s te ro n e  s c ru m  as desc r ib e d  by S a u e r  et 
al. (1982) af te r  w a sh in g  the p la te  wells w ith  T w e e n  20 (S ig m a  C h e m ic a l  Co, 0 0 5 %  
v/'v) a n d  r ins ing  twice w ith  d is ti lled  w a te r .  T h e  m ic ro t i t re  p la te  E IA  p ro c e d u re  was 
ca r r ied  ou t essentia lly  as r e p o r te d  by  S a u e r  el al. (1982) us ing  p ro g es te ro ne  s t a n d a r d s  
p re p a r e d  in w hole  milk from a cow at o e s t ru s  o r  from an  o v a r iec to m izcd  cow. A d d i t io n  
o f  im m u n o a s s a y  reag en ts  ( s ta n d a rd s ,  10 /xl; con ju g a te ,  200 [m\) w as p e r fo rm ed  a t  4°C1 
for s t a n d a rd iz a t io n  p u rp oses ,  c i th e r  s im u l ta n e o u s ly  using  a  p ip e t to r /d i lu te r  ( I M V ,  
I /A ig le ,  F ran ce )  o r  in rap id  succession  us ing  solid in terface p ip e t te s  (Socorex , R encns ,  
S w itz e r lan d  o r  S M I ,  Berkley, U S A ) .  Both  the  im m u n o a s sa y  in c u b a t io n  (3 h) an d  
en z y m e  in c u b a t io n s  (1 h) w ere  ca r r ied  o u t  a t  40°C. T h e  s u b s t r a t e  (o -n i tro p h cn y l  
/3 -D -g a lac to py rano s idc ,  3 m g /m l;  S ig m a  C h e m ic a l  Co.)  so lu t io n  w as cooled to 4°C 
before ad d i t io n .  'Flu* co lo u r  p ro d u c e d  on  in c u b a t io n  was m e a s u re d  d i rec t ly  th ro u g h  
the wells us in g  an  a u to m a t ic  p la te  re a d e r  ( D y n a te c h  M R  580).
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Radioimmunoassay procedures
Roth the ’’ , ' , ' :»sc a n d  m ic ro t i t re  p la te  R IA  p ro c e d u re s  w ere  c a r r ied  o u t  a t  4°C
essentia lly  as d e sc r ib ed  by S a u e r  el al. (1982).
Cross-reactivity studies
S tero id  s t a n d a r d s  w ere  p r e p a r e d  in P A S -g e la t in  bufier  a n d  assays  p e r fo rm ed  as 
d esc r ib ed .  T h e  c ross-reac t iv i ty  d a t a  w as  assessed  by the  c r i te r ia  o f  A b r a h a m  (1969).
Collection o f  m ilk samples
R e p re se n ta t iv e  m o r n in g  m ilk  sa m p le s  from F ries ian  cows w ere  taken  from the 
ind iv idu a l  bu lk  milk j a r s  by  s to ck m en  following ag i ta t io n  o f  the  milk. S o d iu m  az ide  
so lu tion  (2 0 %  w /v )  w as  a d d e d  to th e  s am p le s  (5 /u,l/ml) a n d  th e  m ilk  s to red  a t  4°C 
unti l  a ssayed .
Study o f  conjugate association time
S ta n d a r d s  p re p a r e d  in w ho le  m ilk  w ere  used  to assess the  t im e  taken  for m a x im u m  
b in d in g  o f  label  to the a n t ib o d y -c o a te d  p la te s  w ith  o r  w i th o u t  c o m p e t in g  s tero id  
p resen t.  A  co m p a r i so n  w as  m a d e  b e tw ee n  the  b in d in g  o f  en z y m e  c o n ju g a te  a t  b o th  4°C 
a n d  40°C w ith  the  b in d in g  o f  5H -p ro g e s te ro n e  a t  4°C.
RESULTS AND DISCUSSION
S ta n d a r d  cu rves  typ ica l  o f  those  o b ta in e d  in th e  p re se n c e  a n d  a b sen ce  o f  milk using 
ho m olo go us  F I  A a re  sh o w n  in Fig. 1. T h e  p resence  o f  milk c aused  a  co n s id e rab le  d ro p  
(2 6 % )  in co n ju g a te  b ind ing ,,  nec e ss i ta t in g  the  use  o f  s t a n d a r d s  p r e p a r e d  in w ho le  milk 
w h en  assay in g  u n k n o w n  milk sam p les .  A d r o p  in label b in d in g  (6 5 % )  in the
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Fig. I. C o m p a r i s o n  o l 'K I A  s ta n d a r d  curves  us ing  s t a n d a rd s  p r e p a re d  in bu t le r  ( •  —• )  o r  milk (a . — a ). 
V alues  were  correc ted  lor su b s t r a te  b lanks  a n d  are  m e a n  o f  four d e te rm in a t io n s  ±  2 SH M . For ease  of 
co m p a r is o n  results  a re  expressed  in te rm s  o f  a b so r b an c e  a n d  B/B„.
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c o m p a r a b le  m ic ro t i t re  p la te  R IA  (Fig. 2C ) b u t  no t  in l iqu id  p h a se  R I A  (Fig. 2A) 
in d ica te d  th a t  b in d in g  in h ib i t io n  is a  fea tu re  o f  the  m ic ro t i t re  p la te  sys tem . T h e  
q u a n t i ty  o f  a n t ib o d y  a d so rb e d  on  the  m ic ro t i t re  p la te  wells is far less th a n  th a t  p re se n t  
in th e  l iqu id  p h a se  sys tem : a p p ro x im a te ly  5 0 %  in the  case  o f  the  m ic ro t i t re  p la te  R IA  
a n d  2 0 %  in the  case  o f  th e  E IA  as d e te r m in e d  by b in d in g  o f  3H -p ro g e s te ro n e  to the 
wells in the  p re sen ce  o f  milk.
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Fig. 2. C o m p a r i s o n  o f  l iquid  phase  (A) a n d  m ic ro t i t re  p la te  (B a n d  C )  R IA  s ta n d a r d  curves  us ing  s ta n d a r d s  
p re p a re d  in buffer ( • - • )  o r  whole  milk ( + ■ - ■ * ) .  V a lues  a re  m e a n  o f  four d e te rm in a t io n s  ±  2  S E M .
A lth o u g h  lu tea l  p h a se  c o n c e n t ra t io n s  o f  milk p ro g e s te ro n e  w ere  o v e r - e s t im a te d  
us ing  th e  ho m o lo g o u s  E IA  sy s tem  (Fig. 3) profiles co r r e sp o n d e d  well w i th  those  
d e te rm in e d  by l iqu id  p h a se  R IA  a n d  have  been  successful ly  used  in p r e d ic t in g  the  t im e 
o f  ar t if ic ia l in s e m in a t io n  in  ca t t le  (Foulkes,  C o o k so n  & S a u e r ,  1982). P ro g e s te ro n e  
peaks  m a y  o ccu r  a r o u n d  o e s t ru s  in som e  a n im a ls  (e.g. P ro  39, Fig. 3). S u c h  t r a n s ie n t  
peaks  have  also been  n o ted  u s in g  R IA  (E. D . W a ts o n ,  u n p u b l i s h e d  d a ta )  a l th o u g h  
none  w ere  d e te c ted  here .  T h e s e  a n o m a l ie s  cou ld  be e x p la in ed  in p a r t  by  the  inc reased  
c ro ss-reac t iv i ty  o b se rved  for ce r ta in  s te ro ids  u s ing  E I A  w h e n  c o m p a r e d  w i th  l iqu id -  
p h a s e  m ic ro t i t re  p la te  R IA  (T a b le  I) . In  p a r t ic u la r ,  5 a - p r e g n a n e d io n e  a n d  
p reg n e n o lo n e  show  cross-reac t iv i t ies  a n  o rd e r  o f  m a g n i tu d e  h ig h e r  th a n  those  seen  
w ith  l iqu id  p h a se  R IA .  T h e  p resen ce  o f  5 a -p r e g n a n e d io n e  in milk has been  
d e m o n s t r a t e d  p rev iou s ly  (D a r l in g  & H a rk n e s s ,  1973; P u rd y  el al., 1980) a n d  cou ld  
there fo re  be resp on s ib le  for the  ‘sp ik e s ’ seen a ro u n d  oes trus ;  it is less likely th a t  levels 
w ou ld  be h igh  e n o u g h  (P u r d y  et al., 1980) to co m p le te ly  exp la in  the la rge  o v e r ­
e s t im a t io n  o b se rv ed  he re  in the  lu tea l  p h a se  o r  th a t  o es t rog ens  (M o n k ,  E rb  & M olle t ,  
1975; H e a p  & H a m m o n ,  1979; P a n d c y  et al., 1981) o r  co r t ico s te ro id s  (S c h w a lm  & 
T u c k e r ,  1978) a re  p re sen t  in sufficient q u a n t i t i e s  in w ho le  milk to c ro s s -reac t  
s ign if ican tly  in the  assay . I t  is im p ro b a b le  th a t  use o f  the  y -g lo b u lin  frac t ion  o f  the  
p ro g e s te ro n e  a n t i s e ru m  for the  E I A  r a t h e r  th a n  w ho le  a n t i s e ru m  as u sed  in the  l iqu id
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Fig. 3. C o m p a r i s o n  o f  p roges te rone  c o n cen tr a t io n  in whole  milk a ssayed  by m ic ro t i t re  p la te  E IA  ( ...... ) arid
liquid phase  R I A  ). S am ple s  were  col lected ov e r  a  30 -day  period  a ro u n d  oestrus.
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Fig. 4. D y n a m ic s  o f  enzy m e-p ro g cs te ro n c  con ju g a te  (A a n d  B) o r  [3H ]-p ro g es te ro n e  (C) b in d in g  to 
an t ib o d y - r o u te d  m ic ro t i t re  p la te  wells at 4°C or  40°C in the presence  o f  0 ( V  — V ) ,  10 (-*■ — ■*■), 20 — ^ ) ,
50 (■ — ■ ) ,  100 ( 0 ~ 0 ) .  200 ( •  — • ) ,  800 (□ —□) or 5000 (0 — 0 ) pg p roges terone.  W ho le  milk  s ta n d a rd s  were  
used. V a lues  a re  m e a n  o f  two d e te rm in a t io n s  o r  four  d e te rm in a t io n s  ±  2 S E M .
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p h a se  R IA  w as resp on s ib le  for the  d ifferences in c ross-reac t iv i ty  s ince  sue!) differences 
w ere  not a p p a r e n t  w h en  c o m p a r in g  th e  liqu id  p h a se  R IA  w ith  the m ic ro t i t re  p la te  
R IA  (Fig. 4).
'The w ork  o f  V in in g  et al. (1981) in d ica te d  th a t  e q u i l ib r iu m  m u s t  be a c h ie v e d  in an  
im m u n o a s sa y  in o rd e r  th a t  m a x im u m  specific ity  a n d  sensit iv ity  a rc  a t t a in e d .  
E q u i l ib r iu m  was not ach ieved  in the  E IA  sy s tem  even  af te r  in c u b a t io n  for 8 h a t  40°C 
or  72 h at 1°C w h e rea s  in the  R IA  sy s tem  e q u i l ib r iu m  w as a t t a in e d  af te r  4 to 6 h a t  4°C 
(Fig. 1). T h e  ch a n g e d  c ross-reac t iv i t ies  seen w ith  the m ic ro t i t re  p la te  E IA  could  
there fo re  be a result o f  the  n o n -e q u i l ib r iu m  n a tu r e  O f  this p roced u re .
I f  non-specific  in f luences re su l ted  in the  c o n ju g a te  b in d in g  inh ib i t ion  seen in the 
s t a n d a r d  cu rves  (Fig. I ) a n d  w ere  p re s e n t  in g r e a te r  q u a n t i t i e s  in the  test milk s am p le s  
a fu r th e r  d e p ress ion  o f  b in d in g  w ou ld  o ccu r ,  w ith  a c o n se q u e n t  o v e r -e s t im a t io n  o f  
p ro g e s te ro n e  c o n c e n t ra t io n .  S ince  no a t t e m p t  has  been  m a d e  to e l im in a te  such  n o n ­
specific b in d in g  in h ib i t io n  o r  to co rrec t  p ro g e s te ro n e  e s t im a t io n s  by use  o f  in d iv id u a l  
sa m p le  b lanks ,  su ch  a n  o cc u r re n c e  cou ld  also c o n t r ib u te  to the  o v e r -e s t im a t io n  o f  
lu tea l  p ro g e s te ro n e  co n ce n t ra t io n s .
T h e  p rogress ive  increase  in sens it iv ity  a ch ie v ed  w h e n  a series o f  h e te ro lo go us  b r id ge  
a n d  site  sys tem s  w ere  c o m p a r e d  w ith  the  h om o lo g o u s  assay  is sh ow n  in Fig. 5. T h e  
effect o f  us ing  co n ju g a te s  p r e p a r e d  us in g  a 25 o r  250-fold m o la r  excess o f  s te ro id  
de r iv a t iv e  is g iven  in Figs 5A a n d  5B respectively . W h e re  the  25 m o la r  excess o f s te ro id  
w as  used the  s lopes o f  th e  cu rves  in c rea sed  in the  o rd e r  PI 1-HS, PI 1 -H M , P 3 - C M O ,  
PI 1-G. A s im i la r  p ic tu re  w as  seen us ing  a 250 m o la r  s te ro id  excess b u t  th e  s lopes o f  the  
P 3 - C M O  a n d  PI 1 -H M  curves  w ere  a lm o s t  iden t ica l .  T h e  PI 1-G c o n ju g a te  p r e p a r e d
T A B L E  I
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11«-11 EM I S U C C IN A T E  S E R U M  (G 711/12): C O M P A R IS O N  O E L I Q U I D  PHASE RIA W IT H  
M I C R O T I T R E  PL A T E  RIA A ND M I C R O T I T R E  V l .A T E  EIA
Steroid %  Cross-reaction at 50%  label*displacement
Liquid-phase
R IA
Microtitre plate 
R IA
Microtitre plate 
E IA
Progesterone 100 100 100
Androstencdione <0-03 0*01 0-3
5/3-Pregnane-3, 20-dione 6-8 12-1 18-3
5«-Pregnane-3, 20-dione 1-3 0 05 31-8
1 7cr-Hydroxy progesterone 3-6 7-8 1-9
Pregnenolone 0 05 0-3 8-1
Cortisol < 0 0 3 <0-07 0-07
1 la-Hydroxyprogesterone 75-8 17-5 36-2
Corticosterone 1-6 0-4 3-2
Dehydroepiandrosterone 0-03 0-02 0-8
* R IA  ( *H |-pn>gestc ronc label , E IA  proges te rone  I Ia -li rmi.succinatr- /)-galact<>sidase label (con juga te  98, 
I I tig/well)  p re p a re d  us ing  25:1 m o la r  s te ro id  excess at con jugat ion .
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using a 25 m o la r  excess c learly  gave  rise to the  m ost sens it ive  s t a n d a r d  curve .  S ince  the  
h em isu c c in a te  a n d  h e m im a le a tc  b r idges  differ on ly  in respect o f  on e  d o u b le  b on d  
(Fig. 6) it is no t  su rp r i s in g  th a t  use o f  the  la t te r  gave  rise to the sm a lle s t  increase  in 
sensitiv ity . T h i s  co n tra s ts  w ith  the  find ings o f  G ros ,  F lecheux  & D ra y  (1978) w ho 
rep o r ted  th a t  the  use o f  h e m im a le a tc  c o n ju g a te s  re su lted  in b in d in g  inh ib i t ion  curves  
m ark e d ly  s te e p e r  th a n  those  seen us in g  the  h e m isu c c in a te  co n ju g a te s  a n d  essentia lly  
iden tica l  in slope  to those  o b ta in e d  in R IA  using  !H -p ro g e s te ro n c  as the  label.
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Fig. 5. C o m p a r i s o n  o f  F.1A s ta n d a r d  curves  us ing  p roges te rone  1 l a -h e m is u c c in a tc  ( •  — • ) ,  p roges terone  
I l<r*licmimulcalc ( n  O). p roges te rone  3-( ()-carl>nxymciliy l)uximc (Cl — rJ) o r  proges te rone  I 1 (r -g lucuronide 
(■ —■) con juga tes  p re p a re d  us ing  a 25 m o la r  (A) o r  250 m o la r  (1$) excess o fs te ro id .  Values  are  m ean  o f  four 
d e te rm in a t io n s  ±  2 S E M .
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Fig. I). C o m p a r i s o n  o f  s t ru c tu re s  o f  cn / .ym c-progcs tc rone  con juga tes  formed using: A I l a -h y d ro x y -  
p roges le rone  1 I- l icm isucc ina te ,  B I Ic r- f iydroxyprogeste rone 1 1 - l icrnim aleatc ,  C  p roges te rone  3-(0- 
c ar l )oxym etl iy l)ox im c a n d  0  1 lu - l tyd roxyproges ic i  one  I 1 -glucurOnidc .
5 3 0 Br i t i s h  v e t e r i n a r y  j o u r n a l , i 38, g
TABLE II
THE INFLUENCE OF SITE AND BRIDGE HETEROLOGY AND THE DEGREE OF STEROID 
INCORPORATION ON THE BINDING OF PROGESTERONE-/3-GALACTOSIDASE CONJUGA TES 
TO AN 11-PROGESTERONE I l«HEMISUCCINATE y-GLOBULIN
Conjugate
no.
Bridge position 
and type
Molar ratio 
steroid: enzyme 
at conjugation
Mass 
conjugate 
used in 
E IA  ng/well
B 0 value 
absorbance 
units*
Mass progesterone 
requiredfor 
50%  conjugate 
displacement
Pg
104 1 lur-hcnusuccinatc 25:1 12 0-320 875
105 1 la-hemisuccinatc 250:1 10 0-487 1220
101 1 la-hemimaleatc 25:1 21 0-389 380
90 11 d-hcmimalcatc 200:1 40 0-412 216
110 3-(0-carboxymethyl)-
oxime 25:1 136 0-217 100
111 3-(0-carboxymcthyl)-
oximc 250:1 11 0-247 230
114 1 lor-glucuronide 25:1 102 0-109 56
115 1 la-glucuronide 250:1 10 0-156 87
* C o rrec te d  Tor s u b s t r a te  b lank.
T a b le  II su m m a r iz e s  the  sens it iv ity  o f  (‘itch s t a n d a r d  cu rv e  in te rm s o f  the  m ass  o f  
p ro g e s te ro n e  re q u i red  to d isp lace  5 0 %  o f  each  co n ju g a te .  I t  w as  p rev iously  
d e m o n s t r a t e d  th a t  h ig h e r  s te ro id  ra t ios  a t  co n ju g a t io n  re su l ted  in a  h ig h e r  d eg ree  o f  
s tero id  in c o rp o ra t io n  (S a u e r  et al., 1981). I t  w as a p p a r e n t ,  therefore,  th a t  low er  levels 
o f  s tero id  in c o rp o ra t io n  re su l ted  in g re a t e r  sensit iv ity  in all co n ju g a te s  ex cep t  those  
us in g  the  h e m im a le a tc  b r idge .  U s in g  the  PI 1-G a n d  P 3 - C M O  co n jug a tes ,  
ap p ro x im a te ly  ten times m o re  co n ju g a te  w as  r e q u i re d  to a t t a in  a s im i la r  d eg ree  o f  
b in d in g  in the a b sen ce  o f  free p ro g es te ro n e  (B„ va lue)  w h e n  co n ju g a te s  w ith  th e  low er 
d eg ree  o f  s te ro id  in c o rp o ra t io n  w ere  e m p lo yed .  W i th  P l l - H S  a n d  PI 1 -H M  
con ju ga tes ,  how ever ,  this d ifference w as less m a rk e d  poss ib ly  d u e  to a  h ig h e r  d eg ree  o f  
b r id g e  recognit ion .  T h e  efficiency o f  th e  co n ju g a t io n  p ro c e d u re  us ing  the  PI l - H M ,  
P 3 - C M O  a n d  PI 1-G d e r iva t iv es  has  no t been  inv es t iga ted  a n d  therefore  the  effect o f  
v a r ia t io n  in the d eg ree  o f s te r o id  in c o rp o ra t io n  c a n n o t  be exc luded .
It can  be a rg u e d  th a t  inc reas ing  the  a s say  sensit iv ity  w ou ld  en ab le  less milk to be 
tsed for the  p ro g e s te ro n e  d e te r m in a t io n  a n d ,  as a c o n seq u en ce ,  th a t  this w o u ld  reduce  
the  non-specific  in f luence  o f  milk c o m p o n e n ts  on  co n ju g a te  b ind ing .  It has  been 
sugges ted  by o th e rs  (V a n  W e e m a n  & S c h u u rs ,  1975; H o s a d a  et al., 1980) th a t  such an  
increase  in sensitiv ity  m igh t  be a t t a in e d  by the use o f  h e te ro lo go us  sy s tem s a l th o u g h  
ev idence  derived  from I J , I-R1A  sys tem s  ind ica te s  th a t  p rev iou s  success  has  been  
largely as a result o f  the  c h a n c e  av a i lab i l i ty  o f  excep t io na l  a n t i s e ra  (C a m e r o n  el al., 
1974; P ra t t ,  1978; C o r r i e  et al., 1981 a). T h e  w ork  o f  C o rr ie  et al. (1981b) sugges ts  th a t  a 
m o re  sy s tem at ic  a p p ro a c h  m igh t  be a d o p te d  for se lec tion  o f  b r id ge -h e te ro lo g o u s
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sys tem s .  In  p a r t ic u la r ,  w h e re  a  h e m isu c c in a te  b r id g e  h a d  been  u sed  for im m u n o g e n  
p ro d u c t io n  ( the  m o s t  c o m m o n  in the  case  o f  a n t i -p ro g e s te ro n e  se ra ) ,  se lection  o f  a 
g lu c u ro n id e  b r id g e  for the  c o n ju g a te  w ou ld  be in d ica ted .  T h i s  a p p r o a c h  resu l ted  in an  
l25I - R I A  for p ro g es te ro n e  in w h ich  b r id g e  recogn i t ion  w as  a p p a re n t ly  red u ced  to a  
m in im u m  a n d  w hich  as  a re su lt  w as  effective us in g  a n u m b e r  o f  a n t i s e ra  (C orr ie  et al., 
1981b). O n e  a n t i s e ru m  w as  e x a m in e d  in this la b o r a to r y  b u t  since  it  w as  n o t  selected 
for p a r t ic u l a r  use in E IA  the  im p ro v e d  sens it iv ity  ach ieved  (Fig. 5) w h en  
PI l -G - /3 -ga lac tos idase  con ju g a te s  w ere  e m p lo y ed  su p p o r ts  the  a r g u m e n t  o f  C o rr ie  et 
al. (1981b).
I t  is h o p e d  th a t  a  sens it ive  h e te ro lo go us  sy s tem  will p ro v id e  a  so u n d  basis for the  
d e v e lo p m e n t  o f  a n  o n - fa rm  test for p ro g e s te ro n e  en a b l in g  a  v isual  d is t in c t ion  to be 
m a d e  b e tw ee n  m ilk  sam p le s  from  cows a t  fo l licular o r  lu tea l  p h ase s  o f  the  oes t rous  
cycle. T h is  will a l low  r e a d y  in v es t ig a t ion  o f  rep ro d u c t iv e  d iso rde rs ,  im p ro v ed  t im ing  o f  
A l  a n d  co n v en ie n t  p re g n a n c y  d iagnos is .
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I N T R O D U C T I O N
The developm ent of rad io im m unoassay  (RIA) 25 years ago (Berson & 
Yalow. 1959) m arked  the beginning of a new era in biochemical analysis, 
offering the possibility of  assaying a wide variety of  proteins and 
polypeptides. A lmost 10 years passed before the potential of this m ethod  
for the determ ina tion  of haptens was realised (Oliver et al., 1968). With 
this came the very real possibility of assaying, with unprecedented 
sensitivity and specificity, any  biochemical substance against which an  
antibody could be raised. D isadvantages, such as there are, revolve 
around the use of radioisotopes for quantification. Some isotopes have 
short half-lives, their determ ina tion  requires sophisticated and  expensive 
equipment and  their toxic nature  necessitates the application  of strict 
regulatory controls.  As a result, RIA has been excluded from m any small 
laboratories, especially in the food m anufacturing industry.
Although m any alternative forms of labelling have been considered 
(Schall & Tenoso , 1981), the use of enzyme-labelled reagents for im m u­
noassays (Engvall & Perlm ann, 1971; van W eemen & Schuurs, 1971) has 
provided the most convenient means by which the sensitivity and 
specificity of RIA can be more generally applied. The reagents used are
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those com m only  employed in general laboratories  and are thus not 
associated with special hazards: the enzymes used for labelling are cheap 
and may be stored for in excess of one year at 4°C, or  at room  
tem perature  when freeze-dried. Similarly, the equipm ent required for 
enzyme im m unoassay  (EIA) is com m on to the m ajority  of  the labora­
tories and requires only the availability of accurate  pipettes and  d ispen­
sers, and a colorimeter or spectrophotom eter.  E nd-poin t  determ ination ,
i.e. the quantification of co lour or  fluorescence, need no t be ra te  limiting. 
M icrotitre  plate readers enable au tom atic  optical density (OD) de­
te rm ination  at approxim ate ly  one per second and  microprocessor in­
terfacing is possible for d a ta  reduction. Since EIA can  be easy to perform 
and  colorimetric end-points  visually assessed, it has been adop ted  for 
simple screening procedures for use in the field (V o l le re t  al., 1976a).
ASSAY P R IN C IP L E S
Tw o basic types of im m unoassay  employ enzyme-labelled reagents: the 
enzyme im m unoassay  (EIA) and the sandwich assay, which are broadly 
ana logous with RIA and  im m unoradiom etr ic  assay, respectively. They 
rely on the inherent characteristic of antigen and  an t ibody  to  bind with 
high avidity and  specificity.
Enzyme immunoassay
EIA encom passes im m unoassays based on  the ‘sa tu ra tion  assay’ p rin­
ciple in which the analyte is enzyme-labelled (Fig. 1). The  assay co m ­
prises three com ponents : (i) a limited and  cons tan t quan t i ty  of antiserum 
specific for the analyte, (ii) a limited and cons tan t  quan t i ty  of enzyme- 
labelled analyte, and  (iii) s tandard  quantities of ana ly te  for calibration 
purposes  (or unknow n  quantities of analyte in the test sample). W hen the
Afl
+ Enz — Ag
Ab-K
Ab-
Ab
AB. ..Ab^:
Enz — Ag . .. Ab- /
Afl Ab.
Fig. 1. Principle of enzyme immunoassay; Ag =  antigen or hapten, Enz= 
enzyme label, =  solid phase, Ab =  specific antibody.
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three com ponen ts  of the system are mixed, labelled and  unlabelled 
analyte com pete  for the limited num ber  of an t ibody  binding sites (Fig. 1). 
Since each test con tains  the same am oun t  of an t ibody  and  labelled 
analyte, the greater  the quant i ty  of unlabelled analyte present, the 
smaller will be the quan t i ty  of labelled analyte binding to antibody. 
Separa tion  of free labelled analyte from tha t  bound  to an tibody , and 
subsequent addition  of substra te  to the bound  fraction, allows enzyme 
activity to be measured and the degree of com peti tion  to be ascertained. 
The greater the quan t i ty  of analyte present, the fainter will be the co lour 
produced. The use of s tandard  am ounts  of analyte enables calibration  
curves to be construc ted  and  quantification of analyte  in the unknow n  
sample by in terpolation  (Fig. 2). A typical EIA pro tocol is given in Table 
1.
This type of EIA requires separation  of free analyte from an tibody- 
bound analyte for quantification and  is term ed ‘heterogeneous’. The 
hom ogeneous EIA or enzym e-m edia ted  im m unoassay  technique (EM IT) 
is a special case of EIA which does no t  depend  on free and  bound  label 
separation  to enable assessment of the degree of  com peti tion  (Boguslaski 
& Li, 1982). Until recently, this m ethod  could only be applied  to the 
determ ination  of haptens. It relies on  the use of enzym e-hap ten  co n ­
jugates in which enzyme activity is altered on binding with the antibody. 
Figure 3 illustrates the principle behind the most co m m on  form of E M IT  
in which enzyme activity is inhibited by specific interaction with the 
antibody: enzyme activity is p roportional to  the concentra t ion  of hapten  
since the degree of inhibition will be reduced by its presence. A lthough 
these assays can provide very rapid tests (2-3 min) since separation  is not 
required, these procedures are far less sensitive than  their heterogeneous 
conterpar ts  (100-1000 fold) and  their applica tion  has largely been limited 
to the m onitoring  of drugs dur ing  therapy.
Sandwich Assays
‘Enzyme-linked im m unosorben t assay’ (ELISA) encompasses all solid- 
phase im m unoassays using enzyme-labelled reagents, bu t  is most com ­
monly used to  describe non-competitive solid-phase sandwich assays: it 
will, therefore, be used here in the m ore restricted latter context.  These 
heterogeneous m ethods are ana logous  with im m unorad iom etr ic  assays 
(Miles &  Hales, 1968; Addison &  Hales, 1971) and  are based on the 
principle of ‘reagent excess’. In con tra s t  to EIA, there is no  element of 
com peti tion  and the am o u n t  of enzyme label bound  is directly prd- 
portional to the concentra t ion  of analyte. Solid-phase reagents are used
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QO
Dosa
Log dosa
Fig. 2. Typical calibration curves for enzyme immunoassay.
Table 1
Typical Assay Protocol for Microtitre Plate Enzyme Immunoassay
1. Adsorb specific antibody onto wells of microtitre plate (Voller et al., 1976a). 
This involves addition of diluted, purified antibody (200-300 pi, dependent 
on plate type) and incubation for 3 h at room temperature or overnight at 
4°C. Store until required. Wells are emptied and washed prior to use.
2. Add sample or standard, then enzyme-labelled antigen (or hapten) to the 
wells and incubate for 2—3 h at room temperature.
3. Empty and wash wells with buffer ( x 3).
4. Add substrate solution and incubate at a temperature suited to enzyme 
(20°C for peroxidase, 20-40°C for alkaline phosphatase or P-galactosidase). 
S top reaction by addition of sodium hydroxide and determine absorbance. 
The reaction need not be stopped if an automatic microtitre plate reader is 
used since all 96 wells may be read in 1-1^ min.
5. Plot calibration curve and interpolate results.
for separation  of free label from bou n d  label which also facilitates the 
rem oval of excess reagents after each stage. 
A lthough  based on the same principle, there are n um erous  variants of 
the ELISA procedure (Schuurs &  van Weemen, 1980), the majority  of 
which use enzyme-labelled an t ibody  as tracer: Table 2(a) il lustrates the
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(a)
ENZYME Conjugated
hapten
Active
s ite Antibody
S u b strate
(b)
Fig. 3. Principle of homogeneous enzyme immunoassay. In this type of hom o­
geneous assay, enzyme activity is inhibited when antibody is bound to the 
enzyme conjugate (a). The presence of hapten reduces the degree of antibody 
binding to conjugate and thus the degree of enzyme,inhibition (b).
principle of these procedures and  Table 2(b) the end p roduc t of some of  
these variants. Solid-phase-linked antigen or  antigen-specific an t ibody  is 
required for the b inding and  subsequent detection of an t ibody  o r  an t i­
gen, respectively. In the latter  case, an assay is performed by sequential 
addition of antigen and  enzyme-labelled an t ibody  to  the solid-phase- 
linked an t ibody  system with a washing step being performed after each 
addition. Addition  of substra te  enables quantif ication  of the b o u n d  label.
W hichever p rocedure  is used, the solid-phase reagent should  ideally be 
present in sufficient excess to ensure com plete im m u n o ad so rp t io n  of the 
analyte in the s tandard  or test sample. Similarly, an  excess of all o ther  
reagents ensures com plete sandwich fo rm ation  for each analyte molecule. 
The process o f  sandwich form ation  obviously requires tha t  the antigen 
be multivalent. The  solid-phase an t ibody  and  labelled an t ibody  must 
both be specific for the antigen bu t should  be directed against different 
and spatially separated  antigenic determ inants .  A typical calibration  
curve and  assay pro tocol are shown in Fig. 4 and  Table 3, respectively.
The enzyme-labelled species-specific an t i- im m unoglobulin  is one of the 
more com m only  used labels and  forms the basis of the indirect ELISA 
(Table 2(b)). A lthough  this p rocedure m ay involve an addi t iona l  step in 
the assay, it obviates the need to label the analyte-specific an t iserum  or 
the analyte which m ay be in limited supply. F u rthe rm ore ,  the same label 
may be used in assays of a  num ber  of analytes depend ing  u pon  the 
species of the specific antiserum. In order  to avoid non-specific binding 
of label, it is im p o r ta n t  tha t  the two analyte-specific antisera are raised in 
phylogenetically d is tan t species, the labelled species-specific anti-
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Table 2
Principles of the Sandwich Assay 
(a) Sandwich assay Jar detection o f antigen
3~Ab +  Ag ——► 3 ~ A h . . .  Ag ^ _ >J^ -»-^-Ab. . .  A g . . .  Ab,-Enz
Ab,-Enz
(Kato et al., 1975; Maiolini & Masseyeff, 1975; Ishikawa & Kato, 1978; Ishikawa 
et a/., 1982)
(b) Final products o f  commonly employed types o f sandwich assay
(i) Detection of antibody r 
(Schmitz et a l,  1977) ■ <_
3 - A g . . .. A b . ..  Ag-Enz
(ii) Detection of antibody. -------». ____ ►
(Schuurs & van Weemen,
1980)
3 - A g . . . . Ab . , .. Protein A-Enz
Indirect sandwich assays:
(iii) Detection of antibody. — — ► ____ ►
(Engvall & Perlmann,
1972)
3 - A g . . . . A b , ;. . .  A b 2-Enz
(iv) Detection of antieen. — — ► — — ► -------»
(Voiler et a l, 1978) *”
. 3 * A b ., • Ag . . . A b , ..  Ab2 Enz
3 * =  Solid phase; Ab =  Antigen-specific antibody; Ab, =  antigen-specific antibody 
raised against different antigenic determinants to those of Ab; Ab2 =  antibody against 
immunoglobulin of the species in which Ab, was produced: in (iv) Ab, should 
therefore be raised in a different species than Ab; Protein A =  a protein isolated from
S. aureus which can interact specifically with the Fc region of most mammalian 
immunoglobulins.
im m unoglobulin  being raised against im m unoglobulin  of the species in 
which the second anti-analyte an tibody  (Ab, in Table 2(b)) was raised.
E N Z Y M E -L A B E L L E D  R E A G E N T S  
Choice of Enzyme
The choice of enzyme and  its specific activity are p rim ary  considerations 
in relation to assay sensitivity since it will determ ine the size of signal at 
the assay end-point .  Table 4 indicates im por tan t  criteria for the selection 
of enzymes for use as labels. Few enzymes fulfill all these criteria but
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Fig. 4. Typical calibration curves for a sandwich assay.
Table 3
Typical Assay Protocol for a Microtitre Plate Sandwich Assay for the Deter­
mination of Antigen
1. Adsorb specific antibody onto wells of the microtitre plates (Voller et al., 
1976<j), as Table I. Store plates (containing buffer and a bacteriostat) at 4 ’C 
until required. Plastic film may be used to seal the plates.
2. Empty and wash wells with buffer prior to use.
3. Add sample or standard at a suitable dilution and incubate for 2 h at room 
temperature. Empty and wash the wells with buffer (x3 ) .
4. Add enzyme-labelled specific antibody and incubate for 2 h at room tempera­
ture. Empty and wash wells (x3) .
5. Add substrate solution, incubate for a suitable period and, if necessary (see 
Table 1), stop the reaction. Determine the absorbance.
6. Plot calibration curve and interpolate results.
Other types of sandwich assay (Table 2) are performed in a similar way. In the 
indirect assay for antigen a further incubation stage is required prior to addition 
of substrate.
enzymes such as P-galactosidase, alkaline phospha tase  and peroxidase 
are most com m only  used. All produce assays of approxim ate ly  equiva­
lent sensitivity and are available commercially in a suitably pure form 
and at reasonable cost.  G iven this, the pruden t o pera to r  would perhaps
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Table 4
Considerations for Selection of Enzyme
1. Purity of enzyme preparation.
2. Specific activity of enzyme.
3. Sensitivity of detection of products.
4. Absence of interfering factors or enzyme-like activity in test fluid.
5. Ease and speed of estimation of enzyme activity and the safety of the 
reagents used.
6. Availability and cost of enzyme.
7. Stability of the enzyme and its conjugate.
base selection on the ease of enzyme activity determ ination  and the 
safety of the chemicals used. Peroxidase, for instance, is one of the least 
expensive enzymes and  has m any of the properties required for EIA, but 
the majority  of chrom ogens used in its determ ination  are mutagenic or 
carcinogenic: the form ation of carcinogenic p roducts  is also likely which­
ever ch rom ogen  is used (Saunders et al., 1964).
A lthough colorimetric end-points  are preferred for most applications, 
p-galactosidase, alkaline phospha tase  and  peroxidase may also be as­
sayed using substra tes  tha t  form fluorescent products.  This can increase 
the sensitivity of detection of enzyme by at least an order of magnitude 
(van der W aart  & Schuurs, 1977; Ishikawa & K ato ,  1978; Arakaw a et al., 
1979; Ishikawa et al., 1982).
Formation of Enzyme-Conjugates
M any potentia l users of EIA or ELISA are apprehensive of the chemistry 
involved in production  of enzyme-labelled reagents. In ELISA, however, 
it is invariably possible to adop t procedures such as the indirect sand­
wich assay (Table 2(b)) in which commercially-available labels such as 
species-specific enzyme-labelled anti- im m unoglobulin  are used.
In general,  enzyme-labelled forms of particular analytes or  primary 
antibodies however, are not available commercially, and  careful co n ­
sideration should be given to the method of conjugate formation. 
Conjugates  are required in which both  the catalytic activity of the 
enzyme and im m unoreactivity  of the analyte or binding characteristics of 
the an t ibody  are retained.
C onjugation  of analyte or an t ibody  with enzyme is generally achieved 
by covalent bonding  th rough  the lysine e-amino groups of  the enzyme or,
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where glycoprotein enzymes such as peroxidase are used, th rough  ca r ­
bohydrate  residues. M ethods  of conjugation and their relative merits 
have been discussed by a num ber of au thors  (Schuurs & van Weemen, 
1977; O 'Sullivan et al., 1979; Sauer et al., 1982a) and  will be described 
only briefly here.
Protein-Enzyme Conjugates
Since enzymes are themselves proteins contain ing  reactive groups, the 
main problems in the p roduction  of enzym e-pro te in  conjugates  are 
related to the prevention of  co-conjugation (polymerisation) of the 
enzyme or  protein. C oupling  reagents such as glu taraldehyde (Avrameas, 
1969; Avrameas & Ternynck, 1971; Voller et al., 1976a) an d  periodate 
oxidation (N akane  & K awaoi, 1974) are still widely used and reported  to 
provide conjugates of useful quality  despite the probabil ity  of some 
degree of polymerisation and denaturation .  It has been reported  that 
formation of these undesirable by-products  can be avoided using hetero­
bifunctional reagents (Kitagawa & Aikawa, 1976; O ’Sullivan et al., 1978; 
Tae, 1983). Norm ally, incorporation  of 1-2 enzyme molecules per antigen 
or an t ibody  will be op tim um  since more extensive coupling m ay result in 
reduced enzyme activity o r  immunoreactivity.
Hapten Enzyme Conjugates
Haptens may, in some instances, be coupled directly with enzymes, but 
usually it is necessary to form a derivative to provide a reactive g roup  at 
a suitable location (Robinson et al., 1975). H ap ten -enzym e conjugates 
are com m only  produced th rough  formation of a peptide bond  between 
carboxylic acid groups of the hapten  and am ino-groups  on the enzyme 
or vice versa. Since enzymes contain  bo th  of these groups, methods 
which avoid polymerisation of the enzyme are preferred: mixed an h y d ­
ride (Erlanger et al., 1957) and N -hydroxysuccinimide ester (Anderson et al., 
1964) procedures have been used to covalently bind haptens or their 
derivatives to enzymes with minimal enzyme dena tu ra tion  (Comoglio & 
Celada, 1976; Joyce et al., 1978; H osoda  et al., 1980; Sauer e t al., 1981). 
Direct carbodiim ide condensation ,  on  the o ther  hand, will inevitably 
cause some degree of dena tu ra t ion  since the condensa tion  reagent will 
necessarily com e into contac t with the enzyme with the result th a t  the 
conjugate may need to be purified by fractionation or affinity ch ro m a t­
ography (Dray et al., 1975; Exley & A buknesha,  1977). In theory, the 
coupling of one hapten  per enzyme should be optimal, but in practice the 
location and orientation  of the hapten on the enzyme may be im portan t  
since the possibility of steric h indrance of an t ibody  binding arises (Sauer
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et a l., 1981). It may, therefore, be necessary to a t tach  several hap ten  
molecules to each enzyme to ensure immunoreactivity: the op tim um  
degree of incorpora t ion  m ay thus need to be determ ined experimentally 
and will depend  on the enzyme and  hapten  employed.
Purification of Conjugates
It is essential that enzyme-labelled reagent is free from unlabelled analyte 
o r  an t ibody  following conjugation  to prevent a reduction  in the sensi­
tivity of the im m unoassay. F o r  bo th  enzym e-hap ten  and enzym e-pro te in  
conjugates, this is most com m only  achieved by gel f iltration on the basis 
of m olecular weight difference. The presence of unconjugated  enzyme is 
rarely problem atic  since this is washed away with the u n b o u n d  label 
during  the im m unoassay.
C onjugates  can often be s tored at 4°C in buffer contain ing pre­
servatives such as sod ium  azide (f3-galactosidase and  alkaline phos­
phatase) or merth io late  (peroxidase). The preservative used should be 
carefully considered since some may inhibit enzyme activity.
S E P A R A T IO N  O F  F R E E  F R O M  A N T I B O D Y -B O U N D  LABEL
N um erous  m ethods are employed for separation  of free label from 
an t ibody-bound  label (Table 5) a l though  the m ost convenient means is 
th rough  the a t tachm ent of one of the im m unoreagen ts  to a solid support.  
The  antigen o r  an t ibody  may be a t tached  covalently  to particulate 
m ateria l such as cellulose or  agarose (Wide, 1981) or. by passive adso rp ­
tion to the inner walls of plastic tubes or  m icrotitre plate wells (Engvall 
& Per lm ann ,  1971; Voller et a l., 1974). S epara tion  of free and  bound  label 
during  the im m unoassay  can be achieved by pouring-off o r  aspirating the 
free label: a particulate solid phase would obviously require to be 
sedimented before separation.
Im m unoprec ip ita t ion  (by the doub le  an t ibody  technique) has often 
been used in EIA, particularly  in the perform ance of steroid horm one as­
says (Dray et al., 1975; C om oglio  &  Celada, 1976; Joyce et al., 1978). It 
offers the advan tage  of better availability of p rim ary  an t ibody  to  the 
o ther  reagents, since all reagents rem ain  in so lu tion  until the precipi­
ta ting second an t ibody  is added. It has been suggested th a t  this may re­
sult in assays of  increased sensitivity (Joyce e t al., 1978) a l though  this 
has no t been a general finding (Arakaw a e t al., 1979; van W eem en et al., 
1979). This m ethod  does, however, require an ex tra  incubation  stage fol-
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Table 5
Methods of Separating Bound from Free Label
1. Polyethylene glycol precipitation (Osterman et al., 1979).
2. Double antibody precipitation (Comoglio & Celada, 1976; Joyce et al., 1978).
3. Double antibody solid-phase (Comoglio & Celada, 1976; Bosch et al., 1978).
4. Solid-phase primary antibody:
Agarose, cellulose, magnetisable cellulose (covalent binding: Engvall & 
Perlmann, 1971; K ato  et al., 1975; Guesdon & Avrameas, 1977; Joyce et 
al., 1977; Turkes et al., 1982).
Polycarbonate-coated, polystyrene or nylon balls (covalent or passive 
binding: M iranda et al., 1977; Smith & Gehle, 1977; Hendry & Herrman, 
1980).
Polystyrene test tubes (passive binding: Engvall & Perlmann, 1972; 
Stimson & Sinclair, 1974; Voller et al., 1975).
Polystyrene or polyvinyl microtitre plates (passive binding: Voller et al., 
1976a, 19766; Sauer et al., 1982a).
lowing addi t ion  of second an t ibody  and  so may be less convenient than  
solid phase EIA procedures. Again, separa tion  is achieved fol­
lowing centrifugation.
EIA and ELISA procedures were considerably simplified with the 
adoption  of disposable plastic microtitre plate systems (Voller et al., 
19766) and these are w orth  particular  consideration . The 
125 mm x 85 m m  plates are m anufactured in polystyrene or polyvinyl 
and comprise 96 wells in a 8 x 12 format: dependen t upon  type, each well 
may contain  a volume of up  to 400|il. Antigen or  an t ibody  is passively 
adsorbed on to  the inside of the wells and the plates stored until required. 
They m ay be sealed and  kept at 4°C with buffer/preservative in the wells 
or dried and s tored at room  tem pera tu re  in sealed dehydra ted  sachets, 
depending on the stability o f  the adsorbed  material. D uring  im m u­
noassay, separation  of free from bound  label is performed sim ultaneously  
in all 96 wells by inversion and  tapping dry  over abso rben t material. 
Over the past few years num erous  au tom atic  (through-the-well) col­
orimeters with microprocessor interface facilities have become available. 
These enable optical density de term inations to be carried ou t w ithout 
transfer of the samples into  cuvettes. Since all 96 wells m ay be read in 
1-1^ minutes it is no t generally necessary to stop  the enzyme reaction.
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F A C T O R S  I N F L U E N C I N G  S E N S IT IV IT Y
The factors tha t influence sensitivity of EIA and ELISA parallel those in 
their radio-labelled analogues, a l though additional consideration  must 
be given to factors which may modify enzyme activity and  have been the 
subject of recent reviews (van der W aart  & Schuurs, 1977; Sauer et al., 
1985).
The sensitivity of im m unoassays is com m only  defined as the smallest 
am oun t  of analyte which gives rise to a response significantly different 
from zero at the 95% confidence level (limit of detection). This would be 
determined from the assay calibration  curve and is defined as the mean 
value of the zero s tandard  minus two s tandard  deviations for EIA and 
for ELISA is the mean of the zero s tandard  plus two s tandard  deviations. 
When optim ising conditions in order  to improve sensitivity, the slope of 
the s tandard  curve and  the precision of determ inations m ust be taken 
into account. A ca libra tion  curve of shallow slope may, for instance, be 
more capable of d iscriminating between similar concentra tions of analyte 
than  a steeper slope if precision of the former is grea ter  (Ekins, 1983).
Influence of the Antiserum
The limit of detection of EIA is essentially determined, in accordance 
with the Law of Mass Action, by the avidity of binding of analyte to 
antibody: the more avid the antiserum  the more sensitive will be the 
assay. In ELISA, the influence of avidity of b inding is no t  so apparen t 
since excess reagents are used and sensitivity will depend  on  the signal to 
noise ratio  and, by implication, on  the specific activity of the label 
(Ekins, 1978: Ishikawa & K ato ,  1978).
The mass of an tibody  used in EIA or ELISA is determined by 
experiment th rough  com parison  of a range of an t ibody  dilutions and 
conjugate concen tra t ions  in the presence or  absence of clinically signi­
ficant quantities of analyte (antibody dilu tion  curves). In this way, the 
mass of reagents required to provide ca libration curves over the range of 
clinical concentra t ions and  with the required sensitivity can be ascer­
tained. Objective assessment of the effect of a l terations in method on 
assay performance may be aided by plotting precision profiles (Ekins, 
1983).
The quan t i ty  of antigen required for detection of antibodies  in ELISA 
would be similarly assessed by the p repara tion  of dilution curves. For 
serological diagnosis of infectious diseases, e.g. T rich inella  spiralis  in­
fection in pigs (see Bibliography index p. 20), however, only crude
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antigens are normally available. In these circumstances coating- 
'concentra tions of antigen for ELISA are normally determ ined by do ing  
chequer-board  ti tra tions against positive and negative sera and  su b ­
sequent tests performed using the antigen dilution which gave the 
greatest d iscrimination (Voller et a l ,  1976b).
T IM E  A N D  T E M P E R A T U R E  O F  IN C U B A T IO N
There are no hard and  fast rules regarding op t im um  time and  tem pera ­
ture for incubation, and  where sensitivity is no t critical, conditions are 
often adopted  on the grounds  of convenience. Short incubations may not 
be approp r ia te  where large num bers  of samples are involved since this 
can result in overlap  of assays: 2 - 3 h  im m unoreac tion  time is norm ally  
suitable. In ELISA, room  tem perature  or  37°C incubations are co m m on  
and can enable b inding to ap p roach  com pletion  within this period. EIA 
procedures are often carried out at 4°C however, since elevated tem pera­
ture can drastically reduce assay sensitivity: where the an t igen -an t ibody  
reaction involves a large enthalpy com ponen t,  b inding affinity will 
decrease with increased incubation tem perature  (Keane et a l ,  1976). 
Enthalpy plays only a small part  in the binding reaction of some 
antisera, however, and in these cases sensitivity may be relatively inde­
pendent of incubation tem perature  (M alvano  & Rolleri, 1975; K eane et 
al., 1976). Such antisera should  be identified at an early stage since they 
may enable incubations to be carried ou t at higher tem peratures  (e.g. 
37TT or  40CC) and therefore for shorter  periods w ithout loss of 
sensitivity.
T H E  N A T U R E  O F  T H E  L IN K  B E T W E E N  
H A P T E N  A N D  E N Z Y M E
RIAs of haptens are often performed using tritium-labelled hap ten  and 
the label is considered to be immunologically  identical to  the unlabelled 
hapten. In the case of enzyme-labelled hapten ,  however, the label may be 
bound with greater avidity than  the native hap ten  because structurally  it 
is very similar to the im m unogen  against which the antibodies were 
raised —  a phenom enon  referred to  as ‘bridge recognition’. This may 
result in a considerable loss in sensitivity (van W eem en &  Schuurs, 1975) 
typified by a reduction in slope of the s tandard  curve com pared  with
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tri t ium-based RIA using the same antiserum. W here such a loss in 
sensitivity is problem atic , it has been found tha t  changing  the bridge 
linking the hap ten  to the enzyme an d /o r  the site of a t tachm ent on the 
hap ten  can  result in recovery of sensitivity (van W eem en &  Schuurs, 
1975; Exley & Abuknesha ,  1977; A rakaw a et a i ,  1979; H osoda  et a i ,  
1980; Sauer et a i , 1982b).
N O N - S P E C I F I C  E F F E C T S
Non-specific adsorp tion  of enzyme label, interference with specific b ind­
ing and  factors interfering with de term ination  of enzyme activity have 
been reported  to reduce assay performance, especially where relatively 
large volumes of undiluted or  unextracted  sample are assayed. Biological 
samples may, for instance, con ta in  high concen tra tions  of endogenous 
enzyme or substances which inhibit or enhance enzyme activity. In 
general,  however, adequate  wash procedures between assay stages can 
prevent such interference.
Non-specific adsorp tion  of enzyme-label to  the solid phase has been 
reported  with solid-phase systems using passive adso rp tion  of reagent to 
the solid phase (plastic tube and  microtitre plate methods). This can 
normally be avoided by procedures which are now s ta n d a rd  in most 
protocols: excess adsorp tion  sites unoccupied by an t ibody  m ay  be b lock­
ed by add it ion  of  a high concentra t ion  of unrela ted  protein after 
antigen or  an t ibody  has been adsorbed. Alternatively, the inclusion of 
detergent or  high m olarity  salt a t  the im m uno-incubat ion  stage can be 
used to inhibit non-specific binding (Engvall &  Perlm ann, 1971; Engvall 
et a i ,  1971; Engvall &  Ruoslahti , 1979; Saunders, 1979).
In steroid ho rm one  EIA, as in RIA, the presence of steroid binding 
globulin in the p lasma or serum  of some species has been reported to 
interfere with the specific interaction of steroids and  antibody. Specific 
d isplacement of steroid from the binding globulin has been achieved by 
reducing the pH  at which the im m unoreac tion  is performed (Riad- 
F ahm y et a i ,  1981) or  by prior heating of the sample (Ogihara et a i ,  
1977).
C O N C L U S IO N S
EIA and ELISA have been extended to many disciplines in the biological 
sciences and assays have been developed for a b road  range of biochemi-
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cal substances. These include serum proteins (Schuurs & van Weemen, 
1977), horm ones (Sauer et a l., 1982u), antibodies against infectious 
diseases (Voller el a i ,  1978), viral antigens in infected plants (Voller et al., 
1976c; Clark & Adams, 1977), food constituents (M organ  et al., 1983; 
chapters in this book and  others listed in the Bibliography), antibiotics 
(Standefer & Saunders, 1978; M iura et al., 1981) and herbicides (Niewola 
■ et al., 1983). H eterogeneous EIA and ELISA are in limited use on a 
routine basis outside the sphere of infectious disease d iagnosis a l though  
an increasing num ber  of assays have been dem onstra ted  to com pare  
favourably with long established techniques (Oellerich, 1980; Schuurs & 
van Weemen, 1980).
The increasing dem ands  m ade for more, and  more varied, tests to be 
performed while staff num bers  are reduced means tha t  either tests will 
need to be circumvented by a greater  degree of selectivity on the part of 
the person requesting the analysis o r  tha t they should  be met by the 
use of simpler, m ore  flexible and more rapid procedures. M icrotitre  
plate and related tests hold much promise since they can be readily 
performed in a sem i-au tom ated  form, using dispensing and  washing 
devices and quantified using au tom atic  plate readers. U nder  less 
favourable circumstances, qualitative and sem i-quantitative results can 
be obta ined using pipettes and wash bottles and the co lour  simply read 
by eye, com parisons  being m ade  with calibrators.
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Use of progesterone ll-glucuronide-alkaline phosphatase 
conjugate in a sensitive microtitre-plate 
enzymeimmunoassay of progesterone in milk and its 
application to pregnancy testing in dairy cattle
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RG 2 9 B Z ; * M ilk  M arketing  Board, Veterinary Laboratory, C leeve H ouse, Low er W ick, W orcester 
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Sum m ary. A  sim ple d irec t-ad d itio n  m icro titre  p la te  enzym eim m unoassay  (E IA ) fo r 
p rogesterone  in w hole m ilk is described. T he assay used an tise rum  raised  aga in s t 
1 la -h y d ro x y p ro g es te ro n e  11-hem isuccinate  (p rogesterone  11-hem isuccinate) an d  
a he te ro logous label p rep a red  by co n juga tion  o f  1 la -h y d ro x y p ro g es te ro n e  11- 
g lucuron ide  (p rogesterone  11-g lucuron ide) w ith  a lkaline  p h o sp h a tase  using an  active 
ester p rocedu re . T he sensitivity , analy tica l recovery , linearity  o f  response an d  precision  
o f  the  assay com pared  fav o u rab ly  w ith rad io im m u n o assay  (R IA ). R esu lts from  E IA  o f  
m ilk sam ples w ere com pared  w ith dete rm in a tio n s m ade a fte r iso la tion  o f  p ro g este ro n e  
by H P L C  (r =  0-910). M ilk sam ples (200) were assayed by R IA  a t b o th  the  M ilk  
M ark e tin g  B oard  an d  the C attle  B reeding C en tre  an d  the  results w ere co rre la ted  w ith  
EIA  perfo rm ed  a t the C attle  B reeding C en tre  (r  =  0-890 an d  r — 0-833 respectively). 
C alv ing  d a ta  w ere o b ta in ed  from  a  fu rth e r 110 cow s fo r w hich the  m ilk  p rogeste rone  
E IA  h ad  p rov ided  a p regnancy  test 24 days a fte r A I; 46 cow s w ere co rrec tly  identified  
as n o n -p reg n an t an d  58 as p reg n an t an d  there  w ere 4 false positive an d  2 inconclusive 
results.
Introduction
In 1971, L aing & H eap  d em o n s tra ted  th a t concen tra tio n s o f  p rogeste rone  in the m ilk  o f  cow s 
reflected the  stage o f  the o estrous cycle as assessed by p a lp a tio n  o f  the ovary  per rectum . P ro ­
gesterone concen tra tio n s in m ilk w ere la te r show n to  paralle l those in p lasm a (H eap , G w yn , L aing 
& W alters, 1973; H offm ann  & H am b u rg er, 1973) an d  to  p rov ide  a  m eans o f  d e te rm in in g  w hether 
o r  no t p regnancy  had  been estab lished  a fte r in sem ination . Such m easurem en ts have enab led  the 
func tiona l s ta tu s  o f  the  co rpus lu teum  o f  d a iry  cow s to  be m o n ito red  an d  the causes o f  rep roductive  
failure to  be identified (H offm ann , G iinzler, H am b u rg er & Schm idt, 1976; L am m ing  & B ulm an, 
1976; F o o te  e t al., 1979; Ball & Jack so n , 1979). H ow ever, the enfo rced  restric tion  o f  com m ercia l 
R IA  services to  licenced specialized lab o ra to rie s  has m ean t th a t the on ly  ro u tin e  p rac tica l ap p li­
ca tion  o f  th is ap p ro ach  has been a p osta l p regnancy-testing  service (B oo th  & H o ld sw o rth , 1976). 
T he p o ten tia l advan tages o f  enzym eim m unoassay  (E IA ) over R IA  have been discussed prev iously  
in term s o f  general accessibility, low cost an d  the innocuous n a tu re  o f  the reagen ts em ployed  
(L an d o n , C ro o k a ll & M cG regor, 1975; S chuurs & V an W eem an, 1977; Blake & G o u ld , 1984).
E IA s have been described fo r the de te rm in a tio n  o f  p rogeste rone  in ex trac ts o f  serum  o r  p lasm a 
from  an im als o f  several species (D ray , A ndrieu  & R enaud , 1975; Joyce, R ead  & F ah m y , 1977;
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P atrico t, Poggi & R evol, 1978; Seeger, T h u ro w , H aede & K nappe, 1979; K am o n p a ta n a  et al., 1979; 
Johm en , N ak ao , T su n o d a  & K aw ata , 1980) an d  in ex trac ts o f  w hole m ilk o f  cow s (van de Wiel, 
K am o n p a ta n a , N g ram su rija roy , K oops & S inghajan , 1982), de fa tted  m ilk (N ak ao , Sugihashi, 
Saga, T su n o d a  & K aw ata , 1983) and  m ilk fat (A rn stad t & C leere, 1981). D irect E IA  procedures' 
requ iring  no ex trac tion  o f  p rogeste rone  have been described fo r bovine w hole m ilk (Sauer, 
Foulkes & C ookson , 1981; C hang  & E stergreen , 1984) an d  cream  (N ak ao  & K aw ata , 1980). T he 
developm ent o f  a m icro titre-p la te  p rogesterone  E IA  (S auer et al., 1981; S auer, F oulkes &  O ’N eill, 
1982a; van de W iel & K oops, 1982; M u n ro  & S tabenfe ld t, 1984; T a llon  et al., 1984) has, in 
particu la r, rem oved  m any  o f  the co n stra in ts  im posed by R IA . P rogesterone  m easurem en ts m ade 
directly  on  w hole m ilk sam ples by an  hom ologous m icro titre -p la te  E IA  enabled  assessm ent o f  
lu teal function  to  be used fo r m anagem en t o f  fertility  in com m ercial herds (F oulkes, C o o k so n  & 
Sauer, 1982). T his successful app lica tion , how ever, em phasized  th a t a m ore  robust an d  sensitive 
technique w as required  to  ensure g rea te r reliability  in general use.
T he com para tive  novelty  o f  d irec t E IA  requires th a t special a tten tio n  be paid  to  valida tion  
p rocedures an d  stresses the need fo r full d iscussion o f  its essential characteristics, particu larly  since 
the labelled an d  unlabelled  analy te  are  n o t physically  identical. T here  have been no rep o rts  o f  d irec t 
E IA  o r  R IA  o f  p rogeste rone  in m ilk in w hich such p rocedu res have included com parisons w ith 
results a fte r ch ro m ato g rap h ic  iso la tion  o f  p rogesterone  from  the sam e sam ples. C orrie , Ratcliffe 
& M acP herson  (1982) have d em o n s tra ted  the benefit o f  the g lucuron ide  bridge o f  125I-labe!led 
p rogesterone  11-g lucu ron ide -ty ram ine  con jugate  in reducing  bridge recogn ition  an d  im proving  
R IA  sensitivity . In  the p resen t study  a he te ro logous m icro titre -p la te  E IA  using progesterone  
11-g lucuron ide  label w as investigated . -
Materials and Methods
M aterials
Reagents. A .A T-dicyclohexylcarbodiim ide, A -hydroxysuccin im ide, /> -n itrophenylphosphate  
d isod ium  sa lt (“ Sigm a 104” , pN P P ), a lkaline p h o sp h a tase  (E C  3.1.3.1) type V II-T  (from  bovine 
in testina l m ucosa), sod ium  azide, ac tiva ted  charcoa l (u n trea ted  pow der) an d  d ie thano lam ine  were 
o b ta ined  from  Sigm a C hem ical C o m p an y  L im ited  (Poole , U .K .). T o luene  S c in tilla to r was 
o b ta in ed  from  P ack ard  In s tru m en ts  L im ited  (C aversham , U .K .) an d  L ac tab  M k III po tassium  
d ich rom ate  tab le ts from  T h o m p so n  and  C ap p er L im ited (R u n co rn , U .K .). P rogesterone  11a- 
g lucuron ide  (C orrie , H u n te r & M acP herson , 1981) w as a gift from  D r J. E. T . C orrie  o f  the  M R C  
Im m unoassay  T eam , E d in b u rg h , U .K . [ l,2 ,6 ,7 -3H ]P rogesterone  (sp. act. 8 0 C i/m m o l) was 
purchased  from  A m ersham  In te rn a tio n a l PL C  (A m ersham , U .K .). P rogesterone  w as ob ta ined  
from  K och  Light L ab o ra to rie s  (C o ln b ro o k , U .K .) an d  all o th e r stero ids from  S tera lo ids L im ited 
(C ro y d o n , U .K .). All so lvents used in the co n ju g a tio n  p rocedu re  were d ried  over m olecu lar sieves 
(type 3A , B D H  C hem icals L im ited , Poole, U .K .). A ll o th e r reagents w ere o f  A n a la r qua lity  and  
supplied  by B D H  C hem icals L im ited . G o a t an ti-p ro g este ro n e  11-hem isuccinate (an ti-p rogesterone) 
serum  (G 7 1 1/12) w as a gift from  D r G . S. Pope, N IR D , Shinfield, an d  w as used fo r all E IA  and  
R IA  studies a t the C attle  B reeding C entre .
Buffers. P h o sp h a te  buffers (0-1 m , pH  7-0) w ere p rep a red  w ith d isod ium  hydrogen  o rth o p h o s­
p h a te  (12 H 20 )  an d  sod ium  d ihyd rogen  o rth o p h o sp h a te  (2 H 20 )  w ith  sod ium  ch lo ride  (0-9%  w/v; 
PS buffer), sod ium  azide (0 -1 %  w /v; PA S buffer) an d  gelatin  (0-1 %  w /v; P A S-gelatin  buffer) added. 
D E M  buffer (pH  9-8) con ta in ed  d ie thano lam ine  (1 m ), m agnesium  ch loride (0-5 mM) and  sodium  
azide (0-1%  w /v).
Treatm ent o f  m ilk  sam ples. M ilk sam ples (20 ml) w ere tak en  from  the co llection  ja r  after 
ag ita tio n  o f  the  com plete  m ilk ing , p reserved by a d d itio n  o f  one L ac tab  M k III tab le t an d  sto red  a t 
4°C  un til assayed.
Progesterone standards.P ro g e s te ro n e  (100 pg/m l m ethano l) w as ad d ed  (0-1 m l/20 m l) to  w hole
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m ilk collected from  an  ovariectom ized  cow  and  preserved by ad d ition  o f  one L actab  M k III 
tab let/20  ml. T his so lu tion  w as fu r th e r d ilu ted  w ith the sam e m ilk to  prov ide s tan d a rd s  (m ilk 
s tan d a rd s) co n ta in in g  0 -8 0  ng progesterone/m l. Buffer s tan d a rd s  w ere p repared  in PA S-gelatin  
buffer in the sam e m anner.
A ntibody preparation. T he  an ti-p rogeste rone  serum  (G 711/12) was raised  in a c a s tra ted  m ale 
goat a fte r im m unization  aga in s t p rogeste rone  11-hem isucc inate-bovine serum  a lbum in  (F u rr, 
1973). T he y -g lobulin  frac tion  o f  th e  bovine serum  a lbum in  (B S A )-absorbed  an tise rum  w as 
p repared  by trea tm en t w ith R ivanol pH  9-0 (Sauer, C o o k so n , M acD o n a ld  &  F oulkes, 1982b).
R adioim m unoassay at the C attle  Breeding Centre
S tan d ard s  (10 pi, in q u ad ru p le t)  o r  sam ples (10 pi, in dup lica te) were p ip e tted  in to  po lystyrene 
test tubes. [3H ]P rogesterone  in PA S-gelatin  buffer (200 pi, =  7 pg p rogesterone) an d  a n ti­
p rogesterone  y-globulin  (100 pi, equ ivalen t to  1: 15 000 d ilu tio n  o f  serum ) in PA S-gelatin  buffer 
were then added . T he tubes w ere m ixed an d  in cuba ted  o vern igh t a t 4°C . Ice-cold PA S-gelatin  
buffer (500 pi) w as added  to  each tube  an d  free [3H ]progesterone  w as sep a ra ted  from  b o u n d  by the 
ad d itio n  o f  dex tran -co a ted  charcoa l suspension  (200 pi, co n ta in in g  6-25 m g cha rco a l/m l an d  
0-625 m g d ex tran /m l) in PA S-gelatin  buffer a t 4°C. A fte r 10 m in a t 4°C  the tubes w ere cen trifuged  
a t 1600# (5 m in), the  su p e rn a ta n t w as pou red  in to  scin tilla tion  vials an d  the rad ioac tiv ity  
determ ined  follow ing ex trac tion  in to  T o luene S cin tilla to r (7 ml).
Preparation o f  an tibody-coated  m icrotitre p la tes
T he an ti-p rogeste rone  y-globulin  w as d ilu ted  (equivalen t to  1 :8000  d ilu tion  o f  serum ) in 
0-17 m M -sodium ace ta te  buffer, pH  5-0, an d  an  a liq u an t (200 pi) w as ad d ed  to  each well o f  the 
m icro titre  p lates (N U N C -im m u n o p la te  IF , G IB C O , U xbridge, U .K .). T h e  p lates w ere covered 
w ith a lid an d  even ad so rp tio n  o f  an tib o d y  w as ensu red  by m a in tenance  in a d raugh t-free  en v iro n ­
m ent aw ay from  poin t-sources o f  heat fo r 3 h a t  ro o m  tem p era tu re  (20-22°C ). T he m icro titre  p lates 
w ere em ptied  an d  PA S-gelatin  buffer (350 pi) was ad d ed  to  each well before tightly  covering  w ith 
p lastic  film (P ayne Scientific A p p ara tu s , C roydon , U .K .) an d  sto rin g  a t 4°C . B inding ac tiv ity  w as 
retained  fo r a t least 6 m o n th s u n d er these cond itions.
Preparation o f  alkaline phosphatase-progesterone conjugates
A lkaline pho sp h a tase  (2-5 mg/0-3 ml; 25 nm ol) w as d ialysed aga in s t PS buffer (1 litre), fo r 24 h 
a t 4°C  and  ad ju s ted  to a co n cen tra tio n  o f  5 m g/m l w ith PS buffer before use. yV-hydroxy- 
succinim ide (110 nm ol in 20pi d ry  d ioxan) an d  d icyclohexylcarbodiim ide (110 nm ol in 20 pi d ry  
d ioxan) were added  to  p rogesterone  11-g lucuron ide  (100 nm ol in 20 pi d ry  d ioxan ) an d  s tirred  fo r 
1 h a t room  tem p era tu re  (20-22°C ). U n reac ted  d icyclohexylcarbodiim ide w as inac tiv a ted  by 
ad d itio n  o f  acetic acid  (50 nm ol in 20 pi d ry  d ioxan). A fter a  fu rth e r 15 m in the  in so lub le  by ­
p ro d u c t d iclyclohexlyurea w as rem oved by cen trifu g a tio n  (2 000#  fo r 10 m in). A  100% conversion  
o f  p rogesterone  to  ‘active este r’ w as assum ed. S tero id  so lu tion  (40 pi) w as slow ly added  to a lkaline  
p h o sp h a tase  in PS buffer (500 pi) to  p rov ide  a m o la r ra tio  o f  2 :  1. T he m ix tu re  w as stirred  fo r 2 h a t 
room  tem p era tu re  before d ialysing  a t 4°C aga in s t 4 changes o f  3 litres o f  PA S buffer over 4 days. 
T he co n juga te  so lu tion  was finally passed dow n a S ephadex  G 25 co lum n to  rem ove any  rem ain ing  
free stero id . G ela tin  so lu tion  (10%  w/v in PA S buffer) w as then  added  to  a final co n cen tra tio n  o f  
0-1%  (w /v). T h e  con jugate  w as sto red  a t 4°C  and  u nder these co n d itio n s has been show n to  be 
stable for a t least I year.
E nzym eim m unoassay
M icro titre  p lates previously  coated  w ith  a n tib o d y  (above) w ere em ptied , shaken  d ry  and
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b lo tted . W hole m ilk s tan d a rd s  an d  sam ples w ere allow ed to  com e to  ro o m  tem p era tu re  (20-22°C ) 
an d  tho ro u g h ly  m ixed before assay. S tan d a rd s  (10 pi, co n ta in in g  0 -800  pg progesterone) o r 
sam ples (10 pi) w ere added  to  dup lica te  wells. C o n ju g a te  d ilu ted  in PA S-gelatin  buffer (200 pi; 
20 ng/w ell) w as then  added  a t am b ien t tem p era tu re . B lank values w ere de te rm ined  by ad d itio n  o f 
buffer a lone  to  dup lica te  wells co n ta in ing  10 pi o f  the  zero  p rogeste rone  s tan d a rd . T he p lates were 
covered w ith  a p la te  lid an d  incuba ted  a t am b ien t tem p era tu re  fo r 3 h in a covered p lastic box lined 
w ith  d am p  p ap er before  em pty ing  an d  w ashing  3 tim es w ith PA S-gelatin  buffer (350 pl/w ell) a t 
40°C  delivered from  an  8-channel perista ltic  d ispenser (M icro  C o m p u -P e t M u lti-D ilu to r, G eneral 
D iagnostics, A b ingdon , U .K .). S u b stra te  (p -n itro p h en y lp h o sp h a te , 15mM in D E M  buffer) w as 
added  to  each well (200 pi) and  the p lates w ere in cuba ted  fo r 1 h a t 40°C  in a w ate rb a th  on  a grid  a t 
w ate r level. T he ab so rb an ce  (405 nm ) o f  each well w as recorded  directly  using a D ynatech  M R 580 
au to m a tic  p la te  reader. Since the w hole p la te  w as read  in 1-2 m in the enzym e reaction  w as no t 
stopped . T he p rogeste rone  co n cen tra tio n  in each  sam ple w as estim ated  by  in te rp o la tio n  from  the 
ca lib ra tio n  curve on  each p la te  (Fig. 1). F o r  large num bers o f  sam ples th is p rocedu re  has been 
perfo rm ed  au tom atica lly  by in terfac ing  w ith  a  m ic ro -com pu ter an d  app ly ing  a  fo u r-p aram eter 
logistic curve fit (R o d b a rd , 1978).
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Fig. 1. C alibration  curves for EIA (A) and R IA  ( • )  using standards prepared in milk (a) or
buffer (b). F o r EIA, mean B/B0values ±  s.d. and CV (------) for 8 (a) or 6 (b) consecutive assays
are shown. Values for a single R IA  calibration curve are included for com parison. M ean 
absorbance values in the absence o f com peting progesterone (B0) fell within the ranges 
0-659-0-894 (a) and 0-624-1-017(b ).
A ssay validation
E xtraction  o f  progesterone fr o m  m ilk  sam ples. W hole m ilk sam ples (« =  25) were selected, using 
a ran d o m  num bers tab le , from  sam ples collected on  a  ro u tin e  basis. [3H ]P rogesterone  (0-9 ng in 
50 pi m ethano l: 5 x 10s d .p .m .) w as ad d ed  to  a liq u an ts  (15 ml) o f  each  sam ple an d  allow ed to 
eq u ilib ra te  a t 4°C  overn igh t. S ubsequen t de te rm in a tio n  o f  rad ioac tiv ity  by liquid  scin tilla tion  
sp ec trom etry  allow ed co rrec tions to  be m ade fo r p ro ced u ra l losses.
P rogeste rone  w as ex trac ted  by a m eth o d  sim ilar to  th a t described  by A xelson & Sahlberg
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Fig. 2. Separation o f steroids by H PLC  using conditions described in the text. Peaks are in 
o rder o f elution, ( l)  5a- and 5P-pregnane-3,20-dione; (2) progesterone; (3) 3P-hydroxy- 
5-pregnen-20-one; (4) 3P-hydroxy-5a-pregnan-20-one; (5) 17-hydroxy-4-pregnene-3,20-dione; 
(6) 20P-hydroxy-4-prcgncn-3-one; and (7) 1 ip-hydroxy-4-prcgnene-3,20-dione.
(1981) using 6 ml B ak e r-10 octadecyl silica co lum ns (L in to n  P ro d u c ts  L im ited, H arlow , U .K .). T he 
co lum ns w ere cond itioned  by e lu tion  w ith m e thano l (2 x 5 m l) an d  deion ized  w ater (2 x 5 ml). 
M ilk sam ples w ere heated  in a w a te rb a th  a t 64°C  fo r a m in im um  o f  10 m in an d  im m ediately  added  
to  the co lum ns in th ree a liq u an ts  o f  4-66 ml using a positive d isp lacem en t p ipe tte  (T ran sfe rp e tto r, 
A. R. H orw ell L im ited, L ondon , U .K .). Sam ples w ere ex trac ted  under reduced  pressu re  using a 
B ak er-10 m anifo ld ; the flow th ro u g h  each co lum n w as ad ju s ted  to  a m axim um  o f  1 m l/m in . 
C o lum ns w ere w ashed w ith  d istilled  w ate r (64°C , 2 x 5 m l) before e lu tio n  o f  stero id s w ith  
m ethano l (3 x 0-5 ml) in to  conical glass test tubes. T he tubes w ere left o v ern igh t a t — 20°C  an d  the 
lipids th a t p rec ip ita ted  w ere sep ara ted  by cen trifuga tion  (1600 g , 10 m in). T he ex trac ts  w ere 
asp ira ted  in to  screw -capped glass vials (2 m l capacity ), d ried  dow n u nder n itrogen , redisso lved  
in the h igh-pressure liquid  c h ro m a to g rap h y  (H P L C ) m obile phase (e thano l, 1% v/v in 
d ich lo rom ethane ; 0-7 ml) and  s to red  a t — 20°C  until requ ired .
Isolation o f  progesterone fr o m  m ilk  ex trac ts  by H P L C . P rogesterone  w as iso lated  from  m ilk 
ex trac ts  (100 pi) by H P L C  using a  125 m m  x 4-6 m m  stain less-steel co lum n packed  w ith  R oSil 
3 pm  spherical silica (A lltech A ssociates, C a rn fo r th , U .K .), an  A C S 351 p u m p  (A pplied  
C h ro m a to g rap h y  System s, L u ton , U .K .) an d  a  V aleo 10-port in jection  valve (C  10 U , A lltech 
A ssociates) fitted w ith a 100-pl sam ple loop  to  perm it tim ed co llec tion  o f  sam ples an d  co lum n  back  
flushing. A n u ltrav io le t (280 nm ) d e tec to r (Pye U nicam  P U  4020, 8-pl flow cell) w as used to 
estab lish  op tim um  isocratic  co nd itions fo r separa ting  p rogeste rone  from  related  stero id s . T he 
m obile phase (flow ra te  2 m l/m in) allow ed baseline reso lu tion  (Fig. 2) o f  p rogeste rone  from  all 
stero ids tested  (5a- and  5P-pregnane-3 ,20-dione; 3p -hydroxy-5-pregnen-20-one; 3P -hydroxy-5a- 
p regnan-20-one; 20P-hydroxy-4-pregnen-3-one; 1 ip -hydroxy-4 -p regnene-3 ,20 ;d ione  an d  17- 
hydroxy-4-pregnene-3 ,20-dione). Since the occurrence  an d  iden tity  o f  p rogeste rone  m etabo lites
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in milk is no t fully estab lished  the co lum n w as backflushed  for 6 m in a fte r collection  o f  the 
p rogesterone  fraction , a  period  three tim es the re ten tio n  tim e o f  p rogesterone . T h is m inim ized any 
carry -over o f  slow runn ing  com p o n en ts  from  one sam ple to  an o th e r . T he progesterone  fraction  
w as dried  dow n a t 6 0 X  under a  stream  o f  n itrogen  and  redissolved in PA S-gelatin  buffer (0-7 ml) 
before EIA  and  R IA  using buffer s tan d a rd s  (in qu ad ru p le t) .
Comparison o f  pregnancy test results using R IA  and E IA
M ilk sam ples (200) su bm itted  to  the M ilk M ark e tin g  B oard  by com m ercial farm s for p regnancy  
testing 22-26  days a fte r service o r by veterinary  su rgeons investigating  h erd  fertility  w ere assayed 
by the R IA  in rou tine  use a t the M M B  V eterinary  L ab o ra to ry  (H o ldsw orth , C hap lin  & B ooth , 
1979) before tra n sp o rt to  the R ead ing  C a ttle  B reeding C en tre  fo r fu r th e r d e te rm ina tion  by R IA  
an d  EIA . T he m ajo rity  (168) w ere w hole m ilk sam ples taken  a fte r ag ita tio n  o f  the  m ilk collecting 
ja r  bu t 32 w ere fore-m ilk  sam ples collected by hand .
C onfirm ation o f  pregnancy test results obtained by E IA
A fu rth e r 110 w hole m ilk sam ples w ere ob ta in ed  from  cow s in fo u r herds 24 days a fte r service 
an d  progesterone  concen tra tio n s w ere determ ined  by E IA . T he conclusions were subsequen tly  
verified from  calving d a ta .
S ta tis tica l analysis
W hen assay  techniques w ere com pared , w eighted  linear regressions w ere ca lcu la ted  assum ing 
e rro r  in b o th  procedures: slopes an d  in tercep ts w ere co rrec ted  a fte r estim ating  th e  variance in each 
technique from  their coefficients o f  v aria tio n  an d  their com patib ility  w ith a line o f  iden tity  
( s lo p e = l ,  in tercep t =  0) tested  using  an  F -ra tio  based  on  the ‘ex tra  sum -o f-squares’ princip le  
(M unson  & R o d b ard , 1982).
R esults
A ssay sensitivity
T he sensitivity  o f  each assay is defined in T ab le  1 in term s o f  bo th  lim it o f  de tec tion  (A b rah am , 
1969) an d  the m id -po in t o f  the ca lib ra tio n  curve (F e ld m an  & R o d b a rd , 1971). V alues show n were 
from  ca lib ra tio n  curves using s tan d a rd s  p rep ared  in m ilk o r P A S-gelatin  buffer (F igs la  & lb ).
Table 1. Assay sensitivities
EIA RIA
Limit of detection* Calibration curve Limit of detection* Calibration curve
Standards (confidence limit) mid-pointf (confidence limit) mid-pointf
Whole milk 5 pg (95%) 24 pg 5 pg (99%) 40 pg
PAS-gelatin 2 Pg (99%) 10 pg 5 pg (99%) 2 0  pg
♦Smallest quantity of progesterone measured which gives rise to a response significantly different from zero 
(Abraham. 1969). Confidence limits were derived from the appropriate t statistic. 
tThc mass of progesterone required to produce a 50% reduction in label binding (Feldman & Rodbard, 1971).
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Precision o f  E IA
Precision o f  adsorption o f  antibody to m icrotitre-pla te wells. T he enzym e-labelled stero id  
con jugate , d ilu ted  in PA S-gelatin  buffer (20 ng/200 pi), w as added  to  88 wells on  each o f  6 p lates 
previously co a ted  w ith an ti-p rogeste rone  y-globulin: 8 wells in the cen tre  o f  the plates received 
buffer a lone  to  p rov ide  b lan k  values. T he p lates w ere trea ted  as described fo r E IA  and  the s ta n d a rd  
dev ia tion  (s.d.) o f  the abso rbances o f  the 88 wells w as ca lcu la ted  fo r each p late . T he m ean 
w ith in-assay  coefficient o f  v a ria tio n  (CV ) fo r the 6 p la tes w as 5-1 %  (range 4-1-7-9% ). T he m ean  
abso rbance  ca lcu lated  fo r the wells a t the  ou ts ide o f  each o f  the  6 p lates did n o t differ significantly  
from  the m ean  value fo r the rem ain ing  wells.
Blank values. T he b ind ing  o f  enzym e-progesterone con juga te  to  non im m une y -g lobulin  and  
enzym e to  an ti-p ro g este ro n e  y-globulin  w as tested  to  investigate non-specific b ind ing  in the 
m icro titre -p la te  system . E ach  o f  2 p la tes w as co a ted  w ith  b o th  an ti-p rogeste rone  y-g lobulin  ( 2 x 4  
row s o f  8 wells) an d  non im m une y-globulin  (4 row s o f  8 wells). M ilk  sam ples (10 pi; n — 8) c o n ta in ­
ing high ( >  15 ng/m l) co n cen tra tio n s o f  p rogesterone  w ere added  in q u ad ru p lica te  to  each g ro u p  
o f  4 row s on  one p la te  an d  m ilk sam ples (10 pi; n =  8) co n ta in ing  low  ( <  5 ng/m l) con cen tra tio n s 
o f  p rogesterone  to  the o th e r p late. A lkaline p h o sp h a tase  in P A S-gelatin  buffer (40 ng/200 pi) was 
added  to  one g ro u p  o f  wells co n ta in in g  an ti-p rogeste rone  y-globulin  on each p la te  an d  co n juga te  in 
P A S-gelatin  buffer (40 ng/200 pi) w as added  to  the rem ain ing  g roups co n ta in in g  an ti-p ro g este ro n e  
o r non im m une y-globulin . T he p lates w ere trea ted  as described  fo r E IA  an d  th e  non-specific 
b ind ing  o f  con jugate  o r enzym e w as expressed as a percen tage ( ±  s.d .) o f  the specific b ind ing  seen in 
the presence o f  the high o r  low  concen tra tio n s o f  p rogesterone  in m ilk. C o n ju g a te  b ind ing  to  the 
non im m une y-globulin  w as 4-4 ±  1-2% and  2-15 ±  0-61%  in the  h igh an d  low  sam ples respectively 
and  enzym e b ind ing  to  the specific an tib o d y  w as 6-1 +  1-2% an d  2-5 ±  0-8% .
E IA  drift. R epeated  dup lica te  estim ations (1 -12) were m ade o f  the p rogeste rone  co n cen tra tio n  
in each o f  3 m ilk sam ples a rran g ed  in sequence across a m icro titre  p late. T h e  slopes an d  in tercep ts 
o b ta ined  by least squares regression analysis o f  the p rogeste rone  co n cen tra tio n s  determ ined  (7 ) fo r 
each sam ple aga in s t o rd e r o f  ap p lica tion  to  the  p lates (,v=  1 to  12) w ere com pared  w ith  0 slope 
an d  in tercep t a t the m ean  sam ple co n cen tra tions. A t m eans ±  s.d . o f  2-6 ±  0-13 ng/m l, 
v =  0-015.v +  2-505 (F = 0 -6 1 9 ); a t 7-8 ±  0-4 ng/m l, y  =  0 021.x: +  7-970 (F  =  0-150); an d  a t 
28-4 ±  3-1 ng/m l, y  =  — 0-360* +  30-758 (F  =  1-026). T here  w as no significant difference fo r any  
sam ple.
W ithin- and  betw een-assay precision. M ilk sam ples w ere assayed by E IA  an d  9 sam ples, c o n ta in ­
ing 15-30 ng p rogesterone/m l m ilk, w ere com bined  to  form  a ‘h ig h ’ qua lity  co n tro l. N ine sam ples 
co n ta in in g  5 ng/m l were sim ilarly  com bined  (‘low ’ qua lity  con tro l). E qual volum es o f  the  2 pools 
w ere m ixed to  prov ide a ‘m ed ium ’ qu a lity  co n tro l. T he 3 qu a lity  co n tro ls  w ere assayed in dup lica te  
a t 5 d ifferent positions on each o f  8 m icro titre  p lates d u rin g  the course o f  a rou tine  assay  an d  the 
m ean and  s tan d a rd  dev ia tion  were ca lcu la ted  fo r each  to  allow  the w ith in -assay  coefficient o f  
v a ria tion  to be determ ined  (T able 2). A  m ean  dup lica te  de te rm in a tio n  from  each qu a lity  co n tro l on 
each p la te  w as selected using ran d o m  num bers tab les an d  the m ean  betw een-assay  coefficients o f  
v a ria tion  were calcu la ted  by repeating  the exercise a fu r th e r 4 tim es (T able 2). T h e  betw een-assay  
precision  o f  ca lib ra tio n  curves ob ta in ed  using e ith er m ilk o r  PA S-gelatin  s ta n d a rd s  a re  show n in 
Figs 1(a) an d  1(b), respectively.
Precision o f  R IA
C attle Breeding Centre. T he . assay  w as p erfo rm ed  in batches o f  56 o r  64 tu b es to  allow  
synch ron iza tion  o f  charcoa l ad d itio n  an d  cen trifuga tion . R eplicate  estim ates o f  q u a lity  con tro l 
sam ples assayed in dup lica te  w ith in  each ba tch  (n =  5) o r  betw een batches (n =  8) a llow ed  w ithin- 
and  betw een-batch  precision  to  be calcu lated  (T able  2).
M ilk  M arketing  Board. M ilk  sam ples su bm itted  fo r p reg n an cy  testing in a 1-week period  and
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found  to co n ta in  > 9  ng p rogesterone/m l w ere poo led  to prov ide  a quality  co n tro l sam ple. E ight 
assays, each including 3 qu a lity  co n tro l d e te rm ina tions, were selected using ran d o m  num bers tables 
from  34 assays co n d u c ted  in 1 week an d  the m ean  w ith in-assay  CV was ca lcu la ted  (T able  2). T he 
betw een-assay CV w as ca lcu la ted  from  40 values selected a t ran d o m  from  assays perfo rm ed  d u r in g . 
the sam e period  (T able  2).
Specific ity  o f  E IA  and  R IA  at the C attle Breeding C entre
C ross-reactivity. T h e  cross-reactiv ities o f  various stero ids (dissolved in P A S-gelatin  buffer) w ith  
the an tiserum  (G 7 1 1/12) w ere determ ined  by the c rite ria  o f  A b rah am  (1969) an d  a re  p resen ted  in 
T ab le  3.
Table 3. Specificity o f antisera
Cross-reaction (% )
R IA f E IA f RIAJ
Steroid* atCBC atCBC at M M B
4-Pregnene-3,20-dione 1 00 1 00 1 0 0
4-Androstene-3,20-dione <0-03 004 <0-30
5a-Pregnane-3,20-dione 1-30 2-80 2 -0 0
5p-Pregnane-3,20-dione 6-80 8 -0 0 — §
17-Hydroxy-4-pregnene-3,20-dione 3-60 11-3 0-40
3P-Hydroxy-5-pregnen-20-one 0-05 0-40 1-50
I I  P. 17a,21 -T rihydroxy-4-pregnene-3,20-dione < 0 0 3 0-06 <0-30
11 p,2 l-Dihydroxy-4-pregnene-3,20-dione 1-60 0-80 <0-30
3p-Hydroxy-5-androsten-17-one 0-03 0-03 — §
1 la-Hydroxy-4-pregnene-3,20-dione 75-80 — § 44 00
21-Hydroxy-4-pregnene-3,20-dione - § 5-80 4 00
17p-Hydroxy-4-androsten-3-one - § —§ 0-35
20a-Hydroxy-4-pregnen-3-one - § —§ 0-35
Cross-reactivity is defined as the molar quantity of steroid, relative to progesterone (mol.
progesterone/mol steroid) required to reduce label binding by 50%.
*IU P A C -IU B  (1967) revised tentative rules for steroid nomenclature. 
tAntiserum G711/12.
JAntiserum A F 18/3 (data of Sheldrick, Mitchell &  Flint, 1980).
§Not tested.
Comparison o f  results obtained by direct assay or a fter chrom atographic isolation o f  progesterone. 
T he  m ean +  s.d. recovery o f  the p rogeste rone  trace r a fte r C t8 co lum n ex trac tio n  o f  the  25 m ilk 
sam ples exam ined w as 78-8 ±  4-5% . T he recovery  a fte r  H P L C  an d  redissolving the  p rogeste rone  
frac tion  in PA S-gelatin  buffer w as 52-8 ±  10-4%.
P rogesterone co n cen tra tio n s were determ ined  b o th  before  an d  a fte r  ex trac tio n  an d  purifica tion  
an d  w ere co rrec ted  fo r p rocedu ra l losses. C om p ariso n s o f  results from  E IA  w ith those from  R IA  
before (r =  0-933) and  a fte r (r =  0-969) ex trac tio n  were highly  co rre la ted  an d  the slopes and  
in tercep ts d id  n o t differ significantly  from  1 an d  0 respectively (F igs 3a & 3b). L inear regressions for 
E IA  before and  a fte r ex trac tion  (r =  0-910) an d  R IA  before an d  a fte r  ex trac tio n  (r =  0-952) w ere 
also  n o t significantly  d ifferent from  a line o f  iden tity  (F igs 3c &  3d).
Linearity o f  response. T en m ilk sam ples show n to  co n ta in  p rogeste rone  c o n cen tra tio n s  co n ­
sisten t w ith  the lu teal phase  ( ^ 1 0  ng/m l) by E IA  w ere tak en  a t ran d o m  an d  serially  d ilu ted  w ith 
m ilk from  an  ovariectom ized  cow . T he d ilu ted  sam ples w ere assayed  by b o th  E IA  an d  R IA  an d  
linear regressions w ere ca lcu la ted  fo r each set o f  results ag a in s t d ilu tio n . C o rre la tio n  coefficients
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Fig. 3. Linear regression o f  progesterone concentrations in milk determ ined by EIA  and RIA 
(a) before and (b) after extraction and isolation by H PLC  and (c) by EIA and (d) R IA  both
before and after extraction and purification by H P L C . —= line o f  regression,- - - - = line
o f identity.
fell w ithin the  range r  = 0-984-0 -999  fo r the R IA  an d  r  =  0-946-0-997 fo r the EIA . C o rre la tion  
coefficients a fte r linear regression  o f  the results from  E IA  on  those  o b ta ined  by R IA  w ere in the 
range r =  0-946-0-998. F o r  6 o f  the d ilu tion  series, analysis o f  the F -ra tio  show ed no  significant 
dev ia tion  from  slope =  1 an d  in te rcep t =  0. S ignificant differences w ere found  in 4 o f  the series (Fig. 
4) a lth o u g h  g o o d  co rre la tio n s w ere still exhibited  (r =  0-967-0-997).
A naly tica l recovery o f  progesterone added to m ilk  sam ples. P rogesterone w as added  to  m ilk 
sam ples taken  from  6 d ifferent cow s d u rin g  the oestrous period  (endogenous progesterone  
<  1 -0 ng/m l by  E IA ), in the m an n er described fo r p rep a rin g  p rogeste rone  s tan d a rd s , to provide 
co n cen tra tio n s  o f  20 ng/m l. T h e  sam ples w ere d ilu ted  in m ilk from  an  ovariectom ized  cow  to 
p rov ide  a  range o f  co n cen tra tio n s  (20, 16, 12, 8, 4 an d  2 ng/m l). T h e  sam ples w ere assayed by E IA  
a n d  R IA  an d  the  m ean  co n cen tra tio n s an d  percen tage  recoveries o f  p rogeste rone  are  show n in 
T ab le  4. L in ea r regression o f  m ean  concen tra tio n s m easured  (y) on  the  values expected (x) gave 
y  =  1-01 Ox — 0-784 an d  y  =  l-026x  — 0-718 fo r E IA  (r =  0-993) an d  R IA  (r =  0-995) respectively.
Pregnancy testing
Com parison o f  R IA  results a t the M ilk  M arke ting  Board and  R IA  and  E IA  results a t the C attle  
Breeding C entre. P rogesterone  co n cen tra tio n s determ ined  in 200 m ilk sam ples by the th ree  p ro ­
cedures show ed som e scattering , p a rticu la rly  w hen h igh values w ere recorded . T h is w as true when
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Fig. 4. Progesterone concentrations determ ined by RIA and EIA in 4 luteal-phase milk samples 
after dilution for which regressions differed significantly from a line o f  identity (------ ).
Table 4. M ean concentration (ng/ml milk) and recovery o f  progesterone added to 
milk samples (n — 6) from oestrous cows
Expected conc. 
of progesterone
EIA C B C R IA
Mean +  s.d.
Recovery
(% ) Mean +  s.d.
Recovery
(%)
2 0 20-6 +  4-5 103 20-9 +  1-0 105
16 14-5 +  3-4 91 14-6 +  0-8 91 .
12 10 4 ±  2-3 87 11-3 +  10 94
8 7-3 + 0-8 91 7-2 +  0-5 90
4 3-3 ±  0-8 83 3-5 ±  0-3 8 8
2 1-8 ± 0 -6 92 1-8  ±  0-1 90
results from  the R IA  o r  E IA  a t the C attle  B reeding C en tre  were com pared  w ith  those  from  the  M ilk 
M ark e tin g  B oard  R IA  (r =  0-890 an d  0-833 respectively; T ab le  6). T he M ilk M ark e tin g  B oard  
used 4-5 ng/m l and  1-0 ng/m l in w hole m ilk an d  fore-m ilk  respectively to  d isc rim ina te  betw een 
sam ples from  p regnan t an d  n o n -p reg n an t an im als a t 22 -26  days a fte r  in sem ina tion . U sing linear 
regression eq ua tions calcu la ted  an d  correc ted  fo r e rro r  in b o th  techniques as described , equ ivalen t 
d iscrim ination  po in ts were determ ined  fo r the  assays a t the C attle  B reeding C en tre  an d  s ta n d a rd  
dev ia tions w ere estab lished  from  their coefficients o f  varia tio n  (T ab le  5). R esults falling w ith in  tw o 
s tan d a rd  dev ia tions o f  the d iscrim inating  p o in t w ere considered  inconclusive. E xclud ing  these, 
129 sam ples w ere classified by the M ilk M arke ting  B oard  R IA  as ind ica ting  p regnancy  an d  63 
non-p regnancy . C onclusions from  the  EIA  results co incided fo r 122 an d  52 sam ples respectively, 
w ith 7 values in each case falling w ith in  tw o s tan d a rd  dev ia tions o f  the d isc rim ina tion  value. 
T he figures from  the R IA  a t the C a ttle  B reeding C en tre  w ere 126 an d  56, w ith 2 an d  5 results in co n ­
clusive. B oth the E IA  an d  the R IA  a t the C a ttle  B reeding C en tre  p ro d u ced  4 results th a t w ere a t
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Table ,5. Regression o f results from EIA and RIA  o f 200 milk samples
r Regression F t
Discrimination 
point + 2 s.d.f
Whole milk («=  168)
EIA on M M B  RIA 0-901 j-=  0-832* +  1-72 13 1 5-46+1-62
EIA on CBC RIA 0-838 y — 0-699* +  3-21 32-8
CBC R IA on M M B  R IA 0-905 v =  1 • i 40.t — 1-63 7-4 3-50 ±  0-69
Fore-milk (« = 32)
EIA on M M B  RIA 0-662 y — 1-579* -  0-555 15-6 1 -0 2  ±  0-31
EIA on CBC RIA 0-768 >• = 1-365* +  0-815 2 0-1
CBC RIA on M M B  RIA 0-901 v =  1023* -  0-286 0-27* 0-74 ± 0  15
All samples (n =  200)
EIA on M M B  RIA 0-890 >• =  0-831*'+ 2-00 15-3
E IA  on CBC RIA 0-833 v =  0-702x +  3-36 38-6
CBC RIA on M M B  RIA 0-908 >>=1-133* -  1-45 8 -2
■(■Calculated for the deviation from a line of identity: *not significantly different 
(P>0-25).
^Calculated from 4-5 ng/ml (whole milk) and 1-0 ng/ml (fore-milk) in the M M B  RIA and 
standard deviations from the mean overall coefficients of variation observed in the 
individual assays (Table 3).
Table 6. Progesterone concentration  (ng/ml) in .milk 
samples subm itted to the M M B for which different 
conclusions were reached on reproductive status
Veterinary
Sample no. M M B  RIA EIA  CBC R IA  examination
81 1-9 ( - ) 11-0 ( +  ) 4-3 ( +  ) Oestrus
i o r 3-0 ( - ) 7-3 ( +  ) 5-1 ( + ) Luteal
145f 0-7 ( - ) 2-1 ( + ) 1-3 ( +  ) —
149f 0-6 ( - ) 1-6 ( +  ) 1-0 (?) Pregnant
154f 3-6 ( +  ) 1-2 (?) 0 ( - ) —
fFore-milk samples
+  =  Luteal-phase or pregnant; — = follicular phase; ? =  
within +  2  s.d. of discriminating level.
variance  w ith conclusions d raw n  from  the M ilk M ark e tin g  B oard  R IA  an d  these are  sum m arized  
in T ab le  6: th ree (N os 145, 149 an d  154) were fore-m ilk  sam ples. V ete rinary  investiga tion  o f  the 5 
ap p a re n t anom alies p rov ided  an  ind ica tion  o f  the  co rrec t conclusion  in 3 cases (T able 6).
C onfirm ation o f  pregnancy test results obtained by  E IA . C alv ing  da tes  w ere ob ta in ed  from  a 
fu rth e r 110 cow s in 4 com m ercia l herds fo r w hich E IA  h ad  been  used fo r p regnancy  testing  a t 24 
days a fte r A I. O f  62 d iagnoses o f  p regnancy , 58 (93-5% ) w ere show n to  be com patib le  w ith sub- 
sequen t calv ing d a ta  assum ing  a gesta tion  length o f  280 ±  10 days (Salisbury  & V anD em ark , 
1961). A ll 46 cow s th o u g h t to  be n o n -p reg n an t calved to  a su b sequen t service.
Discussion
T he m ethod  described  is the first rep o rted  use o f  a lka line  p h o sp h a tase  in a  p rogeste rone  E IA : this 
p rov ided  a m ore sensitive assay th an  use o f  P-galactosidase as prev iously  described  (S auer et a i ,
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1982a). P eroxidase is also well su ited  fo r use as a  label fo r p rogeste rone  E IA  (Joyce, W ilson , R ead 
& R iad -F ahm y , 1978; A rn s tad t & Cleere, 19 8 1; van de W iel & K oops, 1982; M u n ro  & S tabenfe ld t, 
1984; T a llon  et al., 1984) b u t m any o f  the  ch rom ogens used fo r its assay are  know n to be m utagen ic  
o r carcinogenic  (V oogd, van der Stel & Jacobs , 1980) an d  this m ay lim it its a reas  o f  application ."
H om ologous p rogesterone  E l A s are  ad eq u a te  fo r m any  app lica tions (N a k a o  & K aw a ta , 1980; 
A rn stad t & C leere, 1981; F oulkes et al., 1982) b u t a re  o ften  less sensitive th an  R IA . Som e h o m o ­
logous E l A s have good  sensitivity  (see R iad -F ah m y , R ead , Joyce & W alker, 1981); how ever, the 
p rep a ra tio n  o f  enzym e con jugates using a p rogeste rone  derivative  hete ro logous to  th a t used fo r 
p rep a ra tio n  o f  the  im m unogen  has been show n to  im prove perfo rm ance  th ro u g h o u t the  ca lib ra tio n  
curve (G ro s, F lecheux & D ray , 1978; Sauer et al., 1982a; van  de W iel & K o o p s, 1982; M u n ro  & 
S tabenfe ld t, 1984). T he use o f  p rogeste rone  11-g lucuron ide-P -galac tosidase  label w ith  an tise rum  
raised aga in s t p rogesterone  11-hem isuccinate-B SA  p roduced  ca lib ra tio n  curves an  o rd e r  o f  
m agn itude  m ore  sensitive th an  the  hom ologous system  (S auer et al., 1982a). T his p a rtic u la r com ­
b in a tio n  o f  bridges effectively elim inated  bridge recogn ition  w ith a large p ro p o r tio n  o f  an tise ra  
raised aga in s t p rogesterone  11 -hem isucc inate-p ro te in  (M . J. Sauer, P. M . O ’N eill &  J. A . Foulkes, 
unpub lished  d a ta ); this reinforces the conclusions o f  C orrie  e t al. (1982) w ho used the sam e 
co m b in a tio n  in a R IA  w ith  125I-labelled  p rogeste rone  11-g lucuron ide-ty ram ine . T h e  p rogeste rone  
11-g lucu ro n id e -a lk a lin e  p h o sp h a tase  label used here p rov ided  ca lib ra tio n  curves w ith  lim its o f  
de tec tion , m id -po in ts and  precision  values th a t w ere a t least co m p arab le  o r  b e tte r th a n  those  o f  
R IA  (Fig. 1; T ab le  1). T h e  lim its o f  de tec tion  an d  m id -p o in t sensitivities w ere ~ 5 0  tim es b e tte r 
th an  those  o f  the hom ologous E IA  used by C h ang  & E stergreen  (1984) fo r the  d irec t assay  o f  
p rogesterone  in w hole m ilk.
T he presence o f  m ilk has been show n to  cause a significant depression  in an tib o d y -a n tig e n  
b ind ing  an d  sensitivity  in b o th  R IA  (H eap , H o ld sw o rth , G ad sb y , L aing  & W alters , 1976) an d  EIA  
(S auer et al., 1981; C h ang  & E stergreen , 1984) o f  p rogeste rone  an d  in recognition  o f  th is s tan d a rd s  
are  o ften  p repared  in m ilk. Indeed , v a ria tions in non-specific effects betw een sam ples have been 
rep o rted  (H eap  e t al., 1976; P enn ing ton , S p ah r & L odge, 1976; H o ldsw orth  et al., 1979; Stevens, 
L ong & Perry, 1981) a lth o u g h  m any  descrip tions o f  im m unoassays fo r p rogeste rone  have m ade no 
reference to  such an  occurrence. T his p rob lem  w as illu s tra ted  in the p resen t study  w hen 10 sam ples 
show n to  co n ta in  lu tea l-phase  co n cen tra tio n s  o f  p rogeste rone  w ere d ilu ted  w ith m ilk from  an 
ovariectom ized  cow . A ll sam ples show ed linear co rre la tio n s  w ith  d ilu tio n  w hen m easu red  by R IA  
o r E IA  and  w hen these resu lts w ere com pared . F o u r o f  the  sam ples, how ever, show ed significant 
v aria tion  from  a line o f  iden tity  betw een E IA  and  R IA  (F ig . 4), ind ica ting  th a t the sam ple m atrix  
had  affected the co n cen tra tio n  o f  p rogeste rone  perceived by one techn ique o r  the o ther. A  sim ilar 
effect w as no ted  w hen p rogeste rone  w as added  to  6 m ilk sam ples taken  from  cow s a t oestrus. 
A lthough  the m ean  recoveries o f  p rogeste rone  a fte r  fu r th e r d ilu tion  w ith m ilk from  an  o v a ri­
ectom ized cow  w ere close to those  expected  (T able 4), g rea te r v aria tio n  in the recovery  o f  p ro ­
gesterone from  ind iv idual m ilk sam ples w as seen w ith  E IA  th an  w ith  R IA . In  co m p ariso n , C h an g  
& E stergreen (1984) rep o rted  recovery  values betw een 80 an d  88%  bu t a h igh degree o f  variab ility  
(s.d. 26 -7 1 % ). A lthough  co m p arab le  recovery d a ta  fo r R IA  are  scarce o r  lim ited  (H eap  e t a l ,  
1976), recovery ranges have been rep o rted  by  som e lab o ra to rie s  an d  vary  considerab ly , e.g. 
97 -110%  (B ulm an & L am m ing, 1978), 104-126%  (van  de W iel, van  E ld ik , K oops, P o stm a  & 
O ldenb roek , 1978); and  100-136%  (B atra , Pahw a, Suri & P andey , 1980).
A n exp lana tion  for the varia tio n  seen in E IA  in p a rticu la r m ight lie in the com position  o r  
s tru c tu re  o f  m ilk since the label used cou ld  in te rac t w ith  p a rtic u la r m ilk sam ples. T he investiga tion  
o f  non-specific b ind ing  in 16 m ilk sam ples co n ta in in g  h igh o r  low  co n cen tra tio n s o f  p rogeste rone  
show ed no  evidence o f  ind iv idual non-specific b ind ing  effects .and m ean  values o f  2-15%  and  4-4%  
w ere reco rded  in the presence o f  fo llicular- an d  lu tea l-phase  sam ples respectively. E qu ivalen t 
studies w ith R IA  have p roduced  variab le  values as h igh as 20%  (H o ld sw o rth  e t al., 1979; S tevens et 
a l ,  1981).
D ifferences in cross-reactiv ity  betw een R IA  an d  E IA  cou ld  p roduce  sim ilar d iscrepancies in
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values m easured: the occurrence o f  p rogestagens in m ilk has been investigated  by D arling , Laing & 
H arkness (1974) b u t since the oxidative p rocedures em ployed  w ould  only allow  b road  classification  
the influence o f  specific stero id s is h a rd  to  discern. C ross-reactiv ity  studies were conduc ted  using 
the criteria  o f  A b rah am  (1969) bu t no large differences were found  betw een EIA  and  R IA  (T able 3) 
a lthough  V an W eem an & Schuurs (1975) and  V an W eem an, Bosch, D aw son , V an Hell & Schuurs 
(1978) have show n th a t the use o f  he te ro logous assay system s can increase cross-reactiv ity . Steric 
considera tions, how ever, suggest th a t this is less likely to  occur w hen the hetero logy  involves the 
bridge itself ra th e r th an  the site o f  a ttach m en t o f  the b ridge to  the stero id . D arling  et al. (1974) and  
P urdy , D urocher, M oore  & R ao  (1980) show ed th a t 5a- an d  5J3-pregnanediones occur in m ilk b u t it 
is the suggested presence o f  p rogestagen  con jugates (H eap , H enville & Linzell, 1975) th a t shou ld  
give rise to concern  since these are  n o t defined and  were n o t tested . T he ir p reponderance  in the 
aq u eo u s phase o f  m ilk w ou ld  enhance  the ir in te rac tio n  w ith  the an tib o d y  in com parison  w ith 
p rogesterone  and  their g rea te r availab ility  w ould  be accen tu a ted  by the non-equ ilib rium  n a tu re  o f  
EIA  (Sauer et a l.r 1982a; M orino , N ak ao , T su n o d a  & K aw ata , 1984; M unro  & S tabenfe ld t, 1984); 
the  im portance  o f  the ‘first-com e, first-served’ p rincip le  (P ra tt & W oldring , 1976) in 
non-equ ilib rium  R IA  an d  E IA  has been dem o n s tra ted  by a n um ber o f  o th e r investigators (V an 
W eem an e ta l .,  1978; V ining, C o m p to n  & M cG inley , 1981).
W ith  these co n sidera tions in m ind , it w as necessary to  d em o n s tra te  th a t p rogesterone  w as the 
m ilk co m p o n en t being m easured  by EIA . A fter co rrec tion  fo r p ro ced u ra l losses, p rogesterone  
concen tra tio n s determ ined  in 25 m ilk sam ples before an d  a fte r  ex trac tio n  an d  iso la tion  by H P L C  
were highly co rre la ted  fo r b o th  E IA  an d  R IA  (r =  0-910 an d  0-952: F igs 3c & 3d). In  ad d itio n , 
results from  the tw o techniques w ere closely co rre la ted  before (F ig . 3a; r =  0-933) an d  afte r (F ig . 3b; 
r  =  0-969) ex trac tio n  and , m ost im p o rtan tly , none o f  the regressions differed significantly  from  a 
line o f  iden tity , ind ica ting  th a t p rogesterone  w as the m a jo r co m p o n en t in m ilk m easured  by bo th  
R IA  an d  EIA .
T he use o f  m icro titre  p lates to  p rov ide b o th  a so lid -phase  su p p o r t fo r the an tib o d y  an d  a vessel 
to  co n ta in  the assay g reatly  facilitates its ap p lica tion  in unsoph istica ted  labo ra to ries . P revious 
studies (K ricka  et al., 1980) have fo und  evidence for v a ria tio n  in th e  ad so rp tio n  o f  an tib o d y  to 
p lates (CV =  5-2-30% ). A lth o u g h  sim ilar p rob lem s w ere o rig inally  enco u n te red  w ith b o th  po ly­
vinyl and  polystyrene p la tes in this lab o ra to ry , the use o f  p la tes specifically m an u fac tu red  for 
im m unoassay  an d  a tte n tio n  to de ta il in ensu ring  a stab le  en v iro n m en t d u rin g  an tib o d y  co a tin g  and  
in cu b a tio n  resulted  in accep tab le  precision  (CV  =  5-1% ). In  p a rticu la r, no  evidence w as seen o f  
p referen tia l b ind ing  to  wells a t the edge o f  the p la te  (see K ricka  et al., 1980). T he w ith in- and  
betw een-assay  precision  o f  E IA  w ere 12-5 an d  14-8% respectively an d  com pared  fav o u rab ly  w ith 
values fo r R IA  b o th  in th is study  (T able 2) an d  o thers  (H eap  e t al., 1976; H o ldsw orth  et al., 1979; 
van de W iel, K alis & S hah , 1979; B atra  et al., 1980). B ulm an & L am m ing  (1978), how ever, have 
given deta ils  o f  an  R IA  w ith  g rea te r precision  (CV s =  8-9%  and  10-3% ).
I f  s tan d a rd s  an d  40 sam ples are  assayed in d up lica te  on  a m icro titre  p la te , a b o u t 15 m in will 
elapse betw een in tro d u c tio n  o f  the  first sam ple and  ad d itio n  o f  the con jugate . M u n ro  & S tabenfeld t 
(1984), using 50 pi an tib o d y  per well to co a t the p la te  an d  50 pi sam ple, fo und  th a t  this resulted  in a 
system atic  v a ria tio n  in the value determ ined  fo r a sam ple depend ing  on the tim e o f  ad d itio n  to  the 
p la te  (‘d r if t’), p resum ably  because the earlier the ad d itio n  the  g rea te r the tim e fo r con tac t betw een 
the sam ple an d  an tibody . Since the m icro titre  p la te  E IA s described  d o  n o t a tta in  equilib rium  
(S auer et al., 1982a; M u n ro  & S tabenfe ld t, 1984) this p resen ts a p o ten tia l source  o f  e rro r. T he use 
o f  200 pi o f  a n tib o d y  to  co a t the p la te  an d  only 10 pi o f  the sam ple a p p a ren tly  preven ted  d rift in the 
p resen t app lica tion .
T h e  co m b in a tio n  o f  precision  an d  specificity d em o n s tra ted  fo r th is E IA  allow s a ready  distinc­
tion  to  be m ade  betw een lu teal- an d  fo llicu lar-phase co n cen tra tio n s  o f  p rogeste rone  in w hole milk 
from  dairy  cow s. T his w as illu stra ted  by the results ob ta in ed  by assay o f  m ilk sam ples taken  fo r 
pregnancy  testing  22-26  days a fte r service, a lth o u g h  the co rre la tio n s betw een resu lts  from  R IA  and  
E IA  fo r sam ples o b ta in ed  from  the  M ilk M ark e tin g  B oard  w ere low er ( r  — 0-890 fo r the M M B  R IA
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an d  r = 0-833 fo r the  C B C  R IA ) th an  those seen w hen 25 m ilk sam ples w ere assayed a t the C attle  
B reeding C en tre  a lone  ( r = 0-933; Fig. 3a) as p a rt o f  the valida tion  study . T h e  delay  in re-assaying 
sam ples m ay have allow ed changes in the s tru c tu re  o f  m ilk to  occur th a t affected the perfo rm ance  
o f  the EIA  m ore th an  the R IA . Som e evidence is availab le  fo r this since freshly p repared  milk 
s tan d a rd s  reduce b ind ing  in the ca lib ra tio n  curve percep tib ly  m ore than  s tan d a rd s  p repared  1 m on th  
previously  (unpub lished  observations). T his is a difficult phenom enon  to  investigate since it w ould 
require  th a t new stan d a rd s  be p repared  from  a fresh b a tch  o f  m ilk  w hose co m p o sitio n  m ay differ 
from  the orig inal and  thus no ab so lu te  co n tro l is availab le  fo r the ageing process. Since m ilk 
sam ples subm itted  fo r assay will usually  be o f  recen t o rig in  it m ay  be a wise p recau tio n  to  renew  
m ilk s tan d a rd s  a t least a t m on th ly  in tervals. T his ap p a re n t difficulty d id  n o t, how ever, p reven t a 
high degree o f  co rrespondence  betw een the  conclusions d raw n  from  the various assays. Such 
d isparities as there  w ere revolved a ro u n d  sam ples show ing  concen tra tio n s o f  p rogeste rone  n ea r the 
d isc rim ina tion  po in ts  o f  the assays so th a t one o r  o th e r  test w as inconclusive. O nly  5 sam ples 
(T ab le  6) p roduced  results fo r w hich the deduc tions from  the assays differed an d  3 o f  these were 
fore-m ilk  sam ples w hich have previously  been show n to  p roduce  results th a t m ay  be variab le  in 
som e c ircum stances (H o ldsw orth , B oo th , S h arm an  & R a ttray , 1980). E IA  o f  one o f  the tw o w hole 
m ilk sam ples (N o . 81) p roduced  a value consisten t w ith the luteal phase  an d  w as from  a cow  in 
w hich the  occurrence o f  b ehav iou ra l oestru s w as confirm ed  by the veterinary  su rgeon . R ectal 
p a lp a tio n  ind ica ted  th a t the o th e r sam ple (N o . 108) w as correc tly  identified  by E IA  an d  R IA  a t 
the  C attle  B reeding C en tre  as being from  a cow  in the lu teal phase. A n earlier ho m o lo g o u s E IA  
techn ique recorded  a p ro p o r tio n  o f  results re lating  to  the fo llicu lar phase  o f  o estrous cycles fo r 
w hich p rogeste rone  co n cen tra tio n s w ere h igher th an  expected  (F ou lkes et al., 1982). I t rem ains 
possib le th a t the single real d iscrepancy  (N o . 81) in th is stu d y  rep resen ts a sim ilar occurrence. 
C alv ing  d a ta , how ever, ob ta in ed  from  a fu rth e r 110 cow s in 4 com m ercial herds, o f  w hich 62 
w ere determ ined  as p ro duc ing  a  positive test resu lt by E IA , show ed no evidence o f  this 
phenom enon . T he 4 cow s th a t d id  n o t calve to  the expected  insem ination  re tu rn ed  to  service and  
w ere re-insem inated  31, 113, 160 an d  161 days la ter. N o n e  o f  these in tervals is co m p a tib le  w ith  a 
single cycle occurring  a fte r service an d  it is suggested th a t the lu teal phase  w as p ro lo n g ed  in each 
o f  these cow s. Sim ilarly, no  unexpected ly  h igh values w ere seen d u rin g  the  fo llicu lar phase  in a 
separa te  study  (W ilson, P arker, F ou lkes & Sauer, 1985) in w hich o estrous cycles o f  29 cow s w ere 
m o n ito red  by E IA  o f  m ilk sam ples taken  each day . C alv ing  d a ta  from  the 46 cow s show n to  be 
n o n -p reg n an t by E IA  o f  m ilk tak en  24 days a fte r  in sem ina tion  in this study  ind ica ted  th a t none  had  
conceived to  th a t service.
In conclusion , this E IA  fo r p ro geste rone  has been show n to  rival R IA  in precision  an d  sen ­
sitivity. Its sim plicity , cheapness an d  safety  will allow  p ractica l expression  o f  the detailed  
know ledge o f  bovine rep roductive  physio logy, acqu ired  th ro u g h  stud ies em ploy ing  R IA , by 
m aking  a technique availab le  to  lab o ra to rie s  w ith lim ited  equ ipm en t. T he use o f  m icro titre  p la tes 
perm its large num bers o f  sam ples to  be exam ined  if requ ired  an d  a u to m a tio n  o f  b o th  sam ple  and  
d a ta  hand ling  if necessary. T he co lo rim etric  n a tu re  o f  the test allow s a visual en d p o in t, w ith  high 
and  low  con cen tra tio n s read ily  d is tingu ished . R ecent a d a p ta tio n s  have p rov ided  tests th a t m ay  be 
perfo rm ed  in less than  I h. T hey  have been successfully used by veterinary  su rgeons an d  farm ers 
(B. D rew  & J. A. F oulkes, unpub lished  observations) and  such w idespread  availab ility  p rom ises 
g rea t econom ic benefit.
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p rov id ing  m ilk sam ples; D r I. F o rsy th , N a tio n a l In s titu te  fo r R esearch in D airy ing , Shinfield, 
fo r use o f  iso tope co un ting  facilities an d  D r G . S. Pope fo r advice an d  encou ragem en t th ro u g h o u t 
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